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I - INTRODUCTION
A – Combinatorial libraries for affinity selection of novel ligands
Protein-ligand interactions form the basis of almost all cellular functions. All
processes, in living organisms, are tightly controlled by highly specific interactions between
biological macromolecules. The identification of disease relevant target molecules, and the
selection and optimization of specific ligands, is therefore a focus of much of current
biochemical research, and a prerequisite for most pharmaceutical applications. Various
approaches have been developed during recent years, to improve our understanding of the
principles governing molecular interactions.
A conventional method, the so-called ”rational design”, is performed by computer
modeling of molecular structure, prediction of three dimensional alterations which may
follow on individual amino acid exchanges. This is followed by construction of the
corresponding DNA and expression of the recombinant protein for testing and evaluation.
This approach seeks to design proteins for specific tasks by drawing correlations between
amino acid sequence and specific folding in an attempt to understand a complex system,
through its topography. However, this technique is limited by several factors. Among them,
the knowledge about the structure/function of most proteins or molecules within the cell is not
sufficient. There is a poor correlation between in vitro results, and the computer predictions,
due to the complexity of parameters involved. Another main difficulty is the astronomical
number of relevant mutants which might be designed, in order to optimize a given function
(Pisabarro and Serrano, 1996).
In contrast to rational design procedures, nature employs mutations, and selections to
evolve highly adapted individuals. Recent technological advances have demonstrated that it is
possible to mimic these natural evolutionary processes. Current trends in the search for novel
pharmaceutical agents have focused on generating combinatorial libraries as large as 1012
molecules, using in vitro evolution techniques. Combinatorial libraries are a very powerful
tool to identify highly specific and affine binders to particular targets. Repeated rounds of
screening and amplification of candidates, have produced novel molecules capable of binding
their targets with higher affinity than their natural counterparts. The main limitation of these
libraries, is their low complexity. The greater the diversity of a bank, the more likely it will
contain a ligand with optimized properties to interact with a given molecule. Therefore,
increasing numbers of researchers devote their work to enhance the in vitro evolution
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processes, and thus, the diversity of the library. Several approaches, which will be discussed
in more details later, have been successfully developed to create mutations, such as error
prone PCR, or directed mutagenesis. However, the use of recombination, with or without
somatic mutagenesis, mimics further the evolutionary process in natural systems, and
generates additional diversity. Using these techniques (chain shuffling, DNA shuffling, and
cosmix-plexing), one can generate reassortment between mutagenized regions and
accumulate modifications over larger areas in complex proteins.
Different sorts of combinatorial libraries are in use, which can be composed either of
synthetic or biosynthetic molecules. Several of these libraries are briefly described in this
work. However, the most powerful of these systems, the phage display libraries, with respect
to the size of the banks, the range of applications, or the possibility to reproduce the natural
evolution, will be discussed in more details.
1- Combinatorial chemistry libraries
During the last few years, a variety of methodologies have been developed that permit
simultaneous synthesis of multiple peptides. It is thus possible to generate the large number of
different sequences required for a library. The generation of molecular diversity using
strategies that covalently connect together members of a set of chemical building blocks, in
all possible combinations, represents a revolution in multiple synthesis (for a review on
multiple peptide synthesis, see Fields et al., 1990). The applications of these peptide libraries
include investigating protein/protein (Kramer and Schneider-Mergener, 1995; Reineke et al.,
1998), protein/DNA (Kramer et al., 1993; Reuter et al., 1999), and protein/metal interactions
(Malin et al., 1995). In addition, substrate specificities of kinases (Toomik et al., 1996; Tegge
et al., 1998; Mukhija et al., 1998), proteases (Duan and Laursen, 1994), and chaperones
(Rüdiger et al., 1997) can be investigated.
The problem of finding peptide ligands that bind to monoclonal antibodies which
recognize discontinuous epitopes within a protein antigen was first approached by Geysen
using a combinatorial synthesis procedure referred to as  the “mimotope strategy” (Geysen et
al., 1986). In this strategy, peptide mixtures are synthesized in the format: XXXO1O2XXX,
where positions O1 and O2 are defined amino acids, while the X positions are randomized.
400 sets of peptides of this form are generated, in order to ensure the presence of all possible
O1O2 combinations within the peptides. The preferred set for a given target, is defined (for
example by ELISA), and used as a starting point for the creation of the next subset of
libraries, of the form XXO3D1D2O4XX, where D1 and D2 are the positions previously defined,
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and which are now kept constant. O3 and O4 are their direct flanking positions, and are
presently scanned: all possible combinations are prepared on these positions. These cycles of
synthesis and screening are reiterated until the entire sequence is optimized, and the resulting
peptide is termed a “mimotope” (for epitope mimetic) for the target.
This strategy has been modified by Dooley and Houghten, in order to avoid the time
consuming resynthesis of the sub-libraries. For this purpose, a moderate number of very large
synthetic libraries are generated, by introducing only one defined position, and coupling at all
other positions, mixtures of the building blocks (O1XXXXX; XO1XXXX; XXO1XXX...). The
different pools are subjected for testing for the library which gives the strongest response. The
optimized peptide for a particular target is obtained by aligning the defined positions of the
best libraries isolated (Dooley and Houghten, 1993).
Frank et al. (1995), proposed a modified strategy of the previous one, using a larger
number of pools, each consisting of a smaller component. The pools are designed in such a
way that two positions are defined, whereas the other ones are randomized (O1O2XXXX;
XO1O2XXX; XXO1O2XX...). Matching the overlaps of these dipeptide sequence  preferences
for a particular target, permits to conceive the optimized sequence for this target.
The different synthetic methods can adopt the preferred combinatorial strategies. One
of these methods, the SPOT method, developed by Ronald Frank, presents a strong advantage
in its ease to manipulate. The Spot synthesis is a flexible technique for simultaneous, parallel
chemical synthesis on membrane supports (Frank, 1992). The synthesis areas (spots) are
defined on a cellulose membrane, by spotting a Fmoc-β-alanine-pentafluorophenyl ester
solution. Routinely, peptides up to a length of 20 residues can be synthesized with sufficient
fidelity. The peptides can be used for binding assays directly on the membrane, or cleaved
from the solid support, for use in solution (for a review, see Reineke et al., 1999). The
analysis between the peptides immobilized on the membrane, and the target of interest, is
done in a Western blot-like manner. Positions at which the target was detected can be directly
used to determine the sequence of the peptides with affinity for the target.
The combinatorial chemistry libraries were shown to be successful in epitope
mapping, and in defining T-cell epitopes. However, the size of the libraries are at the limits of
the technology with  a diversity of approximately 108 variant molecules per ml. Furthermore,
once a library has been used to check for peptides with particular features for a given target, it
is not possible to reuse it. New libraries have to be generated for further work with the target
of interest. In addition, new libraries are required for each target that has to be tested. This is
time consuming, and increases the costs of the analysis.
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2- Yeast two hybrid system
The two hybrid system is designed to detect and study protein-protein interactions in
vivo. The basic strategy of the two hybrid system is the modular architecture of a group of
eukaryotic transcription factors, of which the yeast GAL4 transcription factor is the prototype.
These factors consist of a DNA binding domain which confers specificity for a given
promoter sequence, and an activation domain that interacts and activates the transcription
machinery.
The DNA binding domain binds DNA in a sequence specific manner, but fails to
activate transcription. The activation domain cannot activate transcription on its own, as it is
not sufficient to localize and bind the DNA of interest.
The two hybrid system offers advantages to study protein-protein interactions, since it
is possible to bridge the two domains through a secondary interaction, without disrupting their
function (Ma and Ptashne, 1987). Two hybrid proteins, each containing one of two interacting
proteins, fused with the DNA binding domain, or with the activation domain of the GAL4
transcription factor (as instance), can be created. When the two interacting proteins make a
contact, the two domains of the GAL4 are brought together, and their function is restored
(Fields and Song, 1989; for a review about new hybrid technologies: Kolanus, 1999). It is
then possible to discriminate which hybrid interacts, using the expression of a reporter gene
product as signal.
The main drawback of the two hybrid system is that this method found applications
only when potential binders for a target are known. Then, the technique can be used to check
for this interaction, or to search for optimized binding peptides, by fusing to one domain of
the transcription factor, peptides with modified positions. Then, it is possible to screen for the
altered peptide which shows the best binding characteristics for the target. It has the
advantage for the analysis of intracellular peptides and proteins in that they are produced with
the correct folding, in this system.
3- Ribosome display
An in vitro system based on the display of nascent peptides in ribosome complexes has
been developed to circumvent the limitation in library diversity faced by peptide libraries.
Mattheakis and coworkers obtained successful results with this technique. They constructed a
molecular DNA library encoding 1012 decapeptides, and expressed the library in an E.coli S30
in vitro coupled transcription/translation system. Conditions were chosen to ensure that the
poly-ribosomes containing nascent peptides remained attached to their encoding mRNA.
Introduction
5
Therefore, when a complex shows good affinity for a target, the RNA can be recovered from
the bound complex, and converted into cDNA. The cDNA from the enriched pool of
ribosomes (after several rounds of screening), has then to be cloned into a phagemid vector.
This vector serves as both a peptide expression vector, and as a DNA sequencing vector, for
peptide identification. By expressing the ribosome derived peptides on phage, one can either
continue the affinity selection procedure in this format, or assay the peptides on individual
clones for binding activity in a phage ELISA test (Mattheakis, et al., 1994). For a recent
review about ribosome display, one can refer to Hanes and Plückthun (1999).
Szostak developed a new strategy to use ribosome display, where a stable linkage
between the informational (mRNA) and the functional (encoding peptide) domains of the
resulting joint molecules is established (Roberts and Szostak, 1997; Nemoto et al., 1997). A
covalent fusion between an mRNA and the peptide that it encodes, is generated by in vitro
translation of synthetic mRNAs that carry puromycin, a peptidyl acceptor antibiotic, at their
3´ end. The recycling is performed via error prone PCR, which introduces further mutations.
The advantage of this technique, is the large number of variants obtained. In addition, it
allows a specific mRNA to be enriched from a complex mixture of mRNAs based on the
properties of its encoded peptide. The drawbacks are that the initial binding kinetics are very
poor, and that there is a low enrichment rate per round.
4- Bacterial surface display
Several systems have been described for the bacterial display of antibody fragments
(see Georgiou et al., 1997, for a review). The cell envelope of E.coli and other Gram-negative
bacteria consists of the inner membrane, the peptidoglycan cell wall, and the outer membrane.
Although the outer membrane serves as a barrier to protein secretion, Francisco and
coworkers constructed a chimeric targeting sequence that directs fused proteins to the cell
surface. The chimeric targeting sequence consists of the leader peptide and first 9 amino acids
of the E.coli major outer membrane lipoprotein, and amino acids 46-159 of the outer
membrane protein OmpA (Francisco et al., 1993). The function of the lipoprotein is to direct
the chimera to the outer membrane. The OmpA region transverses the membrane, bringing
the fusion protein on the cell’s exterior. Lipoprotein fusions (without partial OmpA) was
found to be detrimental for the integrity of the cell envelope, caused extensive cell lysis, and
was tethered to the interior face of the outer membrane, and thus, not exposed to the
extracellular fluid. These problems were addressed by using the OmpA in correlation with the
lipoprotein.
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In the pAP system, Fuchs et al., expressed a scFv as fusion protein with the
peptidoglycan-associated-lipoprotein (Fuchs et al., 1996). This fusion protein binds strongly
to the cell wall, and is displayed by the bacteria.
The ability of the fused protein to bind to the target of interest can be determined with
methods such as ELISA. However, screening of the cell surface displayed libraries is faster
and more efficient when using fluorescence activated cell sorting (FACS). The libraries are
incubated with the fluorescently-labeled target molecule. No elution step is required, ruling
out some possible complications, including nonspecific binding to the support material, or
inability to elute the very tightly binding clones. Cell sorting provides two distinct
advantages. In principle, a bacterial display system might provide a high enrichment factor of
positive clones, since it is possible to select one bacterium stained with a fluorescently labeled
antigen, from 1000 to 10000 unstained bacteria, after only one passage through a FACS. The
second benefit of the FACS, is the ability to discriminate directly between binders of different
affinity and specificity. It has been shown that mean fluorescence intensity of cells displaying
the fusion proteins varies proportionally to the antigen affinity for the chimeric protein.
Libraries are propagated by growing the cells in liquid cultures. Selected clones are
purified and amplified in one step by plating on agar.
However, the bacterial display has severe limitations. First, the cell surfaces are very
complex. Then, the size of the library is restricted to 105 clones, due to limitation of the
transformation efficiency. In addition, only secreted peptides or proteins can be presented.
Furthermore, it appears with the peptidoglycan-associated-lipoprotein system, that large
proteins, along with, small ones, cannot be used as antigens. Large antigens are unsuitable due
to their limited accessibility for the system, whereas small proteins bind unspecifically,
probably depending on their charge or hydrophobic character. In the lipoprotein-OmpA
system, restrictions occur, as the amount of surface expressed fusion protein was reported to
be critical for viability. Moreover, the relatively large number of antibodies per cell (50 000 to
100 000 copies) present in both systems, might be an inconvenient. The polyvalent
presentation might lead to avidity problems, and prevent the isolation of clones with high
affinity for the target molecules.
B – Phage display
Phage display technology represents a system in which filamentous bacteriophage
display proteins or peptides on their surface. The resulting libraries exhibit an enormous
Introduction
7
molecular diversity, and are used as a huge source of sequences to select for molecules
possessing the essential structure(s) to bind a particular target. Thus, this method is
particularly convenient to understand protein-protein interactions, and structure-function
relationships.
To facilitate a discussion of how the variant proteins or peptides are efficiently
expressed on the bacteriophage surface, a description of the biology of the bacteriophage is
presented.
1- Life cycle of bacteriophage
1-1 The Ff bacteriophage particle
Filamentous phage are virus particles able to infect a variety of gram negative bacteria,
using pili as receptors. They are temperate phage living in symbiosis with their host cell,
continuously producing phage particles, without lysing the host. The best characterized of
these phage are M13, fl, and Fd, which infect Escherichia coli containing the F conjugative
plasmid. Because of their similarity (Van Wezenbeek et al., 1980; Beck and Zink, 1981; Hill
and Petersen, 1982), and their dependence on the F plasmid for infection, M13, fl, and Fd are
collectively referred to as the Ff phage.
The Ff phage genome has 9 genes which encode for 11 proteins. The genes are
grouped on the DNA according to their functions in the life cycle of the bacteriophage. Three
sets are distinguished, which respectively encode for DNA replication proteins (pII, pV, and
pX), capsid proteins (pIII, pVI, pVII, pVIII, and pIX), and for proteins involved in the
membrane associated assembly of the phage (pI, pIV, and pXI). A short stretch of DNA,
called “intergenic region”, contains the site of origin for the synthesis of the viral and
complementary DNA strands (+/-), as well as a hairpin region which is the site of initiation
for the assembly of the phage particles (packaging signal) (Webster, 1996).
Ff phage have a single stranded, covalently closed DNA genome (6407 nucleotides)
which is encased in a long cylinder approximately 7 nm wide by 900 to 2000 nm in length.
This flexible cylinder is composed of many copies of the major coat protein (pVIII ca. 2700
units), with several minor proteins (pIII, pVI, pVII, and pIX), located on the extremities. One
end of the particle contains about 5 molecules each of pVII and pIX. The DNA is oriented
within the virion with the packaging signal located at the pVII and pIX end of the particle. It
is suggested that only pIX is exposed at the end of the particle, and pVII is buried.
At the other end of the particle, about 5 copies each of pIII and pVI are present. The
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amino-terminal portion of pIII is required for the infection process. It is proposed that the
hydrophobic amino terminus of pVI is buried within the particle. The observation that phage
particles containing foreign proteins fused to the carboxyl end of pVI can be produced would
argue that the carboxyl terminus of pVI is very near the surface of the virion (e.g. pDONG61
vectors; Jesper et al., 1995).
The pVII and pIX proteins are required for efficient particle assembly, while pVI and
pIII are crucial for particle stability and phage infectivity.
1-2 The infection process
Infection of E.coli by the Ff phage is initiated by the specific interaction of pIII with
the tip of the F conjugative pilus. pIII is sufficient to mediate the phage infection, and has,
therefore, been intensively studied (Holliger and Riechmann, 1997), to help the understanding
of the infective process. The pIII protein is divided into three domains separated by glycine-
rich regions. It contains a short C-terminal transmembrane segment (figure I-1). The N-
terminal domain (D1) is thought to be responsible for membrane penetration, the middle
domain (D2) for adsorption to the F-pilus tip, and the C-terminal domain (D3) for anchoring
the pIII in the phage particle.
   pIII      pIV
          D2 (86-216)
  D1 (1-66)        D3 (257-377)  (378-406)
    N-ter
Membrane                Adsorption         Incorporation   Membrane
           penetration             to F-pili        into phage coat      anchor
Figure I-1: The minor coat protein pIII of Ff phage. Schematic organization and sequence
localization of domains. The numbers refer to the amino acid contained by each domain
(Holliger and Riechmann, 1997).
The F pilus consists of a protein tube made up of pilin subunits which are assembled
and disassembled by a polymerisation and depolymerisation process in the bacterial inner
membrane. Pilus retraction (by depolymerisation) draws the donor and recipient bacteria
together: the end of the phage attached to the F pilus, is brought to the membrane surface. The
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major capsid proteins (pVIII) integrate into the inner membrane, and the phage DNA is
translocated into the cytoplasm. The translocation event requires the product of the tolQRA
genes. The tolQRA proteins are located in the inner membrane. They may form a complex
which can communicate between the inner and outer membranes. One of the normal functions
of these Tol proteins may be to maintain the integrity of the outer membrane, to avoid a leak
of periplasmic proteins into the media.
              OM
              periplasm                 F pilus
              IM
              cytoplasm
                                                    ssDNA phage
        RF
            Protein
            expression
          DNA
                     replication          pII  pV
            ssDNA 
       pII directs     
     the formation of ssDNA
      pV
              sequesters
           ssDNA                         the ssDNA
      Assembly
      RF
Figure I-2: Schematic representation of the life cycle of the Ff bacteriophage. The phage
particle enters the host cell through the F pilus, and is translocated into the cytoplasm.
Bacterial enzymes synthesize the complementary strand (replicative form: RF). The RF
molecule serves as template for transcription, and translation of the phage proteins. pII and
bacterial enzymes direct the synthesis of single-stranded phage DNA. The newly synthezised
single-stranded DNA either is converted to another RF DNA by host enzymes, or, when pV
phage protein reaches the proper concentration, is sequestered into a complex which is
assembled into new phage particles. The phage are released into the media. OM and IM, outer
and inner membrane; RF, supercoiled double-stranded replicative form DNA; pII and pV,
products of phage genes II and V, respectively (adapted from Webster, 1996).
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After the phage DNA translocation, bacterial enzymes convert the infecting single-
stranded phage DNA into a supercoiled, double stranded replicative form (RF) molecule
(figure I-2). pII binds and introduces a specific cleavage on the (+) strand of the RF molecule.
The resulting 3’ end is used by the host enzymes as a primer in order to synthesize a new (+)
strand which is converted in a new RF DNA by bacterial enzymes. pX is crucial for the
proper replication of the phage DNA, and functions in part as an inhibitor of pII function
(Fulford and Model, 1984). All phage proteins are synthesized from the RF molecule, and
their production increases with the accumulation of the RF molecules. Phage proteins
involved in the assembly of the particle become integrated into the cell envelope while
proteins involved in DNA replication remain in the cytoplasm.
When the pV (phage specific single-stranded DNA binding protein) reaches the proper
concentration, it sequesters into a complex, the newly synthesized phage single-stranded
DNA, obtained due to a specific cleavage on the (+) strand of the RF molecule, directed by
pII. pV binding prevents the conversion of the newly synthesized single-stranded DNA to RF.
The pV/DNA interaction give a structure of approximately 880 nm long, and 8 nm in
diameter, containing one (+) strand, and around 800 pV dimers. The packaging signal is at
one end of this structure, available for the initiation of phage assembly (Model and Russel,
1988).
1-3 The assembly process
The assembly process occurs at the bacterial envelope, at a site where the inner and
outer membranes are in close contact. Interaction of the pV-phage DNA complex with
proteins in the assembly site is the initiating event for assembly of the particle. Assembly
proteins pI, pIV, and pXI are required for phage assembly, but are not present in the phage
particle. pI monomers interact in the membrane to allow the transmembrane regions to form a
channel through the cytoplasmic membrane. Like pI, pXI spans the membrane. pIV is
secreted across the cytoplasmic membrane, and then, integrates into the outer membrane as an
oligomer (10 to 12 pIV monomers). pIV oligomers form a large exit pore in the outer
membrane through which the assembled phage particle can pass. However, in the absence of
phage assembly, it may act as a gate to maintain the integrity of the membrane.
Assembly is a progressive process in which the pV dimers are displaced from, and the
appropriate capsid protein added to, the DNA as it is extruded through the bacterial envelope
into the media. Assembly continues until the end of the DNA is reached and the phage is
released into the media. Throughout this whole process, the membrane must retain its
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integrity, as the bacteria continues to grow and divide. The assembly process is divided in 3
parts: initiation, elongation and termination.
Initiation: The substrate for the assembly process is the pV-phage DNA complex. An
interaction between the packaging signal and the cytoplasmic domain of pI may initiate
assembly. A hypothesis is that pI is able to direct an orderly assembly of pVII, pIX, and pVIII
around the packaging signal to form the tip of the particle.
Elongation: The phage is elongated by the processive set of reactions which removes
the pV dimers from the phage DNA and replaces them with pVIII as the DNA is extruded
through the membrane. These reactions are probably catalyzed by the cytoplasmic portion of
pI, and may require ATP hydrolysis. Assembly needs the presence of reduced thioredoxin.
Termination: When the end of the DNA is reached, assembly is terminated by the
addition of pVI and pIII.
It is not known whether an assembly site can be used for the synthesis of more than
one particle. If only one particle can be assembled in one site, the initiation might be expected
to be one of the rate-limiting steps in phage assembly.
The assembly process is tolerated quite well by the host, as the infected bacteria
continue to grow and divide with a generation time approximately 50% longer than for an
uninfected bacteria. About 1000 phage are produced during the first generation following
infection, after which the host produces approximately 100-200 phage per generation. Turbid
plaques can be visualized in overlay lawns of E.coli, due to the reduced maximal growth of
the host cells where phage are produced. Plaques are of varying size and contain around 108
infective phage particles (Model and Russel, 1988).
2- Principle of phage display
The membrane-associated assembly of filamentous phage has made them a valuable
tool in biological research. The apparent flexibility of the assembly process has led to an
impressive array of applications for the use of phage display, where the bacteriophage is used
as cloning vehicle. The presence of  single-stranded DNA in the particles, allowed a simple
and clean substrate for DNA sequencing.
By insertion of coding regions into genes encoding specific phage capsid proteins,
Introduction
12
 chimeric proteins can be produced which are able to be assembled into phage particles, and
are thus displayed on the surface of the filamentous phage particle. Foreign peptides or
proteins fused to the pIII capsid proteins have little, if any, influence on the assembly of the
capsid proteins around the DNA. Chimeric peptides fused to the pVIII proteins are limited to
6 amino acids, unless particular vectors are used, as described later.
In theory, any protein can be displayed on the surface of the phage, if the following
criteria are fulfilled. The foreign protein must be translocated efficiently across the inner
membrane into the periplasm so that enough of the protein is available for assembly into
particles. Once in the periplasm, it has to be able to fold correctly in the oxidative
environment encountered in the periplasm, as well as being able to enter the assembly site and
not interfere with the processes that occur at this site during assembly.
George Smith is the first to have displayed a protein on a phage surface. He fused a
part of the gene encoding the EcoRI endonuclease to the pIII protein (Smith, 1985), and then
demonstrated that phage containing the EcoRI-pIII fusion protein could be enriched more
than 1000 fold from a mixture containing wild type phage, when selected with an
immobilized polyclonal antibody specific for the EcoRI endonuclease. From this work, it has
been concluded that using recombinant DNA technology, it should be possible to build large
libraries (>108) where each phage displays a unique random peptide, and that this
methodology provides a direct link between phenotype and genotype.
Two aspects of phage display are described here in more detail: the vectors which are
used to display the foreign proteins, or random peptides, and the affinity selection methods
applied, to select phage displaying elements which have the desirable features, e.g. affinity to
a particular target.
2-1 Vectors for phage display
Many vectors have been designed for displaying proteins or peptides on the surface of
phage. They can be classified into two distinct categories: the phage and phagemid vectors.
2-1-1 Phagemid vectors
By combining the features of phage and plasmids, new cloning vectors, called
phagemids have been constructed. They contain the replication origin and packaging signal of
the filamentous phage together with the plasmid origin of replication, to maintain themselves
in the absence of phage proteins, in E.coli host, and gene expression systems, to ensure
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efficient transcription and translation of the gene-fusion of interest. Except for the capsid
phage protein used as fusion partner for the protein or peptide to be displayed, they do not
contain any phage genes. They are, thus, unable to replicate as phage-like particles by
themselves. After transduction or transformation of bacteria with phagemid DNA, they
maintain themselves as plasmids. This feature give a strong stability advantage to the DNA,
compared to phage DNA. Indeed, when the DNA replicates as a plasmid, it is double-
stranded, while the phage DNA, mainly propagates as single-stranded DNA, where it is
observed to be subject to frequent deletions, and where those smaller phage have a selective
advantage due to shorter replication time.
To be packaged into phage particles, phagemids require superinfection with a
filamentous helper phage (M13KO7), which activates the phage replication origin. The
resulting phagemid single-stranded DNA is encapsulated into phage-like particles using phage
proteins, provided by the helper phage. The phagemid genome is packaged and secreted more
efficiently than the helper phage genome which is defective in replication.
Approximately 90% of the secreted phage particles carry the phagemid genome. All
particles display a mixture of wild-type and fusion proteins. The number of fusion proteins
displayed, depends on the type of phage protein used for the fusion. This system provides a
direct physical link between the protein exposed on the surface, and the genome packaged
into the phagemid particles. Since particles from a single clone are assembled in a single cell,
a variant from a library maintains coupling between that particular variant protein, and the
gene for that variant, although occasional deviations may arise in the case of multiple
infections in a single host cell.
2-1-2 Phage vectors
A bacteriophage vector contains a bacteriophage replication origin, along with all
phage functions required for viral propagation. That means that it is able to replicate and be
assembled as phage particle on its own. Since the phage protein gene used for the fusion is not
present as a wild type gene, the phage exposes on its surface only fusion type from this
protein. Attempts failed to display some elements on the surface of M13 phage, failed due to
defects in viral assembly, stability, and infectivity.
An alternative type a vector uses two copies of one of the capsid protein genes one of
which can be used as fusion partner. One copy is the wild type gene, while the second is fused
to the protein or peptide to be displayed. Bacterial cells infected with these phage incorporate
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both wild-type and fusion copies of the gene products into the same viral particles. These
phage vectors have the advantage that they do not require a helper phage for the infectious
process (presence of all wild type proteins necessary for the infection, replication and
assembly), and display a lower number of fused proteins, in this latter respect, they are
comparable to the phagemid system.
2-1-3 Phage genes for the fusion with the protein to be displayed
The two commonly used phage proteins for the fusion, are the pIII and pVIII capsid
proteins. Viral vectors that accept and display fusions for genes III and VIII have been termed
type 3 and 8. In several vectors, the displayed element is separated from the remainder of pIII
or pVIII, by short linkers.
Some proteins have been successfully fused to the carboxyl end of the pVI protein, the
vectors generated for the display of pVI-fusion proteins are referred as type 6 (Jespers et al.,
1995). But they will not be further discussed here.
The vectors are classified under six nominations, according to the system of fusion
protein they deal with (Smith, 1993). Type 3 represents phage vectors which expose the
foreign proteins fused to the pIII proteins. All five copies of the pIII display the foreign
protein (figure I-3). The type 33 stands for phage vectors which express a hybrid pIII, in
addition to a wild type pIII protein. The virion displays a mixture of pIII molecules, only
some of which are fused to the foreign protein. And finally, the type 3+3 represents the
phagemid system. The vector contains only the pIII gene from the phage, which is fused to
the foreign protein. In this system, when the superinfection with the helper phage takes place,
wild type (from the helper phage), and recombinant pIII (from the phagemid), are assembled
together, leading to a monovalent presentation of the recombinant pIII (Röttgen and Collins,
1995). During the assembly, both phagemid and helper phage are packaged at the same time,
and both display the hybrid pIII.
Type 8, 88, and 8+8 vectors are the gene VIII counterparts of the gene III vectors.
The display of peptides or proteins in M13 can have a valency of one (e.g. 3+3 type)
to thousands (e.g. type 8) of copies. This is dependant on the display site and the type of
vector. The type of fusion, expression levels, and experiment will dictate which display
system is appropriate.
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pIII gene
pIII
Wild type phage
      
pVIII 
pVIII gene
Figure I-3: Comparison of different phage display vector system. The red boxes and
spheres correspond to the foreign genetic elements and their encoded proteins, respectively.
The vector system is classified as 3 or 8, depending on whether the foreign element is fused to
pIII or pVIII proteins. All types possess a single copy of the fusion protein, in addition, types
33 and 88 contain a further copy of the gene used as fusion gene, but this additional copy
represents a wild type gene.
   +
     Helper phage          Type 8+8
   +
      Helper phage            Type 3+3
           Type 88
Type 8
          Type 33
         Type 3
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Many short peptides and a variety of proteins have been displayed at the N-terminus of
mature pIII. Protein domains are more accessible when linked to domain II of pIII. Most
antibody display experiments have utilized this truncated form of pIII for efficient display.
Replacement of domain I of pIII with an exogenous sequence leads to noninfectious phage.
Thus, these particles must also carry a wild-type pIII, expressed from a second gene III in the
vector (type 33) or a helper phage genome (type 3+3).
One major feature of the 33 and 3+3 vector systems, is that the displayed element is
often monovalent, compared with the type 3 vector system which exhibits 5 fusion particles.
In 33 and 3+3 systems, both helper and phagemid/phage viral particles will have 0-5 copies of
the pIII fusion protein per particle (this can be advantageous when the pIII fusions yield
phage which are not stable of infectious). The reduced valency is also valuable in eliminating
avidity, thus permitting discrimination between low- and high- affinity display elements.
Multivalent display
Type 3 and 8 phage
Displayed element might affect phage
infectivity.
Isolation of modest affinity binders
   Valency: 3-5  (pIII) or 2700 (pVIII)
fusion proteins
(pVIII fusion: limited to short peptides)
Monovalent or reduced display
Type 3+3, 8+8 phagemids, 33, 88 phage
Negative effect of the displayed element
is minimized
Isolation of high affinity binders
Valency: 0-1 (pIII) or 25-100 (pVIII)
fusion proteins
(size of the fusion proteins unlimited,
also for pVIII)
Table I-1: Comparison of properties of monovalent and polyvalent displays. Monovalent
display can be used to discriminate between modest and high affinity binding peptides.
Monovalent display is also a tool for the display of variants that may not be tolerated by M13
in 5 to 2700 copies. It has been pointed out by Armstrong (1996), that the selection of weak
binders with polyvalent vectors yields sequence (consensus) information which may lead to
the development of high affinity ligands.
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pVIII appears to tolerate only short inserts of 5 or 6 amino acids additional residues, in
the type 8 vectors, but however, can tolerate foreign domains as large as 50 kDa, in type 88,
and type 8+8 vectors.
In the 88 and 8+8 vector systems, the valency of the displayed element, is between 25
and 100 copies per viral particle (Kang et al., 1991a). The viral particles have a mixture of
both fusion and wild-type pVIII. The increased valency of pVIII display, as compared to pIII,
has advantages in experiments in which low-affinity receptors are the target, and has been
proposed as an ideal vehicle for developing vaccines where the entire phage particle may be
particularly antigenic.
Monovalent or polyvalent displays present different features, and the method of choice
has to be defined for each particular target. Their properties are summarized in the Table I-1.
2-1-4 Other viral display vectors
Other vectors have been successfully used to display element on their surface. Among
them, bacteriophage λ is commonly used. Proteins can be fused at the C-terminus of its
protein V. This is a useful vector for the display of cDNA segments, because large
recombinant libraries can be generated in this vector.
Recently, vectors based on the E.coli phage T7 have been developed for the display of
peptide libraries. Phage T7 has an icosahedral symmetry, and the peptides are displayed at the
C terminus of the major coat protein (Houshmand et al., 1999).
Other viruses remain to be exploited, such as RNA phage Qβ, baculovirus, and
retroviruses.
2-1-5 Genetic markers
It is essential to use vectors carrying genetic markers, for example, in order to allow a
selection of the cells which contain the phage. There are a number of convenient markers,
which include antibiotic resistance, epitope expression, lacZ expression, and supressor genes.
In a number of vectors, drug resistance genes have been introduced by bacterial
transposons. A selectable marker (e.g. drug resistance factor) allows only plasmid-containing
cells to survive.
Several vectors have been engineered to express short peptide ”tags” that can be
recognized by particular monoclonal antibodies, e.g. the c-myc epitope. In some vectors, the
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c-myc epitope is in the stuffer fragment where it is useful in immunologically discriminating
between parental and recombinant phage particles, for the purposes of estimating the
percentage of recombinants in a library.
When a vector carrying lacZ gene is in the appropriate bacterial host that has been
exposed to the inducer isopropyl-β-D-thiogalactopyranoside (IPTG), functional β-
galactosidase activity is present. This gene can easily be detected by the occurrence of blue
plaques in bacterial lawns containing the indicator bromo-4-chloro-3-inodocyl-β-D-
galactoside (XGal).
In a few vectors, suppressed stop codons have been placed between displayed protein
domains and domain II of pIII. When such recombinants are propagated in a suppressor
carrying bacterial strain, virus particles are produced incorporating chimeric protein domain
pIII into the capsids. After screening phage populations for virus particles with certain
properties, individual isolates can be introduced into bacterial strains that lack suppressors. In
these hosts, there is efficient translational termination at the stop codon in the chimeric gene
III, and consequently, the protein domain is secreted by itself. This is a very efficient way to
secrete antibodies (Hoogenboom et al, 1991), or growth hormone (Lowman and Wells, 1993)
for testing purposes.
2-2 Screening phage display libraries
The screening of a phage display library is a way to isolate peptide ligands for targets
of interest. The bacteriophage expressing binding peptides are selected by affinity purification
on a target of interest. The peptide sequences are subsequently deduced from the DNA
sequences.
The library screening involves several steps: a suitable library has to be obtained,
together with a source of target. Then, the target and the library are incubated together, in
order to capture the binding phage. Washing steps remove the non-binding phage. After this,
the binding phage are eluted from the immobilized target, and propagated. This cycle has to
be repeated several times, until a significant enrichment of the eluted phage is observed.  At
this stage, individual clones are further analyzed by sequencing, and the clones are compared,
with the aim of distinguishing a consensus sequence.
This work focuses on phage display random peptide libraries, as it is the type of bank
which is investigated in order to isolate highly specific ligands to our particular targets (SH3
domains).
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2-2-1 Important parameters to improve the biopanning
Library quality: the quality of the phage library to screen has an important influence
on the probability of isolating phage, binding to a particular target. It is therefore crucial to
establish a strategy which will generate an adequate sized bank. The library should, for
example, display random peptides, long enough to allow maximization of ligands which cover
a large proportion of the surface of the target binding site. However, the display of long
random peptides, requires a high complexity of the bank, in order to be diverse enough to
contain all possible peptide sequences. The table I-2 gives an idea of the bank diversity
necessary to be obtained, according to the random peptide size that they display.
   
                Transformants required for
         complete library with:
     Positions            Peptide      DNA diversity               90%     99%
   randomized           diversity     (NNK codons)                        confidence        confidence
           (n)              (20n)              (32n)
      1    20    32    74    149
2   400 1.0x103 2.4x103       4.8x103
3 8.0x103 3.3x104 7.6x104 1.5x105
4 1.6x105 1.1x106 2.4x106 4.9x106
5 3.2x106 3.4x107 7.7x107 1.6x108
6 6.4x107 1.1x109 2.5x109 5.0x109
7 1.3x109 3.4x1010 7.9x1010 1.6x1011
8 2.6x1010 1.1x1012 2.5 x1012 5.1x1012
Table I-2: Theoretical required diversity of phage display libraries to ensure the
presentation of all possible random peptides. NNK codons (where N is any nucleotide, and
K is G or T) is commonly used for randomization in biological libraries. NNK encodes all the
amino acids except two of the stop codons, reducing the stop codons occurrence of two third.
The confidence that a library contains all possible amino acid sequences is calculated
assuming a Poisson distribution (Lowman and Wells, 1991). Adapted from Clackson and
Wells observations (1994).
For a phage library displaying 8 amino acid long peptides on the phage surface,  a
diversity of at least 2.5 x 1012 variants would be necessary to represent every possible
sequence (with a confidence of 90%). However, the largest combinatorial peptide libraries
which have been generated, contain about 1011 variants. Therefore, many laboratories are
focusing on developing methods able to overcome this limitation. The generation of
recombination within the hypervariable region of the libraries is a powerful concept which is
exploited to increase the bank diversity. The DNA shuffling, in use for instance by Stemmer’s
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group (Stemmer, 1993a/b), and the cosmix-plexing approach1, developed in our laboratory
(Collins and Röttgen, 1997a, 1997b), demonstrate the advantages of this idea. The advantages
and drawbacks of these methods will be discussed later on.
The diversity of the bank might be, in some cases, overestimated. Indeed, in some
libraries, the frequency of the number of non-recombinant parental clones, which do not
present any peptide, is high. In the worst case, the library would not contain enough variants
to be considered useful (e.g. <107). It is important to be able to test for their presence, or
frequency, to have a correct evaluation of the complexity of the bank. In any case, it is crucial
to prevent or limit their presence. At the very least, empirical selection experiments should be
performed to correlate the results with theoretical expectations. Several methods have been
applied to create high quality libraries. Some of them are discussed below:
One technique is to destroy, intentionally, the reading frame of genes III or VIII by
inserting a stuffer fragment in the vector. The presence of a stuffer fragment also allows a
closer examination of the restriction digests ensuring complete cleavage of the vector with
both enzymes at the site at which the hypervariable cassette is to be integrated. Thus, pIII or
pVIII proteins are not expressed anymore. The reading frame is restored in the vector when
the stuffer fragments are replaced with DNA encoding peptides or protein domains which
have the appropriate reading frame. As pIII and pVIII are required components of the virus
particle, this strategy permits positive selection of recombinant versus parental genomes (with
phage vectors). One caveat of this selection scheme, however, is that reversion of the
defective genes occurs frequently, leading to a loss of discrimination between recombinant
and parental genomes.
Another means of selecting recombinant versus parental phage, is to include a stop
codon in the stuffer fragments of genes III or VIII. The amber stop codon (TAG) can be
suppressed efficiently in bacteria containing supE or supF. When these vectors are propagated
in such bacterial strains either a glutamine or tyrosine is inserted at the TAG codon,
respectively. However, when TAG containing genes III or pVIII  are in bacterial strains that
lack either supE or supF, no full length pIII or pVIII accumulate, and no virus particles are
generated. Almost no parental phage have been found, when ligation mixes are introduced
into suppressor-less F’ bacteria.
Another alternative which will be described later on, is used in our laboratory. In our
hands, absolutely no parental phage have been isolated, using this method.
                                                          
1 Cosmix-plexing is a trademark belonging to Cosmix molecular biologicals GmbH (patent pending)
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When checking the bank quality by sequencing random clones to estimate the
frequency of non-recombinant phage, parental phage has to be taken into account, along with
phage displaying variants containing stop codons, or variants which show changes in the open
reading frame, due to point mutations. A high frequency of these three types of defective
clones has to be reduced to the minimum, in order to maintain of the complexity of the
libraries.
The libraries should remain stable, even when greatly amplified. In general, the
phagemid vectors are considered more stable than phage libraries, as the latter depend almost
entirely on single-stranded DNA propagation during amplification, which frequently generate
small deletion fragments which overgrow the rest of the library. In addition, problems may
occur due to intolerance by E.coli for certain sequences during DNA replication, e.g. with
vectors containing deletion of repeats and palindromes (Collins, 81; Collins et al, 82). The
intolerance of particular gene products can be reduced during propagation, by using strongly
repressible promoters, such as λpL, for the control of production of the protein or peptide to be
presented on the phage (Courtney et al, 95; Röttgen and Collins, 95; Maenaka et al, 96). The
displayed elements might also be wrongly folded.
To minimize problems arising from instability of phage displayed peptides, phage
should be protected from proteolytic degradation. Therefore, phage used in screening
experiments should be from a freshly amplified stock.
The target quality is also an essential parameter influencing the success of the
panning. The target must retain its native conformation during affinity purification of binding
phage, at least during the initial binding and the washing steps. When possible, it is of interest
to have a functional activity test for each particular target. In addition, for standard libraries,
the target has to be highly purified (this not always necessary for cosmix-plexing libraries,
where successful selections have also been carried out on complex targets). Otherwise, the
clones that bind to the target may be discriminated from those that interact with contaminants
in binding reaction. Furthermore, the panning procedure seems to depend to a great extent on
the way in which the target is presented (e.g. immobilized) to the phage library, during the
affinity selection.
The most common strategy to immobilize a target is to adsorb it onto ELISA-treated
microtiter plates. Passive adsorption is typically sufficient to immobilize the modest quantities
of target required for successful isolation of binding phage. Using this format, a single well is
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generally required per round of purification per target/library combination. However, the
target may be immobilized onto many other solid supports such as Sepharose (Dedman et al,
93), or paramagnetic beads. Immobilization on paramagnetic beads offers the potential
advantages of increased surface area, and therefore target concentration per unit volume,
relative to target immobilization onto microtiter plates, although a larger amount of protein is
typically required for immobilization (it should be noted that target concentration is the
driving force for the binding kinetics, at least in the initial selection round. Target
concentration becomes less important in later rounds and can be deliberately reduced as a
factor in increasing stringency). A strong magnetic source is used to draw the target-bead-
binding phage complexes during washing steps.
Some proteins may become denaturated and lose binding activity when bound to
plastic or solid supports. These problems may be circumvented by using an intermediate
capture protein to immobilize the target, such as immobilized protein A can be used to capture
an antibody via its Fc while still allowing access to its Fab, or immobilized anti-target
antibodies can be used to capture the target. It is critical, when using this capture method, to
minimize recovery of phage which bind to the capture protein rather than to the target protein.
2-2-2 Affinity selection
Initial challenge: the affinity selection allows isolation of variants from a phage
library, which exhibit required properties, e.g. high binding affinity to a particular target
molecule. This strategy is often referred as “panning”, in analogy with the procedure of
panning for gold dust by shaking river sediment in flowing water. The initial number of phage
used from a library for a first round of panning selection is typically about 1011-1012 cfu.
The affinity selection of the phage library can be performed using two different
approaches. In one case, the phage library is incubated with preimmobilized target, such that
the binding phage are temporarily immobilized onto solid-phase while non-binding phage are
washed away.
In the alternative approach, the phage library is incubated with target in solution, and
subsequently captured as phage-target complexes onto solid phase while the non-binding
phage can be washed away.
Washing steps: after the incubation between the target and the phage library,
intensive washing steps are achieved in order to wash away the particles showing low affinity
for the target, leaving the strongly binding particles attached to the target. This allows
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 discrimination between weak and strong binding particles.
Elution: the enriched phage population, remaining bound to the target after the
stringent washing is then eluted from the target-phage complexes. This is an essential phase of
the panning procedure. The most commonly used method, is to elute the phage with drastic
pH changes (i.e., glycine-HCl, pH 2.2), which result in target or peptide denaturation without
loss of phage infectivity.
An alternative procedure is the elution by treatment with 6M guanidine-HCl, 2M urea,
or 10 mM DTT, although these reagents must be removed prior to phage amplification. The
use of 1% SDS or phenol to elute the binding particles is also possible, although, it requires
DNA transformation to regenerate infectious phage particles.
Another means is to take advantage of particular binding characteristics of the target.
For example, if the target needs a metal ion for binding, phage elution might be successful
with EDTA, or EGTA.
Another kind of elution is the use of natural or synthetic ligands for competitive
elution from receptors, or interacting proteins for competitive displacement by formation of
multimeric complexes. This has the advantage of selecting for specificity for the site at which
the selected ligands binds. Specificity can also be increased by adding competitive targets
(soluble) during the initial affinity selection steps.
A simple and reliable elution method which can always be used in the absence of
knowledge of an appropriate elution method, is to add the E.coli host cells directly to the
immobilized  complexes after the washing steps.
Amplification: the eluted phage, still biologically viable, can reinfect a new E.coli
host in which it propagates, leading to amplification. Despite the high number of phage used
in the first round of selection (1011-1012 cfu), the number of phage particles representing any
given binding clone that are recovered from the first round is reduced to the point that binding
clones may be lost if subjected to a second round of purification without intervening
amplification.
The amplification should result in a 105 to 107 fold increase in the titer of any given
clone from the previous round of affinity selection. Every single clone enriched in the first
selection round, participates in the further rounds of selection at a greatly increased
concentration.
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Figure I-4: The affinity selection cycle. Phage particles presenting the various protein or
peptide variants are incubated with the immobilized target molecule. Particles with low
affinity for the target are washed away. The remaining particles are eluted and fresh E.coli
cells are infected with them. Clones are selected for antibiotic resistance. Particles are
collected, and packaged, by superinfection with helper phage. The enriched clones are now
ready to be screened in the next cycle.
Phage amplification may be performed on petri plates or in liquid culture. It is
suggested that there is little difference in the growth of phage by either method (McConnell et
al, 95). Liquid culture can accommodate a higher amount of input phage than amplification on
plates.
One round of affinity selection with a target immobilized on ELISA plates, typically
results in an 103 to 105 fold enrichment of binding over non-binding phage. Thus, three or
four rounds of panning are generally sufficient for the isolation of a small number of clones
containing the phage with the highest binding affinities.
The panning protocol described in figure I-4 is conceived for a phagemid random
peptide library, taking advantages of the methods using preimmobilized target, acidic elution
of the binding phage, and plate amplification of the library between each round of affinity
purification.
3- Applications
The ability to construct libraries of enormous molecular diversity, having a direct link
between phenotype and genotype, in combination with selection for molecules with
predetermined properties, has made this technology applicable to a wide range of problems.
3-1 Phage display of natural peptides
The main application of displayed natural peptides, is for the epitope mapping of
monoclonal, or polyclonal antibodies. In this case, phage display is seen as a means of
identifying clones that were expressing epitopes recognized by a given antibody.
Traditionally, epitope mapping of protein antigens has relied on heavy physical
chemical analysis: First, the purified antigen was fragmented with proteases, followed by
identification and sequencing of the reactive fragments. Then, chemical modification
experiments were performed, in which residues interacting with the antibody are protected
from modification. A series of peptides corresponding to the primary  structure of the antigen
have to be synthesized. And finally, a direct physical characterization using NMR or X-ray
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crystallography has to be achieved.
As an alternative to this method, phage display can be used to localize the antigenic
epitope relatively quickly. Fragments of DNA that encode portions of the protein antigen are
fused to the gene encoding capsid protein III.  And phage can then be tested with the antibody
to determine which displayed fragments react with it (Tsunetsugu-Yokota et al., 1991; Wang
et al, 1995).
The limitation of this strategy is that each antigen represents the construction of a new
phage library. Furthermore, the starting point, DNA encoding the antigen must encode the
epitope.
The display of natural peptides can also be used with the aim of generating
immunogens. Short segments of various proteins have been displayed on M13 virus particles
for the purposes of eliciting antibodies against the coat proteins of certain parasites and
viruses (De La Cruz et al., 1988; Greenwood et al., 1991).
3-2 Phage display of random peptides
Combinatorial peptide libraries are an important application of phage display.
Synthetic oligonucleotides, fixed in length but with unspecified codons, can be cloned as
fusions to genes III or VIII of M13 where they are expressed as capsid fusion proteins.
These random peptide libraries can be tested for binding to target molecules of
interest, due to affinity selection. The library is incubated with the immobilized target
molecule, followed by washing procedure to remove the weak or non binders. Finally, the
bound phage are eluted, and amplified, before being again selected for binding to the target
molecule, thus enriching those phage that bind strongly to it. Thus rare phage that bind can
easily be selected from greater than 108 different individuals in one experiment.
The displayed peptides can have a free amino terminus, thus allowing the peptide
considerable flexibility much like peptides free in solution.
Random peptide libraries have been invaluable in mapping the specificity of the
antibody binding sites. They represent a source of sequences from which epitopes and
mimotopes can be operationally defined (Geysen et al., 1986).
Random peptide libraries are a very powerful tool to identify peptide ligands. This
way of working with phage display is the one which was chosen for this work. Random
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peptide libraries are a rich source of peptide ligands for a variety of receptors. They also
provide antagonists for protein-protein (as instance, on Src SH3 domain: Cheadle et al., 1994;
Rickles et al., 1994; Sparks et al., 1994) and protein-nonpeptide ligand interaction (Krook et
al. (1994) identified peptide ligands against single-stranded DNA), in vitro and in vivo.
Another important use of random peptide libraries has been the  development of
“substrate phage” (Matthews et al., 1993). In this case, the library is used as a means of
defining substrate specificity rather than simply binding to a target molecule. In theory, many
different post-translational modifications (i.e., phosphorylation, glycosylation...) can be
mapped the same way.
3-3 Phage display of protein and protein domains
In many cases, the phage displayed protein retains its normal binding or enzymatic
activity even when fused to the N-terminus of mature pIII or pVIII phage proteins.
The coding region for a protein to be displayed on surface of a phage, can be
mutagenized by cassette mutagenesis, error-prone PCR, or shuffling to generate a plurality of
altered sequences. This is a way to direct evolution, and from the mutagenized population, it
is possible to select stronger binding ligands to a particular target (as instance, Lowman et al.
1991; Dennis and Lazarus, 1994).
One of the more powerful applications of phage display has been in the area of
antibody engineering. It is possible to express both Fab and single-chain Fv (scFv) antibody
fragments on the surface of M13 viral particle with no apparent loss of the antibody’s affinity
and specificity. The coding region of VL and VH chains can be obtained from naive mice
(Gram et al., 1991), immunized mice (Clackson et al., 1991), or germline genes
(Hoogenboom and Winter, 1992). High affinity antibodies can be isolated in this way.
It is also possible to express cDNA-encoded proteins on the surface of phage which
can then be tested against a particular immobilized target in vitro, using biopanning
enrichment (Crameri and Suter, 1993). This allows the study of signal transduction pathways,
in which a whole series of protein domains interact with one another.
Direct selection of protein-protein interactions has also proven possible with phage-
displayed libraries. For M13 phage particles to be infective both amino and carboxy domains
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of pIII must be present. It is possible to express the target protein as a fusion protein with the
carboxy-terminal half of pIII separately from cDNA segments which have been expressed and
fused to the amino terminal domain of pIII. When the target and particular cDNA-expressed
protein domains interact, the two pIII domains are brought together and the resulting phage
particles regain infectivity (Gramatikoff et al., 1994; Duenas and Borrebaeck, 1994). This
system complements the yeast two hybrid system.
C – Optimization of binding capacities of interacting partners
A close look at the results achieved in studies of protein-protein interactions shows
how crucial it is, to characterize interacting partners with optimized affinity and/or specificity.
Several kind of approaches have been developed to isolate more strongly interacting partners.
These can be classified into two groups. The first tends to ameliorate binding capacity of
already existing ligands (so called, natural ligands). The second strategy,  on the contrary,
concentrates on isolating novel ligands (through phage display for example), and focuses on
developing alternatives to increase their binding capacities to the target molecule.
1- Natural ligands
Natural ligands are found in nature, and are able to make interactions with other
partners also existing in nature.
1-1 Consolidated ligands
In this approach, Cowburn et al. (1995), created a series of bivalent ligands, which
interact simultaneously with two different domains of the same protein. They chose as model
the SH2/SH3 domains, since it is very common to find both of them within one protein. The
Abl protein (Abelson protein-tyrosine kinase) was taken for these experiments, as it contains,
in addition to a kinase domain, a SH2 domain and a SH3 domain. Furthermore, natural
ligands are well characterized for each of these domains. The method is based on the
synthesis of “bivalent consolidated ligands”, which are formed through the association
between both natural ligands of SH2 and SH3 domains of Abl. The two ligands are separated
by a linker, and the bivalent ligand is expected to bind with higher affinity and specificity to
Abl, than the isolated ligands, when the linker between the two affine segments is of optimal
length. This approach takes advantage of a potential cooperative effect of both ligands.
Cowburn successfully shows that such bivalent consolidated ligands present an increased
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affinity of approximately two orders of magnitude (Cowburn et al., 1995).
1-2 Rational design
The rational design strategy, proposed by Pisabarro and Serrano, is based on computer
predictions (due to GRID and LUDI computer programs), to select for mutations which might
enhance the binding capacity of two interacting partners (Pisabarro and Serrano, 1996).
They also took as model the Abl protein, and attempt to improve the affinity and
specificity of Abl-SH3 domain natural ligands. Therefore, they selected a natural ligand
which shows cross reaction with the Fyn SH3 domain, and attempted to design a ligand which
discriminates between Abl and Fyn SH3 domains. Two strategies have been used.
The first one takes advantage of the fact that SH3 ligands have to form a polyproline
type II helix to be able to bind to SH3 domains. Thus, the tendency of the natural ligand to
adopt such a polyproline type II helix, was increased, by mutation of non proline residues, one
after the other, to proline, so that the entropic cost upon formation of the helix would be
smaller. This strategy might increase the affinity, but not the specificity.
The second approach is using the GRID and LUDI computer programs to identify
reasonable substitutions which might create favorable interactions, more specific to Abl-SH3
domain. Substitutions might occur which fill up the space between the two partners, in a
similar way, but which might generate stabilizing interactions such as hydrogen bonds
between the two interacting partners.
By using these strategies, Pisabarro and Serrano succeeded to design a peptide which
differs from the original ligand at only two positions (P4-Y, and L8-P), but which binds the
Abl-SH3 100 fold higher than the original natural ligands (KD of 0.4 µM was reached), and
has 1000 fold more affinity for Abl, than for Fyn SH3 domain.
2-Novel ligands – increasing the diversity of the banks
One factor limiting the success of phage display technology is the size of the library.
To maximize interactions between the selected ligand and the target to which it binds, it
would be desirable to display relatively long randomized peptides. However, the minimal
number of clones required within a library (in order to contain all possible sequences)
increases exponentially with the number of amino acid residues in the variant peptide. A
phage library which displays a 9 amino acid long peptide on its surface, would require a
population of at least 1.5x1014 variants, to ensure a confidence level of 99% that all possible
variants are presented (1.6x1020 for a 13 amino acid long peptide). However, the largest
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combinatorial peptide libraries which have been constructed contain about 1011 variants, thus
only a fraction of all possible variants are represented in the library. Therefore, methods to
minimize this problem have been developed.
2-1 Generating more primary clones
The first parameter to be considered in increasing the library diversity, is the number
of clones obtained from the electroporation step. Indeed, the dependency on the
electroporation steps, seriously limits the efficiency of primary bank formation (105 to 106
clones per µg of ligated plasmid DNA, when using a standard cloning method to insert the
variants within the vector). Therefore, λ carrier vectors have been constructed which allow the
efficient use of the λ in vitro packaging system for introducing the phagemid display vector
into the cell via transduction. Since the phagemid vector is bracketed by the packaging-start
and-stop sequences of bacteriophage M13, superinfection of the transduced λ-phagemid
hybrid with an M13-type helper phage causes the phagemid genome to be efficiently excised
(Short et al., 1988), packaged, and secreted in the culture medium. The efficiency of the λ in
vitro packaging is some 4 fold higher than the efficiencies quoted for electroporation, namely
6 to 7.107 pfu/µg of DNA (Hogrefe et al., 1993).
A novel protocol is optimized in which a cosmid vector is used to package and
efficiently transduce up to 9 phagemid genomes at a time. The vectors used in this system
carry a λ cos site, which is recognized by the λ phage, and which allows the packaging within
the lambda prehead. These are then resolved to individual phagemid genomes upon
superinfection of the recipient bacterium with M13 helper phage (Collins et al., unpublished
data).
Another route to increase the number of primary clones obtained by electroporation, is
to optimize the method used for the cloning of the variant inserts within the vectors. Such an
approach was applied in our laboratory, reaching a very high electroporation efficiency, over
108 colonies/µg of ligated DNA (described on the results chapter).
2-2 Create new clones from the primary library
By using different approaches, it is possible to modify the variants of a primary library
to create a more diverse or modified secondary library. Several groups have been involved in
the attempt to elaborate strategies which try to reproduce the process of natural evolution
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(Gallop et al., 1994). The elements involved are mutation and recombination, and in many
cases, are simultaneously applied.
2-2-1 Introducing mutations
 One way to increase the size of the library is to create mutations within the gene which
codes for the peptide to be displayed on the surface of the phage. Several approaches have
been successfully attempted to reach this aim.
Error prone PCR
Error prone PCR is commonly used to introduce mutations in the DNA during
amplification. It has been used to introduce random mutations into the scaffold of phage-
displayed proteins, in an attempt to imitate the introduction of mutations during the somatic
maturation of antibodies. DNA synthesis in vitro tends to produce random sequence errors.
Vent and Pfu are less error prone than Taq DNA polymerase (Cline et al., 1996). The
mutation frequency can be easily increased by modifying the buffer composition (raising the
Mg2+ concentration, including Mn2+, or increasing the pH) or by other factors, such as,
lowering the initial concentration of the template for PCR, increasing the amount of
polymerase, using a great number of cycles, a long extension time, or a low annealing
temperature. In addition, a biased pool of the four dNTPs, with concentrations differing by a
factor of 10 to 1000, also encourages a higher error rate (Leung et al., 1989; Pannekoek et al.,
1993; Cline et al., 1996; Ling and Robinson, 1997).
As an example, Krykbaev et al. (1997), built a library of mutant CD4 proteins from
which variants with improved binding to the HIV gp120 have been isolated after biopanning.
Interestingly all of these selected variants had one or two amino acid substitutions within the
V1 domain of CD4, at positions located in the strands surrounding the main binding loop.
Mutator strains
Another method, introduced by Low et al. (1996), is to use modified bacterial strains
which bear a proof-reading-negative DNA polymerase III (E.coli mutD5 mutator strain). In
this strain, the fidelity during replication of the DNA is highly reduced. The mutation rate in
these strains is only 50 fold above background in minimal medium, but can be increased by
20 to 2000 fold by growth in rich medium. This approach is applied in our laboratory, where
the DNA is propagated into WK6λmutS E.coli strain, which is mutated to affect the fidelity in
DNA replication. The accumulation of created mutations might generate more diversity, and
Introduction
32
might contribute to an increase of the binding affinity of a few variants (not demonstrated).
Mutational libraries: the 70:10:10:10 approach
The mutational library approach developed by Yanofsky et al. (1996), takes advantage
of previously isolated ligands from a peptide library (through panning of affinity selection).
The idea is that, when a ligand has been identified against a particular target, it is still
possible, after modification by mutations, to select, among the new batch of clones, for better
binding variants. The principle of this strategy is not to increase the diversity of the library by
itself, but instead, to enhance the binding capacities of a previously determined ligand.
The sequence of the original binding peptide is mutated at a rate of 50% per amino
acid residue (for amino acids encoded by codons where the third position is completely
degenerated; 66% mutation rate for amino acids encoded by a single codon sequence). Three
additional completely random amino acids are added, as extensions, at both ends.
This frequency of mutation is achieved by synthesizing the oligonucleotides in which
the original base at a particular position, is incorporated at a frequency of 70% and the 3 other
bases at 10% each. Therefore, this method is referred to as the 70:10:10:10 approach
(Yanofsky et al., 1996). This strategy can be used in optimizing the affinity of a particular
ligand. The initially isolated binding ligand is submitted to this 70:10:10:10 approach, further
rounds of panning are achieved, from which better binding clones might be characterized.
Alanine scan
The alanine scanning mutagenesis is designed to determine which amino acid residues,
within a particular ligand, are critical for high affinity and specificity binding to the target. To
reach this aim, individual positions of a peptide ligand are successively substituted by alanine,
and the modified peptides are tested for their ability to bind to the target. Their binding
capacities are compared to the one of the original ligand. Replacement of certain residues
leads to a loss or diminishment of binding, whereas replacement of other positions does not. It
is therefore possible to determine the relative importance of each residues within the peptide.
This technique is routinely used to confirm the consensus sequence conceived from ligands
isolated with phage display technology. Commonly, the positions determined within the
consensus sequence are the one where an exchange with an alanine residue leads to the loss of
the binding abilities for the target, as shown in the work of Kurakin et al. (1998), or Feng et
al. (1995).
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However, all of these approaches: error prone PCR, modified bacterial strains,
mutational library, or alanine scan methods, have a common limitation. They alter DNA only
with respect to the starting DNA.
2-2-2 Recombination
Another way to increase the diversity of a library, is to allow recombination within the
gene coding for the displayed variant, or directly within the exhibited protein. The use of
recombination techniques to generate reassortment between regions of DNA or proteins
represents a very important recent development with respect to phage display technology.
DNA shuffling
A method to create in vitro DNA recombination has been proposed and developed by
Stemmer, and demonstrates that the generation of diversity via recombination is a very
powerful concept. Libraries can be cross combined by using DNA shuffling, also called
sexual PCR (Stemmer, 1994a,b).
This method takes advantage of both mutagenesis and recombination approaches,
since mutated DNA fragments are reassorted together, in order to obtain novel variants. The
DNA shuffling involves a partial digestion of a large gene with DNaseI, to form a pool of
random DNA fragments (Figure I-5). These fragments are reassembled into a full length gene,
by repeated cycles of annealing in the presence of DNA polymerase. The different
overlapping DNA fragments act as primers. The fragments prime each other based on
homology, and recombination occurs when fragments from one copy of a gene, prime on
another copy, resulting in a template switch. Sequences of at least 10 kb, such as genes, gene
libraries, or plasmids, can be reconstituted by DNA shuffling, starting with 100-300 bp
fragments obtained by nuclease digestion of the sequence of interest. However, this method
cannot be used in all cases. It can work only with families of genes or gene variants which
contain a high homology among themselves.
Chain shuffling
Winter´s group proposed the chain shuffling method, to mimic the affinity maturation
of antibodies that occurs in vivo during the course of an immune response (Clackson et al.,
1991; Kang et al., 1991b; Hawkins et al., 1992). In vitro affinity improvement is
accomplished by selecting a pool of antibodies on an immobilized target which is submitted
to variations, and to reapply selection. The variation is produced by shuffling heavy and light
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chains to create new chain pairings and by mutagenesing the complementarity determining
regions (CDRs) to create new variations of the site (CDR1,-2,-3). Many of the new pairings
are likely to give a low affinity, however, a few of them may have an improved affinity.
Single gene
Random fragmentation (DNaseI)
Pool of random
DNA fragments
Reassembly by mutagenesis PCR
Family of related
DNA sequences      REPEAT
Random fragmentation (DNaseI)
Pool of random
DNA fragments
Reassembly by mutagenesis PCR
and selection for positive mutations
Figure I-5: DNA shuffling: schematic illustration. An original gene is digested with
DNaseI, and reassembled through mutagenesis PCR (error prone PCR, as instance). The pool
of homologous genes with different point mutations which results from this PCR, is submitted
once more to a fragmentation with DNaseI. Reassembling of the random fragments into full-
length genes, results in frequent template switching and recombination. Selection from the
library of recombinants points out recombinant genes, based on their improved function. The
selected pool of improved recombinants provides the starting point for another round of
mutation and recombination.
This method has been successfully applied to isolate antibodies with higher affinities
against a panel of different targets, among them: the hapten nitrophenyl phophonamidate
(Kang et al., 1991b), the hapten phOx (Marks et al., 1992), or the cytomegalovirus
glycoprotein B (Ohlin et al., 1996).
Two chain shuffling recombination systems have been described: the att and the
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Cre/loxP systems. They find an application in the generation of hypervariable banks of
antibody libraries by chain shuffling of the light and heavy chain  subunits.
The att system: this is a λ recombination method, to generate combinatorial libraries,
which utilizes the lysogenisation system of λ. λ phage uses a site-specific recombination to
integrate into the host chromosome during lysogenisation. The only λ phage function that it
requires is the λint gene. The recombination is irreversible in the absence of λxis gene
product.
 VH-CH-pIII
        attP VL-CL
                     pM834         cat        pM827
             ApR          Pcat       attB         KmR
λint      λint
   +
attPB      λxis     
       VH-CH-pIII       Km
R
  
           pM835
     ApR                VL-CL
    
             attP’B’
      Pcat-cat = CmR
Figure I-6: The att system. The phagemid pM834 heavy-chain-pIII fusion library is
introduced into the same strain as the light chain library, carried in a low copy number
plasmid pM827. Pcat refers to the promoter for the chloramphenicol resistance gene. cat is
the structural gene for chloramphenicol transacetylase without promoter. After the Int-
mediated site-specific recombination the required phagemid form pM835 is achieved. ApR,
KmR and CmR refer to the ampicillin, kanamycin and chloramphenicol resistance genes,
respectively. The two sites attB and attP give site-specific recombination mediated by the
phage protein Int, to yield a cointegrate bordered by recombined att sites designed attPB and
attP’B’. The reaction can only be reversed if Int and another phage protein Xis are present.
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Geoffroy et al. (1994) have described a pair of vectors: a plasmid (pM827) containing
attB; and a phagemid (pM834) containing attP (Figure I-6). On induction of Int protein (heat
shock induction of E.coli strain D1210HP) the two plasmids recombine irreversibly at these
sites, forming a cointegrate, pM835.
pM834 contains the promoter for the chloramphenicol resistance gene (cat) near the
att site, while pM827 carries the promoterless cat gene. After recombination the promoter is
juxtaposed upstream of the resistance gene, so that the new cointegrate is a phagemid
encoding chloramphenicol resistance (only the recombined vector carries a functional
chloramphenicol resistance gene). One vector encodes immunoglobulin VL-CL and the other
encodes VH-CH-pIII fusions. The final cointegrate is a phagemid (3+3), specifying
chloramphenicol resistance, which will present Fab on packaging, after superinfection with a
helper phage. Chain shuffling, and the generation of large combinatorial libraries, can thus be
achieved by infecting a heavy chain library on the phagemid pM834 into a population
carrying a light chain library in pM827. Each time the bank is created new combinations of
heavy and light chains are produced.
The Cre/loxP system derived  from the bacteriophage P1, and requires a 33 bp target
sequence (loxP) which brackets the insert after recombination. Waterhouse et al. (1993), and
Griffiths et al. (1994), first demonstrated the use of the Cre/loxP mediated gene cassette
exchange to shuffle the light and heavy chains in a type 3 library. The phage used in the
library encode genes whose products associate to form a Fab fragment presented on the
phage, since the heavy chain is fused to the pIII gene. The heavy chain genes are bracketed by
a copy of the loxP511 and the loxPwt (wild type) sites, allowing exchange of this cassette
between two replicons, via Cre mediated site-specific recombination. The mutant only
recombines with another mutant loxP site, but not with a wild type site, and vice versa.
Recombination is induced by infecting the cells carrying the phage, with a P1-cre phage,
which supplies the Cre recombinase. The efficiency of recombination was estimated to have
caused 28% of the acceptor phage to have received a heavy chain from the donor vector
(Waterhouse et al., 1993). This acts in a reversible fashion to allow recombination between all
homologous loxP sites.
The method has also been successfully applied to the chain shuffling of scFv
presenting type 3+3 phagemids (Tsurushita et al., 1996). In a recent development, Bradbury
(unpublished) used single vector recombination system in which infection of single bacteria
by multiple phagemids followed by Cre mediated recombination resulted in the creation of a
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library estimated to be greater to 1010 in size. This method has the potential advantage that
recombination between cycles of selection may result in considerable improvements in
affinity, although this was not shown yet.
Libraries generated by Cre/loxP recombination are considerably larger than commonly
produced (Griffiths et al., 1994, Bradbury, unpublished). In addition, they have been proved
to allow isolation of high affinity antibodies to a number of targets.
However, libraries constructed by Cre/loxP recombination, where the loxP sites are
present as direct repeats, might be expected to show instability, due to deletions of the repeats.
The exon shuffling is an ingenious method developed to avoid the problem of having
the loxP site (11 amino acids defined) in the reading frame of a gene fusion, when using the
Cre/loxP in vivo recombination system to shuffle contiguous regions. Fisch et al. (1996) use a
self-splicing intron, which removes itself from the mRNA. A loxP site has been inserted into
the intron, while still preserving the splicing function of the intron. More than 1011 clones
have been produced using this technique, and highly specific binding clones were obtained on
several distinct targets.
A technology developed by Collins and Röttgen is also based on DNA recombination,
but overcomes the homology problem faced with the DNA shuffling method. This DNA
recombination strategy, leads to the formation of new recombinant variants displayed on the
surface of the phage particle, which is the equivalent, for random peptide libraries, of the
chain shuffling system, convenient for antibody libraries.
This strategy can lead to an increase of the diversity of the primary library at any time
during or after creation of the primary library (by recombination between variants, and/or by
introduction of a project specific cassette within the hypervariable domain of a random
peptide library). It is also possible to apply this method to a preselected population (i.e.,
clones recovered after a first round of panning selection), in order to recombine the variants
among themselves. During further panning cycles with this recombined library, clones with
optimized affinity for the target of interest, can be characterized.
This powerful strategy is the cosmix-plexing approach.
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D – Cosmix-plexing
The development of a novel technology, termed cosmix-plexing, allows
recombination within hypervariable DNA regions which bear only a two base pair homology.
This novel approach has been applied to reassort DNA which encodes random peptides, or
antibodies displayed on surface of the phage (Collins, Röttgen patent).
With this method, the potential diversity of the library is no longer represented solely
by the number of variants present in the initial library. Libraries made for use with this
technique contain a recombination site within the hypervariable domain. Typically,
recombination will be carried out with preselected population of (say) 104 variants, thus
generating 108 possible recombinants, containing essentially all the possible combinations of
sequences on either side of the recombination site (Collins and Röttgen, 1997b). The
advantage of this technique due to the increase in diversity of a preselected population thus
achieved, is shown in Figure I-7.
Using the cosmix-plexing approach, one reassorts the left and right sections of the
variable domain, by the use of Type IIs restriction enzymes. The characteristic of these
enzymes, is that they bind at a defined sequence, but cleave at a site a fixed distance away, i.e.
in a region with no demands on sequence specificity. Thus, a population with “optimized”
sequences for a larger number of residues can be generated.
The generation of recombination within a particular region is a powerful concept, as
discussed previously with respect to the DNA shuffling system developed by Stemmer
(Stemmer, 1994a/b). However, by comparison to the DNA shuffling, our method is not
limited by homologies between recombination partners, and shows a higher efficiency for
recombination within short regions.
Although the main advantage of cosmix-plexing induced recombination is obtain
through the increase in diversity during selection, it can also be used for the simple production
of large libraries (e.g. >109 variants).
In addition, the production of extension libraries, by the introduction of project
specific cassettes into existing libraries, is facilitated (Figure I-8). These cassettes are of
particular interest if a “core motif” is known (for example, Pro Pro Xxx Pro motif for the SH3
or EVH1 domains, which show a preference for proline rich ligands).
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    Primary
     library
Preliminary panning
       Cosmix-plexing  recombination
                 Further  panning
Figure I-7: Cartoon of the principle of cosmix-plexing induced recombination during
screening. A medium-sized combinatorial library (upper section) is subjected to an affinity
selection procedure, leading to the isolation of several thousand variants at least partially
fulfilling the selected requirement, in which on average some six amino acid residues may be
“optimal” (middle section). The left and right section of the hypervariable domain is
recombined so that all possible recombinants are produced. Further selection now leads to
isolation of “optimal” variants containing eight or nine optimized residues (Theoretically, one
can optimized until 12 residues, if the sequence is that long; lower section).
7 to 9
  optimal residues
   5 to 6 residues
        optimal
Primary
 library
Introduction
40
Figure I-8: Summary of the way in which cosmix-plexing can be applied. The upper
section shows the selection of an optimal primary ligand (principle outlined in Fig.I-11). The
consensus motif can be inserted as a “project specific” cassette into a secondary “extension”
library from which novel variants with optimized flanking sequences can now be isolated.
The cosmix-plexing induced recombination of the flanking sequences can now be used here,
once again, to advantage as an evolutionary strategy.
Project-specific
cassette
 Insertion of the cassette
                and reassortment
 
Reassortment after
        cleavage
Continue optimization?
1. reassort, left and/or right extension
2. insert extra cassette
Introduction
41
The theoretical advantage which can be obtained through cosmix-plexing library, can
be deduced by a consideration of the procedure of classical clone enrichment during standard
panning. “Normal” pannings are performed on a target of interest, and after a few rounds of
affinity selection, some enriched variants can be identified. These variants exhibit appropriate
properties to interact with the target molecule. Typically, a few clones are enriched, but some
unique variants are also present, which are highly related (i.e., show sequence homology), to
the enriched dominant clone(s), so that a consensus sequence can be conceived. This
consensus sequence represents the essential structure required for the binding to this target.
During the first panning round, the future dominant clones are present at extremely low
concentration (subnanomolar), as well as many other clones which exhibit weak affinity to the
target. As the dominant clone(s) become enriched, during further rounds, compete with the
weaker binders which are then eliminated during the washing steps of the panning.
The cosmix-plexing takes advantage of structural motifs from the low affinity ligands
present in early rounds, by recombining them with motifs from the stronger ligands, thus
creating novel diversity not present in the initial population. This novel diversity is strongly
enriched for the structural elements required for binding to the target!
The preselected population recovered after the first round of panning, is the working
material which is then submitted to recombination. At this stage, many of the clones present,
show an affinity capacity for the target, even if very weak. This preselected population is
recombined with a cross-over in the hypervariable region, producing all possible
recombinants (in order to produce all possible recombinants (say 108) from the preselected
population (say 104), a particularly efficient protocol had to be designed). By recombining
these clones amongst themselves, one reassorts two halves of the hypervariable region in each
clone. This raises the chance of bringing together domains which initially alone only allowed
weak affinity, but which now exhibit new features which may correspond to a theoretically
“perfect” structure for the binding to the target (at least over a region of 13 amino acids, for
the size of library used).
Further selection with this optimized library leads to the isolation of new clones which
should be optimal regarding to their affinity to the target.
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E – Target proteins
The initial aim of this work was to isolate strong ligands to SH3 domains. Aberrant
SH3 interactions are sometimes associated with uncontrolled signaling, which is a
characteristic of cancer cells (Cowburn and Kuriyan, 1996). SH3 containing proteins have
also been shown to be a causative factor in a fusion following chromosomal translocation,
leading to tumor (Mayer et al., 1995; Pendergast et al., 1993; Puil et al., 1994; Feller et al.,
1998). It was thus decided to develop competitive high affinity ligands to SH3 domains, so as
to develop tools for the investigation of the function of SH3 domain containing proteins in the
signal transduction cascade and cytoskeleton. These binders might lead to a better
understanding of the cells signaling pathway. However, they might also be able to compete
natural ligands in vivo, and therefore be able to induce or inhibit the SH3 interactions,
providing potential therapy agents against cancer, in combination with cell targeting
strategies. Considering the high preference of SH3 domains for proline rich ligands, we built
biased random peptide libraries containing prolines at three defined positions.
Recently, it has been shown by others, that the EVH1 domains, protein-protein
interaction modules implicated in the spatial control of actin assembly, mediate the interaction
with their partners, through a proline rich motif. Proteins of the EVH1 domain family have
been shown to interact directly with a bacterial surface protein of the intracellular pathogen
Listeria monocytogenes. Through this interaction, L. monocytogenes is able to recruit the host
actin filament in order to support its motility, augmenting its virulence. Strong binders to
EVH1 domains could disrupt the interaction between L. monocytogenes and the EVH1
modules, and therefore, prevent the cell to cell spreading of the bacteria. Since the EVH1
domains share with SH3 domains the property to bind proline rich ligands, the proline biased
library generated for the SH3 domains might be highly advantageous to isolate novel EVH1
domain ligands.
The project was therefore extended beyond the initially proposed characterization of
high affinity binders to SH3 domains, to include also EVH1 domain studies.
1- SH3 domains
1-1 Function and structure of SH3 domains
The Src Homology 3 (SH3) domains are found in a wide variety of unrelated proteins,
many of which are involved in signal transduction, indicating their important role in protein-
protein interactions. SH3 domains organize protein complexes within the cell, bring substrates
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to enzymes, and regulate enzymatic activities. SH3 domains are involved in pathways that
provide potential targets for therapeutic agents.
SH2 and SH3 domains are found together on many proteins (Figure I-9). Evidence
suggests that their activities might be coordinated, as shown in the work of Superti-Furga,
where mutation of the Src SH3 activates the kinase, and increases the accessibility of the SH2
to exogenous substrates (Superti-Furga et al., 1993).
SH2/SH3 domain containing proteins can be divided into two groups. The first group is
formed by enzymes, such as the Src family and phospholipase Cγ. The second group is the
adaptor protein group, which do not have any known catalytic activity, such as Grb2, Nck, or
Crk (Buday, 1999). The discovery of these adaptors revealed a new mechanism by which
signaling proteins can form multiprotein complexes. These complexes are held together by
the specific interaction of proline rich motifs with the SH3 domains of the adaptors. The SH2
domains of the adaptor can then recruit the complex to phosphorylated tyrosine residues.
        SH2/SH3 enzymes Activity
Src  SH3        SH2         kinase Tyrosine kinase
Abl  SH3        SH2         kinase Tyrosine kinase
PLCγ         PLC   SH2         SH2   SH3          PLC Phospholipase C
        SH2/SH3 adaptors Targets
Grb2     SH3         SH2          SH3 Ras pathway
Nck     SH3         SH3          SH3               SH2
c-Crk   SH2          SH3   SH3
p85 PI3K   SH3        SH2   SH2 PI  3’-kinase
Figure I-9: Structure of selected SH3 containing proteins (Buday, 1999; Pawson and Gish,
1992). The proteins are divided into those with intrinsic enzymatic activity, and those without
known catalytic domains, which may act as adaptors, to couple tyrosine kinases to
downstream targets.
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SH3 domains are protein modules of approximately 60 residues, which can be
expressed, purified and crystallized independently of the rest of the protein. The ligand
binding pocket is formed by a cluster of hydrophobic residues, and is flanked by two charged
and variable loops (n-Src, and RT loops) that contain clustered aromatic residues (Pawson and
Gish, 1992; Cohen et al., 1995; Brown and Cooper, 1996).
1-2 SH3 ligands form a left-handed polyproline type II helix
Homologies between natural-, and phage display isolated-ligands, suggest that the
binding motifs are 8 to 10 residues long, and are proline rich (Viguera et al., 1994; Lim et al.,
1994; Pawson, 1995; Alexandropoulos et al., 1995; Cohen et al., 1995). They present a
common PXXP core motif, which interacts with the hydrophobic groove. The specificity for
each particular SH3 domain, is determined by the flanking amino acids which allow more
extensive contact with a third pocket located in a valley between “n-Src” and “RT” loops.
This third pocket is the most structurally diverse in different SH3 domains, and play a major
role in binding specificity.
Interactions of proline-rich peptides with SH3 domains takes place through formation of
a left handed polyproline type II helix (PPII). This PPII helix contains 3 residues per turn,
with a triangular cross-section. One face is contacting the floor of SH3 domain binding
groove as shown in Figure I-10 (Cohen et al., 1995; Nguyen et al., 1998).
Adzhubei and Sternberg present interesting results pertaining to PPII helices (Adzhubei
and Sternberg, 1993). PPII helices are usually short segments of four to eight residues.
However, they are quite voluminous. A PPII helix is two times longer than an α-helix,
containing the same number of residues (the length of a PPII segment that includes four Cα
atoms is approximately equal to the length of a seven residue α-helix).
The most preferred amino acid within PPII helices, is proline. Its advantage is that, due
the preferred folding angle at proline residues, proline rich sequences adopt a PPII
conformation without a significant loss in conformational entropy. However it seems that
proline is not essential within the PPII helices, since 28 of the 96 PPII helices listed by
Adzhubei and Sternberg, are formed without a single proline (Adzhubei and Sternberg, 1993).
The work of Pisabarro and Serrano also tends to minimize the role of proline in PPII helices.
They indicate that prolines within the PPII helices are not essential. They show that proline
can be replaced by other amino acids, as long as a replacement and/or a compensating
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mutation is introduced elsewhere. It is thus concluded that there seems to be no essential
requirement for a particular Pro residue for an efficient interaction with an SH3 domain.
However, they could not prove that it was possible to mutate several Pro residues at the same
time (Pisabarro and Serrano, 1996). Whatever, the repertoire of SH3 binding peptides might
be much larger than previously thought.
SH3 ligand
      
    SH3 domain
     Proline rich core          Specificity
               binding grooves           pocket
Figure I-10: Peptide/SH3 domain complex interface shown schematically: polyproline
type II helix conformation (diagram according to Nguyen et al., 1998). The PPII helix
contains 3 residues per turn, with a triangular cross-section, with 3 spines. One face is
contacting the floor of SH3 domain binding groove. The residues located on the upper spine
cannot make any contact with the SH3 domain. Its role is to stabilize the PPII helix. The red
circles indicate positions were proline are advantageous. The blue line between the last
residue of the helix, on the N terminal side, and the SH3 domain specificity pocket, indicates
a salt bridge.
Other residues commonly present in PPII helices (according to the Chou-Fasman
algorithm, i.e. frequencies higher than average in the sample), are Gln, Ser, Arg, Ala and Val
(Chou and Fasman, 1978). Interestingly, Chou-Fasman predictions consider Gly as a residue
of choice for PPII helices, however, it is not commonly observed. Most of the PPII helices do
not form regular interchain hydrogen bonds. Thus, it is assumed that Gly would destabilize
the helix.
PPII helices lie mostly on the protein surface. Hydrophilic residues tend to occur
commonly in this structure. High accessibility, and orientation of NH and CO groups in PPII
helices suggest that potentially the formation of main-chain hydrogen bonds is favorable for
NH3+
COO -
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this structure. It is assumed that the most probable partners for this hydrogen bonding are
water molecules of the protein hydration shell, as well as water molecules incorporated in
protein structure. PPII helices, on the protein surface, form hydrogen bonds with water.
Hydration has a strong stability effect on the PPII helices.
1-3 Two classes of SH3 ligands
SH3 domains were considered to be unique in that they can bind their ligands in
opposite orientations, being classified as class I and class II ligands, both found in nature
(Feng, et al., 1994; Yu, et al., 1994). It has been recently shown that they share this
particularity with profilin, which also interacts with highly proline rich motif (Mahoney et al.,
1999). Class I and II ligands bind in NH2 - COOH and in COOH - NH2 orientation
respectively. The class I ligands for several SH3 domains, show the consensus sequence
RXLPPXP, while for the class II ligands the consensus sequence XPPLPXR has been
deduced. The major difference between the two classes, is the position of a critical arginine,
which forms a salt bridge with a conserved acidic residue in the SH3 domain, and thus,
determines the orientation of the ligand. This orientation-determining salt bridge was found to
be an important specificity determinant for cellular proteins binding to SH3 domains.
In summary, previous to this study, it was considered that SH3 ligands must contain a
central proline core motif, which adopts the PPII helix conformation, and interacts with the
aromatic grooves of SH3 domains. This core motif is flanked by N and C terminal amino
acids, one of each being assumed to be responsible for the specificity of each SH3 domain.
The binding of the flank appears to require the presence of the core, since a peptide having
only the flank sequence does not bind the SH3 domain. The core serves as a common anchor
used by SH3-binding peptides for initial docking, while the flank allows more extensive
contact at the intermolecular interface, thereby providing increased affinity and specificity
(Feng, et al., 1995).
1-4 Src SH3 domain
Over the 20 last years, much has been learned about Src and the related Src-family
kinases. Src family kinases are evolutionary conserved, with members found in both
vertebrates and non-vertebrates. In the mouse, 8 members of the family have been identified:
Src, Fyn, Yes, Lyn, Hck, Fgr, Blk, Lck), and one additional has been characterized in the
chicken, Yrk. All of these kinases share a common structure: a short amino-terminal
membrane anchor, a unique domain characteristic of each individual kinase, the SH3 domain,
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a SH2 domain, which  binds phosphotyrosine-containing peptide sequences, a catalytic
domain which encodes kinase activity, and a short carboxy-terminal tail containing the major
regulatory tyrosine residue. In all regions, except the unique domain, all family members
show extensive sequence homology (Lowell and Soriano, 1996; Brown and Cooper, 1996).
Src and the other Src family kinases, are believed to associate with the cytoplasmic
tails of transmembrane receptors that lack kinase domain, and thus, serve to transduce signals
from these receptors. A great deal of redundancy between members of the family is observed.
Ligation of receptors for growth factors (PDGF, EGF), cytokines (IL-2, IL-3, IL-6), antigens,
antibodies (thrombin, chemoattractants), and adhesion receptors (integrins) have all been
shown to result in activation in one or more of the Src family kinase members, in many
different cell types (Erpel and Courtneidge, 1995).
Src is found nearly ubiquitous, but highest in brain, platelets, and osteoclasts. Src have
essential functions in regulating cell growth and differentiation. However, most cells
developed normally in mice with a homozygous disruption in the src gene (Soriano et al.,
1991). Even cells in which Src is normally expressed at high levels, such as blood platelets,
seem to be unaffected, probably due to a compensation by other members of the Src family.
One cell type is affected by the deletion of the src gene. In Src deficient mice,
osteoclasts are unable to resorb bone effectively, resulting in osteopetrosis (Soriano et al.,
1991), suggesting that Src has an essential function in osteoclasts. A hypothesis to explain
that on this case, no compensation appears when Src is deficient, is that the other Src family
members are not stimulated by the signal recognized by Src, or, more presumably, that Src
have unique substrates which cannot be phosphorylated by the other Src family members.
1-5 Nck SH3 domain
The human Nck gene has been localized to the 3q21 locus of chromosome 3 (Huebner
et al., 1994). Aberrant genetic rearrangements within this region of chromosome 3 are
associated with various human hematopoietic malignancies, suggesting a potential
involvement of Nck in oncogenesis (Mitelman et al., 1991). Nck is a 47 kDa protein
ubiquitously expressed in mammalian cells (Lehmann et al., 1990), and is composed of three
SH3 domains, followed by a single SH2 domain. Nck has no intrinsic catalytic activity and
acts as an adaptor molecule, to couple upstream signals, usually those initiated by activation
of receptor tyrosine kinases, to downstream signal transducer molecules (McCarty, 1998;
Buday, 1999).
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Ligand binding to receptor tyrosine kinases induces the receptor chains to dimerization
and to transphosphorylate on specific tyrosine residues that provide docking sites for SH2
domains. Nck interacts via its SH2 domain with phosphotyrosine residues in receptor tyrosine
kinases (such as the receptors for epidermal growth factor (EGF), platelet-derived growth
factor (PDGF), or vascular endothelial cell growth factor (VEGF)). Nck interacts via its SH3
domains with effector molecules containing proline-rich sequences, bringing them to the
proximity of ligands-activated receptor tyrosine kinases.
1-6 Nephrocystin SH3 domain
The nephrocystin SH3 domain has been discovered very recently, in the group of
Hildebrandt (Hildebrandt et al., 1997a; Hildebrandt, 1998). The nephrocystin gene is
contained within a chromosomal region which is deleted in 80% of families suffering from
nephronophthisis.
Juvenile nephronophthisis (NPH), an autosomal  recessive cystic kidney disease, is the
primary genetic cause of chronic renal failure in the first two decades of life. The end-stage
renal failure is reached at an average age of 13 years, and leads to death unless treated with
dialysis or renal transplantation. The earliest anomaly is the presence of groups of atrophic
tubules with an irregularly thickened tubular basement membrane and focal interstitial
fibrosis. Diffuse tubulo-interstitial changes and medullary cysts are found later. These early
tubular basement membrane abnormalities and the inability to label them with certain anti-
tubular-basement-membrane antibodies (Cohen and Hoyer, 1986), suggest that the
fundamental defect in nephronophthisis might be the production of an abnormal tubular
basement membrane. A number of heterogeneous extrarenal abnormalities have been
described, associated with the renal disease (Kleinknecht and Habib, 1992).
A gene locus for NPH, termed NPH1, has been located on chromosome 2q12-q13
(Antignac et al., 1993). The NPH1 genetic region was cloned, as a means to identify the
responsible gene, and the presence of a large homozygous deletions of the NPH1 critical
region was demonstrated in 80% of NPH1 families (Hildebrandt et al., 1997b). A novel gene,
termed NPHP1, was characterized, which consists of 20 exons. Almost the entire gene was
found to be deleted in 16 of 22 families with NPH1, with one family exhibiting a smaller
deletion. It has been shown that there is at least one additional gene locus present in the
human genome (Medhioub et al., 1994).
Northern blot analysis of NPHP1 revealed a transcript of 4,5 kb, with strong
expression in skeletal muscle, and weak expression in kidney, pancreas and heart. The fact
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that NPHP1 is expressed only weakly in kidney should not diminish its candidacy as the
disease gene, as there are now many instances, where tissue expression levels of disease genes
do not correlate with the site of clinical manifestation (Meindl et al., 1996). The sequence data
base comparison of the full length cDNA sequence showed that NPHP1 gene is unrelated to
known gene families. However, a short fragment of the deduced amino acid sequence of its
gene product, termed nephrocystin, shows strong similarity to SH3 domains, particularly to
the c-crk proto-oncogenes from mouse and man, as well as to other SH3 containing genes of
Drosophila, Caenorhabditis elegans, and Schizosaccharomyces pombe. The potential
function of the SH3 domain in the NPHP1 gene product is unknown.
2- EVH1 domains
The Ena/VASP homology (EVH1) domain is a protein interaction module found in
several proteins that are involved in transducing migratory and morphological signals into
cytoskeletal reorganization (Prehoda et al., 1999). EVH1 specifically recognizes proline-rich
sequences in its binding partners and directs the localization and formation of
multicomponent assemblies involved in actin-biased motile processes (Mitchison and Cramer,
1996; Laurent et al., 1999) and neural development (Tu et al., 1999).
The EVH1 domains composed  family of adapter proteins, including Enabled (Ena),
identified in genetic screens for dominant mutations that alleviate phenotypes associated with
mutations in the Drosophila homologue of Abelson tyrosine kinase (Abl), Vasodilator-
stimulated Phosphoprotein (VASP), characterized as a major substrate for cAMP- and
cGMP-dependent protein kinases in human platelets, two murine proteins, Mena and Evl,
identified by their similarity to Ena, the Wiskott-Aldrich syndrome protein (WASP), or
Vesl/Homer, which belong to a family of postsynaptic proteins that are thought to function in
synaptic plasticity (Brakeman et al., 1997; Kato et al., 1997).
The proteins share a similar overall structure: the highly conserved N-terminal Ena-
VASP Homology Domain 1 (EVH1), a central proline rich sequence, containing SH3 or
profilin binding motifs (except for Vesl/Homer), and the conserved C-terminal EVH2 domain
(or WASP homology 2, WH2 for WASP).
Specific interaction between EVH1 domains and their ligands serves to mediate the
proper localization of proteins from the Ena/VASP family and to link them to other molecules
with which they cooperate. EVH1 domains localization occurs through binding to proline-rich
motifs of consensus sequence FPPPP (Niebuhr et al., 1997). Subsequently, they act as
scaffolds to recruit or activate downstream components of the actin assembly machinery.
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FPPPP motifs are found in several proteins involved in transmitting external signals to the
actin cytoskeleton, including the focal adhesion proteins zyxin and vinculin, and the axon
guidance receptors SAX-3/Robo.
The  proline rich EVH1 ligands, as for SH3 domains, bind to the EVH1 domain through
a polyproline type II helix conformation (Prehoda et al., 1999).
The cellular proteins VASP and Mena, have been shown to interact directly with a
bacterial surface protein of Listeria monocytogenes: ActA. This interaction is mediated by the
EVH1 domain which bind to a minimal consensus binding sequence E/DFPPPPTD/E, a motif
repeated four times within the bacterial ActA protein (Niebuhr et al., 1997).
L. monocytogenes is a widespread, rapidly growing, Gram-positive bacterium, capable
of invading a variety of host cells, that causes food-borne infections in animals and humans
with severe implications, especially for pregnant women, newborns, and
immunocompromised individuals. Its virulence and cell to cell spreading is dependent on its
ability to exploit the actin-based cytoskeleton of host cells to support its motility. ActA is
necessary and sufficient for the recruitment of host actin filament. It contains two separable
domains required for interaction with the actin cytoskeleton: a N-terminal 23 amino acid
region, essential for actin filament nucleation, and a proline-rich repeat region, required for
efficient actin filament recruitment.
ActA initiate a cascade of events leading to formation of a specific F-actin structure,
and subsequent actin-based movement in favor of L. monocytogenes, through its interaction
with EVH1 domains. This suggests that VASP, Mena and their relatives act as efficient
accelerators of actin filament assembly, probably by delivering profilactin to sites of high
actin filament dynamics (Niebuhr et al., 1997). ActA attracts profilactin to the interface of the
bacterium and its actin tail by recruiting VASP and Mena, thereby enhancing local actin
polymerization and enabling rapid actin-based movement. VASP and Mena are therefore
required for efficient intracellular motility and virulence of L. monocytogenes (Niebuhr et al.,
1997; Carl et al., 1999; Laurent et al., 1999; Prehoda et al., 1999). Furthermore, EVH1
domains bind strongly to ActA than to natural ligands. Therefore, the study of EVH1
interactions is of medical interest, with respect to L. monocytogenes pathogenesis.
3- The use of fusion proteins for higher expression: GST fusion proteins
During the early stage of recombinant DNA technology, it was thought that a strong
promoter and a start codon at the beginning of the gene would be sufficient for good
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expression in Escherichia coli. Since then, it has been learned that in addition to a promoter
and a start codon, good expression requires that the mRNA contain a ribosome-binding site
that is not blocked by mRNA secondary structure. The level of expression is also affected by
codon preferences, especially in the second codon of the gene (Stormo et al., 1982), and may
be affected by the coding sequence in other ways that are not yet well understood. These
problems can be solved by altering the sequence preceding the start codon and/or by making
changes in the 5’ end of the coding sequence that do not change the protein sequence, taking
advantage of the genetic code.
However, since much of this data on translation variables is anecdotal, it is often
quicker to solve these problems by making fusions between genes. In this approach, the
cloned gene is introduced into an expression vector fused to a sequence (carrier sequence)
coding for a highly expressed protein (carrier protein). The carrier sequence can be from any
gene that is strongly expressed in E. coli. The carrier sequence provides the necessary signals
for good expression.
These carrier regions can often be exploited in purifying the protein, either with
antibodies, or with affinity purification specific for the carrier protein. Alternatively, unique
physical properties of the carrier protein can be exploited to allow selective purification of the
fusion protein.
There are two problems often encountered when expressing fusion proteins. The first
one concerns the solubility of the fusion proteins. In many cases, a high level protein
expression leads to the formation of inclusion bodies (very dense aggregates of insoluble
protein and RNA that contain most of the expressed protein). This difficulty can be solved by
lowering the expression level of the protein, or by using another strain to propagate the fusion
proteins (La Vallie et al., 1993; Schein, 1989).
The second problem deals with the stability of the expressed protein and the presence
of the carrier protein. Fusion proteins are sometimes cleaved in vivo at the junction/linker of
the fusion protein, which creates problems if the carrier protein is to be used as an aid in
purification. It might happen that the carrier domain and/or the expressed protein do not fold
correctly and might be degraded by E. coli proteases. One solution to stabilizing the fusion
proteins is to express them as insoluble aggregates. Another possibility is to use E. coli strains
deficient in known proteases. In addition, shorter induction times may increase the ratio of
full-length proteins to breakdown products, although the total amount of protein will be
lower.
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In some cases it is advantageous to remove the carrier protein in order to facilitate
biochemical and functional analyses. In most cases, the linker between the carrier protein, and
the protein to be expressed, contains cleavage possibilities, either for chemical cleavage
(cyanogen bromide or low pH which allow cutting respectively after Met or between Asp and
Pro, as examples) or for enzymatic cleavage (e.g. factor Xa, thrombin, enterokinase, renin or
collagenase). All of these enzymes have extended substrate recognition sequences which
greatly reduces the likelihood of unwanted cleavages elsewhere in the protein, although
cleavage is commonly inefficient.
The fusion protein can be coupled to many different carrier proteins, such as β-
galactosidase, trpE, maltose-binding protein (MBP), thioredoxin (Trx), or glutathione-S-
transferase (GST). The GST fusion protein is the only fusion expression system discussed in
this work as it is the system applied in our laboratory. The main advantage of GST fusion
proteins over these other methods is its use during purification, and at a later stage, in its use
for immobilizing the target during panning and measuring kinetic binding constants. Indeed,
for β-galactosidase, trpE, MBP and Trx, the denaturing reagents used during purification can
be expected to alter the antigenicity and functional activity of the purified product. However,
GST can be purified by affinity chromatography on immobilized glutathione followed by
competitive-elution with excess reduced glutathione (Simons and Vander Jagt, 1977).
pGEX vectors have been designed to express foreign polypeptides as fusions with
GST. Such fusion proteins are soluble and are easily purified from lysed cells under
nondenaturing conditions.
Each pGEX vector contains an open reading frame encoding GST, followed by unique
restriction sites, followed in turn by termination codons in all three reading frames. The GST
carrier of pGEX vectors can be eventually removed by site-specific proteolysis, or by
chemical hydrolysis at low pH.
Expression of the GST fusion proteins is controlled from a ptac promoter. The lac
repressor (product of the lacI gene) binds to the promoter, repressing the expression of the
fusion protein. Upon induction with IPTG, derepression occurs and GST fusion protein is
expressed. Typical yields of fusion protein vary from 1 to 3 mg/liter up to 10 mg/liter.
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F – BIAcore – real time interaction measurements
The BIAcore is a biosensor-based analytical system, designed for functional
characterization of protein-protein, protein-DNA, and ligand-receptor interactions in real
time. As all the interactions are dynamic processes, the ability to measure precisely their
kinetic parameters and determine how fast one molecule binds to and dissociates from another
is very important for understanding the regulation of the biological processes involved.
The BIAcore is based on a surface plasmon resonance (SPR) to monitor the adsorption
of biomolecules on a sensor chip. This optical technique measures changes in refractive index
of the medium very close to the surface. Such changes are directly proportional to the amount
and molecular weight of the macromolecules bound at any time.
The system includes a sensor chip to which the ligand can be immobilized on a matrix
composed of flexible dextran, a miniaturized fluidics cartridge for the transport of analytes
and reagents to the sensor chip, a SPR detector (Jönsson and Malmqvist, 1992; Malmqvist,
1993). A laser source emits a plane-polarized light which is aimed through a prism, on a gold
covered sensor chip where the targets of interest are immobilized. When the analyte binds to
this target, the beam angle is altered, and monitored, so that the intensity of the interaction can
be determined. The measurements are performed continuously and the angle differences are
expressed in arbitrary resonance units, so that a real time plot (sensorgram) of the sensor
response, in resonance units, versus time can be obtained (Panayotou et al., 1993).
In this work, the BIAcore was used to study the binding kinetics of peptides to our
target molecules. The adsorption rate can be measured using BIAcore, since the adsorption of
an analyte to a surface-immobilized ligand is carried out at a constant flow rate whereby the
concentration of the analyte is kept constant. This adsorption can be regarded as a pseudo first
order reaction. From this, the association rate constants can be obtained by carrying out a
series of adsorption experiments with different analyte concentrations. The decrease in
complex concentration on the surface after the sample pulse has passed can be used for the
determination of dissociation rate constants.
The BIAcore has been shown to be valuable in several other applications, such as
determination of interacting ligands (Malmborg et al., 1996), protein/DNA interactions
(Sibille et al., 1997), or epitope mapping (Fägerstam et al., 1990). In addition, some groups
used the BIAcore as an alternative affinity selection procedure, to select binders from phage
displayed antibody libraries. Malmborg et al. injected Fab phage stocks displaying antibodies
specific for hen egg lysozyme, over a biosensor chip containing immobilized lysozyme. The
bound phage were eluted, and characterized as antigen-specific (Malmborg et al., 1996).
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G – Testing the functionality of the selected peptides, in vivo
Structure-function analysis of signal transduction proteins, can be aided by synthetic
peptide analogs, representing putative sites of intracellular protein-protein interactions.
Unfortunately, the cell membrane is usually impermeable to synthetic peptides, or antibodies.
Therefore, a wide variety of methods have been proposed for the delivery of proteins and
other macromolecules into living cells for either experimental or therapeutic uses. These
include microinjection of antibodies and peptides to individual cells (Diacumakos, 1978;
Wang et al., 1982); the use of membrane disrupting pore-forming reagents (Wang et al.,
1982); electroporation (Stauffer et al., 1997); liposome encapsidation (Renneisen et al., 1990;
Wu et al., 1991); bacterial toxins (Prior et al., 1992; Stenmark et al., 1991); or receptor-
mediated endocytosis (Ishihara et al., 1990; Wilson et al, 1992; Leamon and Low, 1992).
Most of these methods are either inefficient or time-consuming, cause appreciable cell death,
or result in uptake into intracellular vesicles without efficient cytoplasmic delivery. Several
approaches rely on binding of macromolecules to the cell surface, followed by internalization
via the endocytic route. However, since proteins that have entered this pathway remain
enclosed within the lipid vesicles, they do not have access to the cell cytoplasm.
Alternatively, transfection experiments can be used to introduce DNA encoding truncated or
mutated intracellular proteins (Henkel et al, 1992; Perlmutter et al., 1996). Such approaches
have, however, severe limitations which obstruct progress in analysis of intracellular proteins.
During the past years, new strategies to deliver functional peptides to cells, have been
developed, to probe intracellular protein-protein interactions. Techniques used to transfect
proteins or peptides within cells are briefly described and compared in this chapter.
1- Conventional methods for transfection
1-1 Antennapedia homeodomain peptide
The 60 residue homeodomain of the Drosophila Antennapedia has the ability to
rapidly cross the plasma membrane of neuronal cells, and accumulate in their nuclei (Joliot et
al., 1991a). The third helix within the homeodomain, encompassing 16 residues, was shown
to translocate through the cell membrane in a temperature-, energy-, and receptor-independent
manner (Derossi et al., 1996). This discover gave rise to its application as a nuclear targeting
agent. However, the internalization of Antennapedia homeobox domain requires a neuronal
cell adhesion molecule decorated with α-2, 8-polysialic acid. Therefore, this domain has
special predilection for neuronal cells, since they express this neuronal cell adhesion
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molecule. To some extent, other cells (such as fibroblasts: Joliot et al., 1991b) express this
adhesion molecule, and thus, allow uptake at a low level.
However, this system cannot be commonly applied, as it is restricted to particular
types of cells, and presents interest only if imported peptides are to be localized in the
nucleus.
1-2 Myristoylated peptide
Another approach to cellular import of peptides utilizes modification of peptides by
attachment of a fatty acid as a means to overcome the permeability barrier of the plasma
membrane. Amino-terminal myristoylated peptides are cell permeable (Eichholtz et al., 1993).
Attachment of a myristoyl group to the amino-terminus of the peptide, provides a suitable
membrane anchor, and therefore, it potentially restricts the use of this imported peptide to the
cytoplasmic face of the plasma membrane.
Furthermore, these complex molecules exhibit intolerable cytotoxicity, limiting their
use for structure-function analysis of intracellular protein in living cells.
1-3 Signal sequence h region
Cell-permeable peptide import (CPPI), based on the signal sequence hydrophobic
region (h region), takes advantage of its ability to translocate across cellular membranes, due
to a short membrane translocating sequence (MTS) (Lin et al., 1995; Hawiger, 1997). This
region is present in Kaposi fibroblast growth factor (FGF), and in integrin β3 signal sequences
(16 and 15 residues respectively). The ability of signal peptides to insert into membranes, and
their in vivo function, correlate with the residue-average hydrophobicity of their hydrophobic
cores. The short h region of a signal peptide can be used as a carrier for import of a cargo
peptide. The h region can be placed at either the N- or C-terminus. Rojas et al. (1998),
succeeded to import a 41 kDa GST-Grb2SH2-MTS protein into NIH 3T3 cells.
When such cell-permeable peptides are associated with a short peptide sequence called
the nuclear localization signal (NLS), the imported peptide is found to be present in the
nucleus. Typically, NLS motifs represent a cluster of basic residues (arginine and lysine)
flanked by acidic amino acids and/or prolines. The NLS is recognized, and binds to the
cytoplasmic face of a NLS receptor, on the nuclear pore, with the help of an accessory protein
(p90), and the NLS bearing protein is shuttled to the nucleus.
The intracellular localization of imported C-terminal MPS fusion peptides, reaches a
maximum concentration within 45 minutes, at 37°C, and is detectable in cells, up to 180
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minutes after peptide addition. The intracellular concentration of imported peptides reaches
4% of the peptide added to the media. Therefore, this technique appears to be limited by the
short life time of the imported peptide within the cells, and a relatively low efficiency, since
96% of it, will not be transfected. In addition, when presence of imported peptides is required
within the nucleus, a more complex system has to be faced: the presence of the NLS is
required in the construct, but moreover, the translocation involves other proteins, and depends
on the p90 accessory protein (see Powers and Forbes, 1994, for a minireview on nuclear
import).
2- HIV-1 Tat protein
In 1988, Green and Frankel independently discovered that human immunodeficiency
virus type 1 (HIV-1) Tat protein was able to cross cell membranes. When, in 1994, Fawell et
al. demonstrated that chemically cross-linking Tat to heterologous proteins, conferred the
ability to transduce into cells, it has been submitted to criticism, as it was thought that the Tat
protein was highly toxic for the cells. Indeed, it has been shown that Tat effects include
alteration of normal neuronal and astrocyte organization (Kolson et al., 1993), upregulation of
β2 integrins in monocytes, thereby increasing their adhesiveness (Lafrenie et al., 1996),
angiogenic activities (Albini et al., 1995), and apoptosis of cultured human blood cellular
mononuclear cells (Li et al., 1995).
However, these toxicity difficulties have been overcome by using truncated Tat
domains for the fusion with the heterologous proteins. Tat is an 86-amino acid protein,
involved in the replication of HIV-1. A region of the Tat protein, extended from residues 37
to 72, and centered on a cluster of basic amino acids allows the internalization of fused
proteins. Originally, truncated Tat (37-72) was selected because it retains the basic domain
implicated in uptake, and lacks the cysteine-rich region of Tat (residues 22 to 37) that has
complicated the handling and analysis of fusion-peptides (Fawell et el., 1994). Vivès et al.
(1997) showed that, unexpectedly, the domain extending from amino acids 37 to 47, and
which adopts an α-helical structure, with amphipathic characteristics, is not required for
efficient and fast cell uptake. It even appears that a high concentration of peptides with full
length α-helix decreased the cell viability. The Tat segment essential for Tat translocation and
nucleolar localization, was delineated as the previously described cluster of basic amino acids
(Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg, from positions 49 to 58), which additionally
contains a nuclear localization signal (NLS) sequence. NLS causes the ever-open central
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channel of the pore (90 Å) to expand transiently up to 260 Å in diameter to allow nuclear
protein entry (Powers et al., 1994).
The mechanism by which Tat traverses a membrane remains unclear. It is not believed
any longer that endocytosis would be involved, as low temperature incubation do not alter
cellular uptake. It has also been proved that a significant membrane disruption by Tat basic
peptides, or a well defined internalization pathway were not involved in the import (Vivès et
al., 1997).
It has been demonstrated that Tat binds to specific cell surface proteins, raising the
possibility that delivery is receptor-mediated. However, since delivery at present appears to be
independent of cell type, then, if such a receptor exists, it would have to be ubiquitous.
Currently, the most likely hypothesis for the Tat translocation mechanism, involves a
tight ionic interaction between the basic groups of the peptide side chain, and the negative
charges of the phospholipid heads, which would induce a local invagination of the plasma
membrane. The local reorganization of the phospholipid bilayer would then lead to the
formation of inverted micelles with the peptide enclosed in the hydrophilic cavity and
ultimately to the cytoplasmic release of the peptide. Since protein transduction is thought to
target the lipid bilayer component of the cell membrane, in principle, all mammalian cell
types should be susceptible to import of proteins.
The short cluster of basic amino acids of Tat protein (49-58) has been extensively used
in Dowdy’s laboratory, where a new strategy for the transfection has been developed. In the
work of Fawell, or Vivès, the heterologous protein was chemically cross-linked to the Tat
fragment. However, the synthesis of peptides carrying clusters of basic residues (and
succession of arginine in particular) often lead to coupling problems. In addition, it appears
that optimal uptake of Tat required the presence of the lysomotropic agent chloroquine to
reduce protein degradation.
In Dowdy’s approach, rather than depending on the uncertainties and inefficiencies of
chemically cross-linking proteins, a bacterial expression vector (pTAT-HA) was constructed,
to produce in-frame Tat fusion proteins. Because of reduced structural constraints, high
entropy, denatured proteins may transduce more efficiently into cells than low entropy,
correctly folded proteins. Once inside the cell, transduced denatured proteins may be correctly
refolded in vivo by host chaperones (such as HSP90). Therefore, the proteins are expressed
and purified in a urea-denaturating protein purification protocol (Nagahara et al., 1998).
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Tat fusion-proteins prepared in this way rapidly transduced in 100% of cells,
achieving maximum intracellular concentration in less than 10 min, in a concentration-
dependent manner. In addition, they retain known biological and biochemical activities.
Around 60 Tat fusion- proteins have been successfully transduced in Dowdy’s laboratory, in a
variety of cell types (e.g. fibroblasts, bone marrow stem cells, osteoclasts, or NIH 3T3 cells).
Tat fusion-proteins readily transduced into all cells present in whole blood, including both
nucleated and enucleated cells. Confocal microscopy analysis has demonstrated that
transduced proteins are localized in both cytoplasmic and nuclear compartments, and not just
attached to cellular membranes (Nagahara et al., 1998).
Since they developed this system, Dowdy and coworkers already proved that the
method is applicable to delivery of therapeutics. By using a “Trojan horse” strategy, they
managed to specifically kill HIV-infected cells (Vocero-Akbani et al., 1999). They engineered
a modified caspase 3 protein (when activated, caspase 3 induces apoptosis), fused to the Tat
protein. This fusion protein transduced in 100% of infected and uninfected cells. However,
because of the substitution of endogenous cleavage sites, for HIV proteolytic cleavage sites,
Tat-caspase 3 is only activated by HIV protease, in infected cells, resulting in apoptosis,
whereas, in the uninfected cells, it remains in the inactive form. This discovery represents an
alternative of considerable advantage in treatment of HIV patients, whereby death or
apoptosis is achieved in infected cells, thereby limiting or eliminating virus production, while
leaving uninfected cells unharmed.
Recently, they succeeded to deliver a 120 kDa biologically active Tat fusion-protein to
all tissues in mice, including the brain, by intraperitoneal injection (Schwarze et al., 1999).
Previously, importing of bioactive peptides across the blood-brain barrier, was restricted to
small (maximum six amino acids) and highly lipophilic peptides. These results open new
possibilities for direct delivery of proteins into patients, in the context of development of
vaccines, or protein therapies for cancer and infectious diseases.
This Tat fusion system was chosen to transfect ligands into cells in this work. We
considered that these novel ligands, isolated with the cosmix-plexing approach of phage
display, might be strong enough, to compete the natural SH3 ligands in vivo. This method
gives us the opportunity to confirm it.
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H – Aim of the work
Phage display is probably the most powerful of the combinatorial library approaches.
However, as observed in recent literature, the real challenge currently, is to generate an
artificial evolution, and thus to increase the diversity of the libraries, by the introduction of
modifications (mutations or recombinations) within the peptides or proteins displayed on the
phage surface. The aim of this accelerated evolution, is to identify a few altered variants with
optimized binding capacities for their target. This is also the aim of this work.
To reach this goal, to establish a system allowing the isolation of high affinity binders,
SH3 domains were chosen as a model system. SH3 domains are essential to regulate cellular
interactions, since they are involved in signal transduction pathways. It was considered that
increase of the present knowledge about SH3 domains is of interest in developing therapeutic
agents, e.g. against cancer, since aberrant SH3 interactions are sometimes associated with
uncontrolled signaling, which is a characteristic of cancer cells (Cowburn and Kuriyan, 1996).
Furthermore, as many groups concentrated during the last few years on SH3 domains, much is
known about their ligands preferences, giving us also the opportunity to compare results
obtained with different phage display approaches, and to determine which of them are really
advantageous. Therefore, SH3 domains appear as a model of choice to investigate methods
which would allow the isolation of high affinity ligands.
The ligand preferences of the SH3 domains are based on a central proline rich motif.
This feature allows the creation of dedicated biased libraries. A second family of proteins, the
EVH1 domains, were also investigated during this work, as they also show preference for
proline rich domains. Their analysis was a further validation of the strategies chosen.
Two strategies were investigated to isolate and characterize very strong binders
against SH3 and EVH1 domains. The first one, commonly used for different kind of targets,
deals with the utilization of biased constrained libraries. It was unfortunately unsuccessful.
The second approach takes advantage of a DNA recombination strategy developed by John
Collins (Collins and Röttgen, patent applied, 1997), the cosmix-plexing technology. The
goal of this part of the work was to test whether or not the use of this technology, combined to
phage display methods, is advantageous compared to existing technologies.
A brief overview of the aims and the strategies employed in this work begins with the
generation of dedicated libraries to SH3 and EVH1 domains. These libraries might allow the
characterization of binders, during affinity selection procedures, against both families of
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domains. The next objective was to recombine the clones of the dedicated cosmix library
among themselves, and to select, from this secondary bank, ligands which present optimized
properties for SH3 and EVH1 domains. It was considered feasible that such ligands would be
able to compete in vivo with natural ligands of SH3 and EVH1 domains, and thus, open the
possibility of elaborating cellular models where the signal transduction pathways could be
tightly controlled and regulated. These models could open numerous novel possibilities of
developing medical applications.
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II - MATERIAL AND METHODS
A- Material
1- Chemicals
All Chemicals used in the context of this thesis were of analytical quality. Aqueous
solutions were prepared with double deionized (Milli Q) water. Where applicable solutions
were autoclaved.
2- Devices
Electrophoresis
Agarose gel: Horizontal gel electrophoresis system, model H3 and horizon 58. Bethesda
research laboratories, Neu Isenberg, Germany.
Polyacrylamide gel: Vertical gel electrophoresis system, model V16. Bethesda research
laboratories, Neu Isenberg, Germany.
Power supply: Power Pack P30, Biometra Biomedizinische Analytik GmbH Göttingen,
Germany.
PCR reactions
DNA Thermal Cycler. Perkin Elmer GmbH, Weiterstadt, Germany
DNA sequencing
ALF-DNA-Sequencer  and  ALF-Manager  software,  version  2,5. Pharmacia Biotech
Europe GmbH, Freiburg, Germany.
Applied Biosystems ABI Prism 310, and ABI Data collection software, version 2.1.
Perkin Elmer Applied Biosystems GmbH, Weiterstadt, Germany.
Electroporation
Gene pulser and pulse controller (0,2 cm cuvettes). Bio-Rad laboratories GmbH,
Munich, Germany.
Centrifuges
Biofuge Fresco. Heraeus Sepatech GmbH, Osterode, Germany.
Sorvall RC5C. Du Pont de Nemours GmbH, Bad Homburg, Germany.
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Photometer
Multiskan MCC/340 MKII. Bartholomey Labortechnik, Alfter, Germany.
GeneQuant II RNA/DNA calculator. Pharmacia Biotech Europe GmbH, Freiburg,
Germany.
ELISA plate reader
Labsystems Multiscan MS, Labsystems, Frankfurt, Germany.
Affinity studies
BIAcore 2000, and biacontrol software version 3.0. Pharmacia Biosensor, Uppsala,
Sweden.
3- Computer software
ALF-Manager software, version 2,5. Pharmacia Biotech Europe GmbH, Freiburg,
Germany.
ABI Data collection software, version 2.1. Perkin Elmer Applied Biosystems GmbH,
Weiterstadt, Germany.
Vector NTI 5.0. Informax Inc., Gaitherburg, MD 20877, USA.
Biacontrol software version 3.0. Pharmacia Biosensor, Uppsala, Sweden.
4- Oligonucleotides
Oligonucleotides were used for cloning, PCR amplification and DNA sequencing, which
were ordered from Gibco BRL life technologies Ltd, Paisley, United Kingdom or MWG
(Ebersberg, Germany).
4-1 Generation of the constrained libraries: pSKAN8-HypD, -HypE, -HypF, -HypG
4-1-1 Hypervariable oligonucleotides
pSKAN8-HypD
                           Primer A                             KpnI
5’    GCTACAACGAGCTCAACGGTTGC(NNK)4CCANNKAGATGCGGTACCGACGGT
               SacI                                 Primer B
GACACTTACCC    3’
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pSKAN8-HypE   
     Primer A                        KpnI
5’    GCTACAACGAGCTCAACGGTTGCAGA(NNK)3CCC(NNK)2TGCGGTACCGACG
               SacI                                Primer B
GTGACACTTACCC    3’
pSKAN8-HypF   
                             Primer A                                      KpnI
5’    GCTACAACGAGCTCAACGGTTGC(NNK)2CCG(NNK)2CCN(NNK)2TGCGGTACC
               SacI                                         Primer B
GACGGTGACACTTACCC    3’
pSKAN8-HypG
                             Primer A                                      KpnI
5’  GCTACAACGAGCTCAACGGTTGC(NNK)3CCACCCNNKCCG(NNK)2TGCGGTA
                               SacI                                          Primer B
CCGTGACACTTACCC    3’
N stands for A, C, G or T
K stands for C or G
4-1-2 PCR primers
Primer A   5‘  biotin GCTACAACGAGCTCAACGGTTGC   3‘
Primer B   5‘  biotin GGGTAAGTGTCACCGTCGGTACCGCA   3‘
4-1-3 Sequencing primer
#2897  5’  GGAGGTCTAGATAACGAGG  3’
4-2 Display of a short and a long Grb2N ligand, as pIII fusion peptides
 4-2-1 Short Grb2N ligand
           Primer A
5’ CTCAACGGTTGCTGGGATTCTCTGTTGCCCGCACTGCCCTGCGGTACCGAC  3’
 Primer B
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4-2-2 Long Grb2N ligand
Due to the size of this DNA fragment, the sequence was divided in three overlapping
oligonucleotides (the overlapping regions are represented in italic), leading to the desired
product after PCR. The following is representing the overlaps between the three
oligonucleotides. Strands 5’ to 3’ are represented in red, and complementary strands (3’ to 5’)
in green.
                 LgGrbN1           LgGrbN3
                      LgGrbN2             
LgGrbN1
          Primer A
5’  CTCAACGGTTGCCCCAAATGGGACAGTCTCTTGCCT  3‘
LgGrbN2 (complementary strand)
5’  AAAGCAGGTGGTAATGCAGGCAAGAGACT  3‘
LgGrbN3
5’  ACCACCTGCTTTCACTGTTGAAGTTTGCGGTACCGAC  3‘
    Primer B
The reconstitution of the total fragment was performed in three PCR.
PCR1:     Primer A      LgGrbN1
                            LgGrbN2
       LgGrbN1 + LgGrbN2
PCR2: LgGrbN3   
  Primer B
     LgGrbN3
PCR3: PCR1 product + PCR2 product
Primer A        LgGrbN3
                                   LgGrbN1 + LgGrbN2 Primer B
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       LgGrbN1 + LgGrbN2 + LgGrbN3
4-2-3 PCR Primers
Primer A   5‘  biotin GCTACAACGAGCTCAACGGTTGC   3‘
Primer B   5‘  biotin GGGTAAGTGTCACCGTCGGTACCGCA   3‘
4-2-4 Sequencing primer
#2897  5’  GGAGGTCTAGATAACGAGG  3’
4-3 Generation of the CPLPPXP library: 8 amino acid primary library
4-3-1 Hypervariable oligonucleotide
    Primer C                                KpnI
GACGTTGAGCTCGGCTGGAGA(NNB)4 NZZ (NNB)3GATCCCGGGTACCGCTACC
           SacI        BpmI                                Primer D
N stands for A, C, G or T
B stands for C, G or T
ZZ represents AM (AA, AC), CT, GG, TS (TC, TG)
4-3-2 PCR primers
Primer C    5’ biotin GAC GTT GAG CTC GGC TGG 3’
Primer D    5’ biotin GGT AGC GGT ACC CGG GAT 3’
4-3-3 Sequencing primer
#2897  5’  GGAGGTCTAGATAACGAGG  3’
4-4 Generation of the CPLPPXP library: project specific proline rich cassette
4-4-1 Hypervariable oligonucleotide for the proline rich cassette
                     Primer C
5’  GACGTTGAGCTCGGCTGGGCAATGZZCCCCCANNBCCTNZZATCCCGGGTAG
            BpmI              BseMI       Primer E
CCGCTCCAGTACC   3’
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Schematic restriction map of BpmI and BseMI type IIs restriction enzyme:
       ...   GCAATGZZ CCC CCA NNB CCT NZZ ATCCCGGGTAGCCGCTCCAG   ...
       BseMI                                BpmI 
N stands for A, C, G or T
B stands for C, G or T
ZZ represents AM (AA, AC), CT, GG, TS (TC, TG)
4-4-2 PCR primers
Primer C  5’ biotin GAC GTT GAG CTC GGC TGG 3’
Primer E  5’ biotin GGT ACT GGA GCG GCT ACC 3’
4-4-3 Sequencing primer
#2897  5’  GGAGGTCTAGATAACGAGG  3’
4-5 Expression of GST fusion nephrocystin SH3 domain
4-5-1 PCR primers
                               SmaI
Nephro1: 5’  CGTCGCCCGGGAATTCCACAAATGG  3’
                              SalI
Nephro2: 5’  TAGCTTGGCTGCAGGTCGACGGATC  3’
4-5-2 pGEX 5’ sequencing primer (Pharmacia Biotech, Freiburg, Germany)
5’  GGGCTGGCAAGCCACGTTTGGTG  3’
4-6 Expression of Tat fusion peptides
4-6-1 PCR primers
                         XhoI
TATfwd: 5’ TATATTCCTCGAGCTCGGCTGGAGA 3’
         EcoRI
TATrev: 5’ CCGGCGAATTCCTGATATCGGGGTA 3’
4-6-2 Sequencing primer
pTAT-HA fwd: 5’ ATC TCG ATC CCG CGA AAT TA 3’
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5- Bacteria, bacteriophage and plasmids
M13K07 bacteriophage, used as helper phage was obtained from Pharmacia Biotech,
Freiburg, Germany and amplified according to a protocol described below.
Bacteriophage
M13KO7 KmR-Gen (Tn903)  Viera and Messing, 1987
plasmid replication origin (p15A) integrated in replication of origin.
E. coli strains Genotype/Phenotype       References
BL21(DE3)pLysS E.coli, B, F-, dcm, ompT, hsdS(rB-mB-), Studier et al., 1990
gal λ(DE3) [pLysS, Camr]
JM101λ supE, thi-1, ∆(lac- proAB), Yanish-Perron et al., 1985
[F’, traD36, proAB, lacIqZ∆M15], λ+
WK6   galE, strA, nalT, ∆(lac, pro),  Zell and Fritz, 1987
F’[proAB, lacIqZ∆M15]
WK6λ galE, strA, nalT, ∆(lac, pro),  Zell and Fritz, 1987
F’[proAB, lacIqZ∆M15], λ+            Stanssens et al., 1989
WK6λmutS galE, strA, nalT, ∆(lac, pro), Zell and Fritz, 1987
mutS::Tn10,
F’[proAB, lacIqZ∆M15], λ+     Stanssens et al., 1989
Plasmids Genotype/Phenotype      References
pSKAN8 PSTI-pIII-fusion (λPL promotor). Röttgen and Collins, 1995
ori fd; ori ColE1; AmpR, 5,6 kb.
pROCOS4/7 refer to pSKAN8. Röttgen and Collins,
integration of a cos site, from pTL5 vector. unpublished
PSTI gene removed.
pGEX-5X3 tac promoter, lacIq gene, AmpR, Smith and Jonhson, 1988
factor Xa recognition site,
GST as fusion partner, 4,9 kb.
pTAT-HA T7 promotor; AmpR; Nagahara et al., 1998
His Tag; Hemaglutinin tag;
TAT peptide as fusion partner, 3kb.
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6- Media and antibiotics for growth of bacteria
6-1 Media
LB-Medium (1x)
Trypton 10 g
Yeast-Extract  10 g
NaCl 5 g
H2O to 1 l, autoclaved
LB-Top agar
LB-Medium (1x) 1 l
Agar-Agar 6g, autoclaved
M9 salt solution (10x)
Na2HPO4*2H2O 74,1 g
KH2PO4 30 g
NaCl 5 g
NH4Cl 10 g
H2O to 1 l, autoclaved
M9-Medium (1x)
M9 salt solution (10x) 100 ml
Glucose(40% w/v) 12,5 ml
CaCl (1M) 100 µl
MgSO4 (1M) 1ml
FeCl3 (1mM) 0,5 ml
Thiamin (10mg/ml) 100 µl
H2O to 1 l
All solutions are autoclaved separately or filtered (0.2 µm) for sterilization (Thiamin).
Agar stock solution (2X)
Agar-Agar 15 g
H2O to 500 ml; autoclaved
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For the preparation of agar plates, 500 ml agar stock solution (2x) were carefully (with
the lid partially opened) heated in a microwave until the solution was boiling, mixed with 2X
LB-Medium or M9-Medium and allowed to cool down to approximately 50°C. Appropriate
antibiotic(s) were added, and after additional mixing, the solution was poured into petri
dishes.
6-2 Antibiotic stock solutions
All stock solutions of the antibiotics were stored at -20 °C.
Ampicillin (50 mg/ml)
Ampicillin (sodium salt) 2,5 g
Ethanol (70% in H2O) 50 ml
Kanamycin (50mg/ml)
Kanamycin 2,5 g
H2O 50 ml, filter (0.2 µm)
Tetracyclin (20 mg/ml)
 Tetracyclin 1 g
Ethanol (70% in H2O) 50 ml
Selection for a suitable resistance marker was achieved by using the following final
concentrations: Ampicillin (Amp) 300 µg/ml
Tetracyclin (Tc) 20µg/ml
Kanamycin (Km) 50 µg/ml
7- Buffers and solutions
Standard stock solutions and buffers that are used for many different purposes are
described in this section.
Unique buffers or solutions used only for one particular task are given in the context of
the corresponding technique.
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7-1 Buffers
PBS (10x)
NaCl 80 g
KCl 2 g
Na2HPO4*2H2O 14,3 g
KH2PO4 2 g
H2O to 1 l
Adjusted to pH 7 with HCl and autoclaved
TBS (10x)
Tris 61 g
NaCl 80 g
KCl 2 g
H2O to 1 l
Adjusted to pH 7,4 with HCl and autoclaved
TE (1x)
Tris-HCl 10 mM
EDTA  1mM
Adjusted to pH 8,0 with HCl and autoclaved
Tris-HCl
Tris 1 M
Adjusted to pH 8,0 with HCl and autoclaved
TA (25x)
Tris 121,1 g
EDTA 18,6 g
H2O  to 1 l
Adjusted to pH 8,0 with HAc and autoclaved
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7-2 Solutions
Phenol
Crystalline phenol was melted, and extracted with Tris-HCl (1 M, pH 8.0) until the
water phase had a pH between 7 and 8. A spatula-point of 8-hydroxyquinoline was added to
the organic phase. The organic phase was stored protected against light at -20 °C.
Alternatively, Roti Phenol was used (Carl Roth GmbH&Co.KG, Karlsruhe, Germany).
Chloroform-Isoamylalcohol (24/1)
Chloroform 240 ml
Isoamylalcohol 10 ml
EDTA-stock solution
EDTA 0,5 M
Adjusted to pH 7,0 with HCl and autoclaved
Ethidium Bromide  (5mg/ml)
Ethidium bromide 50 mg
H2O 10 ml
Stored protected against light
PEG/NaCl (16,7%/3,3 M)
PEG 8000 100 g
NaCl 116,9 g
H2O 475 ml
APS (Ammoniumpersulfat solution; 10% w/v)
APS 1 g
H2O 10 ml
Stored in 500 µl aliquots at -20 °C
Sodium azid stock solution (2,5%)
 NaN3 2,5 g
 H2O 100 ml
Stored at room temperature protected against light
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8- Antibodies
8-1 Primary antibodies
Anti-pIII: mouse, monoclonal IgG1 Tesar et al. (1995)
Anti-M13: mouse monoclonal, HRP labeled Pharmacia Biotech Europe,
Freiburg, Germany
Anti-HA: rabbit, polyclonal IgG Santa Cruz Biotechnology Inc,
Santa Cruz, California, USA
8-2 Secondary antibodies
Goat anti-mouse IgG + IgM (H+L), HPR labeled Dianova GmbH,
Hamburg, Germany
Goat anti-rabbit IgG, HPR labeled Santa Cruz Biotechnology Inc,
Santa Cruz, California, USA
B- Methods
1- Work with bacteria
1-1 Growth of bacteria
E. coli strains were grown in 0,5 to 2 liters culture baffled flasks containing LB-medium.
Where applicable the suitable antibiotic was added. The incubations were performed at 37°C,
under air agitation conditions (180 rpm).
1-2 Storage of bacteria
Individual colonies of all strains were obtained by striking the pertaining strain out on
agar plates. Strains carrying an F’ factor were spread out on M9 plates (containing the suitable
antibiotic). Other strains were grown on LB agar plates, containing the appropriate antibiotic.
Incubations were performed at 37°C. The plates were stored at 4°C for short time periods
(less than 2 weeks).
For long time storage, 500 µl of a fresh overnight culture were mixed with 500 µl sterile
glycerol (87%) in sterile tubes. The suspension was frozen with liquid nitrogen and stored at -
70°C.
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2- General methods to handle DNA
2-1 DNA agarose electrophoresis
Loading sample buffer
40% saccharose (w/v)
 0,25% bromophenol blue
Plasmid DNA, DNA fragments and PCR products were separated on horizontal agarose
gels, both in analytical and preparative scale.
TA (1x) was used as a running buffer. The 0,6 - 4,5% agarose gels were prepared by
dissolving 0.6 to 3 g of standard agarose (molecular biology grade, Gibco BRL life
technologies Ltd, Paisley, United Kingdom) in 100 ml 1x TA buffer by heating the
suspension of the agarose in TA. The agarose solution was allowed to cool to approximately
60°C and 5 µl of ethidium bromide solution (10 mg/ml; Sigma-Aldrich Chemie GmbH,
Deisenhofen, Germany) were added. Agarose was poured into appropriate gel chambers
containing a comb for the formation of sample pockets, was allowed to polymerize before
being covered with TA buffer.
Depending of the comb chosen, sample volumes ranging from1 to 20 µl were loaded on
the gel after mixing them with 0,5 vol of 2x loading sample buffer. A suitable marker was
loaded. Migrations take place at 60 to 120 V, considering the recommendations of Dube
(1997). The different bands were detected on an UV transilluminator.
2-2 Phenol extraction of DNA solutions
Contaminant proteins within DNA solutions were removed by phenol extraction. An
equal volume of phenol/chloroform/isoamyl (25/24/1) was added to the solution, and the
mixture was vortexed for 1 min and centrifuged for 5 min in a desktop centrifuge (13000
rpm). The top aqueous phase was transferred into a fresh tube and the phenol layer was back
extracted with an equal volume of TE (vortex and centrifuge). Both top aqueous layers were
pooled.
Any trace of phenol was removed by carrying out a chloroform extraction, by adding an
equal volume of chloroform/isoamyl (24/1), and then, by mixing and spinning as for a phenol
extraction. The top aqueous phase was transferred into a fresh tube. Further purification was
achieved by DNA precipitation.
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2-3 DNA precipitation
DNA was precipitated by adding 0,2 volume 3 M sodium acetate (pH 5.2), and 2,5
volume of ice cold 100% ethanol. After mixing, the solution was placed at -20°C for 30 min
(or 2 hours at -70°C for small DNA). DNA was pelleted by centrifugation at 13000 rpm, at
least 30 min (4°C). The supernatant was discarded, and the pellet carefully washed with 70%
ice cold ethanol, to remove salts, and centrifuged for further 15 min (13000rpm at 4°C). The
supernatant was discarded, and the pellet was air dried at room temperature, and dissolved  in
appropriate volume of H2O or TE.
2-4 DNA concentration
DNA concentration was determined with the GeneQuant II RNA/DNA Calculator
(Pharmacia Biotech Europe GmbH, Freiburg, Germany) with the 100µl Hellma quartz
suprasil glass cuvette (10 mm).
After washing the cuvette thoroughly, a background absorption was determined by
measuring the absorption of autoclaved double deionized H2O or appropriate buffer. DNA to
be measured was diluted in the solution used as blank. DNA concentration was obtained by
multiplying the absorbance (A260 nm) by the factor of dilution, and by the nucleic acid
conversion factor:
DNA Concentration [µg/ml] = A(260 nm) x dilution factor x F
where F is the conversion factor: 50 (ds DNA), 33 (ss DNA), 40 (RNA).
When the purity of the isolated DNA was questioned, absorbance of the DNA solution
was measured at 260 and 280 nm. The A(260)/A(280) quotient (DNA/proteins ratio) should
range between 1,8 and 2,0 for pure products. If the quotient exceeds 2, the presence of phenol
or proteins seemed to be likely and the DNA solution was purified a second time.
3- Methods for in vitro recombination of DNA
3-1 Plasmid DNA isolation
Plasmid DNA was isolated with a method based on alkaline lysis, described by
Birnboim and Doly (1979).
Small scale preparation (up to 20 µg) of plasmid DNA was performed with the ion
exchange columns of Qiagen in the QIAprep Spin Miniprep Kit (Qiagen GmbH, Hilden,
Germany). Larger amounts (up to 500 µg) of plasmid DNA were prepared with the Qiagen
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Plasmid Maxiprep Kit (Qiagen GmbH, Hilden, Germany) according to the recommendations
of the manufacturer.
3-2 DNA gel extraction from agarose gels
For the isolation of a particular DNA from a mixture of DNA fragments, the DNA
solution was loaded and fragments were separated on agarose gel through migration. The
agarose containing the DNA fragment of interest, was cut out on an UV transilluminator with
a scalpel. The DNA extraction was performed with the Qiaquick Gel extraction kit (Qiagen
GmbH, Hilden, Germany) according to the manufacturer guidelines.
3-3 Removal of biotinylated DNA
The Dynabeads M-280 streptavidin (Dynal AS, Oslo, Norway) are designed as a matrix
for simple and efficient separations of biotinylated compounds (such as DNA, RNA, proteins,
immunoglobulins, lectins, sugars). In the course of this work, dynabeads coated with
streptavidin, were used to remove the biotinylated restriction fragments of PCR products to
obtain pure PCR products that can be further ligated into the appropriate vector.
The dynabeads were washed to remove the preservative NaN3, by placing the tube
containing the beads to be washed, in a Dynal MPC (Magnetic Particle Concentrator; Dynal
AS, Oslo, Norway) for at least 30 sec. The supernatant was removed by aspiration with a
pipette, and the beads were resuspended in TE/NaCl (2M). The washing step was repeated a
second time.
The DNA to be purified (PCR products, amplified with biotinylated primers, and
digested on their extremities by restriction enzymes) was mixed with an equal volume of
dynabeads M-280 streptavidin, containing a suitable amount of the magnetic beads, and
incubated for 30 min at room temperature, by gentle rotation of the tube. 1 mg of dynabeads
M-280 streptavidin, binds up to 40 pmol of an approximately 300 bp double stranded DNA
fragment.
The purified DNA was recovered by placing the tube containing the mixture in the
Dynal MPC for at least 30 sec. The biotinylated fragments, captured by the beads, were
attracted by the magnet, and stayed on the wall of the tube which interacts with the Dynal
MPC. The supernatant, containing the clean PCR products, was recovered by aspiration with
a pipette.
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3-4 DNA modifications
3-4-1 Polymerase chain reaction
PCR was used for the amplification of DNA fragments. Oligonucleotides flanked by
appropriate endonuclease sites were used as primers. DNA was amplified, based on the
protocol of Sambrook et al. (1989), with Taq-DNA-polymerase and DNA-polymerase buffer
from Promega (Promega Corp., Madison, WI, USA). The reactions were performed in 0,2 ml
PCR reaction tube (Biozym Diagnostik GmbH, Oldendorf, Germany), using DNA Thermal
Cycler (Perkin Elmer GmbH, Weiterstadt, Germany). This cycler contains a heated lid and the
use of mineral oil was avoided.
PCR reaction:
Oligonucleotide 10 pmol
Sense primer 200 pmol
Antisense primer 200 pmol
DNA-polymerase buffer (10x) 10 µl
MgCl2 (25mM) 6 µl
dNTP (2 mM) 10 µl
Taq-DNA-polymerase 2U
H2O to 100 µl
94°C 1 min
60°C 1 min 10 cycles
72°C 1 min
The performance of each PCR reaction was checked by running 5 µl of each reaction on
agarose gels, with appropriate DNA markers.
3-4-2 DNA digestion
DNA was digested with endonucleases from MBI Fermentas (MBI Fermentas Inc,
Amherst, NY, USA) and New England Biolabs (New England Biolabs Inc, Beverly, MA,
USA) using the recommended buffers.
For double digestion the optimal buffer was determined experimentally. When
appropriate, the double digestion was performed in two following restriction steps, with
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modification of the buffer.
The DNA solution was mixed with 1/10 of the final volume of digestion buffer (10x),
and with the appropriate amount of endonucleases (1 Unit of endonuclease was used for 1 µg
of DNA). The mixture was incubated at 37°C (except for SmaI, which requires 30°C to be
active) for at least 2 hours.
For sensitive restriction enzymes, star activity was avoided by diluting the total
DNA/restriction enzyme solution in a final volume exceeding 10 times the volume of added
endonucleases, and by avoiding long incubation times (no overnight incubation).
When PCR products with cleavage sites in direct vicinity to the termini of the strand,
were digested, the amount of endonuclease was increased up to 20 U/µg of DNA and the
incubation time at 37°C, prolonged to 4 hours.
Each digestion was verified by electrophoresis. According to the further utilization of
the DNA of interest, it was phenol extracted, purified through the GFX PCR DNA and gel
band purification kit (Amersham Pharmacia Biotech, Freiburg, Germany), or separated from
other components by gel electrophoresis and extracted from the gel (Qiaquick Gel extraction
kit; Qiagen GmbH, Hilden, Germany).
3-4-3 Dephosphorylation
To avoid ring closure of digested opened vectors during standard ligation reactions, in
addition to the use of two different restriction enzymes, the 5' phosphate groups of the vector
were removed by alkaline phosphatase. The digestion mixture was incubated with the
appropriate amount of shrimps alkaline phosphatase (1 Unit/pmol of DNA; USB corp.,
Cleveland, USA), and this mixture was incubated for 1 hour at 37 °C. The shrimps alkaline
phosphatase was heat inactivated at 60°C for 15 min.
3-4-4 Ligation
DNA fragments were ligated with T4 DNA ligase (Boehringer Mannheim, Germany)
using the provided ligation buffer. Double stranded DNA molecules with complementary
cohesive termini that base pair with one another and bring together 3’-OH and 5’-P termini,
are ligated by the T4 DNA ligase, through the formation of a phosphodiester bond between
adjacent 3’-OH and 5’-P termini.
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Vector and insert were  ligated together at  various  molar ratio (vector : insert = 2:1; 1:l;
1:2; 1:3; 1:5), to determine the proportions which lead to the optimal ligation. One Unit of T4
DNA ligase was added to 0,5 µg of DNA to be ligated. This mixture was incubated at least 4
hours at 4°C.
After the ligation, for an increased electroporation efficiency, the ligated DNA was
heated up at 65°C for 15 min (Ymer, 1991; Koch Michelsen, 1995).
3-5 Transformation
The transformation of Escherichia coli cells was performed through electroporation,
according to Dower et al. (1988), using a Bio-Rad Gene Pulser (Bio-Rad laboratories GmbH,
Munich, Germany).
3-5-1 Preparation of electrocompetent cells
HEPES solution
1mM HEPES dissolved in H20 (pH 7)
Autoclaved
10% Glycerol
(87%) glycerol 11,5 ml
H2O to 100 ml
Autoclaved
Electrocompetent E. coli cells were prepared according to a protocol, adapted from
Dower et al. (1988). The strains to be transformed, in the course of this work, were
WK6λmutS and BL21(DE3)pLysS.
The strain was spread out on M9 agar plates, with appropriate antibiotics. A single
colony was used to inoculate 20 ml of LB (with appropriate antibiotic) and grown at 37°C, at
180 rpm overnight. Two flasks with 500 ml LB (with appropriate antibiotic) were inoculated
at 1% with the preculture, and grown at 37°C/180 rpm until the OD(600) ranged between 0,55
and 0,6. The flasks were chilled on ice for 15 min, and cultures were transferred to 4 sterile,
ice-cold Sorvall GS3 centrifuge tubes, and spinned in a Sorvall RCSC centrifuge (GS3 rotor)
for 15 min at 5000 rpm. After careful discarding of the supernatant, the pellets were
resuspended in 4 x 250 ml ice cold HEPES solution, and spinned for further 15 min at 5000
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rpm.  After decanting the supernatant the pellets were resuspended in 4 x 125 ml ice cold H20,
and pooled in two suspensions. This was followed by a further centrifugation for 15 min at
5000 rpm (G53, RCSC), the supernatant was decanted and the E. coli cells resuspended in 2x
10 ml 10 % glycerol. After transfer into SS34 centrifugation tubes the cells were pelleted by a
10 min centrifugation (6000 rpm, SS34 rotor), the supernatant was discarded and the cells
resuspended in 2x 1 ml of 10 % glycerol. The suspension was aliquoted, frozen in liquid
nitrogen and stored at -70°C. All steps were carried out as quick as possible at 4°C.
Each batch of electrocompetent cells was checked by electroporating 10 ng of pBR322.
Dilution series of the control were plated on LB plates with appropriate antibiotics.
3-5-2 Electroporation
The electrocompetent cells were carefully mixed (by flicking) with 1 to 2 µl of a ligation
mixture (approximately 10 ng of DNA) and incubated on ice for 2 min. This mixture was
transferred into ice cold 2 mm electroporation cuvette (Bio-Rad laboratories GmbH, Munich,
Germany) and were electroporated with the following parameters: 2,5 kV, 25 µF and 200 Ω,
as described by Dower et al. (1988). The time constant was controlled, and ranged between
4,5 and 4,7 depending on the purity of the DNA (salt).
1 ml of prewarmed LB (37°C) was added and mixed to the cells immediately after the
electroporation, using a sterile pasteur pipette, and transferred into a sterile 1,5 ml Eppendorf
tube. This suspension was grown at 37°C for one hour.
In order to evaluate the electroporation efficiency, and therefore, the number of transformants
obtained, dilution series were prepared from an aliquot of the suspension, plated out on LB
plates containing appropriate antibiotics and incubated at 37°C overnight. 
For the generation of phagemid libraries, several electroporations were set up in parallel,
to obtained a large diversity library. Transformed bacteria resulting from each electroporation
mix, were plated out on two large LB plates.
3-6 DNA sequencing
Two sequencing protocols were applied, using the ALF DNA sequencer (Pharmacia
Biotech Europe GmbH, Freiburg, Germany), or the Applied Biosystem ABI prism 310
sequencer (Perkin Elmer Applied Biosystems GmbH, Weiterstadt, Germany). Both systems
work with fluorescence labeling. However, with the ALF DNA sequencer, DNA fragments
are separated through migration along a gel, while for the ABI prism 310, separation occurs
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within a capillary, fill in with polymer.
3-6-1 ALF-DNA-Sequencer
3-6-1-1 Cycle sequencing reaction
Cycle sequencing buffer (10X)
40 mM MgCl2
150 mM (NH4)2SO4
120 mM Tris-HCl (pH 9.5)
dNTP-Mix
dATP, dCTP, dTTP and 7deaza-dGTP: 1 mM each
ddNTP-Mix
ddATP, ddCTP, ddTTP: 5µM each
ddGTP: 3,75 µM
Stop solution .
95% formamide
10 mM NaOH
0.005 % bromophenolblue
The protocol used here, is adapted to the sequencing of double stranded DNA.
For each DNA probe to be sequenced, four cycle sequencing reactions are performed in
0,2 ml PCR reaction tubes. In each of the four tubes, 2 µl of one of the ddNTP was added
(ddATP, ddCTP, ddGTP, or ddTTP). The following 20 µl mix was then added to each of the
tube:
Cycle sequencing buffer (10X) 2,0 µl
fluorescein labeled primer (2 pmol/µl) 1,0 µl
dNTP-Mix (1 mM, each) 3,0 µl
Taquenase/PPase (Amersham, 32 U/µl) 0,16 µl
plasmid DNA 0,5 to 1 µg
ddH2O  to 20 µl
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The PCR-reaction was run as followed: 94°C 2 min
94°C 15 sec
46°C 15 sec 35 cycles
72°C 40 sec
72°C 5 min
After completion of the PCR program, the reaction was stopped by adding 4 µl of stop
solution to each reaction. Samples were stored at -20°C, or directly sequenced.
3-6-1-2 Preparation of Sequencing Gels
TBE (10x)
Tris 100 g
H3BO3 55,6 g
EDTA 9,3 g
ALF DNA-sequencer gel plates were cleaned by washing with SDS (10 %) solution,
ethanol and purified water (millipore). The gel cassette was assembled according to the ALF-
manual.
6,6 % gel of 0.5 mm thickness was prepared by mixing:
urea (ALF grade) 33,6 g
TBE (10X) 9,6 ml
acrylamide/bis (40%;29:1) 13,2 ml
ddH2O to 80 ml
The mix was degased by vacuum filtration, TEMED (65 µl) and APS (10%; 240 µl)
were added, an the solution was immediately poured between the glass plates and the gel
comb was inserted. The gel was allowed to polymerize for at least 2 hr. The comb was
removed and the slots were cleaned. The gel cassette was assembled within the ALF DNA
sequencer, according to the ALF-manual, and TBE (0,6x) was poured within the tanks on
both extremities of the gel.
Immediately before loading, the DNA samples were heated up to 95°C for 3 min, and
chilled on ice. 8 µl of each DNA samples were loaded onto the gel. The gel was run according
to the ALF manual, and the results were analyzed automatically by the ALF DNA sequencer
software.
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3-6-2 Applied Biosystems ABI Prism 310
On the ABI 310 the dye terminator thermo cycle sequencing method was used to
sequence DNA fragments. Plasmid DNA to be sequenced were isolated and purified with the
QIAprep Spin Miniprep Kit (Qiagen GmbH, Hilden, Germany).
In 0.2 ml PCR strip tubes 200 to 500 ng of plasmid were mixed with 3 pmol of the
appropriate sequencing primer, 4 µl of big dye terminator premix (Big Dye Terminator Ready
Reaction Cycle Sequencing Kit with AmpliTaq FS; PE Applied Biosystems, Weiterstadt,
Germany), and this mixture was filled up to 20 µl with water. The resulting mixtures were
subjected to PCR sequencing reaction.
 96°C 30 sec
50°C 15 sec 25 cycles
60°C 4 min
After completion of the PCR sequencing reaction, the mixture was purified by ethanol
precipitation. All steps were performed at room temperature. The 20 µl reactions, were mixed
with 2 µl of NaAc (3M; pH 5,2) and 50 µl 100% ethanol (at room temperature), and mixed by
inverting several times the tubes. Samples were incubated 10 min, and centrifuged 30 min on
a table centrifuge, at maximum speed. Pellets were washed with 250 µl of 70% ethanol (room
temperature) and a further 20 min centrifugation was performed. Pellets were allowed to air
dry for 10 min, and were resuspended in 12 µl TSR reagent (PE Applied Biosystems,
Weiterstadt, Germany). The solution was heated up to 95 °C for 2 min and chilled on ice. The
DNA was stored at -20°C, or directly sequenced.
The capillary of the ABI prism 310 sequencer was filled up with POP6 polymer, and
sequencing could take place.
4- Protein analysis
4-1 Determination of protein concentration
The concentration of the proteins was determined according to Bradford (1976). A
calibration curve was performed with BSA. 160 µl of fixed concentration of BSA were mixed
in a microtiter well, with 40 µl of Bio-Rad reagent (Bio-Rad laboratories GmbH, Munich,
Germany). A negative control with 160 ml of water and 40 ml of Bio-Rad reagent was done,
to evaluate the background value. After 5 min incubation, the OD595 was determined, and the
calibration curve was drawn (concentration versus OD595), after deduction of the background
value from the protein values. The calibration curve should be linear in the range of 20 to 140
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µg.
A dilution series of the protein to be analyzed was done (in water), and 160 µl of each
dilution was mixed in a microtiter well, with 40 µl of Bio-Rad reagent. After 5 min, the OD595
was determined, and the concentration of the protein was evaluated by reporting the OD value
to the calibration curve. To obtain a precise concentration, the evaluation was achieved from
the average of triplicates, taken into account the dilution factor.
4-2 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE)
Upper Tris
 Trisbase 30,5 g
ddH20 to 400 ml; adjust with concentrated HCl to pH 6,7
+ SDS (10%) 20 ml
+ ddH2O to 500 ml
Lower Tris
Trisbase 91 g
ddH20 to 400 ml; adjust with concentrated HCl to pH 8,8
+ SDS (10%) 20 ml
+ ddH2O to 500 ml
Running buffer (8x)
Trisbase 560 g
Glycin 120 g
SDS (10%) 200 ml
EDTA (0,5 M) 80 ml
ddH2O to 2500 ml
Sample buffer (2x)
 Tris (100 mM) pH 6,8
 DTT (200 mM)
SDS (4%)
Bromphenol blue (0,2%)
Glycerin (20%)
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Separation gels, for Biometra 8,5 x 7,5 x 0,1 cm gel (for 15 µl sample volume)
15% 12,5% 10%
acrylamide/bis (30%) 5 ml 4,1 ml 3,3 ml
Lower Tris 2,5 ml 2,5 ml 2,5 ml
ddH20 2,4 ml 3,2 ml 4,1 ml
Temed 8 µl 8 µl 8 µl
APS (10%) 50 µl 50 µl 50µl
Stacking gel, for Biometra 8,5 x 7,5 x 0,1 cm gel (for 15 µl sample volume)
acrylamide/bis (30%) 700 µl
Upper Tris 2 ml
ddH20 4,2 ml
Temed 7 µl
APS (10%) 35 µl
SDS-Polyacrylamide gels (Laemmli, 1970) were used to evaluate the quality, and purity
of proteins.
The suitable separation gel was poured between fixed cleaned glass plates (10% SDS
and ethanol) to approximately 1 cm under the comb and covered with a layer of water. After
20 min of polymerisation the water was removed.
The stacking gel was poured on top of the separating gel. A suitable comb was inserted
and the gel allowed to polymerize (30 min). The gel was placed in the electrophoresis unit,
and covered with the running buffer. The comb was removed, and the sample pockets were
washed with running buffer.
1 to 7 µl of the samples were mixed with equal volumes of the 2x sample buffer, heated
up to 95°C for 3 min, and chilled on ice, together with the molecular weight standards.
Samples were loaded onto the gel, which was run at 60 V to 100 V until appropriate
separation occurred.
Gels were further used for protein detection by coomassie blue or silver staining or by
western blotting antibodies detection.
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4-3 Staining methods
4-3-1 Coomassie blue staining
Coomassie staining solution
Coomassie brilliant blue G250: 1 g in 200 ml ethanol
Coomassie brilliant blue R250: 1 g in 200 ml H2O
+ Glacial acidic acid 40 ml
Filtration
Proteins in PAGE gels were detected after electrophoresis, by incubation for 30 to 60
min in a coomassie staining solution, at room temperature under constant rocking. Surplus
stain was removed from the gel by boiling it in water, on a microwave, until the protein bands
got clearly visible and the background minimized.
4-3-2 Silver staining
Solution A
Methanol 100 ml
Acid acetic 20 ml
ddH2O 100 ml
Solution B
Methanol (50%) 100 ml
TCA (12%) 24 g
CaCl2 (2%) 4g
ddH2O to 200 ml
Solution C
Isopropanol (10%) 20 ml
Acid acetic (5%) 10 ml
ddH2O 170 ml
Solution D
KMnO4 (0,01%) 0,02 g
ddH2O 200 ml
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Solution E
AgNO3 (0,1%) 0,2 g
ddH2O 200 ml
Solution F
Formaldehyde (37%) 500 µl
Na2CO3 (2%) 10 g
ddH2O to 500 ml
Silver staining procedure (Heukeshoven and Dernick, 1988) is more sensitive than the
coomassie blue technique. It is therefore suitable for the detection of low protein amounts.
The gel was incubated on a rocker platform with the freshly prepared following
solutions:
1- twice in solution A, 15 min each time.
2- 15 min in solution B
3- 10 min in solution C
4- 5 min in solution D
5- 10 min in solution C
6- Twice for 10 min in H2O
7- 10 min in solution E
8- 10 sec in H2O
9- the gel was developed in 100 ml of solution F for 2 min. The solution was discarded,
and the gel was once more in fresh solution F incubated, for a further 2 min, and so on, until
the bands are clearly visible.
10- the reaction was stopped with 10 min incubation in 1% acid acetic, and then, rinse in
water.
4-4 Western blot
4-4-1 Blotting of polyacrylamide gels on nitrocellulose
 Semidry blotting buffer
Tris 48 mM
Glycine 39 mM
SDS 0,037%
Methanol 20%
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T-TBS buffer
Tween 20 (0,05%) 0,5 ml
TBS 995,5 ml
The transfer of proteins from SDS-PAGE gel nitrocellulose membrane was performed
through  the use of a semi dry blotting apparatus (PHASE, Lübeck, Germany).
Four sheets of suitable sized Whatman 3 MM paper (Whatman, Maidstone, England)
were soaked in semidry blotting buffer and placed on the blotting chamber. One dry sheet of
Whatman paper was used to pull off the polyacrylamide gel from the glass plate, was
moistened, and placed on top of the other sheets (gel above). A suitable sized nitrocellulose
membrane (HAHY 0.45 mm pores, Millipore, Eschborn, Germany), was moistened in
semidry blotting buffer, and placed above the gel, on the blotting chamber. Air bubbles were
avoided. Five moistened sheets of Whatman paper were placed above the nitrocellulose.
Potential air bubbles were removed by rolling a 10 ml glass pipette over the Whatman
papers. The lid of the blotting chamber was assembled with the bottom part and a currency of
300 mA was applied for 2 hours.
After completion of the transfer, the chamber was disassembled, and the nitrocellulose
was subjected to an immuno-assay.
4-4-2 Immunological detection
T-TBS (1x)
TBS (10x) 100 ml
Tween 20 500 µl (0,05%)
ddH2O to 1000 ml
Blocking solution
T-TBS (1x) 100 ml
Skimmed milk powder 2 g (2%)
Staining solution (freshly prepared)
T-TBS 20 ml
Diaminobenzidine (2%) 200 µl
NiCl2 (10%) 200 µl
H2O2 (30%) 20 µl
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After the transfer of the proteins to the nitrocellulose, the membrane was blocked for 30
min at room temperature, with 2% dried skimmed milk powder (Magermilchpulver,
Glucksklee, Germany) in T-TBS, to cover the part of the nitrocellulose that are free of
protein. The blocking solution was discarded, and the membrane was washed once with T-
TBS buffer.
The proteins were incubated at least 2 hours with the first antibody, diluted to the
suitable concentration in blocking solution. The membrane was washed twice for 5 min with
T-TBS, and incubated for 2 hours with an appropriate horseradish peroxidase labeled
secondary antibody, diluted in T-TBS. The membrane was intensively washed with T-TBS.
Detection of the bound antibody, the membrane was incubated with freshly prepared
staining solution for 5 to 30 min at room temperature, until the intensity of the bands was
appropriate. The membrane was then rinsed in water to stop the reaction.
5- Preparation and characterization of bacteriophage
5-1 Preparation of M13KO7 helper phage
5-1-1 Production of M13KO7 plaques
E. coli WK6 was spread out on a M9 plate and grown at 37°C. A single colony was
picked to inoculate an overnight culture from which an 20 ml LB (in a 100 ml baffled flask)
culture at 1% was started. The culture was incubated at 37°C and 180 rpm until the OD600
reached 0,5.
A 500 µl aliquot of the WK6 culture was infected with 1 µl of M13K07 bacteriophage
(around 9x1011 pfu/ml, Pharmacia Biotech Europe, Freiburg, Germany), and incubated 15
min at 37°C, to allow the phage particles to infect the cells. 3 ml of LB Top agar (pre-melted,
and kept warm at 47°C to prevent solidification) was added to the cell suspension, gently
mixed together, and immediately poured onto a plate containing hardened bottom agar
medium. Swirl the plate gently, to ensure a even distribution of bacteria and top agar. The top
agar was allowed to harden at room temperature for30 min, and the plate was inverted and
incubated overnight at 37°C.
5-1-2 Preparation of a M13KO7 stock
A well separated plaque was picked using a sterile pasteur pipette equipped with a
rubber bulb. The pipette stab through the chosen plaque into the hard agar beneath. A mild
suction was applied so that the plaque,  together with the underlying agar, was drawn into the
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pipette. The plaque was added to 20 ml of LB (2x) containing 50 µg/ml of kanamycin, and
was grown for 6 to 8 h at 37°C/180 rpm. This overday culture was used to inoculate 4 flasks
containing 250 ml of LB (2x)/Kanamycin (50µg/ml) at 1%, which was allowed to grow
overnight at 37°C/180 rpm.
The bacteria were then pelleted by centrifugation (15 min at 8000 rpm, 4°C, GS3 rotor).
The supernatant was transferred to a fresh bottle, and centrifuged a second time, under the
same conditions. The supernatant was then mixed with 0,15 volume of PEG/NaCl, and
incubated on ice for at least 2 hours. The phage were precipitated by 90 minute centrifugation
at 4°C, 8000 rpm (GS3 rotor). The supernatant was decanted and completely removed after a
second brief centrifugation (3 min at 5000 rpm, GS3 rotor). The pellet was dissolved in 10 ml
of PBS (1x), cleared by 10 min centrifugation at 12000 rpm and 4°C (SS34 rotor). NaN3 was
added to the resuspension, at a final concentration of 0,02%, and the M13KO7 stock was
stored at 4°C. The phage titer usually ranged between 1011 and 1012 cfu/ml.
5-2 Packaging of phagemid DNA libraries in bacteriophage particles
After insertion of the hypervariable domains within the pSKAN8 or pROCOS4/7
vectors, the libraries were created by transforming a large number of WK6λmutS bacteria
with the phagemid vectors.
After electroporation, transformed E. coli WK6λmutS were plated out on large LB agar
plate, containing 300 µg/ml ampicillin, and 20 µg/ml tetracycline, and allowed to grow
overnight at 37°C. The colonies were then scraped of all agar plates, by adding 15 ml LB to
each plate. Cells were allowed to resuspend by gently rocking the plates for 20 min at room
temperature, before washing them by pipetting the 15 ml LB up and down with a 10 ml
pipette. The cells were transferred into a sterile falcon tube, and the plates were rinsed with an
additional 5 ml of LB. Recovered cells were mixed by inverting the tube several times. 2 ml
of this suspension were used to inoculate 200 ml LB medium containing 100 µg/ml of
ampicillin. The remaining suspension was mixed with 0,5 volume of sterile glycerol, frozen in
liquid nitrogen, and stored at -70°C.
The 200 ml culture was allowed to grow until OD600 reached 0,5.
Around 1011 cfu of M13KO7 (stock solution) were added to the logarithmic phase
WK6λmutS, and the culture was incubated at 37°C without shaking for 30 min, to allow the
regeneration of the F-pili, and to let time to the helper phage to infect the cells. The culture
was then grown overnight at 37°C/180 rpm.
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The cells were pelleted and discarded by centrifugation (15 min, 8000 rpm, 4°C, GSA
rotor). The supernatant was transferred into a fresh bottle and centrifuged a second time,
under the same conditions. The phage suspension was then mixed with 0,15 volume of
PEG/NaCl, and incubated on ice for at least 2 hours. The phage were precipitated by
centrifugation (1 hour, 8000 rpm, 4°C, GSA rotor). Trace of medium were eliminated by a
brief centrifugation (3 min at 5000 rpm), and the phage pellet was dissolved in 1 ml PBS. The
suspension was cleared by centrifugation (10 min on a bench centrifuge, 13000 rpm, room
temperature), and NaN3 were added to a final concentration of 0,02%. The titer has to be
determined.
5-3 Determination of bacteriophage titers
20 ml of LB medium containing 20µg/ml of tetracycline were inoculated with 200µl of
WK6λmutS overnight culture, and incubated at 37°C and 180 rpm until OD600 reached 0,5.
A dilution series of the phage to be titered was performed: 90 µl of sterile water was
placed in the wells of a standard sterile 96 well microtiter plate and the dilution series was
prepared by transferring 10 µl aliquot of the phage preparation (dilution 0 to 10-10).
100 µl of the logarithmic growing WK6λmutS bacteria (OD600=0,5), were added to the
dilution series, carefully mixed, and incubated for 30 min at 37°C.
20 µl of each dilution were spotted on a LB agar plate containing ampicillin (300 µg/ml) and
tetracycline (20 µg/ml) to evaluate the titration of the phagemid, and on a LB agar plate
containing kanamycin (50 µg/ml) and tetracycline (20 µg/ml) to estimate the helper phage
titer. The colonies in each spots were counted, and allowed the determination of the cfu titer
(colony forming units per ml), taking into account the dilution factors.
6- Affinity selection from the phagemid libraries
6-1 Panning procedure
T(0,05%)-PBS (1x)
PBS (10x) 100 ml
Tween 20 500 µl
ddH2O to 1000 ml
Elution buffer
Glycine (0,1M; pH 2,2)
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Blocking solution
T(0,05%)-PBS (1x) 100 ml
Skimmed milk powder 2 g (2%)
Neutralization buffer
Tris (2M)
A standard protocol has been designed to isolate and enrich for our particular SH3 and
EVH1 domain targets, a few particles of a whole library, which present feature(s) required for
binding to the target. The target domains were immobilized and incubated with the library.
Phagemids displaying peptides containing a motif essential for interaction with the target
were retained during washing steps, and then eluted and used for reinfection of WK6λmutS,
to be amplified. After superinfection with helper phage, the phagemid particles were
subjected to subsequent panning cycles.
Affinity selections were performed in microtiter plates which were subjected to a special
treatment of the polystyrol surface, in order to increase the affinity for polar groups. The
chosen plates were the maxisorb microtiter plates (Nunc A/S, Roskilde, Denmark), except
when specified (Reacti-Bind Glutathione coated plates; Pierce Chemical Company; Rockford;
Illinois, USA). 1 µg of the GST fusion proteins of the SH3 and EVH1 domains used as target
proteins and resuspended in PBS buffer (100 µl), were immobilized overnight at 4°C, on
constant gently rocking, on the wells of the microtiter plate. The wells were previously sealed
with parafilm strips (American National Can, Chicago, IL, USA). This sealing is repeated
for each incubation step.
The supernatant was removed and the plate washed thoroughly with T(0,05%)-PBS. The
wells of the plate were blocked with 400 µl of the blocking solution, for 30 min at room
temperature, on constant gently rocking, to prevent unspecific binding of the phage to the
walls of the wells, and to keep background levels low. After washing with T(0,05%)-PBS, the
phagemid libraries diluted 1:1 in blocking solution (phage which show affinity for milk,
would interact with milk in solution and not with immobilized milk, and therefore, would be,
later, washed away more easier), were incubated with the immobilized target for at least 2
hours at room temperature, with constant rocking (usually between 1010 and 1011 phage/well).
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The supernatant was removed, and the wells were washed with several cycles of T(0,05%)-
PBS, and alternatively, with blocking solution.  The stringency of the washing steps increased
with the cycles of the panning selection. Refer to Table II-1 to see the washing conditions
used in affinity selection (when other parameters were used, the conditions were specified
directly in the section of interest). The wells were finally rinsed once with water, to remove
trace of Tween 20.
cycle of panning
1 2  3 - 5
T( 0,05%)-PBS 1x 3x 5x
PBS/milk 10 min 10 min 10 min
T( 0,05%)-PBS 1x 3x 5x
PBS/milk 5 min 5 min 5 min
T( 0,05%)-PBS 1x 3x 5x
H2O 1x 1x 1x
Table II-1: Stringency of the washing steps according to the cycle of panning. Basic
procedure for the washing step. The PBS/Tween contains 0,05% of Tween 20. The PBS/milk,
is the blocking solution, with 2% of skim milk powder. Incubation with the blocking solution
tends to reduce the background level. It can happen that phage bind to the milk powder used
to block the walls of the wells, the milk added in solution competes this interaction.
The remained bound phage were eluted with 100 µl of elution buffer, after an incubation
of 15 min at room temperature on constant rocking. The solution was then neutralized by
transferring the eluted phage into a Eppendorf reaction tube containing 6 µl of Tris (2M). A
10 µl aliquot of eluted phage were used to evaluate the titer of the recovered phage, while the
remaining 90 µl were used to infect the E.coli strain.
6-2 Reinfection of WK6λmutS with the eluted phage
A culture of WK6λmutS was incubated at 37°C, until the OD600 reached 0,5 (the culture
volume depends on the number of targets used during the panning; 10 ml of culture were
required for eluted phage from each target).
The 90 µl of eluted phage were mixed with 10 ml of the log-phase WK6λmutS and were
incubated for 30 min at 37°C. The bacteria were then pelleted by centrifugation (8000 rpm; 5
min; SS34 rotor) and resuspended in 400 µl LB medium containing ampicillin (300 µg/ml)
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and tetracycline (20 µg/ml). Each suspension was plated out on LB/Agar (ampicillin: 300
µg/ml; Tetracycline: 20 µg/ml) plates, and grown overnight at 37°C.
6-3 Packaging of phagemids from reinfected cells
The bacteria lawn was resuspended by adding 15 ml of LB medium to each plate and by
gently rocking the plates for 20 min at room temperature, before washing them by pipetting
the 15 ml LB up and down with a 10 ml pipette.
1 ml of the resuspended cells, was used to inoculate 25 ml LB (ampicillin: 300 µg/ml;
tetracycline: 20 µg/ml). The resuspension was incubated for 1 hour at 37°C and 180 rpm.
Superinfection was performed by adding 1011 to 1012 cfu of M13KO7 helper phage, and
incubating the mixture without shaking for 15 min at 37°C, and then, for an additional 5 hours
at 37°C, and 180 rpm
The cells were pelleted and discarded by centrifugation (10 min, 5000 rpm, 4°C, SS34
rotor). The supernatant was transferred into a fresh bottle and centrifuged a second time,
under the same conditions. The phage suspension was then mixed with 0,15 volume of
PEG/NaCl, and incubated on ice for at least 1 hour. The phage were precipitated by
centrifugation (15 min, 18000 rpm, 4°C, SS34 rotor). The phage pellet was dissolved in 200
µl of PBS. The suspension was cleared by centrifugation (10 min on a bench centrifuge,
13000 rpm, room temperature), and NaN3 were added to a final concentration of 0,02%.
The phage were ready for a further cycle of panning selection. After a few rounds of
panning selection, enrichment of eluted phage might be detected through the titration of the
given and eluted phage after each cycle. The enriched clones were characterized by
sequencing randomly picked single clones.
6-4 Characterization of selected single clones
6-4-1 Single clone packaging
A 3 ml LB (ampicillin: 300 µg/ml; tetracycline: 20 µg/ml) overnight culture were
inoculated with a single WK6λmutS colony containing the phagemid of interest.
This preculture was used to inoculate a 100 ml LB (ampicillin, tetracycline) at 1%,
which was incubated at 37°C and 180 rpm, until OD600 reached 0,5. Superinfection was
performed by adding around 1011 M13KO7 helper phage, and incubating the mixture for 15
min at 37°C without shaking, followed by overnight incubation at 37°C and 180 rpm.
The single phagemid particles were then recovered as previously described: the cells
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were eliminated by two following centrifugation steps (10 min, 8000 rpm, 4°C, GSA rotor).
The supernatant was transferred in fresh bottle, mixed with 0,15 volume of PEG/NaCl, and
incubated at least two hours on ice. Phage were pelleted by centrifugation (90 min, 10000rpm,
4°C, GSA rotor), complete trace of medium were removed, and the phage pellet was
resuspended in 1 ml of PBS. The suspension was cleared by centrifugation (10 min, 13000
rpm, room temperature, table centrifuge). NaN3 was added to a final concentration of 0,02%.
The titer of each propagated single clone was determined, and the suspension was stored at
4°C.
6-4-2 Phage ELISA
T(0,5%)-PBS (1x)
PBS (10x) 100 ml
Tween 20 5 ml
ddH2O to 1000 ml
Blocking solution
T(0,5%)-PBS (1x) 100 ml
Skimmed milk powder 2 g (2%)
Staining solution
Na2HPO4 (200 mM) 3,1 ml
Citric acid (200 mM) 2,9 ml
ddH2O 6 ml
O-phenylenediamine 4,8 mg
H2O2 1,5 µl
To check the interaction between the enriched clones (determined by sequencing) and
the target, the clones were propagated as single phagemid particles, and tested on phage
ELISA (Enzyme Linked Immuno Sorbent Assay).
1 µg of the proteins of interest were diluted in 50 to 100 µl PBS, and coated on a
microtiter plate (Nunc-MaxiSorb plates; Nunc A/S, Roskilde, Denmark) by incubation
overnight at 4°C (or alternatively, 2 hours at room temperature).
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The supernatant was slapped out of the wells, which were then wash once with T(0,5%)-
PBS, before being fill in with the blocking solution and incubated for 1 hr at room
temperature. The wells were then washed once with  T(0,5%)-PBS, and the phage preparation
diluted 1:1 in blocking solution, were incubated with the immobilized proteins for at least 1,5
hour (1010 phage per well).
The wells were washed twice with T(0,5%)-PBS and incubated for 1 hour with 100 µl of
αM13-antibody (horseradish peroxydase labeled; Pharmacia Biotech Europe GmbH,
Freiburg, Germany) diluted 1:2000 in T(0,5%)-PBS.
The immobilized proteins were intensively washed with T(0,5%)-PBS, and 100 µl of the
staining solution were added to the wells. After 5 to 30 min, when the coloration was
appropriate, the reaction was stopped by adding 50 µl H2SO4 (2 M), and the absorbance at
492 nm was measured, using an ELISA-plate reader.
6-4-3 Competitive phage ELISA
Competitive phage ELISA were performed according to the same principle than the
phage ELISA. But on this case, the interaction between the immobilized protein, and the
phage displayed peptide, was studied in presence of increasing amount of competitor. In the
course of this work, the used competitor is S1, the highest affinity peptide displayed on phage
surface, for Src SH3 domain, isolated by cosmix plexing library, and synthesized as free
peptide.
The procedure was similar to the one of phage ELISA, the phage preparation were
allowed to bind to the immobilized protein, but after washing, the free peptide competitor was
added to the phage particles attached to the immobilized protein. Alternatively, the phage
preparation, and the free peptide competitor were incubated simultaneously with the
immobilized protein.
Like for the phage ELISA, the amount of remained bound phage was then evaluated by
using anti-M13 antibody (horseradish peroxydase labeled; Pharmacia Biotech Europe GmbH,
Freiburg, Germany).
7- Determination of constant affinity of the selected variants
The BIAcore 2000 (Pharmacia Biosensor, Uppsala, Sweden) was used to test isolated
peptides for binding to their SH3 domain targets, and for determination of affinity constant.
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7-1 Immobilization chemistry
Each ligand to be immobilized was diluted in buffers of pH 0,5 to 3 pH units smaller
than the isoelectric point of the ligand of interest. pI were determined with the ExPASy
Internet service (http://expasy.hcuge.ch/ch2d/pi_tool.htlm).
Two sensor chips, F1 and SA (Pharmacia Biosensor, Uppsala, Sweden), were used to
immobilized the target proteins, using conventional amino coupling.
The F1 sensor chip was used to immobilized the GST-SH3 domain. A continuous flow
of PBS/Tween 20 was maintained over the sensor surface. The carboxyl groups on the sensor
surfaces were activated with an injection of a solution containing 0,2 M N-ethyl-N’-(3-
diethylamino-propyl) carbodiimide (EDC) and 0,05 M N-hydroxysuccinimide (NHS). The F1
dextran matrix was covered with antibody against GST. This was reached by injecting the
antibody. The immobilization procedure was completed by a 7 min injection of 1 M
ethanolamine hydrochloride, to block remaining ester groups. Capture of the GST-SH3
domains by the antibody against GST was obtained by injection of GST-SH3 domain diluted
in PBS/Tween. This yielded an amount of 2000 to 5000 RU of bound protein. This method
was relevant to characterize the ligands able to interact strongly to their target.
The SA sensor chip, coated with streptavidin, was used to immobilized short
biotinylated peptides, according to the EDC/NHS chemistry. 10 to 30 RU of biotinylated
peptides were bound to the chip by carefully injecting small volumes of the peptides by using
the manual inject command. This strategy is convenient to determine the interaction kinetic
constants.
For all immobilization protocols, one reference channel (flow cell 1) was not coated with
the target protein, but treated like the three other flow cells. This reference cell was used for
background correction.
7-2 Binding of the interaction partners
GST-SH3 domains were immobilized on the F1 sensor chip, trapped with the anti GST
antibody. The phage preparations were diluted in PBS/Tween 20, and injected as continuous
flow over the sensor surface, at a flow rate of 5 µl/min. The time for association was 6 min
and the dissociation was studied for 8 min. The sensor chip was regenerated by two washings
with 1 M glycine pH 2,2, for 30 sec, at a flow rate of 20 µl/min. A following cycle was then
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performed, where GST-SH3 domains were immobilized on the anti GST antibody covering
the F1 sensor chip, and other concentration of the phage preparation were injected to the chip.
As far as the SA sensor chip was concerned, the GST-SH3 domains were added in the
flow through buffer, to interact with the 10 to 30 RU of bound biotinylated peptides.
Concentrations of GST-SH3 domain which ranged from 0,3 to 10 nM were injected.
Conditions of injection were identical to the one of F1 sensor chip, except for the
regeneration, with was performed by washing with 10 mM NaOH, for 30 sec, at a flow rate of
20 µl/min. The affinity constants were calculated for each interaction, as described under the
section III-G of results.
8- Preparation of the Tat fusion peptides
After insertion of the peptide of interest within the polylinker site (XhoI and EcoRI
recognition sites) of the pTAT-HA vector (kindly provided by Steven F. Dowdy; University
of Washington, Saint Louis, Missouri, USA), the recombinant vectors were transformed in
BL21(DE3)LysS strain (Stratagen, La Jolla, CA, USA).
8-1 Purification of the Tat-fusion peptides
Urea 8 M
Buffer Z
Urea 8 M
NaCl 100 mM
Hepes 20 mM (pH 8,0)
Imidazole (500 mM)
Imidazole 17,02 g
Buffer Z to 500 ml
A 500 ml LB culture of the transformed cells was inoculated, and incubated for 4 hours
at 37°C, pelleted, washed once in PBS, and finally resuspended in 8 M urea, to denature the
fusion proteins.
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After sonication, purification of the Tat fusion protein was performed, taking advantage
of the His tag, by applying the suspension to a Ni-NTA column (Qiagen GmbH, Hilden,
Germany), previously equilibrated with buffer Z. The suspension applied to the Ni-NTA
column was first diluted in buffer Z/10 mM Imidazole. The column was then washed with
buffer Z completed with 10 mM Imidazole, to minimize non specific binding, and elution was
done by applying 500 mM Imidazole diluted in buffer Z, to the column. The fractions were
analyzed on Coomassie blue stained SDS-PAGE gel, and western blot, where Tat fusion
peptides were detected with anti hemaglutinin antibody.
8-2 Ionic exchange chromatography
An ionic exchange chromatography was performed, to eliminate the urea from the
protein suspension.
Buffer A
NaCl 50 mM
Hepes 20 mM (pH 8,0)
Buffer B
NaCl 1 M
Hepes 20 mM (pH 8,0)
NaCl (1 M)
NaCl 11,7 g
ddH2O to 200 ml
The suspension was applied to a HiTrap SP 1 ml column (Pharmacia Biotech Europe
GmbH, Freiburg, Germany) previously equilibrated with 5 ml buffer A, followed by 5 ml of
buffer B, and once more with 5 ml buffer A. All buffers were applied with a flow through of 1
ml/min.
The column was washed with 5 ml of buffer A, and the proteins were eluted with 3 ml of
1 M NaCl.
The Tat-fusion peptides were then desalted on a PD 10 disposable G-25 sephadex
gravity column (Pharmacia Biotech Europe GmbH, Freiburg, Germany). The PD 10 column
was equilibrated with 25 ml PBS, and the protein suspension was loaded. After the volume
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entered the gel bed, more PBS was applied, and fractions were collected, and analyzed on
Coomassie blue stained SDS-PAGE gel.
8-3 Fluorescein labeling
The Tat fusion peptides were conjugated with fluorescein isothiocyante (FITC; λ
excitation: 494; λ emission 520); Pierce, Rockford, IL, USA), to facilitate the detection of the
Tat-peptides delivered to the cells.
FITC stock solution (daily prepared)
FITC 1 mg
DMSO 500 µl
Kept in dark
10x FITC conjugation buffer (prepared monthly)
NaHCO3 1 M/ Na2CO3 1 M
Adjust the pH to 9,0 by adding solution B to solution a until pH reaches 9,5.
Solution A
NaHCO3 0,84 g
     ddH2O to 10 ml
Solution B
Na2CO3 1,06 g
     ddH2O to 10 ml
The Tat peptides to be conjugated with FITC (usually between 5 and 25 µg) was added
to 30 µl of 10x conjugation buffer, 10 to 50µl of FITC stock solution, and ddH2O was added
to reach a final volume of 300 µl. The reaction mixture was incubated for two hours at room
temperature, in the dark.
The FITC-labeled Tat fusion peptides were loaded to a PD 10 disposable G-25 sephadex
gravity column (Pharmacia Biotech Europe GmbH, Freiburg, Germany), as described above,
section II-8-2.
The fluorescein labeled proteins were stored at –70°C with 10% glycerol.
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9- Transduction of cells with Tat fusion peptides
9-1 Cell culture
The cells used for the Tat-fusion peptide transduction were the NIH 3T3 fibroblasts
(Andersson et al., 1979; Copeland et al., 1979). They were cultured at 37°C, on a humidified
air of 10% CO2.
Trypsin/EDTA
Trypsin (2,5%) 20 ml
EDTA (500 mM) 0,6 ml
PBS 480 ml
FCS: inactivated for 30 min at 56°C
Pen/Strep (100x)
Penicillin 10000 U/ml
Streptomycin 10 mg/ml
Completed DMEM (Dulbecco’s Modified Eagle’s Medium)
DMEM 445 ml
Pen/Strep (100x) 5 ml
Inactivated FCS 50 ml
NIH-3T3 fibroblasts grow as an adherent monolayer of cells.
The medium of the cultured cells was changed each time it was required, in average
every 2 to 4 days. Cultures were split at 1:10 every 4 to 6 days.
Passage of adherent cells was performed when the cells reached a confluent stage. The
medium was carefully discarded, the cells were washed once with PBS, and recovered with a
layer of Trypsin/EDTA solution. After a few minutes, the cells were detached from the
surface. The trypsin was then inactivated. The neutralization was performed by adding at least
the double amount of medium. The cells were then pelleted by centrifugation, and
resuspended in fresh medium to a suitable dilution, prior to be placed in fresh flasks.
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For long term storage, NIH-3T3 cells were resuspended in 70% DMEM, 20% FCS and
10% DMSO (1x106 cells/ampoule). The suspension was frozen with liquid nitrogen and
stored at -70°C.
9-2 Trypan blue exclusion test of cell viability
This technique is based on the principle that viable cells have intact cell membranes and
exclude dyes such as trypan blue whereas dead cells do not. Thus, viable cells have a clear
cytoplasm while non-viable cells are stained in blue.
Equal volumes of the cell suspension and of 0,4% Trypan blue solution (Sigma-Aldrich
Chemie GmbH, Deisenhofen, Germany) were mixed. After 1-2 min incubation, 10 µl were
transferred into the chamber of a Neubauer haemocytometer and the cells counted using a
binocular microscope.
Each corner square of the haemocytometer has 16 small squares and has 1 mm sides;
since the volume of liquid covering each corner is 0,1 mm, the total volume in the field is 10-4
cm3. Since 1 cm3 is equivalent to 1 ml, the subsequent cell concentration per ml was
determined using the following calculation:
No. of cells per ml = average count per square x dilution factor x 104
9-3  Transduction of NIH 3T3 cells with Tat-fusion peptides
NIH 3T3 cells to be transfected with Tat fusion peptides were trypsinized from their
cultured flasks, and resuspended at a concentration of 106 cells/ml of fresh medium completed
with FCS.
1 ml cell suspension was placed on a non treated surface, where adherence is prevented.
FITC labeled Tat-fusion peptides were directly added to the medium, at concentrations
ranging between 10 and 160 nM (to check for dose dependent transduction). Several aliquots
were prepared, so that there were enough samples to check by Fluorescence Activated Cell
Sorting (FACS) analysis for efficient transduction at particular time points (0, 15, 30, 45, 60
min).
Aliquots of transduced cells, after one hour incubation with the FITC-Tat-peptides, were
pelleted and resuspended in fresh FCS/medium. They were placed into usual flasks, and
directly checked on confocal microscopy for transduction. The flasks were then incubated
under normal conditions, and regularly checked on confocal microscopy for a few days.
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9-4 Flow cytometry analysis
In Fluorescence Activated Cell Sorting assays (FACS), cells can be sorted according to
their size, the integrity of their membrane, or due to their conjugation with fluorochrom.
Cells were transduced with FITC-Tat-fusion peptides, as described above (section II-9-
3). After incubation time of interest between the cells and the Tat-peptides, the cells were
recovered, pelleted by centrifugation, and resuspended in 200 µl of cold PBS. This washing
step allowed the reduction of the background level. The samples were then incubated on ice,
and analyzed with FACS.
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III - RESULTS
The aim of this work was to isolate strong ligands for SH3 and EVH1 domains. In order
to characterize ligands against particular SH3 or EVH1 domains, one needs to express and
purify the target proteins under reliable conditions, to obtain pure proteins, free of
contaminants. The GST-fusion system is highly advantageous for achieving a very high
degree of purity.
A - GST-fusion proteins
Several vectors have been constructed that simplify the purification of foreign
polypeptides expressed in E.coli (reviewed by Marston, 1986). The pGEX expression vector
family (Pharmacia) directs the synthesis of foreign polypeptides, as fused to the GST protein,
which can be purified under non-denaturing conditions by glutathione-affinity
chromatography (Smith and Johnson, 1988). The SH3 and EVH1 domains studied in this
work were all expressed as GST-fusion proteins.
The nephrocystin SH3 domain was the only protein that was produced entirely as GST-
fusion protein, in our laboratory, starting from the cDNA (provided by Dr. Hildebrandt,
University of Freiburg, Germany). The cDNA was inserted into the pGEX-5X3 within the
restriction sites SmaI and SalI, on the C-terminal end of the GST (Figure III-1). All other
SH3-fusions proteins were provided by Lawrence Quilliam and Brian Kay (University of
Wisconsin-Madison, Wisconsin, USA).
WK6λmutS cultures transformed with recombinant pGEX plasmids were submitted to
IPTG induction. This step was also performed for all SH3 domains: the nephrocystin
previously cloned into the vector, and several other SH3 domains, supplied by Quilliam and
Kay (University of Wisconsin-Madison, Wisconsin, USA) as GST-fusion constructs (within
pGEX-2T) and ready for the protein expression. After 5 to 7 hours incubation, the cells were
harvested and lysed on ice by mild sonication. The supernatant was then ready to be applied
to a glutathione sepharose column (Sigma). The fusion proteins were eluted by competition
with free reduced glutathione. The Figure III-2A shows the elution profile of the purified
GST-fusion protein. All proteins recovered after this treatment are very pure, as illustrated in
Figure III-2B, from GST-Src fusion protein, as a typical example.
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The EVH1 domains were kindly supplied by Jürgen Wehland (GBF, Braunschweig,
Germany) as purified GST-fusion proteins.
-------------------------cDNA Nephrocystin SH3 domain-------------------------
     SmaI           SalI
  Stop codons           SmaI    SalI
  GST
bla    tac
      pGEX-5X3
 (4,9 kb)
    lacZ
      ori
      lacIq
Figure III-1: Schematic map of the plasmid vector pGEX-5X3. The normal translation
stop codon of the GST cDNA began at nt 7 and has been destroyed through the introduction
of oligodeoxynucleotides encoding unique cleavage sites for the multiple cloning sites and
TGA stop codons in all three reading frame. SmaI and SalI restriction sites were used to insert
the nephrocystin cDNA, C-terminal from the GST. pGEX-5X3 contains additional sequences
encoding protease cleavage sites recognized by factor Xa, between the GST and the multiple
cloning sites. The GST-fusion gene is under the control of the tac promoter. Cells transformed
with this plasmid and induced with IPTG, synthesized the GST-fusion protein. pGEX-5X3
carries a fragment of the lac operon containing the over-expressed lacIq allele of the lac
repressor and part of lacZ. In absence of inducer, the plasmid-encoded lacIq allele is efficient
in repressing transcription from the tac promoter. The following abbreviations are used: bla:
β-lactamase gene (ampicillin resistance); ori: origin of replication.
Both families of proteins (SH3 and EVH1) show preferences for proline rich ligands.
Therefore, the libraries generated for the screening were biased libraries (Figure III-3) which
contain fixed amino acid residues at particular positions (one or several prolines in each
library and, in addition, in two of the libraries, an arginine). By incorporating a structural
motif that favors the target binding to a large collection of peptides, one tends to increase the
chance of isolating ligands with higher affinity for the target of interest, as well as defined the
orientation of the ligands in an uniform way.
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Figure III-2: Purification of GST-Src SH3 domain, on a glutathione sepharose column.
(A-) The GST-Src protein loaded onto the column was produced from a 400 ml culture
incubated with IPTG (0,1 mM) for 5 hours. Elution fractions (0,5 ml) were recovered
throughout the purification procedure, and OD280 was used, to determine the protein
concentration of each fraction. Washing of the column was performed with equilibration
buffer (Tris/EDTA; 10mM/10mM) and was carried out until the eluant reached baseline
OD280 levels. The GST-Src protein was then eluted by competition with free reduced
glutathione. (B-) Elution fractions of the purification of GST-Src domain analyzed by SDS-
PAGE, followed by staining with Coomassie blue. S represents the supernatant of the cell
extract, as applied to the column. E stands for the eluted fractions, which contain GST-Src
protein. The position and sizes (kDa) of molecular weight markers (M) are indicated.
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      Random library      Biased library
Figure III-3: Comparison of preferences for a given target between a random peptide
library and a biased library that contains predetermined ligand-binding preferences.
The biasing element tends to increase the average affinity of the ligands for the receptors.
Five different libraries were constructed in two ways. Four banks were constrained,
expressing the hypervariable sequence bracketed by two cysteines and therefore, displayed as
a loop. The fifth bank, a cosmix-plexing bank, displayed a linear sequence on the surface of
the phage.
The constrained libraries did not result in isolation of ligands for our targets, for reasons
that will be discussed below.
B – Constrained random peptide libraries
The constrained libraries were constructed by insertion of synthetic hypervariable
oligonucleotides within the vector pSKAN8.
pSKAN8 (Figure III-4) is a phagemid-display vector which contains a pancreatic
secretory trypsin inhibitor (PSTI)- pIII  fusion gene (Röttgen and Collins, 1995). The PSTI is
a 56 amino acid long protein which has been extensively studied in our group: the specificity
of the inhibitor was altered to give strong inhibitors (Ki = < 10
-11 M) for chemotrypsin or
human leukocyte elastase (Collins et al., 1990; Szardenings et al., 1990). In the banks derived
from the pSKAN8 vector, the hypervariable region replaced a short PSTI loop (amino acids
17 to 23) at the exposed tip of the PSTI. Serine-protease inhibitors of the ovomucoid
superfamily, to which PSTI belongs, exhibit rapid evolution mainly via diversity in the
constrained loop which is mutated in our banks. This loop is able to accommodate many
structures and still fold correctly.
The “outer membrane”-protein, OmpA-leader peptide (OmpL), was fused to the first
amino acid of PSTI to ensure that production, secretion and correct cleavage of the leader
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peptide occur (Szardenings et al., 1990).
The PSTI-pIII gene is under the control of the bacteriophage lambda pL promoter. The λ
pL promoter is strongly repressed by the λ cI protein which is produced in λ lysogen E. coli
strains. The use of this promoter ensures that the correct ratio of hybrid to wild type pIII in the
particles produced on superinfection, is achieved for essentially monovalent presentation (i.e.,
one hybrid pIII per particle).
The pSKAN8 vector also contains plasmid replication functions, ampicillin and
chloramphenicol resistance genes and the M13 phage replication/packaging origin.
The hypervariable domains replacing the 7 amino acid loop (residues 17 to 23) within
PSTI employed in creating the four gene banks pSKAN8-HypD, -HypE, -HypF and -HypG
were as following:
Each of these banks presents particular advantages in isolating ligands for the SH3
domains, due to the presence of the fixed prolines. In addition, banks pSKAN8-HypF and -
HypG might be highly favorable, to characterize EVH1 domain ligands.
The HypD and HydE libraries were especially designed to isolate strong ligands for
SH3 domains. Both libraries take advantage of the well known preferences of SH3 ligands of
requiring an arginine in order to build a salt bridge with a conserved residue of the SH3
domain (Asp99 in Src).
Two ligand classes for SH3 domains have been reported which bind in opposite
orientations to the domain. These two ligand classes share distinct consensus sequences, the
main difference between them is the position of the arginine which occurs before or after the
proline rich core motif. The class I consensus sequence is RXLPXXP, while it is PXXPXR
for the class II. Interestingly, some SH3 domains, like Src or PI3K, can bind peptides of either
class (with the consensus sequences RPLPPLP and PPVPPR for class I and II Src ligands, and
RXLPPRP and PPLPXR for class I and class II PI3K ligands). Although the biological
implications of this are unclear, a possible explanation is that ligand binding in two
orientations could access different partners in multi-component protein complexes. HypD and
HypE libraries have characteristics (position of the arginine) belonging to class II or class I
ligands, respectively.
HypD Cys  (Xxx)4  Pro    Xxx  Arg    Cys
HydE Cys   Arg    (Xxx)3  Pro  (Xxx)2 Cys
HypF Cys  (Xxx)2  Pro    Xxx  Xxx    Pro  (Xxx)2  Cys
HypG Cys  (Xxx)3  Pro    Pro   Xxx  Pro  (Xxx)2 Cys
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      Primer A
HypD  ACGAGCTCAACGGTTGC(NNK)2NNK NNK CCA NNKAGA TGCGGTACCGA
                         Primer B
HypE  ACGAGCTCAACGGTTGCAGA(NNK)2NNK CCC NNK NNK TGCGGTACCGA
HypF  ACGAGCTCAACGGTTGC(NNK)2CCGNNKNNKCCN(NNK)2TGCGGTACCGA
HypG ACGAGCTCAACGGTTGC(NNK)3CCACCCNNKCCG(NNK)2 TGCGGTACCGA
   SacI      KpnI
        SacI   KpnI
       ompL      psti
      λPL          linker
    cat
pSKAN8 pIII
(5635 bp)
    bla      ori fd
   ori E
Figure III-4: Schematic map of the phagemid vector pSKAN8. pSKAN8 was described by
Röttgen and Collins (1995) for presenting the PSTI on the surface of bacteriophage. The
endonuclease sites SacI and KpnI were used to introduce the hypervariable gene banks:
HypD, HypE, HypF, HypG. The hypervariable inserts were amplified with the primers A and
B, and digested with the restriction enzymes SacI and KpnI. The following abbreviations are
used: λPL: major leftward promoter of the bacteriophage λ; ompL: signal sequence derived
from the E.coli outer membrane protein ompA; psti: gene encoding for the pancreatic
secretory trypsin inhibitor; pIII: gene coding for the minor coat protein pIII of the M13
bacteriophage; bla: β-lactamase gene (ampicillin resistance); cat: chloramphenicol
acetyltransferase gene; ori fd: origin of replication for single stranded DNA of the
bacteriophage fd; ori E: origin of replication for plasmids colE1.
Even if Src and PI3K SH3 ligands are known to bind in two different orientations, it is
unclear for the other SH3 domain ligands. The work done by B. Kay’s group predicts that
Yes, Abl and Grb2NH2 SH3 domain ligands tend to bind in a class I orientation, whereas the
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peptides selected by the Cortactin, p53bp2, PLCγ, and Crk NH2 SH3 domains are expected to
interact in a class II orientation (Sparks, 1996). Therefore, each of the generated banks, HypD
and HypE, might be relevant for different SH3 domains.
The HypF and HypG banks are more general and suited to all SH3 and EVH1 domains.
They take advantage of the proline rich motif, necessary for the formation of the left-handed
polyproline type II helix that the SH3 or EVH1 domain ligands might form in order to bind to
these domains.
HypF presents a PXXP core motif which is the essential basic motif of the polyproline
type II helix. Each ligand capable of binding to SH3 or EVH1 domains might contain this
motif. The PPXP motif displayed in HypG might be selective for SH3 and EVH1 domains, as
the presence of a proline will reduce the entropy cost needed for the formation of the
polyproline type II helix. Most of the SH3 and EVH1 ligands show this PPXP motif. Hence,
of the four constrained banks, HypG may be the one which offers the greatest selectivity.
However, HypF offers a larger freedom which may be interesting by giving a larger amino
acid selection to the ligand sequences.
1- Generation of the libraries
1-1 Preparation of the linearized vector DNA
The phagemid pSKAN8 stuffer used in this work is an expression vector where variant
peptides can be fused to the N terminal part of the pIII gene. Phagemid vectors contain both
plasmid and bacteriophage replication origins. However, with the exception of the partner
gene for the fusion of the peptide or protein to be displayed, they do not carry any of the
phage genes. The phagemids maintain themselves as plasmids, until a superinfection with a
helper phage (M13KO7) activates their phage replication/packaging origins. The helper phage
provides all bacteriophage functions necessary for the synthesis of the circular single-stranded
DNA and for the assembly of the phage-like particles, displaying the hybrid fusion proteins.
The stuffer is a 3 kb DNA fragment, resulting from the digestion of λ DNA with NgoMI
and HindIII, inserted in the region encoding the PSTI inhibitory loop. On complete digestion
with the restriction enzymes (SacI and KpnI), the stuffer and the opened vector are distinct
after separation, on an agarose gel. Since two different restriction enzymes are used for the
digestion, the gel-extracted large vector fragment has two different cohesive ends. This
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fragment cannot undergo ring closure in the absence of an inserted fragment.
The insertion site for the hypervariable oligonucleotide was prepared by linearizing the
vector with the KpnI and SacI restriction enzymes. The hypervariable region was inserted
between a leader “signal” sequence and the M13pIII gene in the phage display vector, so that
the peptide would be presented on the surface of the phagemid particle as an amino terminal
extension.
1-2 Preparation of the double stranded DNA insert from degenerated
oligonucleotides
The codon scheme used to encode random amino acid sequences is NNK, where N is
A,C,G or T, and K is G or T. This scheme minimizes the stop codon frequency (which would
lead to unproductive clones), as only one of the three stop codons (TAG) can be encoded,
while codons for all the 20 amino acids are still represented.
Basic protocols used in many laboratories to clone inserts into a vector lead to the
formation of unwanted products, which might seriously limit the electroporation efficiency.
The advantage of the method employed here, is its ease of manipulation: vector and insert are
digested at both extremities by two different restriction enzymes to prevent ring closure of
vector without insert (unproductive product).
Vector and insert are then simply ligated together. However, this technique offers no
possibility to direct the formation of the desired product (Figure III-5). At best, one can
reduced the proportion of unwanted products by performing a series of test ligations, to
determine the ratio of insert to vector DNA which results in the largest number of
recombinants after electroporation.
To minimize these difficulties, an optimized strategy for insertion of the hypervariable
DNA domain into the vector, was developed. This strategy allows control of the generated
products along with the possibility of eliminating small cleavage products, and leads to the
formation of a clean product.
Although the strategy chosen to prepare the oligonucleotides involves many steps,
however, it guarantees pure products. Figure III-6 illustrates this strategy. The quality of the
digested inserts have a strong influence on the efficiency of ligation with the vector and thus,
on the efficiency of electroporation of the ligated DNA into bacteria.
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formation of a clean product.
Although the strategy chosen to prepare the oligonucleotides involves many steps,
however, it guarantees pure products. Figure III-6 illustrates this strategy. The quality of the
digested inserts have a strong influence on the efficiency of ligation with the vector and thus,
on the efficiency of electroporation of the ligated DNA into bacteria.
  KpnI
  SacI
PCR with biotinylated primers
  S    K
Restriction with KpnI
    S           K         K
Ligation among themselves
  S               K               S
Restriction with SacI
        S       S   K         S       S
Streptavidin bead purification
      S           K         S
Insert ready to ligate to the linearized vector
Figure III-6: Schematic representation of insert preparation. The insert oligonucleotides
were amplified by PCR using biotinylated primers, leading to products carrying biotin at the
extremities. The PCR products were digested with KpnI and ligated among themselves. The
resulting dimeric insert was digested with SacI and the restriction fragments were removed by
magnetic streptavidin beads. S and K stand for SacI and KpnI sites, respectively.
The insert oligonucleotides were converted into double-stranded DNA and amplified via
PCR, using biotinylated primers (to allow subsequent easy removal of restriction fragments).
The inserts were then restricted with KpnI, allowed to ligate among themselves to form
dimeric inserts with a central KpnI site and, at both extremities, SacI restriction sites. This
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fragment was then digested with SacI, generating cohesive ends at both extremities. The
product was purified using superparamagnetic polysterene beads with streptavidin covalently
attached to the bead surface (Dynabeads M-280 Streptavidin; Dynal). These beads captured
and removed the biotinylated DNA from the digested insert. The insert was ready for ligation
with the linearized vector.
1-3 Ligation of the vector and insert DNA
The digested vector and insert were ligated together (Figure III-7). Re-anealment of the
vector (formation of parental vectors) was impossible since the ends were different and
furthermore, the insert could ligate only with the SacI-digested end of the vector. Restriction
with KpnI was performed. The vector attached to one end of the insert was then ligated,
leading to the ring closure of the DNA. This ligation was performed at low DNA
concentration to encourage ring closure and discourage formation of concatemers or potential
reinsertion of the small cleavage products. This protocol led to the formation of a clean
product, since it was possible at each step, to direct the formation of the wished particles. The
obtained product, reached very high efficiency during electroporation.
The hybrid pSKAN8 thus formed, pSKAN8-HypD, -HypE, -HypF, -HypG, were
transformed into WK6λmutS E.coli strain (ampicillin selection; 300µg/ml). This lambda
lysogen strain expresses the cI transcription repressor of the lambda bacteriophage, and
prevents an inopportune production of PSTI-pIII gene product which might be toxic. In
addition, it ensures the presentation of one hybrid pIII per particle.
The electroporations were carried out, until relevant bank diversities were reached. For a
library containing 5 random residues (pSKAN8-HypD, and -HypE), a diversity equivalent to
approximately 108 single clones (Table III-1) is necessary to ensure the presence of all
possible amino acid combinations, with a 99% level of confidence. For  pSKAN8-HypF and -
HypG which contain 6 random amino acids, the necessary diversity is about 5x109 single
clones. The values of necessary diversities for biological libraries, according to the number of
randomized positions are summarized in the Table III-1, adapted from Clackson and Wells
observations (1994).
The diversities obtained for pSKAN8-HypD, -HypE, -HypF, -HypG libraries, are
presented in Table III-2, and show that the diversities of the libraries are sufficient to
represent most of the possible random peptide combinations.
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      K
pIII         +
      K
      pIII       pIII
Restriction with KpnI
               S       K         S
     K      K
  pIII
Ligation
       S
           K
         One vector
         One insert   pSKAN8 pIII
Electroporation
Figure III-7: Schematic representation of primary library construction. Opened vectors
and dimeric inserts (prepared according to the protocol described in Figure III-6) are ligated
together. Ligation between two vectors, in the absence of insert (formation of vector dimers)
is prevented by using an excess of insert. Two vectors may bind to the same dimeric insert
and thereby, blocking the KpnI site, leading to a molecule composed of two vectors and one
insert. Restriction with KpnI exposes the KpnI site of the insert which is then free to ligate
with the second extremity of the vector, leading to ring closure. The ring closure is performed
at low DNA concentration, to avoid the formation of concatemers. The vector with the fusion
pIII protein can now be electroporated into bacteria, resulting in a high diversity library. S and
K stand for SacI and KpnI sites, respectively.
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     Transformants required for
         complete library with:
  Positions  Peptide DNA diversity         90%     99%
randomized diversity (NNK codons)      confidence       confidence
       (n)   (20n)        (32n)
1      20        32        74    149
2     400     1.0x103     2.4x103         4.8x103
3  8.0x103     3.3x104     7.6x104   1.5x105
4  1.6x105     1.1x106     2.4x106   4.9x106
5  3.2x106     3.4x107     7.7x107   1.6x108
6  6.4x107     1.1x109     2.5x109   5.0x109
7  1.3x109     3.4x1010     7.9x1010 1.6x1011
8  2.6x1010     1.1x1012     2.5 x1012 5.1x1012
Table III-1: Necessary sizes of phage display libraries to ensure the presentation of all
possible random peptides. NNK codons (where N is any nucleotide, and K is G or T) is
commonly used for randomization in biological libraries. NNK encodes all the amino acids
except two of the stop codons, reducing the stop codons occurrence by two thirds. The
confidence that a library contains all possible amino acid sequences is calculated assuming a
Poisson distribution (Lowman and Wells, 1991). Adapted from Clackson and Wells (1994).
Library Single clones selected on ampicillin agar plates
  pSKAN8-HypD 9x109 
  pSKAN8-HypE 1.8x108
  pSKAN8-HypF 1x109
  pSKAN8-HypG 1.3x109
Table III-2: Estimation of pSKAN8-HypD, -HypE, -HypF, -HypG diversities. The
number of single clones was estimated from dilution series from each performed ligation,
plated on ampicillin LB plates.
2- Evaluation of the quality of the banks
Randomly selected clones were picked and sequenced, to confirm the presence of a
single insert within the PSTI and to check the quality of the banks. The frequency of clones
which are submitted to a change in the open reading frame (insertion, deletion) or which
contain stop codons has to be estimated. In addition, the frequency of codons for each amino
acid has to be determined and compared with the expected values.
An initial analysis of the sequenced clones showed that between 72% (HypD) and 94%
Results
116
(HypE) of the clones contained one insert within the PSTI gene which was correctly formed
(Table III-3). These clones did not exhibit mutations within the fixed amino acids contained
in the hypervariable region, or within the constant region flanking this domain. In addition,
they did not show a change in the open reading frame, which would lead to phage particles
lacking pIII fusion protein.
In HypD and HypF libraries, some clones were found which contained 3 inserts (20,4%
and 6,7% respectively). However, no clone containing religated vector without insert DNA
was found, in any of the libraries.
Between 5,9% (HypE) and 13,4% (HypF) of the analyzed clones contained point
mutations, such as insertions, deletions or exchanges of 1-3 bp.
pSKAN8-HypD pSKAN8-HypE pSKAN8-HypF pSKAN8-HypG
total of sequenced clones 44 (100%) 34 (100%) 30 (100%) 30 (100%)
correct sequences 32 (72,7%) 32 (94,1%) 24 (80%) 27 (90%)
3 inserts within PSTI 9 (20,4%) 0 2 (6,7%) 0
1bp insertion 1 (2,3%) 0 2 (6,7%) 1 (3,3%)
1-3bp deletion 2 (4,6%) 2 (5,9%) 2 (6,7%) 1 (3,3%)
1bp point mutation 0 0 0 1 (3,3%)
Table III-3: DNA sequence analysis of randomly selected clones from pSKAN8-HypD, -
HypE, -HypF, -HypG. Relative frequency of correctly and incorrectly formed clones.
The correctly formed clones were submitted to further analysis. The hypervariable
regions were further investigated to determine the ratio of particular bases at each of the three
positions of the hypervariable codons (Table III-4).
The codon scheme used to encode the random amino acid sequences of the HypD, E, F,
and G libraries, is NNK. With this NNK system, one would have expected to find 25% of
each base in the first two positions of the codon and a frequency of 50% each, for G and T, in
the third position. These theoretical values were respected for the third position of the codon,
however, not for the first two positions, where G was dominantly found, to the detriment of A
and C which were under-represented. T was also slightly over-represented at the first two
positions of the codon.
In both HypD and HypF libraries, a very low frequency of A and C (0,5 to 1,1%,
respectively) at the third position of the codon (“not allowed” position) was found. This may
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have been due to the PCR parameters employed which were permissive and may have
permitted a low frequency of Taq polymerase “errors”. These “errors” may have increased the
diversity of the hypervariable sequences.  
Bank Base Codon position
first second third
HypD A 18 13,3 0,5
C 17 20 0,5
G 35,6 39,9 50
T 29,3 26,6 48,9
HypE A 15,9 17,1 0
C 17,7 15,2 0
G 35,4 35,4 48,2
T 31 32,3 51,8
HypF A 21,1 22,2 1,1
C 20 17,8 1,1
G 35,5 32,2 57,7
T 23,3 27,8 40
HypG A 10,8 19,3 0
C 19,3 16,2 0
G 40,8 38,7 54,8
T 29 25,8 45,2
HypDEFG A 16,5 18 0,4
C 18,5 17,3 0,4
G 36,8 36,5 52,6
T 28,1 28,1 46,5
Table III-4: Percent base distribution within the codons of the hypervariable region of
the pSKAN8-HypD, -HypE, -HypF, -HypG banks. The values of the HypD and HypE
banks were calculated from 32 clones each (160 random codons). For HypF, and HypG, the
values were calculated from 24 and 27 clones (144 and 162 random codons), respectively.
Since the codon scheme used is NNK, where K is G or T, 25% of A, C, G and T were
expected within the first two positions, and 50% G and T at the third position.
Each of the four libraries exhibited the same base position trends (Table III-4).
Therefore, the base distribution of the four banks together was determined, and is shown in
Table III-4.
The over-representation of G and the under-representation of A and C (Table III-4),
allow a first estimation of the amino acid frequency that might be found for the different
libraries. Codons rich in G, might be over-represented, whereas the ones containing several A
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or C might occur at a very low level. Hence, one can predict that  Gly (GGN), Val (GTN), but
also Phe (TTT; TTC), Trp (TGG) and Cys (TGC; TGT) might appear more often than
expected, based on the NNK theoretical values. On the other hand, Thr (ACN), Asn (AAT;
AAC), Lys (AAA, AAG), Pro (CCN), His (CAT, CAC) and Gln (CAA, CAG) might be very
rare.
NNK HypD HypE HypF HypG HypDEFG
Ala 6,2 6,5 3,8 1,1 9 5,1
Arg 9,3 9,8 11,4 7,7 7,8 9,2
Asn 3,1 0,5 1,9 2,2 1,1 1,4
Asp 3,1 2,2 3,1 5,5 4,5 3,8
Cys 3,1 4,9 3,8 2,2 6,7 4,4
Glu 3,1 2,7 3,8 3,3 2,2 3
Gln 3,1 1 1,9 1,1 3,3 1,8
Gly 6,2 16,8 11,4 17,7 18 16
His 3,1 1,6 0 3,3 3,3 2
Ile 3,1 2,2 3,8 2,2 1,1 2,3
Leu 9,3 6,5 7 7,7 7,8 7,2
Lys 3,1 0,5 1,3 1,1 1,1 1
Met 3,1 3,2 1,9 6,6 1,1 3,2
Phe 3,1 7,6 6,3 2,2 5,6 5,4
Pro 6,2 4,3 2,5 6,6 2,2 3,9
Ser 9,3 10,8 7,6 5,5 5,6 6,2
Thr 6,2 3,2 3,1 5,5 1,1 3,2
Trp 3,1 4,9 7 4,4 4,5 5,2
Tyr 3,1 1,6 2,5 2,2 1,1 1,8
Val 6,2 7,6 13,3 7,7 9 9,4
Stop codon 3,1 1 2,5 3,3 3,3 2,5
Table III-5: Expected and actual amino acid frequencies (in percentage) of the pSKAN8-
HypD, -HypE, -HypF, and -HypG libraries. The last raw corresponds to the amino acid
frequencies of the four banks taken together. This represents the data of 115 clones (626
random amino acids).
The actual amino acid frequency found in each of these libraries was determined from
the correct clones which were sequenced. The results of this analysis were compared with the
theoretical frequencies expected in a NNK library, and are summarized in Table III-5.
Figure III-8 gives an overview of the data presented in Table III-5. The amino acid
frequency calculated for the four banks were correlated with the expected amino acid
frequency of a NNK bank, however, it corresponded to the predictions based on the results of
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the base distribution analysis (Table III-4): over-expression of Gly, Val, Trp, Phe and Cys,
under-expression of Thr, Asn, Lys, Pro, His, Gln. With the exception of the histidine in HypE,
every amino acid were represented in each bank.
Amino acid frequency in HypD, HypE, HypF, and HypG
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NNKFigure III-8: Expected and actual amino acid frequencies (in percentage) of the
pSKAN8-HypD, -HypE, -HypF, and -HypG libraries, according to the values presented in
Table III-5.119
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3- Panning selection on SH3 domains
The quality of the four constrained random peptide libraries has been shown to be
relevant in isolating peptides against a particular target. Indeed, the diversity of the banks was
above the theoretical size required for pSKAN8-HypD and -HypE, and was almost as
required for the two other banks, pSKAN8-HypF and -HypG (see Table III-1 and III-2).
Furthermore, the libraries represent all codons, except the two forbidden codon stops.
Therefore, the quality of the banks were considered sufficient to be tested against SH3
domain targets, in the attempt to isolate strong ligands.
In addition, the method used to prepare the SH3 domains as GST fusion proteins, was
proven successful as demonstrated by SDS PAGE and Western blot. Most researchers who
have previously worked with SH3 domains, have successfully used GST-SH3 fusion proteins
(Rickles et al., 1994; Yu et al., 1994; Feng et al.,1995; Alexandropoulos et al., 1995; Bunnell
et al, 1996; Sparks et al., 1996), suggesting that GST-SH3 fusion proteins are suited to
panning selection of phage display libraries. Ligands for GST, when using GST-fusion
proteins in affinity selection, have not been reported.
Although target proteins and libraries were correctly prepared, the panning selections
were unsuccessful. Extended tests were performed on Src SH3 domain, all of which were
negative. To ensure that the problems encountered were not dependent upon the target protein
itself, Grb2 SH3 domain was also tested, without amelioration of the results.
The panning procedure was performed essentially as previously described, with some
modifications, aimed at improving the interaction between the target protein and the phage
library: the fusion proteins (contained in PBS) were immobilized using two types of supports,
a maxisorb (Nunc), or a glutathione microtiter plate (Pierce), by incubation overnight at 4°C.
In case of glutathione plates, the GST is captured by the glutathione fixed to the bottom of the
wells, and the fused protein (Src) is expected to be orientated such that it is available for
interactions with the phage library. However, no improvement was evident by changing the
microtiter plate.
After immobilization, unspecific binding of the phage to the walls of the wells was
blocked with PBS/2% skim milk powder, and incubations with the phage library subsequently
carried out at room temperature for 2 hours. Previously, the library was diluted 1:1 in PBS/2%
skim milk powder, to minimize the background.
After incubation of the target proteins with the phage library, wells are washed to
Results
121
remove unbound, or low binding phage. The stringency of the washing steps increased with
the cycles of selection, as shown on Table III-6.
On the first panning performed, PBS/0,5% Tween 20 was used to wash away the
unwanted phage. As no enrichment of particular clones against the target protein was
observed, PBS with 0,05% Tween 20 was used in subsequent wash steps. In addition, it was
attempted to wash only with PBS during the first round of panning, and to introduce Tween
only from the second cycle on. Reduction or elimination of the Tween during the first panning
round might help to rescue clones which might be able to bind to the target, but which are
under-represented in the library and, therefore, more easily lost during the washing steps. If
such a clone is recovered after the first round of panning, it would be amplified (after elution,
and reinfection) and be present in larger amounts in the second cycle, and Tween can be
introduced. Unfortunately, none of these approaches led to the characterization of ligands for
Src or Grb2 SH3 domains.
cycle of panning
1 2  3 - 5
PBS/Tween 1x  5 min 3x  5 min 5x  5 min
PBS/milk 10 min 10 min 10 min
PBS/Tween 1x  5 min 3x  5 min 5x  5 min
PBS/milk 5 min 5 min 5 min
PBS/Tween 1x  5 min 3x  5 min 5x  5 min
H2O 1x 1x 1x
Table III-6: Stringency of the washing steps according to the cycle of panning. The
PBS/Tween contains the appropriate amount of Tween, according to the target protein, and
the aim to reach. In our experiments, we used 0,5 or 0,05% of Tween 20. The PBS/2% skim
milk powder was the blocking solution used. In case that some phage bound to the milk
powder used to block the walls of the well, the milk added in solution competes this
interaction.
Figure III-9 shows the evolution of the input (amount of phage incubated with the target
protein), output (eluted phage after stringent washing steps), and the ratio of output/input
(O/I) which is an indication of enrichment. When most of the added phage (input) is
recovered after washing and elution (output), this indicates that the majority of the phage
clones had a high affinity for the target, and remained attached to the target during the
washing steps. These clones were enriched during the previous cycles of panning selection.
The enrichment factor is estimated by dividing the ratio O/I from the round of interest (where
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the output and the ratio O/I appear to be very high), with the ratio O/I from the first round. An
enrichment is considered significant when the factor increases by approximately 100 or
greater. It is impossible to recover all of the input, and a minimum background level cannot
be avoided.
As seen in Figure III-9, no enrichment was observed. Furthermore, the titration values of
pSKAN8-HypD on Src SH3 domain were very close to the values obtained for the negative
control, where the library was incubated in a well, without immobilized target protein.
The titration values show in the Figure III-9 are for the phage library pSKAN8-HypD,
tested by affinity selection with Src SH3 domain. However, the four banks, pSKAN8-HypD, -
HypE, -HypF, -HypG, showed the same titration trends, when tested against Src, or Grb2 SH3
domains. The variations introduced to the panning protocol (different way to immobilize the
target, or altering the stringency of the washing steps) did not lead to any improvement of the
affinity selection.
No enrichment was evident after five rounds of panning, nevertheless, some randomly
selected clones were picked and sequenced, to try to identify a potential homology between
the clones. The analysis of the sequences shows that there was no similarity between the
clones. It was obvious that no particular phage was retained by the target, since the clones
which are amplified along the cycles of panning were the unproductive clones, due to
mutations or stop codons. These smaller particles have a selective advantage, due to their
shorter replication time.
Previous analysis of the original pSKAN8-HypD library demonstrated that less than 7%
of the random peptides contained insertions or mutations (Table III-3), and only 1% of the
amino acids were estimated to represent the TAG stop codon (Table III-5). If we consider that
the pSKAN8-HypD library contains 5 random amino acids, only one stop codon is expected
every 20 random peptides (5% of the random peptides contain a stop codon). That means that
the original pSKAN8-HypD library contained approximately 12 % of unproductive clones.
As shown in Table III-7 and Figure III-10, the unproductive clones have been
dramatically enriched during the panning, since they represent 28,6% of the population after
the 2nd round of panning, and dominate after the 4th round (53,8%).
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Panning of pSKAN8-HypD on Src SH3 domain
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9: Titration of the input, output and ratio output/input of the pSKAN8-HypD
er 5 rounds of panning on Src SH3 domain. (A-) Titration values, in absolute
) of the input, output and ratio output/input, followed over 5 rounds of panning.
ram of the values. Src was immobilized and the phage library was incubated with
 negative control was performed, where no target protein has been immobilized.
itted to the same treatment.
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2nd round 3rd round 4th round
correct sequence 71,1 55 46,2
unproductive clone 28,6 45 53,8
stop codon 21,5 25 30,7
insertion/deletion 7,4 20 23
Table III-7: DNA sequence analysis of randomly selected clones from pSKAN8-HypD
after the 2nd, 3rd and 4th round of panning selection on Src SH3 domain. Relative
frequency of correctly and incorrectly formed clones, in percentage. The incorrectly formed
clones are unproductive clones, due to the presence of a stop codon, or a change in the reading
frame, owing to insertions or deletions. 14, 60 and 26 clones were sequenced after the 2nd, 3rd,
and 4th round of panning, respectively.
Figure III-10 shows the proportion of unproductive clones compared to correctly formed
ones, and specify the frequency of stop codons, or mutations responsible for these malformed
clones. Even if the trends tends to equilibrate after a few rounds, the highest cause of incorrect
clones is the presence of stop codon(s) within the hypervariable domain.
The proportion of correct clones compared to unproductive particles for the pSKAN8-
HypD library selected on Src SH3 domain (Figure III-10), shows high homology with the
ratio of correct to incorrect clones, estimated for randomly picked clones after different
rounds of panning selection of libraries pSKAN8-HypE, -HypF and -HypG, using Src, or
Grb2 SH3 domains as targets.
This unsuccessful panning was disappointing, but finally, not really surprising. The
possible reasons for expecting negative results with constrained peptide libraries are argued in
the discussion.
Figure III-10: Ratio of corrected formed clones to malformed particles after panning
selection. DNA sequence analysis of randomly selected clones from pSKAN8-HypD after the
2nd, 3rd and 4th round of panning selection on Src SH3 domain. 14, 60 and 26 clones were
sequenced after the 2nd, 3rd, and 4th round of panning, respectively.
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4- SH3 ligands displayed on bacteriophage
To better understand why the panning selection performed with the constrained libraries
failed, extensive tests were performed: SH3 ligand was inserted into the PSTI region of the
pSKAN8 vector, at sites where the hypervariable domains were located and the four
constrained libraries generated. These clones were used to test the hypothesis that two
cysteines at both extremities of the variable region, may alter PPII conformation and thereby,
obstruct the interaction between the SH3 domains and potential ligands.
A SH3 ligand was inserted into pSKAN8 following the protocol used to clone the
hypervariable region, to create the constrained random peptide libraries. Our choice of SH3
ligand was based on the results of previous studies by other groups. The group of Brian Kay
has worked extensively on SH3 domains, including isolation of ligands with distinct
preferences for different SH3 domains (Src, Abl, Cortactin, p53bp2, Crk and Grb2) by using a
phage display library, presenting the peptide X6PXXPX6 (Sparks et al., 1996).  Based on this
work, a ligand was selected, which was originally isolated against the N-terminal SH3 domain
of Grb2 (Grb2N), which in phage ELISA, also shows strong cross-reaction with other SH3
domains, including Src, Yes, and NckN (N-terminal SH3 of Nck).
Oligonucleotides were designed to introduce the SacI and KpnI restriction sites at the
extremities of the ligand, using PCR, and to facilitate cloning of the ligand into pSKAN8
(protocol was as described in Figures III-6 and -7).
Two forms of the ligand were prepared. Firstly a “short” ligand which had the size of the
longest of our constrained libraries (pSKAN8-HypG). This short ligand conserves the
minimum sequence required for specific binding to the SH3 domains (Arg Pro Leu Pro Pro
Leu Pro). Two amino acids (Tyr Gln, on the N-terminal part), were introduced to lengthen  to
9 amino acids within the two cysteines. The proline core motif (Pro Pro Leu Pro) is essential
for binding of the ligand to the SH3 domains, while the N-terminal Arg Pro Leu motif confers
specificity for Src SH3 domain (Sparks et al., 1994; Rickles et al., 1994;Rickles et al., 1995;
Sparks et al., 1996).
A “long” ligand was also designed to test the influence of the size of the peptide on the
constraint of the loop. This ligand contained the complete 18 amino acid sequence of the
original Grb2N ligand. Since the loop is only partially constrained by the disulfide bridge, the
amino acid sequence flanked by the cysteines may form additional constraints. The larger the
loop, the less the constraint. Hence, a 18 amino acid loop may allow formation of the required
PPII helix.
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Original Grb2N ligand
Tyr Tyr Gln Arg Pro Leu Pro Pro Leu Pro Leu Ser His Phe Glu Ser
Short Grb2N ligand as displayed on the surface of the phage
Cys Tyr Gln Arg Pro Leu Pro Pro Leu Pro Cys
Long Grb2N ligand as displayed on the surface of the phage
Cys Pro Tyr Tyr Gln Arg Pro Leu Pro Pro Leu Pro Leu Ser His Phe Glu Ser Val Cys
The short and long ligands were cloned into pSKAN8 and electroporated in a E.coli
strain, before being packaged by superinfection with the helper phage. The ready particles
were tested on phage ELISA against Src, Grb2, Grb2N, and NckN SH3 domains. Neither the
short nor the long ligands have been able to interact with the SH3 domains. A positive control
was performed to ensure that the phage ELISA assay was functioning: one of the ligands
isolated for chemotrypsin using this PSTI pSKAN8 vector system (Röttgen, 1996) was able to
strongly react with chemotrypsin.
Taken together, our data suggest that SH3 ligands bracketed by cysteines, are not able to
interact with SH3 domains, likely because they are not able to form the required PPII helix.
However, a positive control where the original Grb2N ligand would have been cloned into
pSKAN8 was missing, to make a complete demonstration of this hypothesis.
C – Cosmix-plexing library: CPLPPXP
The second approach used to isolate strong ligands for SH3 domains was through the use
of a cosmix-plexing library. The cosmix-library generated to study SH3 and EVH1 domains
was also a biased library (Figure III-3), with three fixed prolines, but with the variant peptides
displayed as a linear prolongation of the pIII phage protein.
The cosmix-plexing library was constructed in two steps, as illustrated in Figure III-11.
First, the synthetic hypervariable oligonucleotides (24 bases, encoding 8 amino acids) was
inserted into pROCOS4/7-stuffer1 (Figure III-11/A). The second step was to introduce the
proline-rich project specific cassette into the previous 8 amino acid peptide insert (Figure III-
11/B).
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A- Primary library - DNA sequence
Promoter   ...  GGC TGG AGA (NNB)4 NZZ (NNB)3 GAT CCC   ...    pIII gene
                                  BpmIB- Insertion of the project specific cassette127
DNA sequence:
BseMI      CCC  CCA  NNB  CCT NZZ     BpmI
                    ZZ  GGG  GGT  NNB GGA N
        ...  GGC TGG AGA (NNB)4 NZZ    (NNB)3  GAT CCC   ...
                   CCG ACC  TCT (NNB)4 N         ZZ (NNB)3  CTA GGG
   ...  GGC TGG AGA (NNB)4 NZZ CCC  CCA NNB CCT  NZZ (NNB)3  GAT CCC  ...
  CCG ACC  TCT (NNB)4 NZZ GGG GGT NNB GGA  NZZ (NNB)3 CTA GGG
                       +
    ... GGC TGG AGA (NNB)4 NZZ (NNB)3 GAT CCC  ...
  CCG ACC  TCT (NNB)4 NZZ (NNB)3 CTA GGG
Amino acid sequences:
           ...  Gly Trp Arg Xxx5 Pro Pro Xxx Pro Xxx4 Asp Pro   ... 71%
                       +
           ... Gly Trp Arg Xxx5 Xxx3 Asp Pro  ... 20%
   Recombination point
Figure III-11: Principle of the strategy of the CPLPPXP library construction. (A-) The
primary library was generated by insertion of a completely random region, representing a 8
amino acid peptide. (B-) Due to the type IIs restriction enzyme BpmI, the hypervariable
fragment can be opened in the middle, and the proline rich cassette introduced. The cassette
was digested at its extremities with BseMI and BpmI type IIs restriction enzymes. When the
cassette is ligated within the hypervariable domain, a proportion of the vectors may religated
without cassette. These parental clones were estimated as 20% of the whole library. 9% of the
library were incorrectly formed. The recombination point, where cosmix-plexing induced
recombination takes place, used to recombine left and right parts of the peptides, is at the end
of the codon for the fifth random amino acid. ZZ represents AM (AA, AC), CT, GG, TS (TC,
TG).
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The name given to this final library is the CPLPPXP library. CPL stands for Cosmix-
Plexing Linear peptide, and the PPXP represents the proline rich cassette motif (Pro Pro Xxx
Pro). In the CPLPPXP library, (Xxx)5 Pro Pro Xxx Pro (Xxx)4 variant peptides are
displayed.
The cosmix-plexing recombination can be carried out on this extension library by
cleavage at the type IIs restriction site (BpmI), allowing the optimization of the whole region.
The BpmI recognition site is located directly before the hypervariable domain, but BpmI
digests the DNA within the variant, after the fifth random codon (Figure III-11).
The phagemid pROCOS4/7-stuffer1 (Figure III-12) is an expression vector where
variant peptides can be fused to the N-terminus of the pIII gene. pROCOS4/7, like all
phagemid vectors, does not contain any phage genes, other than the pIII gene used as fusion
partner. To be packaged into phage-like particles, pROCOS4/7 needs superinfection with a
helper phage (M13KO7), which provides required bacteriophage functions.
In pROCOS4/7-stuffer1, the fusion-pIII hybrid synthesis is under the control of the λ PL
promoter. The λ PL promoter is strongly repressed by the λ cI protein, which is produced in
E.coli strains containing an integrated copy of the lambda genome (i.e. lysogens). The λ PL
promoter ensures that the correct ratio of hybrid to wild type pIII represents essentially
monovalent presentation (i.e., one hybrid pIII per particle).
The “outer membrane”-protein leader peptide (OmpL), ensures that secretion of the
fusion peptide and correct cleavage of the leader peptide occur. pROCOS4/7-stuffer1 also
contains plasmid replication functions, M13 phage replication/packaging origin, and the
ampicillin resistance gene.
The stuffer is a 950 bp DNA fragment derived from pBR322. Since two different
restriction enzymes are used for the insertion of the peptide to be fused to pIII, the stuffer
(bracketed by the two restriction sites) allows to check for complete digestion of the vector,
since the stuffer and the opened vector have different sizes and are, therefore, distinct on a
gel.
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             Primer C
           GGC GAG CTC GGC TGG AGA (NNB)4 NZZ (NNB)3 GAT CCC GGG TAC CCC
      BpmI                   Primer D
        SacI KpnI
        SacI   KpnI
       ompL
      λPL          
     pIII
pTL5 fragment
Cos       pROCOS4/7
(4614 bp)
    bla      ori fd
   ori E
Figure III-12: Schematic map of the phagemid vector pROCOS4/7. The generation of the
cosmix-plexing library takes place in two steps. First, a hypervariable oligonucleotide is
inserted into pROCOS, N terminal from pIII. Then, a project specific cassette is introduced
within the variant region, due to a type IIs restriction enzyme (BpmI), which digests a fixed
distance away (within the hypervariable region) from the recognition site (within the flanking
region). The endonuclease sites SacI and KpnI are used to insert the hypervariable
oligonucleotides. The hypervariable inserts were amplified with the primers C and D (see
section II-4-3-2), and digested with the restriction enzymes SacI and KpnI. The cassette was
amplified with the primers C and E (see section II-4-4-2), and digested with the restriction
enzymes BseMI and BpmI, which give 2 bp cohesive ends, compatible with the digestion of
the hypervariable region with BpmI. In pROCOS4/7-stuffer1, the stuffer is bracketed by the
SacI and KpnI restriction sites. The pTL5 fragment was added to the vector, in order to
establish a cos site (necessary for λ packaging). The following abbreviations are used: λPL:
major leftward promoter of the bacteriophage λ; OmpL: signal sequence derived from the
E.coli outer membrane protein OmpA; pIII: gene coding for the minor coat protein pIII of the
M13 bacteriophage; bla: β-lactamase gene (ampicillin resistance); ori fd: origin of replication
for single stranded DNA of the bacteriophage fd; ori E: origin of replication for plasmids
colE1.
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1- Generation of the primary library: 8 amino acid random peptides are displayed
1-1 Preparation of the linearized vector DNA
The insertion site for the hypervariable oligonucleotide was prepared by linearizing the
vector with the KpnI and SacI restriction enzymes. The hypervariable region was inserted
between a leader “signal” sequence and the M13 pIII gene, so that the peptide was presented
on the surface of the phagemid particle as a pIII amino terminal extension.
1-2 Preparation of the ds DNA insert from degenerated oligonucleotides
The codon scheme used to encode random amino acid sequences was NNB, where N is
A,C,G or T, and B represents C, G or T. This scheme allows the reduction of the stop codon
frequency (which would lead to unproductive clones), as only one of the three stop codons
(TAG) can be encoded, while codons for all the 20 amino acid are still represented.
Four sets of inserts were prepared which led to four separate libraries. The four sets
differed only by the dinucleotide corresponding to the cohesive ends generated upon cleavage
by the type IIs restriction enzyme BpmI (at the ZZ position, in Figures III-11 and III-12). The
BpmI type IIs restriction enzyme binds a defined sequence within the invariable sequence
adjacent to the inserts, but cleaves at a fixed distance from the binding site, within the middle
of the hypervariable domain, creating a 2 bp cohesive end. ZZ stands for AM (AA and AC),
CT, GG and TS (TC and TG). It is important that no head to head joining of the cohesive ends
occurs on religating the cleaved sequenced. This is achieved by the set of base pairs used at
the ZZ position. Furthermore, when the four libraries were pooled, this NZZ allowed the
presentation of all amino acids, except cysteine.  The BpmI restriction site is necessary for the
insertion of the cassette and for the cosmix-plexing recombination, whereas the SacI and
KpnI restriction sites were used to create the original insert.
Although the strategy chosen to prepare the oligonucleotides involves many steps, it
does guarantee pure products. This strategy is very similar to the one used to generate the
constrained libraries and is illustrated in Figure III-6. The quality of the digested inserts have
a strong influence on the quality of the ligation with the vector and, thus, on the efficiency of
the electroporation of the ligated DNA into the bacteria. The constrained library protocol was
optimized as shown in Figure III-13. The insert oligonucleotides were amplified via PCR,
using biotinylated primers, leading to a product carrying biotin at the extremities. The
difference comes from the digestion of the PCR products, which are cleaved by both KpnI and
Results
131
SacI. The small restriction fragments are captured and removed with the superparamagnetic
polysterene beads, covalently attached to streptavidin (Dynabeads M-280 Streptavidin;
Dynal). The inserts are only in this step, ligated among themselves in order to build a long
chain of monomers (concatemer). With this protocol, it is possible to remove the small
digested fragments earlier and to avoid that they eventually religate with the inserts to form
unproductive clones. Therefore, the formation of the desired products is completely
controllable.
  KpnI
  SacI
PCR with biotinylated primers
          S       K
Restriction with KpnI and SacI
      S        S           K      K
Streptavidin bead purification
Ligation among themselves
K          S               K               S K     
Restriction with SacI
               S   K         S
Insert ready to ligate to the opened vector
The DNA fragment is finally cleaved with SacI and a di
central KpnI site and SacI cohesive ends. The insert is ready 
vector.
1-3 Ligation of the vector and insert DNA
The digested vector (with SacI and KpnI ends) and inser
ends) are ligated together. The same protocol as for the constra
Figure III-7) was used. The insert could only be ligated with oFigure III-13: Schematic
representation of insert
preparation. The insert
oligonucleotides were
amplified by PCR, using
biotinylated primers,
leading to a product
carrying biotin on both
extremities. The PCR
product was cleaved with
KpnI, and SacI. The small
restriction fragments were
removed by magnetic
streptavidin beads. The
inserts were then ligated
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resolved as dimeric inserts
by digestion with SacI. S
and K stand for SacI and
KpnI sites, respectively.meric insert is formed with a
to be ligated to the linearized
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ne extremity of the vector, the
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one digested with SacI.  Restriction with KpnI was performed. The vector attached to one end
of the insert was then ligated, leading to the ring closure of the DNA. This ligation was
performed at low DNA concentration to encourage ring closure and discourage reinsertion of
the small cleavage products.
The recombinant vectors thus formed, were electroporated into a WK6λmutS E.coli
strain (Table III-8). The mixture of the four banks bring a total diversity of 2x108
transformants. According to the Table III-1, one would need around 8x1010 variant to ensure
that all possible codons are represented, with a 90% confidence level. However, since the
clones will be recombined together by cosmix-plexing when the cassette will be introduced,
many new clones will be created, and the diversity is sufficient, i.e. all possibilities are present
for both small 5 random amino acid blocks on each side of the cleavage site.
Library single clones selected on ampicillin agar plates
         PROCOS-AM 6.5x107
         PROCOS-CT 3.6x107
                 PROCOS-GG 5.7x107
                 PROCOS-TS 4.4x107
        Total pROCOS-insert 2x108
Table III-8: Estimation of pROCOS-AM, -CT, -GG, -TS diversities. The amount of single
clones was estimated from dilution series from each performed ligation, plated on ampicillin
LB plates.
2- Evaluation of the quality of the four primary libraries
It was important to ensure that the four primary libraries were well prepared, before
inserting the proline rich cassette. Randomly selected clones were picked and sequenced, to
confirm the presence of a single insert into the vector and to check the quality of the banks.
The frequency of clones which underwent a change in the open reading frame (insertion,
deletion) or which contained stop codons, was estimated. In addition, the frequency of codons
for each amino acid was determined and compared with the expected values.
An initial analysis of the sequenced clones showed that around 80% of each of the four
primary banks, contained one correctly formed insert within the vector (Table III-9). The
other 20% of the clones led to unproductive phage particles, due to changes in the reading
frame (insertions, or deletions of one or two bases) or the presence of a stop codon.
Results
133
pROCOS-AM pROCOS-CT pROCOS-GG pROCOS-TS
total of sequenced clones 40 (100%) 26 (100%) 23 (100%) 27 (100%)
correct sequences 32 (80%) 21 (80,7%) 18 (78,2%) 22 (81,5%)
no insert 1 (2,5%) 0 0 0
1-2bp insertion 2 (5%) 2 (7,7%) 0 0
1-2bp deletion 1 (2,5%) 1 (3,8%) 2 (8,7%) 3 (11,1%)
Stop codon 4 (10%) 2 (7,7%) 3 (13%) 2 (7,4%)
Table III-9: DNA sequence analysis of randomly selected clones from pROCOS-AM, -
CT, -GG, -TS. Relative frequency of correctly and incorrectly formed clones.
The correctly formed clones were submitted to further analysis. The hypervariable
regions were further investigated, to determine the amino acid frequency in each of the bank
(Table III-10). The results of this analysis were compared with the theoretical frequencies
expected in a NNB library.
NNB AM CT GG TS Total
Ala 6 2,5 13,5 1,4 7,7 6,2
Arg 8 7,4 11,3 5,7 8,9 8,3
Asn 4 3,1 1,6 2,8 4,4 2,9
Asp 4 3,7 3,2 4,3 3,3 3,6
Cys 4 4,9 4,8 8,6 3,3 5,4
Glu 2 1,8 4,3 1,4 1,1 2,1
Gln 2 2,5 1,6 2,8 1,1 2
Gly 6 6,2 9,2 2,8 6,6 6,2
His 4 3,7 0,5 1,4 3,3 3,5
Ile 4 6,2 2,1 5,7 7,7 5,4
Leu 8 8,7 10,2 8,6 8,9 9,1
Lys 2 1,8 1 2,8 3,3 2,2
Met 2 2,5 3,2 2,8 3,3 3
Phe 4 4,3 1,6 11,4 6,6 2,9
Pro 6 7,4 3,8 5,7 5,5 5,6
Ser 10 11,1 10,2 4,3 10 8,9
Thr 6 5,6 3,8 5,7 2,2 4,3
Trp 2 1,8 3,8 4,3 1,1 3,3
Tyr 4 4,3 0,5 5,7 4,4 3,7
Val 6 6,8 9,2 12,8 5,5 8,5
Stop codon 2 1,8 1 1,4 1,1 1,3
Table III-10: Expected and actual amino acid frequencies (in percentage) of the
pROCOS-AM, -CT, -GG, and -TS libraries. The last column correspond to the amino acid
frequency of the four mixed banks. The calculations was determined from the correct clones
which were sequenced: 32 clones for AM, 21 for CT, 18 for GG, and 22 for TS.
Results
The Figure III-14 gives an overview of the data presented in Table III-10. The amino
acid frequency calculated for the four banks correlate well with the expected values of a NNB
bank. However, some variations were evident in the individual libraries after closer
inspection.
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The AM  and TS libraries reflected the values according to the theoretical expectations,
except a low frequency of alanine and threonine. CT was very weak concerning Asn, His,
Phe, and Tyr, and too strong in Ala. As far as GG was concerned,  it was deficient in Ala,
Gly, His and Ser, whereas Cys, Phe, and Val were dramatically over-represented. Taken
together, since the four banks were pooled for the insertion of the proline rich cassette, the
amino acids were likely to be properly represented.
This analysis provides evidence that the four primary banks are capable of receiving the
project specific cassette. The second step of the generation of the library was then performed:
the introduction of the proline rich cassette.
3- Generation of the CPLPPXP library, insertion of the proline rich cassette
The next step was to insert this project-specific proline rich cassette into the
hypervariable sequence created in the primary library, thus generating a secondary project-
specific library. Invariable amino acid positions are chosen in the design of this cassette (Pro
Pro Xxx Pro), so as to improve the interaction possibilities between this secondary library and
the SH3 or EVH1 domains. The codon scheme used for the hypervariable codons, is NNB as
it was for the initial inserts (B represents C, G or T).
16 sets of cassettes are prepared, which differed only by the two ZZ dinucleotides
representing the cohesive ends generated on cleavage by BseMI and BpmI, two type IIs
restriction enzymes (Figure III-11/B). ZZ stands for AM (AA and AC), CT, GG, and TS (TC
and TG). It is essential that the ZZ dinucleotides present on both cohesive extremities of the
cassettes, differ on the right and left ends (i.e. whatever the ZZ set found on the right part of
the cassette, AM, CT, GG and TS have an equal chance to be present on the left side). These
distinct extremities promote the formation of concatemers during the cloning of the cassette
into the primary library, as one cassette cannot be cloned within a single vector. This
concatemer formation, strongly increases the diversity of the bank.
The sets used at the ZZ position prevented head to head joining of the cohesive ends
during ligation of the cleaved sequences with the primary library. Furthermore, this set of
dinucleotides allowed, when the 16 cassettes were pooled,  the representation of all amino
acids at the ZZ position, except cysteine, and reduced the frequency of the stop codons (only
TGA is allowed).
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BseMI and BpmI were used to clone the cassettes within the primary library. Both
generate a 2 bp cohesive end on both extremities of the cassettes, allowing a compatibility
with the cohesive ends (set of 6) created by BpmI cleavage of the initial library, within the
hypervariable insert.
The optimized protocol for cloning the cassette into the insert of the primary library, is
shown in Figures III-15, -16 and -17. Here too, a complex strategy was used, but which
yielded extremely high electroporation efficiency (up to 108 transformants/µg DNA).
3-1 Preparation of the ds DNA proline-rich cassette from degenerated
oligonucleotides
The cassette oligonucleotides are converted into double-stranded DNA and amplified via
PCR, using biotinylated primers. They were restricted with BpmI. These half opened cassettes
were ready to be ligated with the vector (Figure III-15).
PCR
      BseMI       BpmI
Digestion with BseMI
        BM    Bp Bp
3-2 Preparation of the linearized vect
The vector containing the insert (the prima
create this extension library. It was first cleaved b
the middle. Then, a second restriction with BseRI c
a large (L) fragment which were extracted from a Figure III-15: Preparation of the
double stranded project-specific
cassette from degenerated
oligonucleotides. The cassette is
converted in double stranded DNA
via PCR, using biotinylated
primers. The cassette is then
digested with BpmI, and is ready to
be ligated to the vector. BM and Bp
stands for BseMI and BpmI
respectively.or of the primary library
ry library) was used as cloning vector to
y BpmI, opening the hypervariable region in
ut the vector into two parts, a small (S) and
gel and kept separate (Figure III-16).
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BpmI     Insert   Bp        Bp    S
  Digestion with       Bp         Digestion with       Bp
         pROCOS
BpmI       BseRI          BR
   BseRI
            BR
     BglI   L
Figure III-16: Preparation of the linearized vector of the primary library.  The vector is
first cleaved within the hypervariable region by the BpmI type IIs restriction enzyme. Then,
digested a second time by BseRI, to cut the vector into two pieces, a small (S) and a large (L)
fragment. Bp and BR stands for BpmI and BseRI restriction enzymes, respectively. The
restriction site of BglI is represented by an orange circle.
3-3 Insertion of the project-specific cassette into the primary library
The half opened cassettes were ligated with the small fragment (S) of the vector (S-
cassette product), and cleaved with BseMI (Figure III-17). Unwanted ligation products and the
small biotinylated ends from the cassette template were removed with streptavidin beads.
The large fragment (L) and the S-cassette, product from the preceding reaction, were
ligated together at equimolar ratios and high DNA concentration (>200 µg/ml), reconstituting
the complete vector, and leading to the formation of concatemers. Concatemers contained
monomer units all oriented in the same direction, due to the fact that the restriction site of
BseRI produces cohesive ends were not compatible with those produced at the BpmI or BseMI
cleavage sites. The ZZ set used did not allow head to head joining of fragments. As the two
extremities of the cassettes do not present (in most cases) identical ZZ dinucleotides, and as
such cannot be cloned into a single vector, most of the ligation products arise from fragments
which come from different clones from the initial library. The ligation thus ensured a
recombination among the vectors, leading to the formation of a more diverse hypervariable
region.
Figure III-17: Insertion of the project-specific cassette within the primary library. (A-)
The half opened cassette is ligated with S, and digested with BseMI. Restriction fragments are
removed by streptavidin beads. (B-) Ligation occurs between L and the S-cassette product, at
high DNA concentration, to direct the formation of concatemers. Concatemers are resolved as
monomers by cleavage with BglI. Ligation at low concentration generate ring closure of the
vector which now contain the hypervariable region complemented by the project-specific
cassette. The recombined vector can be electroporated, packaged, and used in panning to
isolate strong ligands against SH3 or EVH1 domains. Bp, BM and BR represent the BpmI,
BseMI and BseRI restriction sites, respectively. S and L stand for small and large vector
fragments, respectively. The orange circle represents the BglI restriction site.
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The concatemers were resolved into single phagemid molecules on cleavage with BglI,
followed by ligation at a low DNA concentration, to favor the formation of monomers.
This secondary library was then electroporated, packaged and transformed into
WK6λmutS E.coli strain. This lambda lysogen strain expresses the cI transcription repressor
of the lambda bacteriophage, and prevents an inopportune production of pIII gene product
which might be toxic. In addition, it ensures the presentation of mainly one hybrid pIII per
particle. DNA prepared in this way gives extremely high transformation frequencies (around
108 transformants/µg DNA).
Each vector contained a hypervariable region of 13 amino acids, of which three were
fixed prolines (insert + cassette), as shown:
DNA sequence:        (NNB)4 NZZ CCC CCA NNB CCT NZZ (NNB)3
Peptide sequence:       Xxx4   Xxx   Pro   Pro   Xxx   Pro   Xxx   Xxx3
The electroporation was carried out, until relevant bank diversity was reached. The
CPLPPXP library contains 10 random residues and a diversity equivalent to 2,3x108
transformants was obtained. This was obviously not enough to ensure the representation of all
possible peptides, but, the diversity was increased each time a cosmix-plexing was
performed.
4- Evaluation of the quality of CPLPPXP library
The quality of the completed CPLPPXP library had to be evaluated.
35 randomly picked clones were sequenced, and revealed that around 71% of the library
possessed the proline rich cassette (Table III-11); 20% of the clones were religated without
the cassette and therefore, displayed only a 8 amino acid long peptide, meaning that 91%
(71+20) of the bank was adequate for successful panning selections. The other 9% were non
correctly formed particles.
When the vector was opened for the insertion of the cassette into the hypervariable
region, it was cut in two pieces, the S and L fragments (Figure III-16). It has been shown that
in particular cases, the L fragment is able to religate on its own. The BseRI digestion creates a
2 bp cohesive end, as shown in Figure III-18, which exposes a free AG dinucleotide at the L
extremity. The 2 bp cohesive ends generated at the BpmI restriction site present 6 variable
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dinucleotides, according to the set of insert cloned in the vector (AA, AC, CT, GG, TC, and
TG). The two extremities of the L fragment are able to interact together, when the TC set of
insert is revealed at the BpmI site. That means that one sixth of the L fragment are able to
religate, even in the absence of the S fragment. By altering the ratio of  cassette, S and L
fragments, it was possible to reduce the formation of L clones to a minimum, however, they
still represented 9% of the final library.
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  BR
       L     BR
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       AG
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become enriched, due to their selective advantage and should after a few cycles of panning
dominate over other clones. Hence, the number of L clones present in successive panning
rounds, is an indication of the progress of the affinity selection.
Within the 91% of clones appropriate for panning (containing the insert, or the insert
plus the proline rich cassette), nearly 85% are correctly formed (27 clones; Table III-11). The
other 15% were unproductive clones due to changes in the reading frame (insertions, or
deletions) or to the presence of a stop codon.
number of clones percentage
Cassette/insert 25 71,4
Insert 7 20
Cassette/insert + insert 32 (25+7) 91,4 (71,4+20)
L clones 3 8,5
Correct clones 27 84,3
Insertions 2 6,2
Deletions 1 3,1
Stop codons 2 6,2
Table III-11: DNA sequence analysis of 35 randomly selected clones from CPLPPXP
library. Relative frequency of correctly and incorrectly formed clones. The first part of the
table relates to the proportion of clones which present the cassette within the insert, only the
insert, or which are malformed. The bottom part of the table presents a further analysis of the
32 clones correctly formed, to check the DNA quality: insertion, deletions, or presence of stop
codon.
The 27 clones containing the hypervariable insert, with or without proline-rich cassette,
which show a correct reading frame and no stop codon, were further investigated to determine
the amino acid frequency. The results of the analysis are presented in Table III-12, where they
are compared with the theoretical frequency expected in a NNB library. The Figure III-19
gives an overview of the data presented in Table III-12.
The amino acid frequency estimated for the cosmix-plexing CPLPPXP library is very
similar to the expected values of a NNB bank, as seen in Table III-12. The only unusual data
are those obtained for Trp and Phe which were both over-represented, and for Thr and Ser,
which were under-represented. The frequency of different amino acids in the CPLPPXP
library, are nevertheless convenient to carry on panning selection, against the SH3 and EVH1
domain targets.
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NNB CPLPPXP
Ala 6 5,6
Arg 8 8,1
Asn 4 4
Asp 4 3,4
Cys 4 5,3
Glu 2 1,8
Gln 2 3,4
Gly 6 6,8
His 4 2,8
Ile 4 5,9
Leu 8 10,3
Lys 2 1,8
Met 2 1,8
Phe 4 8,4
Pro 6 7,5
Ser 10 5,6
Thr 6 3,1
Trp 2 5
Tyr 4 3,4
Val 6 4
Stop codon 2 1,2
Table III-12: Expected and
actual amino acid frequencies
(in percentage) of the
CPLPPXP library. The NNB
values correspond to the
theoretical amino acid frequency
expected for libraries constructed
with the codon scheme NNB,
where N is A, C, G, or T, whereas
B stands for C, G, or T.
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D - Panning selection on SH3 domains
The CPLPPXP library is composed of an enormous collection of phage variants (2x108)
which display, N-terminally on the pIII protein, linear biased random peptides. The amino
acid sequence of the exposed random peptides has been conceived to interact favorably with
SH3 and EVH1 domains: Xxx5 Pro Pro Xxx Pro Xxx4. A major characteristic of this library is
that it has been designed as a cosmix-plexing library. This means that at any time, it is
possible to recombine the left and the right parts of the peptides, in order to increase the
affinity of the ligands for their targets.
The quality of the CPLPPXP bank was considered adequate. The diversity of the bank is
slightly under the theoretical size required, but this drawback is largely compensated by the
cosmix-plexing recombination possibilities. The library contains codons for all amino acids
(even if a few of them are over- or under-represented), except two of the stop codons.
Therefore, the bank is relevant to be used in the selection of ligands binding to SH3 and
EVH1 domain targets.
Before extending the study to the SH3 and EVH1 domains, the optimal panning
parameters had to be determined, and therefore, the effort was first focused on only one
target, the Src SH3 domain.
1- Src SH3 domain: a validation target
Src was selected as the model of choice to characterize the best conditions for the
experiments, since it has been previously extensively studied. Thus, the idea of the type of
ligands expected to be isolated was quite precise.
The CPLPPXP library used in this work to isolate proline rich ligands against the Src
SH3 domain, looks very similar to some of the banks previously used by other researchers.
However, although it was expected to characterize ligands showing high consensus sequence
homologies, compared to the Src SH3 ligands previously described, it was hoped to find
ligands which show higher binding affinity for their target.
1-1 Optimization of the affinity selection procedures
Extended tests were performed on Src SH3 domain, to determine the panning selection
conditions which lead to the best results.
The panning procedure was performed as described for the constrained libraries,
however, some steps were repeated with modification, in order to encourage the interaction
between the target protein, and the phage library. These steps are emphasized here.
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The immobilization of the Src SH3 domain was performed at 4°C overnight, in PBS, but
two kinds of supports were compared: a maxisorb (Nunc), and a glutathione microtiter plate
(Pierce). On the glutathione plates, the GST is captured by the glutathione fixed to the bottom
of the wells, and the fused protein (Src) is expected to be orientated such that it is available
for interactions with the phage library.
cycle of panning
1 2  3 - 5
PBS/Tw 0,05 1x 3x 5x
PBS/milk 10 min 10 min 10 min
PBS/Tw 0,05 1x 3x 5x
PBS/milk 5 min 5 min 5 min
PBS/Tw 0,05 1x 3x 5x
H2O 1x 1x 1x
cycle of panning
1 2  3 - 5
PBS/Tw 0,05 3x 5x 5x
PBS/milk 10 min 10 min 10 min
PBS/Tw 0,05 3x 5x 5x
PBS/milk 5 min 5 min 5 min
PBS/Tw 0,05 3x 5x 5x
PBS/Tw 0,05 5x
H2O 1x 1x 1x
cycle of panning
1 2  3 - 5
PBS/Tw 0,5 1x 3x 5x
PBS/milk 10 min 10 min 10 min
PBS/Tw 0,5 1x 3x 5x
PBS/milk 5 min 5 min 5 min
PBS/Tw 0,5 1x 3x 5x
H2O 1x 1x 1x
Table III-13: Stringency of the washing steps according to the cycle of panning. (A-)
Basic procedure for the washing step. The PBS/Tween contains 0,05% of Tween 20. The
PBS/milk, is the blocking solution, with 2% of skim milk powder. Incubation with the
blocking solution tends to reduce the background level. It can happen that phage bind to the
milk powder used to block the walls of the wells, the milk added in solution competes this
interaction. (B-) On this procedure, the stringency of the washing is increased, by washing
several time more. (C-) This protocol is also based on higher stringency, but by using a higher
concentration of Tween (0,5%), instead of multiplying the number of times the washing are
performed. Each time the washing was achieved, the incubation was prolonged for 5 min. Tw
stands for Tween 20.
A
B
C
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After immobilization, the wells were blocked with PBS/2% skim milk powder, to
prevent unspecific binding of the phage to the walls of the wells, to keep background levels
low. CPLPPXP library was incubated in the wells, after the blocking. Previously, the phage
were diluted 1 to 1 in PBS/2% skim milk powder, to reduce the background. Indeed, phage
which show affinity for milk, would interact in solution, and would be, later, washed away
more easily.
After incubation between the target and the phage library, the wells were washed, to
remove non binding, or low affinity phage. The stringency of the washing steps increase with
the cycles of selection. The washing step is a crucial stage of the panning, since it is the one
where it is possible to remove the background. However, an equilibrium has to be found, in
order to avoid washing away clones which might be able to bind the target. Therefore several
washing conditions were tested (Table III-13), to determine which is adequate for the
CPLPPXP library, and the Src SH3 target. Three washing procedures were tested, with
different stringency.
Each of the three types of washing (A, B, C; Table III-13) were tested on both
glutathione and maxisorb microtiter plates, when CPLPPXP library was screened against the
Src SH3 domain. As a control, CPLPPXP library was incubated in an empty well, where PBS
alone was coated. This control was performed in both plates, and the washing procedure used
was from the type A (Table III-13), the less stringent washing conditions used in this series of
tests. The progression of the output values (eluted phage at the end of the panning procedure)
can be followed in the Figure III-20.
The comparison of the output values presented in Figure III-20, gives an impression of
the enrichment during the panning. The glutathione and maxisorb microtiter plates show very
different evolutions, and surprisingly, the maxisorb plate seems to give more promising
results.
After the first round of panning selection, more phage were recovered from the
glutathione plate (same amount of phage incubated with Src, everywhere). The dramatic
decrease after the second round of panning, observed with all washing conditions, in both
plates, is explained by the loss of the background. After the first round, the majority of the
non binder clones have been rejected. However, the one still present, and eluted at the end of
the affinity selection, were amplified, before being incubated with Src for the second round.
The observed decline is thus an indicator that this amplified background have been washed
away.
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  Glutathione plate
A B C Blank
1R 5,00E+06 3,00E+05 1,30E+06 6,00E+06
2R 1,20E+03 2,10E+03 5,00E+03 1,30E+03
3R 1,40E+04 2,00E+02 7,00E+02 1,30E+04
4R 1,10E+04 3,00E+03 2,20E+03 4,60E+03
          Maxisorb plate
A B C Blank
1R 1,30E+04 2,00E+04 2,70E+04 1,00E+05
2R 1,20E+03 1,60E+03 4,00E+03 2,50E+04
3R 2,50E+05 7,00E+03 1,80E+04 4,00E+04
4R 2,20E+06 8,00E+04 8,00E+05 3,40E+04
Figure III-20: Evolution of the output titer during the screening of CPLPPXP on Src
SH3 domain. (A and B-) Progression of the output values, in absolute number, after 4 rounds
of panning (noted 1R to 4R). The same amount of phage were incubated with Src, in all tests
(2x1011). The A, B, and C, refer to the washing procedures used, as they are described in
Table III-13. The blank is an empty well where the CPLPPXP library was incubated, and
then, washed using the protocol A. The tables A and B described the output values of the
screening on glutathione or maxisorb microtiter plates, respectively. (C-) Diagram of the
values observed in both A and B tables.
From the third round on, the maxisorb and glutathione plate outputs, diverge in their
profile. In the glutathione plate, the wells washed under the B and C conditions, carry on
decreasing in the output number, and slightly recovered on the fourth round, while the well
washed under the A procedure (less stringent), recovered already after the third round, but
then, get stabilized on the fourth cycle. However, with all three kinds of washing,  the output
values after the fourth round, stay much under the values from the first round. In addition,
A
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C
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they remain very similar to the blank output value. This might indicate that no selection
occurs during the four cycles of panning. The output values of the library incubated with Src,
and washed under the A conditions, follow nearly perfectly the values of the control (which
was washed the same way). This suggests that the GST-Src protein was not retained on the
glutathione of the microtiter plate, or that the interaction between the glutathione and the
GST, somehow masked the Src, which would not be available anymore for interactions with
the CPLPPXP library.
Input Output Output/Input Enrichment
1R 2,00E+11 1,30E+04 6,50E-08 -
A 2R 1,00E+10 1,20E+03 1,20E-07 -
3R 3,20E+10 2,50E+05 7,80E-06 120
4R 2,20E+10 2,20E+06 1,00E-04 1538
1R 2,00E+11 1,30E+04 6,50E-08 -
B 2R 6,00E+09 1,20E+03 2,00E-07 -
3R 5,00E+10 2,50E+05 5,00E-06 77
4R 9,00E+10 2,20E+06 2,40E-05 369
1R 2,00E+11 2,70E+04 1,30E-07 -
C 2R 1,30E+10 4,00E+03 3,00E-07 -
3R 3,20E+09 1,80E+04 5,60E-06 43
4R 7,00E+10 8,00E+05 1,10E-05 84
Table III-14: Enrichment factors of CPLPPXP screened on Src SH3 domain, on
maxisorb plate, according to the type of  washing conditions used (A, B, or C, described in
Table III-13). The evolution of the input (amount of phage incubated with the target protein),
output (eluted phage after stringent washing steps), and the ratio output divided by input (O/I)
are shown, along the cycles of panning. The O/I ratio is a parameter indicating if an
enrichment occurred. When most of the phage given as input are recovered after washing step
and elution (output), that means that the largest majority of the input presented affinity for the
target, and remained bound to the target during the washing steps. These clones have been
enriched during the previous cycles of panning selection. The enrichment factor is estimated
by dividing the ratio O/I from the round of interest (where the output and the ratio O/I appear
to be very high), with the ratio O/I from the first round. 1R, 2R, 3R and 4R, stand for first,
second, third, and fourth rounds of panning.
As far as the maxisorb microtiter plate is concerned, from the third round on, the output
values significantly increased, revealing an enrichment, since the values are higher than they
were after the first round, and in addition, above the control values (after the fourth cycle).
The enrichment factors, which take into account the input (amount of phage incubated with
the target protein), are precisely calculated, and presented in Table III-14. The washing
condition which appears to be the most favorable for the selection, is the less stringent one (A,
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described in Table III-13). Indeed the output values of panning washed under the A
procedure, get higher than the one of the first round, and of the control, already after the third
round.
1-2 Isolated ligands against Src SH3 domain
To confirm the hypothesis about the quality of the affinity selection, according to the
panning procedure used, single clones from the third and fourth cycles, were randomly
selected, and sequenced.
Whatever the washing conditions, and the round of panning, the clones selected from the
glutathione plate show no enrichment. 40% of the sequenced clones were L clones (vector
only partially regenerated, as shown in Figure III-18). 25% contained stop codons, 15% had a
modification in the reading frame, due to 1 bp insertion, or deletion. Finally, only 20% of the
clones show a normal displayed peptide, but without any homology among them.
The maxisorb clones confirmed the enrichment observed after the third and fourth
rounds. 10 clones from each round, and each washing protocol were sequenced. The resulting
sequences are summarized here. Some clones are unproductive (when insertion, deletion, or
stop codons occur, or when a L clone is found), however, most of them are correctly formed,
and are classified in the Figure III-21, regarding their occurrence.
A 1x clone with 1 bp deletion
2x L clones
6x S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp
1x S5 Ser His Tyr Ser Leu Pro   Pro Gly Pro Leu Arg Gly Phe
    3R B 3x L clones
  2x clones with stop codon
1x clone with 1 bp insertion
4x S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp
C 9x S3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala
1x S4 Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser
A 8x S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe
1x S7 Gly Ala Gly Ser Leu Pro   Pro Cys Pro Ala Asp Leu Leu
1x S6 Asn Ala Cys Thr Leu Pro   Pro Phe Pro Trp Asp Arg Cys
B 2x L clones
    4R 1x clone with 1 bp deletion
    1x clone with stop codon
6x S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp
C 3x clones with 1 bp deletion
2x L clones
5x S3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala
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The alignment of the isolated and sequenced clones (Figure III-21), obviously shows a
consensus sequence Arg Pro Leu Pro Pro Ψ Pro Ψ (where Ψ represents hydrophobic amino
acids), similar to the one expected for class I ligands, with respect to the work accomplished
by other laboratories. Class I ligands are assumed to be the dominant class of ligands for Src
SH3 domain.
                    Sequences against Src SH3 domain                               Frequency
                      (3R      4R)
S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe     -     8   
S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp 10      6
S3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala  9       5
S4 Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser  1       -
S5 Ser His Tyr Ser Leu Pro   Pro Gly Pro Leu Arg Gly Phe      1       -
S6 Asn Ala Cys Thr Leu Pro   Pro Phe Pro Trp Asp Arg Cys      -       1
S7 Gly Ala Gly Ser Leu Pro   Pro Cys Pro Ala Asp Leu Leu     -       1
Consensus sequence
Xxx Xxx Arg Pro/SLeu Pro   Pro  Ψ Pro  Ψ Xxx Xxx Xxx
Figure III-21: Sequences of single clones, after 3rd and 4th rounds of panning against Src
SH3 domain, and the deduced consensus sequence. The clones are classified according to
their frequency. The first Pro of the consensus sequence appears, in the single clones, as often
as a Ser. However, the Pro occurs mainly in the strongest enriched clones, demonstrating its
significance. In addition, in term of flexibility, Ser presents similarity to Pro. A residue is
considered as representative for the consensus sequence, when it occurs in 50% or more of the
sequences. Underlined amino acids are fixed residues within the CPLPPXP library. Ψ
represents hydrophobic amino acids.
The clones which present the most homology to the conceived consensus sequence, are
the one which occur the most often, confirming the good efficiency of the enrichment. The
clones that appears only once, might be present only by chance.
The first determined Pro of the consensus sequence appears, in the single clones, as
often as a Ser residue. However, the Pro occurs mainly in the strongest enriched clones,
demonstrating its higher significance. In addition, in term of flexibility, Ser presents similarity
to Pro.
The S5 clone shows characteristics belonging to the class II ligands: the position of the
Arg after the proline rich motif. However, this clone does not completely correspond to the
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consensus sequence conceived for class II ligands (PPLPXR), since the position between the
prolines is not a leucine, and moreover, is not a hydrophobic residue. This clone is not
expected to show strong reaction with Src, since it occurs only once in the third round, and
disappears in the fourth one.
The conception of a consensus sequence similar to the one defined by other groups,
confirmed that the CPLPPXP library is appropriate to isolate and characterize binders against
the SH3 domains, and that the strategy applied for the panning selection is adequate.
It is interesting to note that the three best clones (S1, S2, and S3) were isolated from
different panning protocols. This demonstrates that using different washing methods, more or
less stringent, lead to the obtention of diverse ligands. Therefore it might be advantageous to
analyze the effect of different washing conditions, each time a new protein serves as target in
an affinity selection. However, to facilitate the work, one protocol has been selected, to be
used for the primary panning of all targets.
The maxisorb microtiter plate is the material selected for the next panning procedure,
since, the glutathione plate did not allow discrimination between non-, weak-, or strong-
binders.
The three washing conditions tested, yield good results, when combined with the
maxisorb plate. However, in future work, the procedure A will be preferred, since it leads to
the most favorable enrichment (at least for the Src SH3 domain, Table III-14 and Figure III-
21).
Therefore, the panning procedures performed on different SH3 and EVH1 domains were
achieved on maxisorb microtiter plates, and washed mildly, with PBS containing 0,05%
Tween 20, and with a reduced number of washing cycles (as described under the A
conditions, in Table III-13).
1-3 Cosmix-plexing recombination
During the first panning round, the future dominant clones (S1, S2, S3) were present in a
small amount, as well as many other clones which exhibit weak affinity properties for the
target. The dominant clones get enriched, during further rounds, and compete with the weaker
binders which are then eliminated during the washing steps of the panning.
The preselected populations eluted after the first and second rounds of panning, are the
working material submitted to the recombination. At this stage, most of the clones present are
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able to show an affinity for the target, even if very weak. The hypervariable region of the
clones in this preselected population are recombined together, producing all possible
recombinants. By reassorting these clones among themselves, one links together two parts of
two different clones (Figure I-6, I-7). This raises the chance to bring together initially weak
domains, but which together exhibit new features which may correspond to the “perfect”
structure for the binding to the target (synergism). Further selection with this optimized
library is expected to lead to the isolation of new clones which should be optimal regarding
their affinity to the target.
 Cosmix-plexing is performed from maxiprep prepared from a glycerol stock aliquot of
resuspended cells infected with eluted phage, after the first and second rounds of panning.
The two subpopulations were mixed together in a ratio one to one (i.e., 50% from the clones
came from the first round, and 50% from the second round).
The strategy of this approach is described in Figure III-22. The DNA of the preselected
population, recovered from the maxiprep as plasmids, is restricted by BpmI, opening the
hypervariable region is the middle. After purification, the opened vectors are ligated at high
DNA concentration (>200 µg/ml) leading to the formation of concatemers. This ligation
ensures a recombination among the vectors, increasing the diversity of the hypervariable
region. The ZZ set used at the opened position of the variable domain, does not allow head to
head joining of fragments.
The concatemers are resolved into single phagemid molecules on cleavage with BglI,
followed by ligation at a low DNA concentration (<40µg/ml). The optimized library was
electroporated, and packaged.
The packaged cosmix-plexed library was screened against Src SH3 domain on affinity
selection. Randomly selected clones were sequenced after the first round of panning, as our
experience demonstrated that after cosmix-plexing, enriched clones are efficiently obtained
from the first or second cycles of selection.
The 10 clones which were sequenced, were all identical. The enriched variant was the S1
sequence, previously enriched on panning selection, indicating a very strong binding
preferences of Src SH3 domain for this ligand. 
S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe
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BpmI Insert
       pROCOS
BglI
Digestion with BpmI
Ligation with high DNA concentration
   
     
        Restriction with BglI
Ligation with low DNA concentration
Figure III-22: Schematic representation of cosmix-plexing recombination. The initial
material, is phagemids obtained by maxiprep of a glycerol stock aliquot, which were prepared
from the resuspended colonies infected with the eluted phage from the first and second rounds
of panning. The vectors are opened with BpmI, and religated at high DNA concentration to
yield to the formation of concatemers. The concatemers are resolved as single vectors by
restriction with BglI, and ligated with low DNA concentration, as closed monomers. The
recombined vectors can be electroporated, packaged, and used for further panning to isolate
optimized ligands against a particular target.
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1-4 Phage ELISA
The clones characterized after the panning (Figure III-21), were propagated as single
phage, and individually checked on phage ELISA for affinity against the Src SH3 domain.
The wells of an ELISA microtiter plate were coated with the GST-Src protein. A well, coated
with GST alone, was used as control to ensure that the single phage interact with the Src, and
not with the GST (not shown). The results are summarized in Figure III-23.
On phage ELISA, only four of the clones react positively with the Src domain, S1 to S4.
These clones are the one which contain the Arg Pro(/Ser) Leu sequence, before the proline
motif, demonstrating the crucial role of this sequence for the binding of the ligands to the Src
SH3 domain.
As expected, the S5 clone, which was assimilated to a class II ligand does not bind to the
Src domain, along with the S6 and S7 peptides. Since they could not get enriched in the fourth
panning, it was obvious that the dominant clones (S1, S2, S3) would have bind better to the
Src domain.
More surprising is the clone S4, which appeared once in the third round, but not any
more in the fourth round. Since S1, S2 and S3 clones dominate over the other ones, in the
fourth round, it was expected that S4 binds weakly, or not at all to the Src SH3 domain,
similarly to the clones S5, S6 and S7 which also have a low occurrence. However, the S4
clone is one of the best Src ligand, according to the relative binding of the peptides.
Among the four clones which interact with Src, it is interesting to see that the weaker
one, the S3, is the only one of the four which does not exhibit Arg Pro Leu before the proline
motif, but rather, Arg Ser Leu. This is a very important clue to testify the significant influence
that the Pro have over the Ser, on the binding affinity of a ligand for the Src domain.
The alignment of the four positive clones allows the conception of a new consensus
sequence, which might be more exact, since the clones aligned were selected as the one which
were proved to react with Src. This consensus sequence is thus more precise, and clearer than
the one established after the panning. The consensus is also more extended. The new
consensus sequence corresponds to the preferred properties required  by a peptide, to be able
to bind strongly to the Src domain, and shows the following sequence (where Ψ represents the
hydrophobic residues, and the underlined amino acids were previously fixed in the library):
 Arg Pro Leu Pro (Pro/Leu) Ψ Pro Val Pro Pro S/Ψ
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Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe       2,4
Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser        1,9
    Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp   1,3
Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala   0,7
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Xxx Xxx Arg Pro Leu Pro  P/L   Ψ Pro Val Pro Pro S/Ψ
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Since the clone S1 was the most enriched after the fourth round, and since it was the
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clone was studied to search for cross reaction with a panel of SH3 domains. It was also
interesting to check the potential ability of the clone S1, to bind to EVH1 domains, since these
domains are also known to interact with proline rich ligands.
Equal titers of the clone S1 were incubated in microtiter wells coated with different
GST-SH3 fusion proteins. After several washes, the bound phage were detected with an anti-
M13 antibody (Figure III-24).
2
2,5
Cross reaction of S1 with diverse 
SH3 and EVH1 domains OD492155
Figure III-24: Cross reaction of the clone S1 for a panel of SH3 and EVH1 domains,
tested on phage ELISA. Cross reaction with EVH1 domains (Evl, Mena, VASP, and Vesl)
were also examined, since the EVH1 domains are also known to bind to proline rich ligands.
All SH3 and EVH1 domains were coated as GST fusion proteins. 1010 phage of the clone S1
were incubated in the wells. After several washes, the remained bound phage were detected
with anti-M13 antibody. The absorbance was detected at 492 nm.
The clone S1 shows equivalent ELISA signal for Src, to those obtained previously. No
significant cross reaction is detected, except with the Nephrocystin SH3 domain, but this will
be studied in more details later, along with the clones isolated against the Nephrocystin
protein, since the consensus sequences of ligands which bind Src or Nephrocystin are very
similar. S1 reveals an excellent specificity for the Src and the Nephrocystin SH3 domain.
None of the four EVH1 domains immobilized on the ELISA plate interact with the S1
clone.
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2- Nck2 SH3 domain
The Nck protein has been kindly provided by Lawrence Quilliam and Brian Kay
(University of Wisconsin-Madison, Wisconsin, USA), as GST constructs, which once
expressed, represent the three SH3 domains separately (GST-Nck1, GST-Nck2, GST-Nck3).
Unfortunately, for a unknown reason, the expression of the GST-Nck3 construct resulted in
the expression of the GST alone.
2-1 Panning procedure
GST-Nck1, and -Nck2, were correctly formed, and highly purified due to the GST
sepharose columns (as previously described). Both of the domains were immobilized on
maxisorb microtiter plate, and incubated with the CPLPPXP library. The panning procedure
was performed as developed for Src SH3 protein, with mild washing steps, but a little bit
more stringent every new cycles.
No significant enrichment was observed. However, the sequencing of some randomly
selected clones, after the fifth round of panning, leads to a short consensus sequence. Even if
approximately half of the clones show some changes in their reading frame, or stop codons,
two clones occur several times, for both Nck1 and Nck2. Curiously, these two clones belong
to the 20% of the library which does not contain the proline rich cassette. Therefore, these
clones were called Non Proline 1 and 2 clones (NP1 and NP2):
NP1 Ser  Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
These 8 amino acids long peptides show a 3 residue stretch consensus: Asp Gly Tyr,
which might then be favorable for the binding to Nck1 and Nck2 SH3 domains. It is however
unclear if these clones are really significant, since SH3 ligands are expected to form a
polyproline type II helix, and to contain a proline rich motif (Pro Pro Xxx Pro motif) to be
able to interact with the SH3 domain.
2-2 Cosmix-plexing recombination
A cosmix-plexing recombination was carried out, to better analyze the binding
preferences of the Nck domains. The populations recovered after the first and the second
rounds of the primary panning, for both domains, were submitted to cosmix-plexing, as
previously described (Figure III-22).
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Sequences against Nck2 SH3 domain, from cosmix plexing library
  P1    P2     P3    P4      P5     P6     P7     P8    P9     P10   P11   P12   P13
  First group
Ser Leu Gly Ile Trp Pro   Pro Phe Pro Trp Ile Pro Ile
Ala Ser Cys Phe Gln Pro   Pro Phe Pro Trp Thr Pro Leu
Arg His Cys Val Gly Pro   Pro Asp Pro Tyr Val Pro Met
Thr Cys Thr Ala Leu Pro   Pro Phe Pro Trp Ser Pro Arg
Leu Val Thr Cys Val Pro   Pro Phe Pro Trp Pro Pro Pro
Consensus sequence
Xxx Xxx  C/T   Ψ Xxx Pro   Pro Phe Pro W/YXxx Pro  Ψ
Second group
Pro Arg Asn Val Arg Pro   Pro Ala Pro Trp His Gly Ser
Ser Thr Gly Arg Arg Pro   Pro His Pro Phe Leu Val Ser
Lys Phe Met Asn Arg Pro   Pro Gly Pro Trp Leu Ala Cys
Ala Ser Ser Thr Arg Pro   Pro Cys Pro Tyr Leu Asp Ile
Arg Pro Arg His Arg Pro   Pro Val Pro Val Val Lys Pro
Ser  Val Phe Leu Arg Pro   Pro Cys Pro Ala Leu Gly Asn
Ser Ser Tyr Arg Arg Pro   Pro Leu Pro Ser His Arg Cys
Consensus sequence
       (Ser) Xxx Xxx  (β) Arg Pro   Pro Xxx Pro  ϕ Leu Xxx S/C
Third group
Met Phe Gln Phe Gly Pro   Pro Cys Pro Tyr Leu Asp Ile
Val Gly Leu His Trp Pro   Pro Val Pro Trp Val Gln Arg
Leu Lys Leu Val Asn Pro   Pro Gln Pro Tyr Phe Ile  Leu
Asp Ser Leu Ala Glu Pro   Pro Phe Pro Tyr Met Ile  Val
Gly Glu Tyr Val Trp Pro   Pro Val Pro Trp Ser  Met Met
Consensus sequence
   Ψ Xxx Leu   Ψ Xxx Pro   Pro  Ψ Pro W/Y   Ψ     Ψ      Ψ
Figure III-25: Sequences of single clones, after two rounds of cosmix-plexing panning
against Nck2 SH3 domain, and the deduced consensus sequences. The clones occurred
only once each. A residue is considered as representative for the consensus sequence, when it
occurs in 50% or more of the sequences. Underlined amino acids are fixed residues within the
CPLPPXP library. Ψ, β, and ϕ represent hydrophobic, basic and aromatic amino acids,
respectively. P1 to P13 refer to the amino acid position within the sequence.
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The screening of the optimized CPLPPXP library on Nck1 brought similar results to that
obtained with the primary panning.
However, the affinity selection with Nck2 gave more information. Once more, no
significant quantitative enrichment has been observed. However, randomly selected clones
have been sequenced after the second round of affinity selection, this time some peptides
other than the Non Proline ones were collected, which present the structure expected for SH3
domains, with the proline rich cassette. These clones show some homologies amongst
themselves, as presented in Figure III-25.
A short overview on the proline rich clones bring evidence to the fact that the position
directly after the proline rich motif, is highly advantageous for Nck2 SH3 domain, as an
aromatic residue (mainly tryptophan, or tyrosine). But besides this position, the peptides
appeared to be very different.  However, a closer look allows the classification of the clones
in three groups. The clones of the first group were gathered together, since they all show a
defined proline on position P12. The alignment of these clones highlights other homologies,
like a common cysteine, or threonine on position P3, or hydrophobic residues on positions P4
and P13. Furthermore, the position P8 seems to be clearly defined as a phenylalanine.
The second group was formed with the clones presenting an arginine on position P5. And
here again, their alignment puts the accent on other similarities. Serines (or cysteines at P13)
might be of interest, on both extremities, and a leucine on position P11 also seems important.
The third set regroups the clones which did not belong to the first two classifications,
and here as well, one can be surprised to realize that these clones show a very high content of
hydrophobic residues.
Another point about the Nck clones, concerns the presence of cysteines. It is very
uncommon to find clones against a particular target, with an odd number of cysteines.
However, out of the 17 clones presented, 9 of them contain one cysteine residue (none of
them possess a pair of cysteines). Since more than 50% of the clones (or 66% of the clones
from the first two groups) show this characteristic, one can conclude that it is significant, even
if the reason is unclear. Moreover, the calculated frequency of cysteines, within the CPLPPXP
library is only 3,6% (Table III-10). Within the first group, 4 out of the 5 peptides have a
cysteine, and this cysteine is always located before the proline rich motif (positions P2 to P4).
As far as the second group is concerned, 4 out of the 7 clones also exhibit an unique cysteine,
but this time, the cysteine is C terminal from the proline motif, or within the prolines (P8 and
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P13). It is not known if this cysteine can build a disulfide bridge with a cysteine present in the
Nck2 SH3 domain.
When clones from the third round were sequenced, the frequency of the NP1 and NP2
largely dominates the other clones.
In the case of the Nck2 SH3 protein, the cosmix-plexing recombination appears to be
the only technology allowing isolation of proline rich clones. Until now, no laboratories
report successful characterization of Nck ligands. In our work, the primary panning only
permits the enrichment of non proline clones. The cosmix-plexing recombination can
therefore be considered as a second chance, for target proteins which would appear complex
to investigate on affinity selection.
2-3 Phage ELISA
The clones characterized after the primary panning (NP1 and NP2), and the one obtained
from cosmix-plexing panning (Figure III-25), were propagated as single phage, and
individually checked on phage ELISA for affinity against the Nck1 (NP1 and NP2) and Nck2
SH3 domains.
The wells of an ELISA microtiter plate were coated with the GST-Nck1 or-Nck2
proteins. A well, coated with GST alone, was used as control to ensure that the single phage
interact with the Nck1 and Nck2 SH3 domains, and not with the GST. None of the clones
isolated from the cosmix-plexing panning show positive interaction for the Nck2 domain
(not shown), which is not surprising, since none of the clones get enriched. The results are
summarized in Figure III-26.
On phage ELISA, only the NP1 and NP2 clones react positively with the Nck1 and Nck2
domains. The non proline clones interact strongly with Nck1, but weakly with Nck2 SH3
domain. This is likely to be the reason why it has been possible to isolate some new clones for
the Nck2 domain, since they had a better chance to compete with the non proline clones.
These results, together with the fact that only the NP clones get enriched, demonstrate that the
NP clones have a selective advantage on the proline rich clones, to bind to the Nck domain.
The GST does not react with any of the clones, demonstrating their specificity for SH3
domains.
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       Phage ELISA of Non Proline clones OD492
                       against Nck1 and Nck2 SH3 domains             Nck1   Nck2
NP1 Ser Thr Leu Cys Asp Gly Tyr Cys       0,51     0,53
NP2 Asn Pro Met Gly Asp Gly Tyr Phe       0,06     0,16
Consensus sequence
Xxx Xxx Xxx Xxx Asp Gly Tyr Xxx
Figure III-26: Relative affinity, according to a phage ELISA test, of the clones isolated
against Nck1 and Nck2 SH3 domains. GST-Nck1 and -Nck2 proteins were coated in the
wells. An equivalent amount of phage were incubated in every well (1010 phage/well). After
several washes, the remained bound phage were detected with anti-M13 antibody. The
absorbance was detected at 492 nm. A well coated with GST alone was used as a control, to
ensure that the single clones bind to the SH3 domains, and not to the GST. The OD values are
an average of three repeated tests.
3- Nephrocystin SH3 domain
Nephrocystin cDNA was obtained from Friedhelm Hildebrandt (University of Freiburg;
Germany). Nephrocystin SH3 domain (amino acids 159 to 208 of the NPHP1 cDNA gene,
GenBank accession number AF023674) was expressed as GST-fusion protein, by cloning the
PCR amplified fragments in vector pGEX-5X3, as previously described (Smith and Johnson,
1988). A highly purified GST-nephrocystin fusion protein was obtained (Figure III-2).
Nck1 Nck2 GST
Non Proline 1
Non Proline 20
0,2
0,4
0,6
Phage ELISA: affinity of non proline clones 
for Nck1 ad Nck2
OD492
Results
161
3-1 Panning selection
The purified GST-nephrocystin protein  was used as target for affinity selection with the
CPLPPXP library, according to the protocol optimized for Src SH3 domain (section III-D-1-
1). Briefly, a maxisorb microtiter plate was used as support for the immobilization of the
protein. After incubation of the nephrocystin with the CPLPPXP library, the non- or weak-
binders were eliminated with mild washing steps, becoming more stringent at each cycle of
panning (procedure A, Table III-13). The bound phage were eluted with acidic buffer,
selected, and amplified for the next round of affinity selection. The evolution of input and
output values can be followed in Figure III-27.
After three rounds of panning procedure, the enrichment factor appeared not to be
significant (only 2.7, as shown in Figure III-27). However, if we consider the enrichment
between the second and third round of panning, a 20 fold increase is detected. Therefore, 15
randomly selected clones were sequenced.
Input Output Output/Input Enrichment
1R 1,50E+10 1,30E+03 8,60E-08 -
2R 7,00E+10 9,00E+02 1,20E-08 -
3R 3,90E+10 9,30E+03 2,30E-07 2,7
Figure III-27: Evolution of the input and output titers during the screening of
CPLPPXP on nephrocystin SH3 domain. (A-) Progression of the input (amount of phage
incubated with the target protein), output (eluted phage after stringent washing steps), and
output/input (O/I) values, in absolute number, during 3 rounds of panning procedure (noted
1R to 3R). The O/I ratio is a parameter indicating if an enrichment occurred. The enrichment
factor is estimated by dividing the ratio O/I from the round of interest, with the ratio O/I from
the first round. (B-)  Diagram of the output values of the primary panning on nephrocystin
SH3 domain, compared with the output data of the blank. The blank is an empty well where
the CPLPPXP library was incubated, and then, treated like in the other well.
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Very few clones were recovered after the first panning. However, as a compensation, the
usual dramatic drop of recovery observed after the second round, did not occur, instead, the
output stabilized, and finally increased in the third round, showing an inverse tendency in
comparison to the evolution of the control. This inverted trend suggests that interactions
between the CPLPPXP library and the nephrocystin occurred.
The sequenced clones confirmed this hypothesis, since out of 15 clones, none of them
expressed unproductive clones (change in the open reading frame or presence of stop codon).
Furthermore, from these 15 peptides, only three different sequences were observed, which led
to the conception of a clear consensus sequence (Figure III-28).
This consensus sequence shows very high homologies with the one conceived for the
Src SH3 domain, as shown:
Nephrocystin Arg Xxx Leu Pro Pro Xxx Pro Val Pro
Src Arg Pro  Leu Pro P/L   Ψ  Pro Val Pro Pro
The only position which really seems to be different, is the second one (or P4 on
complete sequences), which is defined as proline in the Src consensus sequence, but appears
to be free for the nephrocystin.
                  Sequences against Nephrocystin SH3 domain                      Frequency
                (3rd  round of panning)
P1     P2      P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
N1 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala   7x
N2 Ser Val Arg Leu Leu Pro   Pro Val Pro Trp His Phe Gly   6x
N3 His Ser Arg Gln Leu Pro   Pro Lys Pro Val Pro Ser Leu   2x
Consensus sequence
Xxx  Xxx Arg Xxx Leu Pro   Pro Xxx Pro Val Pro Xxx Xxx
Figure III-28: Sequences of 15 randomly picked clones, after a third round of panning
selection of the CPLPPXP library, against nephrocystin SH3 domain. The clones are
classified according to their frequency. A residue is considered as representative for the
consensus sequence, when it occurs in 50% or more of the sequences. Underlined residues are
fixed within the CPLPPXP library. P1 to P13 refer to the amino acid positions within the
sequence.
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3-2 Cosmix-plexing recombination
After this successful panning, a cosmix-plexing recombination was performed, in order
to isolate new ligands against the nephrocystin SH3 domain. It was hoped that these would
throw more light on the sequences which determine specific binding to nephrocystin SH3
domain.
Since only very few particles were recovered after the first round of panning, the clones
of the first round population were recombined among themselves. The strategy used for this
approach is described in Figure III-22. The nephrocystin secondary library was screened
against the nephrocystin SH3 domain, and the input and output values, along with the
enrichment factors are summarized in Figure III-29.
Input Output Output/Input Enrichment
1R 1,90E+09 3,00E+02 1,50E-07 -
2R 1,10E+10 5,40E+03 4,90E-07 3,2
3R 7,20E+10 6,20E+06 8,60E-05 574
Figure III-29: Evolution of the input and output titers during the screening of the
cosmix-plexed secondary nephrocystin CPLPPXP library. (A-) Progression of the input
(amount of phage incubated with the target protein), output (eluted phage after stringent
washing steps), and output/input (O/I) values, in absolute number, during 3 rounds of panning
procedure (noted 1R to 3R), along with the enrichment factors. (B-)  Diagram of the output
values of the cosmix-plexing panning on nephrocystin SH3 domain, compared with the
output data observed for the primary panning of CPLPPXP library against nephrocystin (as
shown in Figure III-27).
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After the third panning cycle, a very clear enrichment was observed, since the
enrichment factor was more than 200 fold higher than the one obtained during the primary
affinity selection (574, compared to 2.7 during the primary panning). In the diagram (Figure
III-29/B), the evolution of the output values of both primary and secondary pannings against
the nephrocystin SH3 domain are compared. This illustrates a clear advantage of cosmix-
plexing recombination, in comparison to the initial library.
Randomly selected clones after the second, third and fourth rounds were sequenced
(Figure III-30). The peptides were kept separate within the figure, so that the evolution of the
enrichment is easier to follow.
The clones isolated during the primary panning did not reappear during the secondary
panning. Many new clones were characterized, suggesting that they have higher binding
affinity for nephrocystin than the N1, N2, and N3 clones.
It also has to be pointed out that most of the newly isolated clones do not contain the
proline rich cassette. When the CPLPPXP library was constructed, only 71% of the vectors
have been shown to possess a cassette (Figure III-11), while 20% of them formed back the
parental vectors, containing the 8 random amino acid insert (the last 9% of the library
generated unproductive clones, which formed the so-called L clones, Figure III-18).
It is known that the SH3 ligands are expected to be 6 or 7 amino acids long. Therefore, it
is surprising, but not impossible that the 8 random amino acid peptides, have an advantage
over the 13 residue proline rich peptides, to interact with nephrocystin. This would be the case
especially if the Pro Pro Xxx Pro core motif was not optimal for nephrocystin. Furthermore,
these 8 residue clones show a similar consensus sequence to the one obtained from the
primary panning, indicating that it is not a coincidence if these clones were enriched. A
proline core motif (Pro Val Xxx Pro) is present, as well as the preceding arginine and leucine.
Consensus sequence after primary panning
Arg Xxx Leu Pro Pro Xxx Pro Val Pro
Consensus sequence after secondary panning (cosmix-plexing)
Arg Xxx Leu Pro Val Xxx Pro
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                      Sequences against Nephrocystin SH3 domain,                               Frequency
                                          after cosmix plexing              (%)
2nd round
N4 Thr Arg Arg Leu Pro Val Leu Pro       58
N5 Arg Met Leu Pro Val Tyr Pro Pro       12
N6 Arg Thr Pro Pro Thr Glu Pro Gln Thr       6
N7 Arg Met Leu Pro Val Lys Ile Tyr       6
N8 Arg Pro Leu Pro Pro Thr Pro   Pro Ile Pro Gly Ser Gly Ser 6
N9 Cys Ser Gln His Asp Pro   Pro Phe Pro Trp Arg Val Cys       12
Consensus sequence 2nd round
            Arg M/ΨLeu Pro Val Xxx Pro Pro
3rd round
N4 Thr Arg Arg Leu Pro Val Leu Pro       37
N5 Arg Met Leu Pro Val Tyr Pro Pro       29
N10 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe       25
N11 Arg Ala Arg Val Val Pro   Pro Val Pro Arg Leu His Thr       3
N9 Cys Ser Gln His Asp Pro   Pro Phe Pro Trp Arg Val Cys       6
Consensus sequence 3rd round
Xxx Arg  Ψ Leu Pro V/P   Ψ Pro Xxx
4th round
N4 Thr Arg Arg Leu Pro Val Leu Pro       30
N5 Arg Met Leu Pro Val Tyr Pro Pro       70
Consensus sequence 4th round
Xxx Arg Xxx Leu Pro Val Xxx Pro Xxx
Figure III-30: Sequences of randomly picked clones, cosmix-plexing affinity selection
against nephrocystin SH3 domain. 17, 35 and 10 clones were sequenced, after the 2nd, 3rd,
and 4th round of panning, respectively. The frequency of clone occurrence, is given in
percentage, in order to easier estimate the evolution of the clone appearance after the different
cycles of panning. Underlined residues are fixed within the CPLPPXP library. The first amino
acid of both N6 and N8 sequences (Arg) are written in italic. These Arg do not belong to the
hypervariable domain of the library, but to the conserved sequence which flanks the variable
region. However, these residues seem to be of particular interest for the binding abilities of
the clones for the Nephrocystin SH3 domain (by reference to the consensus sequenced), and
therefore, it was decided to outline them. The N9 sequence was not taken into account when
the consensus sequence was conceived. Indeed, it would not be right to compare it to the other
clones, since the presence of cysteines on both extremities suggest the formation of a disulfide
bridge, which might confer a very particular conformation to the clone. Ψ represents the
hydrophobic residues.
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The interesting point, is that the proline core motif is significantly different from the
biased core sequence used in the construction of the library. It does not contain 3, but 2
prolines (PVXP, instead of PPXP, as the CPLPPXP library was designed). Therefore, a
hypothesis would be that the nephrocystin required a proline motif designed as Pro Val Xxx
Pro, and not the Pro Pro Xxx Pro necessary for the Src SH3 domain ligands. To acquire
ligands containing this required proline motif, the nephrocystin interacts with the 20% of the
CPLPPXP library which show no fixed proline, and selects the variants exhibiting two
prolines separated by two other amino acids.
Very surprisingly, a peptide (N9) bracketed with two cysteines has been isolated, which
occurred several times (in 12% of the sequenced clones, after the second round). This N9
peptide is expected to form a disulfide bridge, and therefore, to exhibit a conformation other
than that found in unconstrained clones. As expected, N9 does not show any similarity to the
other characterized clones. Since the presence of the cysteines can direct the formation of a
loop, the structure of the ligands should be completely different from the other linear clones.
Furthermore, it might interact with nephrocystin in another way, meaning that the contact
between the ligand and the SH3 domain would be achieved by other residues (therefore, this
clone was not taken into account in creating the consensus sequence). However, it was
previously shown, that constrained libraries were not successful in panning to isolate SH3
ligands, presumably since the constrained peptides were not able to form the required
polyproline type II helix. It was therefore unexpected to obtain such a clone. Further analysis
will give more information about the interaction between N9 and nephrocystin.
After the second round, clone N4 was dominant (58%). However, after the third round, a
equilibrium between N4 and N5 dominance was nearly achieved (37% against 29%). The
fourth round revealed that the N5 clone is finally more advantageous for the interaction with
nephrocystin, since it occurred then in 70% of the cases. However, after a fourth round, N4
and N5 are the only enriched clones, suggesting that they both show high affinity for
nephrocystin.
3-3 Phage ELISA
The consensus sequence obtained after the cosmix-plexing panning procedure (Arg
Xxx Leu Pro Val Xxx Pro), appears very similar to the one conceived after the primary
affinity selection (Arg Xxx Leu Pro Pro Xxx Pro Val Pro), except for the proline core motif
which seems highly advantageous when containing only two prolines. However, these two
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consensus sequences have been established from different clones. It is therefore essential to
check the individual relative binding affinity of each clone, before making further
conclusions.
Since the consensus sequence conceived for nephrocystin ligands is very similar to that
established for Src ligands, it was decided to investigate cross reaction, on phage ELISA
(Figure III-31). Furthermore, two identical clone types have been isolated in the selections
against both nephrocystin and Src SH3 domains (N1 and N10 are respectively clones S3 and
S1).
From the 11 clones isolated against nephrocystin, only the N9, which was bracketed by
two cysteines, shows no interaction. It is however not clear if the N9 clone is really unable to
bind nephrocystin, if it is too weak to show a binding on phage ELISA, or if it is dependent
on redox potential.
A new consensus sequence is conceived from the clones showing high relative binding
to nephrocystin, which is more extended, and containing less ambiguities than the one
obtained from simple sequence comparisons.
Nephrocystin consensus sequence after primary panning
Arg Xxx Leu Pro   Pro Xxx Pro Val Pro
Nephrocystin consensus sequence after cosmix-plexing panning
Arg Xxx Leu Pro Val Xxx Pro
Nephrocystin consensus sequence from positive clones after phage ELISA
   β Xxx Arg Pro Leu Pro P/Ψ  (Ψ) Pro P/V Xxx Pro
Figure III-31: Relative binding of nephrocystin, and Src positive clones to nephrocystin
and Src SH3 domains. Isolated clones against Nephrocystin and Src SH3 domains were
propagated as single phage, and tested on phage ELISA, against immobilized Nephrocystin
and Src SH3 domains (1µg). 1010 phage of the single clones were incubated with the SH3
domains (except for the clone N5 were only 5.108 phage were applied), after blocking the
wells. The phage were detected after intensive washing, by antibodies against M13KO7,
labeled with Peroxidase. A well coated with GST alone was used as a control, to ensure that
the single clones bind to the Src, and not to the GST. The phage showed no interaction with
the GST (not shown). The sequence of the clones which react positively with the nephrocystin
domain are shown, and a new consensus sequence is conceived, from the clones presenting a
high absorbance. The OD values are an average of three repeated tests. Underlined residues
are fixed within the CPLPPXP library. Residues in italic represent positions which do not
belong to the hypervariable peptide, but to the flanked regions. These residues were
considered as important, due to their similarity to the consensus sequence. Ψ and β represent
the hydrophobic and basic residues, respectively.
Results
        
Stro
N5
S4
N8
N10/
S2
N3
N4
Con
Wea
N2
N1/S
N6
N7
N11
Phage ELISA on nephrocystin and Src SH3 domains
NephrocystinOD492168
          Positive clones against Nephrocystin SH3 domain,              OD492
 P1     P2     P3     P4     P5     P6     P7    P8     P9     P10   P11   P12   P13
ng binding clones
Arg Met Leu Pro Val Tyr Pro Pro Asp Pro  2,1
Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser  1,8
Arg Pro Leu Pro Pro Thr Pro   Pro Ile Pro Gly Ser Gly  1,3
S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe  1,2
Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp  1
His Ser Arg Gln Leu Pro   Pro Lys Pro Val Pro Ser Leu  0,9
Arg Thr Arg Arg Leu Pro Val Leu Pro Asp Pro  0,8
sensus sequence
    β Xxx Arg Pro Leu Pro P/Ψ (Ψ) Pro P/V Xxx Pro Xxx
k binding clones
Ser Val Arg Leu Leu Pro   Pro Val Pro Trp His Phe Gly  0,4
3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala  0,2
Arg Thr Pro Pro Thr Glu Pro Gln Thr  0,1
Arg Met Leu Pro Val Lys Ile Tyr  0,1
Arg Ala Arg Val Val Pro   Pro Val Pro Arg Leu His Thr  0,1
0
0,5
1
1,5
2
2,5
N
1=
S
3
N
2
N
3
N
4
N
5
N
6
N
7
N
8
N
9
N
10
=
S
1
N
11 S
2
S
4
Src
Results
169
The proline core motif does not require three prolines. Two prolines (P6 and P9)
separated by two hydrophobic residues, are enough to give excellent binding ability to the
nephrocystin ligands. The same goes for the proline between the arginine and the leucine (P4),
4 out of the 7 clones which positively react with nephrocystin exhibit a proline on this
position. However, the best clone (N5), do not possess it, suggesting that this proline can
present an advantage, but is not crucial.
The comparison of the two consensus sequences also show that the one established after
phage ELISA gives more information on the flanking regions, N and C terminal from the
proline core motif.
The analysis of the clones which bind very weakly to the nephrocystin (N6, N7, and
N11), also provides a lot of information in determining which positions appear to be crucial
for the interaction. All three clones differ only by one or two positions from the basic
consensus sequence. N6 does not have Leu5 and Ψ7. N7 is missing Pro9, and N11 lacks the
Leu5 position. These data allow a more stringent definition of the crucial nephrocystin ligand
consensus sequence:   
Arg Xxx Leu Pro  Ψ Xxx Pro
The four clones isolated against Src (two were also selected against nephrocystin) are
able to interact with both nephrocystin and Src SH3 domains. Figure III-32 illustrates the
sequences of the interacting clones. However, of the other nephrocystin clones, only N8
shows a cross reaction with Src. Every clone able to bind to Src, in our phage ELISA test, is
also able to bind to nephrocystin, but the contrary is not true. The ligand preference of Src
appears to be more demanding than that of Nephrocystin.
The analysis of the nephrocystin clones which do not interact with Src, clearly show an
absence of the Arg Pro Leu motif preceding the proline rich core. This again demonstrates the
crucial role of this Arg Pro Leu sequence in Src SH3 ligands, as previously pointed out by the
work of other groups and confirmed here (Figure III-23).
The new Src consensus sequence, conceived from the totality of the clones able to
interact with Src (no matter if isolated against Src or nephrocystin) does not significantly alter
the previously defined consensus sequence (since only one more clone is participating in its
elaboration), however, one position more is defined.
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Src consensus sequence after Src phage ELISA:
Arg Pro Leu Pro  P/L   Ψ Pro Val Pro Pro S/Ψ
Src consensus sequence by considering all interacting clones
Arg Pro Leu Pro  P/L   Ψ Pro  Ψ  Ψ Pro S/Ψ Ser
                Positive clones against Src SH3 domain,      OD492
                          ordered according to their relative affinity for the target
N10/S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe  2,4
S4 Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser  1,9
S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp  1,3
N1/S3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala  0,7
N8 Arg Pro Leu Pro Pro Thr Pro   Pro Ile Pro Gly Ser Gly  0,3
Consensus sequence
Xxx Xxx Arg Pro Leu Pro P/L  Ψ Pro  Ψ  Ψ Pro S/Ψ Ser Xxx
Figure III-32: Sequences of the clones isolated against nephrocystin or Src SH3
domains, and which interact with Src SH3 domains on phage ELISA. A new consensus
sequence is conceived, from the clones presenting relative binding. The OD values are given,
as an average of three repeated tests. Underlined residues are fixed within the CPLPPXP
library. Residues in italic represent positions which do not belong to the hypervariable
peptide, but to the flanked regions. These residues were considered as important, due to their
similarity to the consensus sequence. Ψ represents the hydrophobic residues.
The C terminal region of the consensus sequence, shows a few differences which are,
however, compatible to the previous consensus sequence (the Val10 and the Pro11 are both
hydrophobic residues). A serine at position P14 appears now to be advantageous for the
binding between Src SH3 domain, and its ligands.
E - Panning selection on EVH1 domains
The Ena/VASP homology (EVH1) domain is a protein interaction module found in
several Drosophila and mammalian proteins (the Drosophila protein Ena, their murine
homologue proteins Mena and Evl, the human proteins VASP, WASP and Vesl/Homer) that
are involved in transducing migratory and morphological signals into cytoskeletal
reorganization (Prehoda et al., 1999). EVH1 specifically recognizes proline-rich sequences in
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its binding partners. They direct the localization and formation of multicomponent assemblies
involved in actin-biased motile processes by recruiting proteins like profilin and the Arp2/3
complex, which are thought to directly promote actin filament elongation (Mitchison and
Cramer, 1996; Laurent et al., 1999). In addition, Vesl is involved in neural development (Tu
et al., 1999).
Mena, VASP, Evl, and Vesl EVH1 domains, were kindly provided as purified GST-
fusion proteins, by Prof. J. Wehland (GBF, Braunschweig, Germany).
1- Vesl/Homer EVH1 domain
Vesl, also called Homer, belongs to a family of postsynaptic proteins that are thought to
function in synaptic plasticity (Brakeman et al., 1997; Kato et al., 1997). Vesl is constitutively
expressed in brain and enriched at excitatory synapses, that selectively binds the C terminus
of group 1 metabotropic receptors (mGluR1a and mGluR5) (Brakeman et al., 1997). Vesl
interacts with mGluR1a/5 through its EVH1 domain. The Vesl EVH1 domain binds an
internal, proline rich sequence that is approximately 50 residues from the C terminus of both
mGluR1a and mGluR5 (Tu et al., 1998).
Although Vesl contains a EVH1 domain, it does not seem to be involved in actin
cytoskeleton, but to function in synaptic plasticity (Brakeman et al., 1997; Kato et al., 1997).
This element demonstrates that Vesl stands apart from the other EVH1 domain containing
proteins. This is also illustrated by the ligand preferences of EVH1 domains, as shown in
Figure III-33. There, the natural EVH1 ligands are divided into two groups. EVH1 domains
involved in actin filament assembly show predilection for the first set (ActA, vinculin, zyxin,
ankyrinG, SAX-3 and Robo), whereas Vesl binds preferentially to the second group,
composed by mGluR, and IP3.
Vesl is the only EVH1 domain containing protein, to interact with the proline rich motif
Pro Pro Xxx Pro Phe Arg Asp, found in mGluR and IP3. In addition, whereas all other EVH1
domains show strong affinity to the ActA protein, Vesl interacts very weakly.
The main difference between both group of ligands, is the position of the phenylalanine,
before (first group), or after (second group) the proline core motif. Phe directly before the
proline motif, is essential for the binding with EVH1 domains, since interaction of ActA with
EVH1 domain is disrupted, when Phe is mutated to Ala (Prehoda et al., 1999). EVH1
domains contain a pocket that specifically recognizes this Phe, or large hydrophobic residues,
such as leucine, in the human Robo sequence.
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Robo does not contain Phe, either before or after the core motif, but in both cases, other
large hydrophobic amino acids. This might explain a certain loss of affinity for the binding
with EVH1, compared to the other ligands. Furthermore, Robo shows an interaction with both
EVH1 domain families, even though quite weak, which might be possible through the
absence of the phenylalanine which seems to direct the specificity for one of the two classes
of EVH1 domains.
Natural ligands of EVH1 domains
ActA Ser Phe Glu Phe Pro Pro Pro Pro Thr Asp Glu Glu Leu
Vinculin Glu Pro Asp Phe Pro Pro Pro Pro Pro Asp Leu Glu Gln
Zyxin Glu Glu Ile Phe Phe Ser Pro Pro Pro Pro Pro Glu Glu Glu
AnkyrinG Ala Tyr Ile Glu Phe Pro Pro Pro Pro Pro Leu Asp Ala Asp
SAX-3 Thr Leu Met Asp Phe Ile Pro Pro Pro Pro Ser Asn Pro Pro
hRobo Ser Thr Asp Asp Leu Pro Pro Pro Val Pro Pro Pro Ala Ile
Consensus sequence
Xxx Xxx   Ψ   α Phe Pro Pro Pro Pro Pro   Ψ  α   Glu/Ψ  Ψ
mGluR Glu Glu Leu Val Ala Leu Thr Pro Pro Ser Pro Phe Arg Asp
IP3R Asn Pro Pro Lys Lys Phe Arg Asp
Dynamin III Ala Pro Pro Val Pro Phe Arg Pro
Shank3 Pro Val Pro Pro Pro Glu Glu Phe Ala Asn
Consensus sequence
Xxx Pro Pro Xxx Pro Phe Arg Asp
Figure III-33: Alignment of natural EVH1 binding sequences, including sequences from
the Listeria ActA protein, host cytoskeletal proteins (vinculin, zyxin, ankyrin), and host axon
guidance receptors (SAX-3, Robo). mGlu receptor and IP3 receptor, are ligands showing
interaction specifically for Vesl, but not with the other EVH1 domains. They are therefore
kept separated from the previous group of ligands. Deduced consensus sequences are shown.
α and Ψ represent acidic and hydrophobic amino residues, respectively.
Another important peculiarity of EVH1 ligands, is the presence of an acidic stretch,
flanking both sides of the proline motif, which appears to increase the affinity of the ligands
for the EVH1 domains (Niebuhr et al., 1997; Prehoda et al., 1999).
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The actual consensus sequence for EVH1 domains involved in actin filament assembly,
or in synaptic plasticity, at the beginning of this work, were conceived from the natural EVH1
ligands(Figure III-33), and were as followed:
Actin filament assembly    Ψ   α Phe Pro Pro Pro Pro Pro   Ψ  α   Glu/Ψ   Ψ
Synaptic plasticity Pro Pro Xxx Pro Phe Arg Asp
It has to be noticed that acidic residues do not necessarily occur within the consensus
sequences, since from one ligand to another, the many acidic positions seem to vary all along
the ligand sequence.
1-1 Panning selection
The purified GST-Vesl fusion protein, was submitted to affinity selection, according to
the optimized protocol developed for the Src SH3 domain. A maxisorb microtiter plate was
used  as support for the immobilization of the protein. After incubation of Vesl with the
CPLPPXP library, the non- or weak-binders were eliminated by proceeding to mild washing
steps, becoming more stringent at each cycle of panning (procedure A, Table III-13). The
bound phage were eluted with acidic buffer, selected, and amplified for the next round of
affinity selection. The evolution of the input and output values can be followed in Figure III-
34.
After three rounds of panning procedure, the enrichment factor is very weak (only 5,5,
as shown in Figure III-34). However, after the fourth round, a dramatic increase is observed,
with an enrichment factor of 600
The usual drop of recovery is, as expected, observed after the second round. The output
values rise slightly in the third round, and finally increased significantly in the fourth round,
in comparison to the control, which shows no increase.
Randomly selected clones from the third round were sequenced. A strong enrichment of
particular clones occurred: out of 25 sequenced clones, only one of them was an unproductive
clone (presence of a stop codon). Furthermore, among the 24 correctly formed peptides,
several of them occurred several times, and their alignment leads to the conception of a clear
consensus sequence (Figure III-35).
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Input Output Output/Input Enrichment
1R 1,50E+10 1,80E+04 1,20E-06 -
2R 6,00E+10 1,90E+03 3,10E-08 -
3R 6,00E+09 4,00E+04 6,60E-06 5,5
4R 3,8.9 2,40E+06 7,20E-04 600
Figure III-34: Evolution of the input and output titers during the screening of
CPLPPXP on Vesl EVH1 domain. (A-) Progression of the input (amount of phage
incubated with the target protein), output (eluted phage after stringent washing steps), and
output/input (O/I) values, in absolute number, during 4 rounds of panning procedure (noted
1R to 4R). The O/I ratio is a parameter indicating if an enrichment occurred. The enrichment
factor is estimated by dividing the ratio O/I from the round of interest, with the ratio O/I from
the first round. (B-)  Diagram of the output values of the primary panning on Vesl EVH1
domain, compared with the output data of the blank. The blank is an empty well blocked with
the blocking solution, where the CPLPPXP library was incubated, and then, treated like in the
other well.
The analysis of these clones shows the dominance of a tyrosine or tryptophan after the
proline rich motif, at position P10, and indicates a preference for Arg on position P2 (only 50%
of the clones present this Arg, however, these are all the clones which are clearly enriched. At
position P8, between the prolines, there is a clear preference for hydrophobic residues (or
eventually for aromatics), as well as at the positions 3 and 4.
Clones sequenced after a fourth round of panning, demonstrate a further enrichment for
clone V1 (90%) and V3 (10%). This reinforces the aptness of the conceived consensus
sequence.
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                                    Sequences against Vesl EVH1 domain                             Frequency
                     (3rd  round of panning)
 P1     P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
V1 Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly    13x
V2 Asn Arg Leu Tyr Pro Pro   Pro Trp Pro Tyr Ser Asp Pro    4x
V3 Ser Arg Ser Val Tyr Pro   Pro Pro Pro Tyr Pro Phe Ala    2x
V4 Asp Arg Ile Tyr Leu Pro   Pro Val Pro Trp Ala Asn Ser    1x
V5 Arg Thr Gly Val Trp Pro   Pro Pro Pro His Asp Phe Arg    1x
V6 Tyr Leu Ile Leu Ser Pro   Pro Ala Pro Trp Arg Asp Arg    1x
V7 Cys Ser Arg Ser Arg Pro   Pro Val Pro Leu Gly Pro Phe    1x
V8 His Met Leu Phe Asp Pro   Pro Phe Pro Tyr Ser Asn Glu    1x
Consensus sequence
Xxx  Arg   Ψ (ϕ/Ψ) Xxx Pro   Pro (ϕ/Ψ)Pro W/YXxx D/F Xxx
Figure III-35: Sequences of 25 randomly picked clones, after a third round of panning
selection of the CPLPPXP library, against Vesl EVH1 domain (one  clone contained a
stop codon). Underlined residues are fixed within the CPLPPXP library. ϕ and Ψ represent
the aromatic and hydrophobic residues, respectively.
1-2 Cosmix-plexing recombination
The population recovered after the first round of “normal” panning, was submitted to a
cosmix-plexing, as described in Figure III-22, and screened once more against Vesl.
Randomly selected clones were sequenced after the first round of panning, since the number
of eluted phage was already so high. The output and input data are shown in Figure III-36,
and the sequenced clones are presented in Figure III-37.
After the third panning cycle, a dramatic enrichment was observed, since the enrichment
factor is almost 200 fold higher than the one obtained during the primary affinity selection
(1000, compared to 5,5 during the primary panning). In the diagram (Figure III-36/B), the
evolution of the output values of a control, and both primary and secondary pannings against
the Vesl EVH1 domain are compared. A very large number of clones are recovered after the
first round of cosmix-panning, especially when compared with the data coming from the
standard panning, meaning that the cosmix-plexing recombination allowed the formation of
many variants showing affinity for Vesl. During the following affinity selection cycles, the
number of eluted clones regularly increase.
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Input Output Output/Input Enrichment
1R 2,30E+12 1,00E+06 4,30E-07 -
2R 2,70E+11 5,00E+06 1,80E-05 42
3R 8,60E+10 3,70E+07 4,30E-04 1000
Figure III-36: Evolution of the input and output titers during the screening of the
cosmix-plexed secondary Vesl CPLPPXP library. (A-) Progression of the input (amount of
phage incubated with the target protein), output (eluted phage after stringent washing steps),
and output/input (O/I) values, in absolute number, during 3 rounds of panning procedure
(noted 1R to 3R), along with the enrichment factors. (B-)  Diagram of the output values of the
cosmix-plexing panning on Vesl EVH1 domain, compared with the output data observed for
the blank, and for the primary panning of CPLPPXP library on Vesl (as shown in Figure III-
34).
The first element to be observed after cosmix-plexing, with respect to the Vesl protein,
is that it confirms the results found after the normal panning: the dominant clone is the same
in both cases. This is also emphasized by the clones sequenced after the second round, since
100% of them were the V1 clone.
However, the cosmix-plexing approach allows the obtention of a longer consensus
sequence (only one of the 13 positions is still completely undetermined). In addition, less
ambiguities within the consensus sequence are found. The tyrosine or tryptophan after the
proline core motif, in position P10, is confirmed, along with the P2 Arg. The residue in P8,
between the prolines, shows a preference for a phenylalanine, or a proline, rather than just a
hydrophobic residue (as concluded after the standard protocol). The fourth position is clearly
determined as tyrosine, or eventually phenylalanine residue (but in any case, an aromatic
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residue), which was not obvious after the normal panning.
                                     Sequences against Vesl EVH1 domain,           Frequency
                                         after cosmix plexing (first round)
 P1     P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
V1 Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly 6x
V3 Ser Arg Ser Val Tyr Pro   Pro Pro Pro Tyr Pro Phe Ala 1x
V9 Ser His Ile Phe Asp Pro   Pro Phe Pro Tyr Gly Pro Met 1x
V10 Ser Leu Leu Tyr Glu Pro   Pro Pro Pro Trp Asn Ser Pro 1x
V11 Ser Arg Val Tyr Pro Pro   Pro Phe Pro Trp Arg Ala Val 1x
    Consensus sequence
Ser Arg   Ψ Y/F (α) Pro   Pro F/P Pro W/YXxx   Ψ  Ψ
Figure III-37: Sequences of 10 randomly picked clones, after a first round of panning
selection. The CPLPPXP population recovered after the first round of ”normal” panning
against the Vesl EVH1 domain, was submitted to cosmix-plexing, and screened in this
panning. Underlined residues are fixed within the CPLPPXP library. Ψ represents
hydrophobic residues.
Furthermore, the cosmix-plexing approach gives more information about both
extremities of the consensus sequence. Indeed, the first position seems to be important as a
serine. The most frequent clone (V1) does not contain this serine, however, the four other
isolated variants do. Nevertheless, it has to be remembered that natural ligands show a quite
high proportion of acidic residues, throughout the sequence, and that the V1 is the only clone
isolated (after cosmix-plexing recombination) which contains two acidic residues. One of
these residues is in P1 position, and therefore, might compensate the absence of serine. The
last two positions (P12, and 13) also appear to be preferentially hydrophobic residues.
The comparison of consensus sequences after standard, and cosmix-panning testifies an
improved clarification of the consensus sequence, on the basis of the results obtained after
cosmix-plexing.
Consensus sequence after primary panning
Arg   Ψ (ϕ/Ψ) Xxx Pro   Pro (ϕ/Ψ)Pro W/Y Xxx  D/F
Consensus sequence after secondary panning (cosmix-plexing)
Ser Arg  Ψ  Y/F (α) Pro   Pro F/P Pro W/Y Xxx   Ψ  Ψ
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1-3 Phage ELISA
The clones characterized after the panning (and shown in Figures III-35 and-37), were
prepared as single phage, and individually checked on phage ELISA for affinity against the
Vesl protein. The results are summarized in Figure III-38.
The wells of an ELISA microtiter plate were coated with the GST-Vesl protein. A well,
coated with GST alone, was used as control to ensure that the single phage interact with the
Src, and not with the GST (not shown).
On phage ELISA, 10 out of the 11 isolated clones react positively with the Vesl domain,
although some of them react very weakly. The alignment of the clones which react strongly
with the Vesl EVH1 domain, allows the conception of a new consensus sequence,
corresponding to the actual ligand preferences of Vesl:
Arg   Ψ Y/F (Asp)Pro   Pro F/Ψ Pro W/Y Xxx Asp  Ψ
The analysis of the positive clones, shows how essential are the tryptophan or tyrosine at
P10, directly after the proline core motif.
In addition, it brings evidence for the importance of the arginine at position P2, and
tyrosine or phenylalanine at P4. On both case, hydrophobic residues might be acceptable as
well.
An aspartic acid at position P12 seems to strengthen the interaction, but not to be crucial,
since the three best clones (V1, V2, and V6) contain it, but the others do not.
At P8, phenylalanine, or hydrophobic residues belong to the ligand preferences of Vesl.
In addition, hydrophobic residues at P3 and P13 appears to be advantageous.
It has to be pointed out, that less acidic residues occur in the phage display isolated
ligands, compared to the natural ligands, but in both cases, they are distributed along the
sequence. However, the analysis of the positive clones tends to show that they could
compensate the absence of one of the important positions (like P2 or P4). This might be due to
stabilization of the ligand/Vesl complex, by an interaction with basic residues of the Vesl
domain. The most strongly binding ligand (V1) contains two acidic residues.
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    Phage ELISA on Vesl EVH1 domain       OD492
                    (positive clones)
 P1     P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
V1 Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly 0,87
V2 Asn Arg Leu Tyr Pro Pro   Pro Trp Pro Tyr Ser Asp Pro 0,76
V6 Tyr Leu Ile Leu Ser Pro   Pro Ala Pro Trp Arg Asp Arg 0,67
V3 Ser Arg Ser Val Tyr Pro   Pro Pro Pro Tyr Pro Phe Ala 0,55
V8 His Met Leu Phe Asp Pro   Pro Phe Pro Tyr Ser Asn Glu 0,52
V9 Ser His Ile Phe Asp Pro   Pro Phe Pro Tyr Gly Pro Met   0,48
Consensus sequence
Xxx Arg  Ψ Y/F (Asp)Pro   Pro F/Ψ Pro W/YXxx Asp  Ψ
V4 Asp Arg Ile Tyr Leu Pro   Pro Val Pro Trp Ala Asn Ser 0,21
V11 Ser Arg Val Tyr Pro Pro   Pro Phe Pro Trp Arg Ala Val      0,17
V7 Cys Ser Arg Ser Arg Pro   Pro Val Pro Leu Gly Pro Phe 0,05
V5 Arg Thr Gly Val Trp Pro   Pro Pro Pro His Asp Phe Arg 0,03
Figure III-38: Relative affinity, according to a phage ELISA test, of the clones isolated
against Vesl EVH1 domain. GST-Vesl protein was coated in the wells. An equivalent
amount of phage were incubated in every well (1010 phage/well). After several washes, the
remained bound phage were detected with anti-M13 antibody. The absorbance was detected at
492 nm. A well coated with GST alone was used as a control, to ensure that the single clones
bind to the Vesl, and not to its GST fusion partner. The phage showed no interaction with the
GST (not shown). The sequence of the clones which react positively with the Vesl domain are
shown, and classified according to their OD value. A new consensus sequence is conceived
from the strongest clones. The OD values are the average value from triplicates. Underlined
residues are fixed within the CPLPPXP library. Ψ represents hydrophobic residues.
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2- Evl, Mena and VASP EVH1 domains
The EVH1 domain mediates the interaction of VASP, Mena and Evl (Ena-VASP-like),
with cytoskeleton-interacting proteins, including the eukaryotic proteins vinculin and zyxin,
and ActA of the motile intracellular bacterial pathogen Listeria monocytogenes (Niebuhr et
al., 1997; Laurent et al., 1999).
VASP (vasodilator-stimulated phosphoprotein), is 380 amino acid human protein, and is
a substrate of cyclic AMP-dependent and cyclic-GMP-dependent protein kinases (Halbrügge
and Walter, 1989). It is found in a variety of tissues, and is associated with focal adhesions,
microfilaments, and cell-cell contacts. VASP has been shown to be a multi-ligand protein that
binds directly to filamentous actin (Reinhard et al., 1992), profilin (Reinhard et al., 1995a),
the Listeria monocytogenes surface protein ActA (Chakraborty et al., 1995), zyxin (Reinhard
et al., 1995b), and vinculin (Brindle et al., 1996; Reinhard et al., 1996). The binding of VASP
to vinculin, zyxin, and ActA has been attributed to proline rich sequence from the ligands,
which interacts with the VASP EVH1 domain (Niebuhr et al., 1997).
Mena and Evl are murine proteins that were identified by their similarity to Drosophila
Enabled (Gertler et al., 1996). Brain extract analyses, from Mena knockout mice, have shown
that the Evl protein was sufficient to support movement  in the absence of Mena. Further
studies brought evidence that Mena, Evl, and VASP play interchangeable roles in Listeria
movement and that they most likely bind to the same molecular targets in this function
(Laurent et al., 1999).
Many tissues contain two or three of the Mena, Evl or VASP proteins (Lanier et al,
1999). However, particular tissues contain them at different concentrations. Platelets are rich
in actin-binding proteins involved in motility and contain micromolar amount of VASP,
whereas Mena and Evl are present in low quantity (Aszodi et al., 1999). Brain extracts are
rich in the Mena and Evl proteins, where VASP is expressed at low concentration.
2-1 Panning selection
The purified GST-Evl, -Mena, and -VASP proteins were submitted to affinity selection,
according to the optimized protocol selected with Src SH3 domain. Briefly, a maxisorb
microtiter plate was used as support for the immobilization of the protein. After incubation of
the nephrocystin with the CPLPPXP library, the non- or weak-binders were eliminated with
mild washing steps, becoming more stringent at each cycle of panning (procedure A, Table
III-13). The bound phage were eluted with acidic buffer, selected, and amplified for the next
round of affinity selection.
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No quantitative enrichment was observed during the standard panning procedure.
However, some clones were sequenced, and show interesting homologies (Figure III-39),
even though each of the isolated clones occurred only once. It has to be emphasized that
according to the proteins, and the rounds of panning, between 40 to 70% of the sequenced
clones were leading to unproductive variants (change in reading frame, presence of stop
codons, or L clones, sequences not shown). Furthermore, within the correctly formed variants,
the non proline clones identified against Nck1 and Nck2 SH3 domains, were isolated several
times.
 Target  Sequences
proteins  P1    P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
Evl Phe Trp Ile Phe Ser Pro   Pro Val Pro Tyr Leu Tyr Ser
Phe Ile Val Arg Val Pro   Pro Leu Pro Leu Thr Thr Asn
Asp Thr Ala Val Asp Pro   Pro Phe Pro Trp Gly Pro Ile
Trp Ser Gln Arg Met Pro   Pro Phe Pro Trp Thr Ser Val
Cys Ser Leu Leu Leu Pro   Pro Val Pro Trp Ala Ile Asp
Leu Pro Tyr Leu Glu Pro   Pro Asn Pro Trp Ser Gly Cys
Tyr Trp Arg Ser Ala Pro   Pro Leu Pro Tyr Phe Phe Leu
                                                           
Consensus sequence
  ϕ Xxx Ψ Ψ  Ψ Pro   Pro  Ψ Pro W/Y Xxx Xxx Xxx
                                                                                                                                             
VASP Ile His Leu Asp Trp Pro   Pro Phe Pro Tyr Cys Tyr Val
Thr Ser Val Val Gly Pro   Pro Met Pro Tyr Leu Phe His
Leu Cys Phe Gly Phe Ala Pro Phe Pro Tyr Tyr His Ser
Pro Val Pro Thr Met Pro   Pro Phe Pro Leu Asn Tyr Tyr
Consensus sequence
 Ψ Xxx   Ψ Xxx Ψ/ϕ Pro   Pro Phe Pro Tyr Xxx Y/F Xxx
Mena Cys Asn Gly Phe Leu Pro   Pro Leu Pro Met Tyr Trp Ala
Arg Arg Pro Leu Leu Pro   Pro Val Pro Met Leu Pro Tyr
Thr Ser Gly Ala Glu Pro   Pro Leu Pro Met Tyr Trp Ala
Gln Leu Phe Gln Glu Pro   Pro Gly Pro Met Leu Met Tyr
Ile Ser Asn Leu Asp Pro   Pro Cys Pro Asp Tyr Val Pro
Consensus sequence
Xxx Xxx Xxx   Ψ α/L Pro   Pro  Ψ Pro Met Y/L  Ψ Ψ/Y
Figure III-39: Sequences of single clones, after three rounds of standard panning on Evl,
Mena and VASP EVH1 domains, and the deduced consensus sequences. The clones occur
only once each. A residue is considered as representative for the consensus sequence, when it
occurs in 50% or more of the sequences. Underlined amino acids are fixed residues within the
CPLPPXP library. Ψ, α, and ϕ represent hydrophobic, acidic and aromatic amino acids,
respectively. P1 to P13 refer to the amino acid position within the sequence.
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Even though only a small proportion of the sequenced clones comes from correctly
formed variants, they show strong similarities specific to each target.
The variants isolated against Evl possess some determined positions, especially the
position P10, directly after the proline-core motif, which is highly defined as tryptophan or
tyrosine. Except for this aromatic residue, Evl tends to have preferences for ligands being
highly hydrophobic N terminal from the proline motif.
Similarly to Evl protein, VASP EVH1 domain shows a preference for an aromatic
residue at the P10 position, where however, for the few clones analyzed, the residue is reduced
as a tyrosine. Several other positions appear to be advantageous as an aromatic residue: a
phenylalanine at P8, between the prolines of the core motif, is highly representative of the
VASP isolated clones, along with a tyrosine, or phenylalanine at position P12. In addition,
aromatic or hydrophobic residues might be profitable, at P5, directly before the proline motif.
Mena exhibits slightly different preferences: the aromatic residue of P10 in Evl, and
VASP, seems to be important for Mena, at P11 or P13, as tyrosine. Each of the clones isolated
against Mena, possess a tyrosine either at P11 or P13. The P10 position is also highly defined,
but as methionine. The sequence C terminal to the proline core appears to require tyrosine or
hydrophobic residues to allow interaction with the Mena protein. The part N terminal of the
prolines is less defined than for the other proteins, since only P4 and P5 show homologies
along the aligned variants. P4 is represented by hydrophobic residues, while P5, is the only
position where acidic residues are clearly enriched.
The overview of the consensus sequences of EVH1 domains, conceived from phage
display analyses, puts in evidence some similarities. In addition, their alignment with the
consensus sequences of the natural ligands of EVH1 domains involved in actin filament
assembly, or in synaptic plasticity, allows some more observations:
Evl    ϕ Xxx   Ψ   Ψ   Ψ Pro   Pro  Ψ Pro W/YXxx Xxx Xxx
VASP   Ψ Xxx    Ψ Xxx Ψ/ϕ Pro   Pro Phe Pro Tyr Xxx Y/F Xxx
Mena Xxx Xxx Xxx   Ψ α/L Pro   Pro  Ψ Pro Met Y/L   Ψ Ψ/Y
Vesl Xxx Arg  Ψ Y/F (Asp)Pro   Pro F/Ψ Pro W/YXxx Asp  Ψ
EVH1 actin Xxx Xxx   Ψ   α Phe Pro Pro Pro Pro Pro   Ψ  α   Glu/Ψ
EVH1 synapse Xxx Xxx Xxx Xxx Xxx Pro Pro Xxx Pro Phe Arg Asp
Very few acidic residues are present along the sequence of the isolated clones, compared
to their proportion within the natural ligands (not reflected by the natural ligand consensus
sequence, since the acidic residues are not restricted to one position). However, since none of
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the clones has been dramatically enriched during the panning, this is not surprising.
The main difference between the natural ligand consensus sequences, and the one
conceived after phage display, for Evl, Mena, VASP, and Vesl, lays in the aromatic residues.
Within the natural ligands, a phenylalanine before the core motif is essential for interaction
between EVH1 domains involved in actin filament assembly, and their ligands, while for Vesl
EVH1 domain, the phenylalanine was located after the proline motif. Amino acid substitution
studies show that phenylalanine before the proline motif is crucial for interaction between
Mena and VASP with their ligands. Indeed, phenylalanine can only be replaced by other
aromatic residues; tryptophan (which even improves the binding ability between both
partners), and tyrosine. Every other substitution leads to a disruption of the interaction, except
for Mena, which also allows a leucine at this position (Niebuhr et al., 1997).
Interestingly, the clones isolated with phage display, present, for all four EVH1 domains,
an aromatic residue (preferentially tryptophan or tyrosine), however, after the proline motif.
This was expected for Vesl, but this is the first time that such homologies are reported,
between the two families of EVH1 domains.
However, when the clones were individually checked on phage ELISA for interaction
with the different EVH1 domains, none of them show positive reaction with the EVH1
domains, which is not surprising, since none of the clones showed strong enrichment during
affinity selection and phage ELISA is an assay only suitable for the ranking of clones having
strong affinities.
2-2 Cosmix-plexing recombination
Cosmix-plexing recombination of the population selected after first and second rounds
of panning, for each of the EVH1 domains, was performed. However, the screening of these
optimized CPLPPXP library on EVH1 domains only allows the enrichment of the two non
proline clones previously isolated against Nck1 and Nck2 SH3 domains:
NP1 Ser  Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
It has been thought that these two non proline clones might have been selected against
EVH1 domains because the library was contaminated with these clones. Since there are
smaller than the majority of the variants (only 8 amino acids, compared with 13), they have a
selective advantage, due to a shorter replication time, and if no enrichment of interacting
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partners occurs, they might represent a large proportion of the library, after a few rounds. It
was therefore important to check for potential interaction between NP1, NP2, and the EVH1
domains.
2-3 Phage ELISA
NP1 and NP2 were individually propagated as single phage, and tested on phage ELISA
against Evl, Mena, VASP, and Vesl EVH1 domains. The results of the analysis are
summarized in Figure III-40.
    Phage ELISA of Non Proline clones              OD492
                                against EVH1 domains                   Vesl      Evl     Mena  VASP
NP1 Ser Thr Leu Cys Asp Gly Tyr Cys       0,54     0,04     0,50     0,07
NP2 Asn Pro Met Gly Asp Gly Tyr Phe       0,62     0,03     0,47     0,18
Consensus sequence
Xxx Xxx Xxx Xxx Asp Gly Tyr Xxx
Figure III-40: Relative affinity of the non proline clones with EVH1 domains, according
to phage ELISA. GST-EVH1 proteins were coated in the wells. An equivalent amount of
phage were incubated in every well (1010 phage/well). After several washes, the remained
bound phage were detected with anti-M13 antibody. The absorbance was detected at 492 nm.
A well coated with GST alone was used as a control, to ensure that the single clones bind to
the EVH1 domains, and not to the GST. The OD values are the average of triplicates.
Vesl Evl Mena VASP GST
Non Proline 1
Non Proline 20
0,1
0,2
0,3
0,4
0,5
0,6
0,7
Phage ELISA: affinity of non proline clones for EVH1 
domains
OD492
Results
185
Surprisingly, the non proline clones react positively with the EVH1 domains, even
though very weak with Evl EVH1 domain. These results bring new interest to the field of
proline rich ligands binding proteins, since it is the first time that a link between SH3 and
EVH1 domains can be established. Until now, the only common point between both kind of
domains, was that they both interact with proline rich ligands. However, these ligands showed
different consensus sequences. They were considered as two distinct families, since Niebuhr
(1997) showed that SH3 ligands do not interact with EVH1 domains. But clones were isolated
which are able to bind with both SH3 and EVH1 domains, and furthermore, which are not
proline rich!
The enrichment of the non proline (NP) clones, over proline rich variants, during the
screening of the optimized CPLPPXP libraries, tends to indicate that the NP clones showed
higher affinity for the EVH1 domains than other clones present within the library, and
therefore, might explain the apparent failure of the panning selection procedure.
2-4 Vesl cosmix plexing library
Since the Evl, VASP, and to a smaller extent, Mena proteins, show consensus sequences
similar to the one obtained for Vesl (regarding the position of aromatic residue after the
proline core motif), it was decided to screen the cosmix-plexed library optimized for Vesl
EVH1 protein, against Evl, VASP, and Mena.
The use of this library allows the isolation of new clones for Evl, and VASP, some of
which occurred several times. However, curiously, the output and input values did not show
any enrichment. The panning of this Vesl library against Mena was not successful. Most of
the clones were unproductive clones, and the other one did not show any homology among
themselves.
The clones isolated from Vesl cosmix-plexed library against Evl, show interesting
similarities, which lead to the conception of two consensus sequences, as presented in Figure
III-41. The clones identified against Evl, are very different from the trend obtained after
normal panning. They were classified into two groups, according to their sequences.
The first group gathers the clones which exhibit a serine after the proline core motif, at
P10, whereas the second group comprises the variants showing an aspartic acid at P10.
Except the P10 position, the first group shows an aromatic residue at P12, and Cys at P8,
between the prolines. However, both of these positions might be not significant, since, out of
the three clones which form this group, the dominant clone (which occurs 7 times, compared
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to one for both other clones) does not contain any either of these P8 and P12 preferences
shown by the two other clones.
The second group appears to be slightly more defined than the previous one. Except the
Asp at P10, a phenylalanine at P8 is clearly determined, and hydrophobic residues at P3, 4, 11,
and 12, seem to be advantageous.
                         Sequences against Evl EVH1 domain, Frequency
                       panning with Vesl cosmix-plexing library
 P1    P2     P3      P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
First group
Phe Cys Asp Ile Gly Pro   Pro Val Pro Ser Asp Val Pro 7x
Cys Tyr Ser Ile Glu Pro   Pro Cys Pro Ser Ser Tyr Tyr 1x
Arg Ala His Gln Trp Pro   Pro Cys Pro Ser Leu Phe Cys 1x
Consensus sequence
Xxx Xxx Xxx Ile Xxx Pro   Pro Cys Pro Ser Xxx Ψ/ϕ Xxx
Second group
Gly Cys Pro Phe Ser Pro   Pro Phe Pro Asp Val Ala Gly 3x
Leu Val Thr Gly Arg Pro   Pro Phe Pro Asp His Ser Arg 2x
Tyr Gln Ala Ala Ala Pro   Pro Phe Pro Asp Val Ala Gly 1x
Ser His Ile Phe Asp Pro   Pro Phe Pro Tyr Gly Pro Met 1x
  Consensus sequence
Xxx Xxx   Ψ     Ψ Xxx Pro   Pro Phe Pro Asp   Ψ   Ψ Xxx
Figure III-41: Sequences of single clones, after three rounds of panning on Evl EVH1
domain, with the Vesl cosmix-plexed library, and the deduced consensus sequences. The
frequency of the clones are indicated. A residue is considered as representative for the
consensus sequence, when it occurs in 50% or more of the sequences. Underlined amino acids
are fixed residues within the CPLPPXP library. Ψ, and ϕ represent hydrophobic and aromatic
amino acids, respectively. P1 to P13 refer to the amino acid position within the sequence.
The clones isolated from Vesl cosmix-plexed library against VASP are the most
interesting one. Here also, they lead to the conception of two consensus sequences (Figure III-
42), but the tendency observed after the standard panning, is detected here as well, giving
more credibility to the derived consensus. The consensus sequence of VASP after normal
panning, is repeated here, to help the comparison.
Ψ Xxx    Ψ Xxx Ψ/ϕ Pro   Pro Phe Pro Tyr Xxx Y/F Xxx
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From both groups, the P10 position is clearly determined as tryptophan, or tyrosine, as it
was after standard panning. However, the Vesl cosmix-plexed library allows the proposal of
long consensus sequences. In addition, more acidic residues are found all along the sequence.
The two groups were distinguished according to their preferences within the region N
terminal from the proline rich motif.
The first group shows a clear consensus sequence as Asp Arg Leu Tyr Asp/Glu before
the proline motif. It has to be noticed that two acidic residues are necessary within this short
region, probably to stabilize the interaction between the ligands and the VASP domain.
Interestingly, a tyrosine is found at position P4, which might build a link between the phage
display isolated clones, and the natural ligands, which all possess a phenylalanine directly
before the proline motif, but which can be replaced by tryptophan or tyrosine (Niebuhr et al.,
1997).
                         Sequences against VASP EVH1 domain, Frequency
              panning with Vesl cosmix plexing library
P1    P2     P3     P4     P5     P6     P7     P8     P9    P10    P11    P12   P13
First group
Ser Leu Leu Tyr Glu Pro   Pro Pro Pro Trp Asn Ser Pro 1x
Phe Arg Gly Gln Glu Pro   Pro Phe Pro Trp Leu Pro Trp 1x
Asp Arg Leu Tyr Asp Pro   Pro Ala Pro Tyr Arg Ile Cys 1x
Asp Arg Leu Tyr Asp Pro   Pro Phe Pro Tyr Gly Pro Met 1x
Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly * 2x
Consensus sequence
Asp Arg Leu Tyr   α Pro   Pro  F/Ψ Pro W/Y Xxx Xxx   Ψ
Second group
Val Leu His Val Arg Pro   Pro Thr Pro Trp Val Ser Val 3x
Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly * 2x
Leu Ile  Lys Val Arg Pro   Pro Val Pro Trp Leu Phe Cys 1x
Asn Leu Arg Tyr Arg Pro   Pro Ser Pro Asp Arg Tyr Ser 1x
Consensus sequence
Xxx Leu   β  Y/V Arg Pro   Pro Xxx Pro Trp   Ψ Xxx Xxx
Figure III-42: Sequences of single clones, after three rounds of panning on VASP EVH1
domain, with the Vesl cosmix-plexed library, and the deduced consensus sequences. The
frequency of the clones are indicated. A residue is considered as representative for the
consensus sequence, when it occurs in 50% or more of the sequences. Underlined amino acids
are fixed residues within the CPLPPXP library. Ψ, α, and β represent hydrophobic, acidic,
and basic amino acids, respectively. P1 to P13 refer to the amino acid position within the
sequence. The clone marked with a red asterisk, possess a sequence which belong to both
groups.
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The clones of the second group also allow the conception of a clear consensus sequence.
But, whereas in the first group, the proline region N terminal sequence was determined with 2
acidic residues, and one basic (P1 and P5 for the acidic residue, and P2 for the arginine), for
the second group, the basic residues appear to be advantageous, since two positions, P3 and P5
are defined as basic, as observed on the consensus sequence:
  Leu   β Tyr/Val Arg Pro   Pro Xxx Pro Trp  Ψ
In both groups, the importance of tryptophan or tyrosine at P10 is demonstrated, but they
also both show a high tendency of exhibiting tyrosine at P4. Both groups have a common
consensus sequence, resumed with Tyr Xxx Pro Pro Xxx Pro Trp/Tyr. The clone marked
with an asterisk is very interesting. Indeed, its sequence possesses characteristic belonging to
both groups. The Asp1 and Arg2 are characteristics from the first group, while His3 and Arg5
belong to the second group. Tyr4, the proline core motif, and Trp10 were already defined as
advantageous for both set of clones.
Unfortunately, when the clones were tested for relative affinity with Evl, and VASP
EVH1 domains, on phage ELISA, the clones were not reacting. This negative reaction
suggests that the clones enriched during the panning selection are weak binders, since the
phage ELISA is an assay only relevant for high affinity ligands. However, this low affinity
binding remains unclear, since the dominant clones might have been considered as
preferential binding partners for the interaction with the concerned target.
F- Characterization of two non proline clones: NP1 and NP2
Two unexpected clones have been, in several cases, isolated against SH3 and EVH1
domains. The oddness, and particularity of these clones, is that they are not proline rich, as
SH3 and EVH1 domain ligands are assumed to be.
These clones, NP1 and NP2, have been previously reported in this work, since they have
been enriched during CPLPPXP library screening, against Nck1 and Nck2 SH3 domains, but
also Evl, Mena, and VASP EVH1 domains. However, NP1 and NP2 were isolated more
frequently. Panning selections have been performed against other SH3 domains, like Abl,
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p67phox, and ALP. For these proteins, the non proline clones were the only identified
enriched variants.
It has already been shown by phage ELISA, that NP1 and NP2 specifically bind to
Nck1, Nck2, and the various EVH1 domains (Figures III-26, and -40).
Phage ELISA analyses have been extended, in order to further characterize NP1 and
NP2 clones.
1- Phage ELISA
NP1 and NP2 were individually propagated as single phage, and tested on phage ELISA,
against various SH3 and EVH1 domains, to check which proteins are able to interact with
these non proline clones, and to compare their relative affinity (Figure III-43).
Both non proline clones specifically interact with SH3 and EVH1 domains, since the
GST alone is not able to bind with NP1 or NP2. In most of the cases, NP2 shows slightly
better binding capacities than NP1.
The various SH3 and EVH1 domains react differently with the non proline clones. Src
SH3 domain is the protein which shows the strongest interaction with the non proline clones.
In the contrary, Nck2 and Crk SH3 domains, and VASP, but particularly Evl EVH1 domains
react very weakly with the non proline clones.
The phage ELISA analyses, demonstrate that NP1 and NP2 are really able to interact
with SH3 and EVH1 domains. However, this gives no information on their site of interaction.
The following analyses were performed in an attempt to answer this question.
Figure III-43: Relative binding of the non proline clones for SH3 (A), and EVH1 (B)
domains, according to phage ELISA. GST-SH3, -EVH1 proteins were coated in the wells.
An equivalent amount of phage were incubated in every well (1010 phage/well). After several
washes, the remained bound phage were detected with anti-M13 antibody. The absorbance
was detected at 492 nm. A well coated with GST alone was used as a control, to ensure that
the single clones bind to the SH3 or EVH1 domains, and not to the GST. The OD values are
the average of triplicates. (C-) The sequences of both non proline clones, and deduced
consensus sequence, are shown.
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2- Competitive phage ELISA
In this type of phage ELISA, the interaction between a single clone and the protein of
interest is analyzed, in presence of increasing amounts of competitor. The S1 clone, which
was the clone showing the strongest binding capacities for Src SH3 domain, in phage ELISA
test (Figure III-23), as been synthesized as free peptide, and is used as competitor in this test.
The Src SH3 domain has been immobilized on a microtiter plate, and incubated with a
fixed concentration of the phage variants S1, S2, S3, and S4. After washing, the S1 free
peptide was added to the phage particles attached to the Src SH3 domain. Various
concentrations of S1 free peptide were incubated with the phage/protein complex (0 to 1000
µM). The amount of phage which remain bound, was then evaluated, after new washing steps,
by using an anti-M13 antibody.
Figure III-44 shows the evolution of the binding disruption between the Src protein, and
different phage ligands, as a function of the amount of competitor. As the concentration of S1
synthetic peptide increases, the amount of attached phage decreases. 10 µM of free peptide
added to the wells, is enough to compete around 50% of the phage, away from the Src binding
site (Figure III-44/B). This is shown for the four clones (S1 to S4) which were able to
positively react with the Src SH3 domain in phage ELISA, demonstrating that all four clones
bind to the same site of Src, as expected, in view of the very high similarities between their
sequences.
These results also demonstrate that the synthetic S1 peptide exhibits the same binding
properties as the linear peptide displayed on the surface of the phage. This is not always true,
since in some cases, the linear displayed peptide is constrained by its local environment.
The same experiment was repeated, to investigate if the non proline clone attachment to
Src SH3 domain is disrupted by the S1 synthetic peptide. Src was immobilized, and incubated
with both non proline clones, NP1 and NP2. After washing, various concentrations of the
competitor were added, and the amount of bound phage remaining, evaluated. The results of
the analysis are presented in Figure III-45.
Figure III-44: Competitive phage ELISA of Src positive clones, on Src SH3 protein.
GST-Src SH3 domain has been immobilized on a microtiter plate, and incubated with the Src
positive phage particles. An equivalent amount of phage were incubated in every well (1010
phage/well). After washings, S1 synthetic peptide was added to the complex phage/Src SH3
domain, at various concentrations (0 to 1000 µM). The amount of remained bound phage was
then detected, after new washing steps, with anti-M13 antibody. The absorbance was detected
at 492 nm. The OD values are the average of triplicates. (A-) Relative affinity of S1 to S4
clones with Src SH3 domain, according to the concentration of competitor. (B-) Percentage of
remained bound phage (S1 to S4) to Src SH3 domain, according to the concentration of S1
synthetic peptide. (C-) The sequences of clones and synthetic peptide, are given.
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As can be seen in Figure III-45, the synthetic peptide disrupts the interaction between
Src SH3 domain, and its ligands, NP1 and NP2. This clearly demonstrates that the non proline
clones interact with Src domain at the same binding site as the proline rich ligands. However,
even with a very high concentration of competitor (1000 µM), the non proline clones are not
completely competed. Approximately 15 and 30% of the phage remain attached to Src (for
NP2 and NP1 respectively), whereas competition of S1 to S4 clones, with 1000 µM of S1 free
peptide, allows only approximately 3 to 14% of the S1 to S4 phage to remain bound to the Src
SH3 domain. In addition, since the relative binding capacities of NP1 and NP2 for Src are
weaker than that of the S1 clone, a more complete competition was expected.
  Non Proline clone sequences
NP1 Ser Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
    S1 synthetic peptide - Competitor
Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe
Figure III-45: Competitive phage ELISA of non proline clones, on Src SH3 protein.
GST-Src SH3 domain has been immobilized on a microtiter plate, and incubated with the Non
Proline clones. An equivalent amount of phage were incubated in every well (1010
phage/well). After washings, S1 synthetic peptide was added to the complex phage/Src SH3
domain, at various concentrations (0 to 1000 µM). The amount of remained bound phage was
then detected, after new washing steps, with anti-M13 antibody. The absorbance was detected
at 492 nm. The OD values are the average of triplicates. (A-) Percentage of remained bound
phage (NP1 and NP2) to Src SH3 domain, according to the concentration of S1 synthetic
peptide. (B-) The sequences of clones and synthetic peptide, are given.
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However, one can assume that the non proline clones bind each of the SH3 domains
tested, by contacting the binding site known to interact with the proline rich ligands.
Similarly, they might also bind EVH1 domains also at their active binding site, but this was
not tested.
It also has to be emphasized, that the non proline clones bind different SH3 and EVH1
domains with variable relative affinity (Figure III-43). This suggests that even if these clones
bind in general to each of the SH3 and EVH1 domains, they might however interact with
them in a protein specific way, meaning that they might not solely bind to the grooves which
make contact with the proline core motif, but that they involve in the interaction, all or a part
of the specificity pocket (Figure I-10).
G - BIAcore analysis – real time interaction measurements
To evaluate the binding properties of the phage displayed ligands, the relative binding of
phage isolates was measured by BIAcore. As previously shown by Rickles et al. (1994;
1995), SH3 binding can be studied when the ligands are displayed on the surface of the
bacteriophage. The strategy chosen to investigate the SH3/phage-ligand interactions, is
illustrated in Figure III-46. The phage displayed ligands which had been shown to interact
positively to SH3 domains (Src and Nephrocystin SH3 domains), on phage ELISA (though
weakly), were tested on BIAcore. Since Src and nephrocystin are both immobilized on
different channels of the chip, evaluation of the cross reaction is directly feasible. Negative
controls were performed, to ensure that the phage ligands bind the SH3 domains, and not the
GST, or the anti-GST antibody used to trap the GST-SH3 fusion proteins.
The Figure III-47 is a summary of the BIAcore analysis performed with this strategy.
The phage displayed ligands which interact with Src or nephrocystin SH3 domains under the
BIAcore conditions, are presented in this figure, and it is then possible to compare their
relative affinity for their target protein.
It has to be noticed that not all clones which were positive under phage ELISA
conditions, positively react in the BIAcore analysis. Only the strongest ELISA ligands show a
high affinity for the SH3 domains on real time interaction measurements. However, the
classification of the ligands, according to their relative binding on phage ELISA (Figures III-
31, -32), corresponds in general to the BIAcore classification.
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  C1              C2      C3           C4
Figure III-46: Illustration of the strategy used to determine which phage displayed
peptides have a high affinity for Src and nephrocystin SH3 domains, according to
BIAcore measurements. A F1 biosensor chip was coated on its four channels (C1 to C4),
with antibody anti GST. The channels C1 and C4 are reference channels. On C1, one can
ensure that the phage ligands do not bind to the anti-GST antibody, while on C4, a potential
interaction between the phage ligands and the GST is investigated. On C2 and C3, the GST-
Src and -Nephrocystin SH3 proteins are immobilized on the anti-GST antibody. Then, a
determined concentration of a phage ligand is added to the medium which passes through the
four channels of the chip. The potential interactions with the immobilized proteins, are
monitored and evaluated, due to the altered beam angle (plasmon resonance effect). The
phage and proteins are then washed away with a glycine buffer (only the antibodies remain
attached to the chip), and a new cycle is performed: new proteins are immobilized, and
another phage displayed ligand is given.
The S1, S2, S4, N8, and the Non Proline 1 (NP1) phage displayed peptides, interact with
Src SH3 domain, on BIAcore measurements (Figure III-47), the ligands with the higher
relative affinity, being S1, and then S4. This leads to the conception of a very clear consensus
sequence: Arg Pro Leu Pro   Pro  Ψ Pro Xxx Xxx Pro, where Ψ represents the
hydrophobic residues, and the underlined prolines, were fixed with the CPLPPXP library.
Figure III-47: Binding of phage displayed peptides to Src and nephrocystin SH3
domains, measured by BIAcore. Interaction between the immobilized SH3 domain, and the
ligand (phage displayed peptide), is indicated by an increase of the RU value (Resonance
Units). (A-) Relative affinity of positive clones for Src SH3 domain. (B-) Relative affinity of
positive clones for nephrocystin SH3 domain. (C-) Sequences of the positive clones are given.
         Antibody anti GST
          GST-Src                 GST-Nephrocystin                 GST
            Phagemids propagated as single clones
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Several clones interact with the nephrocystin SH3 domain. Every ligand which was able
to bind to Src under BIAcore conditions (except NP1), was able to interact with nephrocystin.
The N5 phage interacts with nephrocystin. It is the only clone tested which did not show
cross-reaction between Src and nephrocystin SH3 domains. It is assumed that the reason why
N5 is unable to react on BIAcore to Src SH3 domain, is that the absence of Pro between the
Arg, and the Leu, just before the proline rich core motif, disrupts a high affinity interaction,
and therefore, the binding appears to be too weak to be detected on BIAcore measurements.
The two strongest ligands for nephrocystin, are S4 and N8, leading to a consensus
sequence highly homologous to that of Src: Arg Pro Leu Pro Pro Xxx Pro Xxx Xxx Pro.
Interestingly, the S1 ligand reacts differently to the other clones. The association
between nephrocystin and S1 is very fast, compared to the other clones, and a complete
saturation of the immobilized nephrocystin seems to be reached. In addition, the dissociation
rate is also faster than for the other ligands.
This initial BIAcore analysis allows the distinction of the phage displayed peptides
which interact strongly with the Src or the nephrocystin SH3 domains. However, this
investigation cannot be used to evaluate the affinity constants of the different clones for their
targets. In theory, a monovalent expression of the peptide, on the surface of the bacteriophage
is reached, during the particle assembly. However, it cannot be excluded that some particles
display no peptide, and others, two or even more of them. In this latter case, an avidity
phenomenon might amplify the observed signal, and a false interpretation of the affinity
constants might result. To avoid this problem, a second BIAcore strategy has been developed,
which takes advantage of the first selected ligands (Figure III-48). In this technique, to ensure
an interaction between a single peptide, and the target SH3 domain, synthetic peptides are
prepared, corresponding to sequences of the positive selected clones.
In BIAcore measurements, the interaction between the partners, is detected by an
alteration of the laser beam when adsorption of biomolecules on the sensor chip takes place.
Such changes are directly proportional to the amount and molecular weight of the
macromolecules bound at any time. For this reason, it has been chosen to immobilize the
peptides, and to add the SH3 target proteins in the constant flow medium, since the larger size
of the GST fusion proteins will give a stronger signal, and help the determination of the
affinity constants. A very small amount of peptide was immobilized (around 20 RU), in order
to easily reach an association saturation between both partners, since this phase is necessary
to calculate the constants. To facilitate the coating, the peptides were biotinylated, and
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immobilized on a streptavidin sensor chip.
A- Preparation of synthetic peptides, from the phage displayed peptides
   peptide synthesis                             biotinylation
B- Immobilization of the biotinylated peptides, on streptavidin chip
       C1                           C2   C3        C4
C- Affinity test with the proteins: GST-Src, GST-Nephrocystin, GST
       C1                          C2  C3       C4
Figure III-48: Illustration of the strategy used to determine the affinity constants of Src
and nephrocystin peptides, according to BIAcore measurements. (A-) Previously selected
phage displayed peptides are synthesized as free peptide, and conjugated to biotin. (B-) The
biotinylated peptides are immobilized on a streptavidin biosensor chip. The first channel (C1)
is kept without peptide, as reference. Different biotinylated peptides are immobilized on C2 to
C4. (C-) A determined concentration of GST-Src, GST-Nephrocystin, or GST alone (as
negative control) is added to the medium which go through the four channels of the chip. The
potential interactions with the immobilized proteins, are monitored and evaluated, due to the
altered beam angle. The phage and proteins are then washed away with a HCl buffer.
Then, a panel of different concentrations of SH3 target proteins are distributed within the
medium which goes through the four channels of the streptavidin sensor chip, and the
resulting relative binding is compared, in order to determine the affinity constants. The Figure
III-49 illustrates the binding of Src SH3 domain to the synthetic biotinylated peptide S1,
according to its concentration.
On each of the curve of the sensorgram showed in Figure III-49, the saturation response
values (Req) are obtained, from report points in the steady state region (when the association
equilibrium has been reached), for each of the Src concentration tested. A plot of Req versus
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the concentration of the injected proteins (Src or nephrocystin) is created, and used to
estimate the KD of the complex. The Rmax, which is the maximum response expected when
all ligands on the surface are retaining an injected ligand molecule, can be deduced from the
equilibrium phase of the steady state affinity data curve. When the Rmax data, divided by 2,
is reported on Req axis of the diagram, it cuts the curve on a particular point, from which the
coordinate on the concentration axis, give a direct, and very precise evaluation of the KD
value (as shown in Figure III-50/B).
Figure III-49: Binding of Src SH3 domain, to immobilized synthetic peptide S1,
measured by BIAcore. Interaction between the immobilized S1 peptide, and the Src SH3
domain, is indicated by an increase of the RU value (Resonance Units). Concentrations of Src
SH3 domain, varying from 0,3 to 10 nM, were injected to the coated S1 peptide. The response
at equilibrium (Req) is estimated, for each of the Src concentration, and will be used for a
steady state affinity data evaluation.
As shown in Figure III-50/A, the curve resulting from the Req values determined in
Figure III-49, is not satisfying, since the Src concentrations used, were too weak to reach the
equilibrium phase. The experiment was repeated with Src concentrations reaching 100 nM.
However, this was possible only once, since our Src stock was not large enough. It was then
chosen to analyze the interaction between the S1 peptide, and the Src SH3 domain, since S1
appears to be the best interacting ligand that we isolated against Src. The deduced Req versus
Src concentration curve is presented in Figure III-50/B.
Time (sec)
RU
Immobilized biotinylated S1 peptide – relative affinity of Src SH3 domain
Req
10 nM
5 nM
2,5 nM
1,25 nM
0,6 nM
0,3 nM
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 Figure III-50: Steady state affinity data evaluation of S1 clone. Plots of Req against Src
concentrations, used to evaluate the KD value of the S1 peptide/Src SH3 domains complex.
(A-) Plot realized from the Req values obtained from Figure III-49, with Src concentrations
from 0,3 to 10 nM. The equilibrium phase cannot be reached. (B-) Plot realized from another
experiment, with Src concentrations from 1,5 to 100 nM. The Rmax value is deduced from
the equilibrium phase. When Rmax/2 is reported on the curve, the KD is directly readable, on
the concentration axis.
As proved by our analyses, the S1 peptide binds to Src SH3 domain with a KD of 7,3
nM. This is an exceptionally high KD, concerning molecules involved in signal transduction.
Indeed, SH3 modules must recognize ligands with high enough selectivity to maintain proper
information flow, but low enough affinity, to allow for sensitive and dynamic modulation in
response to changing signals. Typically, SH3 domains bind their targets with low affinities, as
demonstrated by their usual KD of 0,2 to 200 µM (Viguera et al., 1994; Cheadle et al., 1994;
Rickles et al., 1994; Alexandropoulos et al., 1995). The recognition strategy of SH3 domains
allows for high specificity binding, mainly through the prolines contained within the SH3
ligands, because there are no other natural sequences that can satisfy the minimal ligand
backbone requirements (Nguyen et al., 1998).
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The same procedure was applied to the other SH3/ligand interactions. For each
immobilized peptide, in contact with defined concentrations of Src or nephrocystin SH3
domains, the Req saturation responses were determined from the sensorgrams, and the plots
Req versus SH3 concentrations were created. They are presented in Figure III-51/A and -
51/B. The KD were determined from these plots, as described above, and their values are
shown in Figure III-51/C.
As previously explained, the KD values for Src SH3 domain with S2, S4 and N8 cannot
be determined from this experiment, since the Src concentrations used were not large enough
to allow the obtention of an equilibrium state. However, the KD between nephrocystin SH3
domain, and S1, S2, S4 and N8 have been precisely determined, and stand between 1,05 and
0,42 nM (Figure III-51/C), which is even more spectacular than the KD of 7,36 nM
determined between Src and the S1 peptide.
The KD between nephrocystin and N5 peptide, cannot be determined from this
experiment, the chosen concentrations did not allow the obtention of the equilibrium state.
H – Testing the functionality of the selected peptides, in vivo
We have characterized ligands against Src and Nephrocystin SH3 domains, using a new
development of phage display techniques, the cosmix-plexing technology. The isolated
ligands interact in vitro with their target, with a very high affinity, as demonstrated by the
phage ELISA, and the BIAcore real time interaction measurement analyses. The KD of the
various complexes, between Src or nephrocystin, and their peptides, are ranged from 7,3 to
0,4 nM, and are therefore, to our knowledge, the highest affinity ligands ever characterized
for SH3 domains.
In order to have a better understanding of the signal transduction pathway in general,
and of the functions of the SH3 domains in particularly, it is now crucial to evaluate whether
these peptides are able to compete SH3 domain natural ligands, in vivo, and then, to study
their influence on the action of SH3 domain containing proteins. The strategy chosen to
deliver the functional peptides into the cells takes advantage of the HIV-1 Tat protein, which
possesses the characteristic to cross cell membranes.
Src has essential functions in regulating cell growth and differentiation. However, little
is known about Src role in signal transduction pathways and its downstream targets. Several
knockout mice have been made to learn more about it. Src-knockouts in osteoclasts leads to
Results
203
osteopetrosis. However, the absence of Src does not seem to disrupt any other cell activity.
The subtlety of phenotype could in principle mean that Src family kinases play no important
roles in the life of most cells in the body, but more likely, is due to redundancy, and
compensation of function by other members of the Src family.
The most noticeable defect in Src- mice is osteopetrosis (Soriano et al., 1991). Src is
required for the normal differentiation and response of osteoclasts, a type of myeloid cell that
absorbs bone. The Src- osteoclasts have an autonomous defect and fail to form a “ruffling
border” and resorb bone. The net result is a decreased absorption of bone, resulting in
thickened bone, decreased marrow space, and also, in failure in tooth eruption. Osteopetrosis
greatly increases mortality. Schwartzberg and coworkers (1997) developed a genetic system
for studying Src function in the osteoclasts of transgenic mice by driving expression of wild-
type and mutant versions of Src with the promoter of tartrate resistant acid phosphatase
(TRAP), a gene expressed highly in osteoclasts. They demonstrate that Src kinase activity is
not essential for rescue of the src-/- phenotype. These results suggest that there are essential
kinase-independent functions for Src in vivo, likely supervised by SH3 and/or SH2 domains.
In addition, Kaplan et al. (1995) studied the adhesion of Src- fibroblasts to fibronectin.
Src- fibroblasts adhere and spread more slowly than control fibroblasts on a fibronectin
surface, but adhere and spread normally on collagen. The adhesion and spreading defects
were corrected by over-expression of either wild-type or kinase-defective Src. A kinase
domain deletion of Src also promoted spreading, and required both SH2 and SH3 domains to
do so. Requirement for SH3 domain may reflect the need for the molecule to localize to focal
adhesions, but the requirement for the SH2 suggests an interaction with a phosphotyrosil
protein.
In both osteoclasts and fibroblasts, Src appears to have a function which cannot be
compensated by another SH3 domain, in the absence of Src (even if the fibroblasts defect, in
the absence of Src does not seem to be dramatic). For both type of cells, it has been shown
that the kinase domain of Src is not responsible of the defect. For the fibroblasts, it has been
shown that both SH2 and SH3 domains of Src are required for normal adhesion and spreading
of the cells.
Therefore, the creation of a cell model where Src SH3 domain natural ligands might be
competed in vivo, by our isolated high affinity peptides, might be of great advantage to
understand the particular role(s) of Src SH3 domain, in both osteoclasts, and fibroblasts. The
Tat system appeared to be the best alternative to further investigate the function of Src in vivo.
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It was decided to prepare Tat fusion proteins with each of the five clones which showed
a high affinity to Src and/or nephrocystin SH3 domain on BIAcore measurements (S1, S2, S4,
N5 and N8).
Dowdy developed an expression vector, to facilitate the cloning and purification of Tat
fusion peptides (Nagahara et al., 1998). This pTAT-HA vector produces genetic in-frame
TAT fusion proteins (Figure III-52). The vector pTAT-HA has an N-terminal 6 histidine
leader, followed by the 11 amino acid Tat protein transduction domain, a hemaglutinin (HA)
tag, and a polylinker. Steven F. Dowdy (University of Washington, Saint Louis, Missouri,
USA) kindly provided us with his pTAT-HA vector, that we used for the cloning of our
peptides.
              XhoI-----------Src/Nephrocystin isolated peptide DNA----------EcoRI
       XhoI   EcoRI
     Hemaglutinin tag     stop codons
      Tat
 His6
T7
        pTAT-HA
   (3 kb)
      bla
Figure III-52: Schematic map of the expression vector pTAT-HA. The 11 amino acid Tat
protein transduction domain, is flanked N terminal by 6 histidines and C terminal, by the
hemaglutinin tag, followed by the multiple cloning site. At the end of the cloning site, stop
codons in all three reading frame are found. XhoI and EcoRI restriction sites were used to
insert the Src and nephrocystin SH3 domain isolated peptide DNA. The Tat-fusion gene is
under the control of the T7 promoter. bla stands for β-lactamase gene (ampicillin resistance).
The five peptides to be fused to the Tat proteins, have been directly amplified from
pROCOS4/7, the plasmid vector which was used for the preparation of the CPLPPXP library.
The primers used to this purpose were designed to introduce the XhoI and EcoRI restriction
sites on both extremities of the peptides, to allow their insertion within the polylinker site of
the pTAT-HA vector.
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After the introduction of the oligonucleotides into the cloning site of the pTAT-HA, the
vectors were transformed into BL21(DE3)LysS (Novagen), for the protein expression.
Because of reduced structural constraints, high energetic, denatured proteins  transduce more
efficiently into cells than low energetic, correctly folded proteins. Once inside the cell,
transduced denatured proteins are correctly refolded in vivo by host chaperones, like HSP90.
Therefore, the proteins are expressed and purified in an urea-denaturing protein purification
protocol (Nagahara et al., 1998).
500 ml culture of the BL21 cells containing the pTAT-peptides/cDNA is inoculated and
incubated 4 hours at 37°C, pelleted, washed in PBS, and finally resuspended in a 8M urea
buffer. After sonication, the expressed Tat fusion proteins are purified in Ni-NTA column
(Qiagen), and eluted with 500 mM imidazole. Elution fractions of the purified pTAT-peptides
are investigated on two SDS-PAGE (Figure III-53), one followed by staining with Coomassie
blue, and the second analyzed in Western blot, to ensure that the observed bands correspond
to the Tat fusion proteins (detection due to antibody anti-hemaglutinin).
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The western blot analysis shows that only a part of the Tat-fusion protein is retained by
the Ni-NTA column, since a small amount of Tat-S1 is detected in the flow through. The
loading cell extract contained a too high concentration of Tat-S1.
After purification, the urea of the buffer where the Tat fusion proteins were resuspended,
had to be eliminated. One possibility to achieve this, is to dialyze the solution. However, this
method leads to very poor yields. A good alternative, is an ionic exchange chromatography.
After loading the sample and washing the SP column (Pharmacia), the Tat fusion protein was
eluted with 1M NaCl, and finally desalted on a PD-10 disposable G-25 sephadex gravity
column (Pharmacia) in PBS (Figure III-54). After the Ni-NTA column, the recovered Tat
fusion proteins were not completely purified. However, the contaminants were not rescued by
the SP column, and therefore, the final Tat fusion protein is a highly purified product.
To facilitate the detection of the Tat fusion proteins within the cells, the peptides were
conjugated to the fluorochrom FITC. After determination of their concentration, with the
Bradford technique, the proteins were ready to be transduced into cells. Unfortunately, time
did not allow for analysis of the effect of these fusion peptides on Src, nephrocystin, or other
potential cross reacting SH3 domains. However, an initial study of the capacity of our Tat-
fusion peptides to reach the cytoplasm of the transfected cells was carried out.
A
B
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Prior to further analyses, the ability of the Tat fusion peptides to interact in vitro with the
Src and nephrocystin SH3 domains was tested. Therefore, ELISA assays were performed to
determine whether the FITC-conjugated-peptides were still able to bind to SH3 domains.
Various concentrations of Tat fusion peptides were incubated with immobilized Src and
nephrocystin SH3 domains, after blocking of the microtiter wells. The amount of bound
FITC-Tat peptides was evaluated by estimation of the fluorescence detected in the wells after
intensive washing steps, on ELISA reader, sensitive to fluorochroms. This demonstrated the
ability of the Tat fusion peptides to bind specifically to the Src and nephrocystin SH3
domains.
NIH-3T3 cells were chosen for the in vivo study of Tat fusion peptide delivery, due to
the fact that Src plays an important role in fibroblasts, and to their ease of manipulation. To
analyze the ability of Tat fusion proteins to transduce into cells, purified Tat-S4 fusion
peptide was conjugated to fluorescein (FITC), and added to the culture media of NIH-3T3
fibroblasts (160 nM of Tat-S4 directly added to 106 NIH-3T3 cells). After one hour
incubation, the cells were trypsinized, collected, resuspended in fresh media/FCS (to reduce
the background), and analyzed by fluorescence activated cell sorting (FACS). However, no
fluorescence was detected.
Currently, the most likely hypothesis for the Tat translocation mechanism, involves a
tight ionic interaction between the basic groups of the Tat side chain, and the negative charges
of the phospholipid heads, which would induce a local invagination of the plasma membrane.
The local reorganization of the phospholipid bilayer would then lead to the formation of
inverted micelles with the peptide enclosed in the hydrophilic cavity and ultimately to the
cytoplasmic release of the peptide. This might mean that flexibility of the cell membrane is
required. In addition, Dowdy warned us that nonadherent cells are best experimentally.
Therefore, a hypothesis was conceived, that NIH-3T3 adherent cells were not
appropriate to a Tat-fusion peptide transduction test, because the adhesion of the cells to the
plastic material might stretched the membrane to such an extent, that the plasma membrane
might not be able any longer to form a local invagination, and therefore, to trap the Tat-fusion
peptide.
Thus, another method was developed to deliver the Tat-fusion peptide within the NIH-
3T3 cells. NIH-3T3 cells were trypsinized, and laid on an untreated plastic material, where
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they have no possibility to adhere. The FITC-Tat fusion peptides were added to this
suspension of NIH-3T3 cells. At various incubation times, some cells were resuspended in
fresh medium, and analyzed by FACS. By using this strategy, the transfection of Tat-fusion
peptides into the cells was successful.
After one hour of incubation between the cells and the Tat fusion peptide, cell aliquots
were transferred into fresh culture flasks, where the cells were finally allowed to adhere to the
surface. These flasks were assigned for confocal microscopy analysis.
It is crucial to let the cells adhere, after a short incubation time with the Tat-peptides
where adhesion is prevented, otherwise, they aggregate, and die. However, no alteration of the
cell morphology, or growing characteristic has been observed when the cells were prevented
to adhere for a short time.
The results of the FACS analysis are presented in Figure III-55. The kinetic analysis of
FITC labeled Tat-S4 peptide (160 nM) directly added to NIH-3T3 cells was performed at 0,
15, 30, 45 and 60 min. As shown in Figure III-55/A and -55/B, after one hour, nearly 80% of
the cells are efficiently transduced with the Tat fusion peptide.
A dose dependent assay of cells treated for one hour with 20, 40, 80 and 160 nM of
Tat-S4 fusion peptide (Figure III-55/C) did not allow the demonstration of a concentration
dependency for protein transduction, in disagreement with Dowdy observations (Nagahara et
al., 1998). It might have been interesting to repeat the FACS analysis with a longer incubation
time (2 hours), and higher concentrations of Tat fusion peptide. The results are showing that it
is possible to efficiently transduce a very high proportion of the NIH-3T3 cells with Tat-
fusion peptides.
Figure III-55: Analysis of transduced proteins. 106 NIH-3T3 cells were used for the
transfection. They were placed on an untreated plastic material, where they have no
possibility to adhere. Before FACS analysis, the aliquot of cells to be analyzed, was pelleted
and resuspended in fresh medium to eliminate the background. (A and B-) FACS kinetic
analysis of 160 nM FITC labeled Tat-S4 fusion peptide added to NIH-3T3 cells, at 0, 15, 30,
45 and 60 min. (A-) FACS profile of the cells were FITC was detected. (B-) Percentage of
cells containing FITC labeled Tat-S4 fusion peptide after 0, 15, 30, 45 and 60 min. (C-) FACS
dose analysis. Percentage of cells containing FITC labeled Tat-S4 fusion peptide after one
hour incubation, when 0, 20, 40, 80 and 160 nM of Tat fusion protein are added to the
medium of NIH-3T3 cells.
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Confocal microscopic analysis showed the presence of Tat-fusion peptides within the
cytoplasm, but not in the nucleus (Figure III-56/A). However, in the work performed by
Dowdy and coworkers (Nagahara et al., 1998; Vocero-Akbani et al., 1999), the Tat-fusion
proteins were found in both cytoplasmic and nuclear localization. It has been shown that the
11 amino acid Tat translocation domain used for the protein fusion, contains a nuclear
localization signal sequence. The absence of Tat-S4 within the nucleus means that it is
retained in the cytoplasm, and a hypothesis would be that Tat-fusion peptides are maintained
within the cytoplasm through their interactions with SH3 domains.
Tat-fusion peptides transduced both healthy and dead cells, as seen in Figure III-56. But
curiously, the incorporation profiles look very different. In healthy cells, the Tat-S4 fusion
protein is found ubiquitously in the cytoplasm (Figure III-56/A). However, in dead cells, it
remains attached on the border of the cell, close to the cell membrane (Figure III-56/B).
Src family kinases are found associated with cell membranes, both the plasma
membrane and intracellular membranes, such as the endoplasmic reticulum and endosomes.
The Src N-terminal 7 residues are necessary and sufficient to program Src for myristoylation,
which is necessary for the membrane localization. In addition to the myristoylation signal, Src
has basic residues in its membrane localization region (SH4), which contribute to membrane
association, most likely by interaction with the acidic headgroups of membrane
phospholipids.
It seems that in dead cells, the Src are directed to the cell membrane. Does it reflect an
absence of activity of the cell, i.e. Src is not necessary anymore at the endoplasmic reticulum
or other intracellular membranes? Or does the cell send a signal to the Src protein (and related
proteins) to localized at the cell membrane?
The NIH-3T3 cells observed on confocal microscopy were kept, and checked once
more every day, to evaluate how long it was possible to detect the FITC-Tat fusion protein
within the cells. It has to be emphasized that the transfection is not permanent, the Tat-
peptides are able to go in and out the cell, through the membrane. Therefore, the observation
that after several days, and regular changes of medium/FCS, FITC labeled Tat-peptides were
still detected within the NIH-3T3 cells, reinforces the previous hypothesis that Tat-fusion
peptides are maintained in the cell cytoplasm, likely through their interactions with SH3
domains. This hypothesis is further supported by the observation that it was impossible to
detect any trace of FIT-Tat-peptide within the nucleus of transfected cells.
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Figure III-56: Fluorescence confocal microscopy sections of NIH-3T3 treated with 160
nM of FITC labeled Tat-S4 for one hour. Before the observation under confocal
microscope, the cells were washed with fresh medium/FCS, to remove the background.
Propidium iodide has been added to the medium, to check for cells mortality, since dead cells
incorporate propidium iodide in their nucleus. Fluo spheres (0,04 µm) provided by K. Dittmar
were used as positive control, since they are able to transfect cells. Both propidium iodide and
fluo sphere emits fluorescence in the red light. (A-) Healthy NIH-3T3 cells which
incorporated both FITC-Tat-S4 (green) and fluo sphere (red) in their cytoplasm. (B-) Dead
NIH-3T3 cell. Propidium iodide is incorporated in the nucleus, and FITC-Tat-S4 fusion
peptide is maintained at the membrane level of the cell.
In summary, we succeeded in isolating and characterizing very high affinity ligands for
Src and Nephrocystin SH3 domains. When fused to the 11 amino acid Tat transduction
domain, the peptides are able to transfect the cells, even when FITC labeled, and seem to be
able to interact in vivo with local SH3 domains. Collaborating laboratories might carry on the
work with these Tat-fusion peptides, to investigate their role(s) in vivo, on SH3 domain
containing proteins. It might be possible to elaborate cellular model where signal transduction
pathways could be tightly controlled and regulated. These models would find numerous
applications in medical and pharmaceutical domains.
A
B
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IV - DISCUSSION
This thesis aimed at establishing a method leading to the isolation and characterization
of very high affinity ligands for SH3 and EVH1 domains. Two strategies based on biased
phage libraries were experimented to reach this aim: the use of constrained peptide libraries,
and of cosmix-plexing® peptide libraries. The first did not allow identification of any SH3
ligands. However, the cosmix-plexing® library permitted the isolation of SH3 domain ligands
presenting a KD approximately 100 to 1000 fold lower than previously characterized SH3
ligands.
A- Constrained libraries
Four biased constrained libraries were prepared in the phagemid vector pSKAN8, where
the hypervariable domains replaced a 7 amino acid loop (residues 17 to 23) of PSTI
(Pancreatic Secretory Trypsin Inhibitor). The constrained peptides were essentially
monovalently displayed on the surface of the phage particles, as a pIII-fusion protein.
Chen et al. (1993) first reported the use of a biased library which contained three fixed
prolines and was conceived to select ligands for the PI3K SH3 domain. This study
demonstrated that biased libraries yield peptides with affinities that were among the highest
reported for SH3 ligands (KD of 7 to 30 µM), and comparable to those of peptides derived
from natural ligands.
The four constrained banks pSKAN8-HypD, -HypE, -HypF and -HypG displayed
peptides bracketed by two cysteines, and therefore, presented as a loop on phage surface. The
periplasm of E.coli, where the phage particles are assembled, is an oxidizing environment and
favors the formation of disulfide-bridged cysteines. The presence of disulfide-mediated
peptide loops on phage has been demonstrated experimentally (Hart et al., 1999). The
displayed peptides were as followed:
HypD Cys (Xxx)4     Pro Xxx   Arg   Cys
HydE Cys   Arg    (Xxx)3   Pro  (Xxx)2 Cys
HypF Cys (Xxx)2    Pro Xxx   Xxx   Pro  (Xxx)2   Cys
HypG Cys (Xxx)3     Pro  Pro   Xxx   Pro  (Xxx)2  Cys
The fixed prolines or arginines gave a selection advantage for SH3 domains which show
preferences for proline rich ligands, containing an arginine before, or after the proline core
motif.
The diversities obtained for the libraries, range between 1,8x108 and 9x109 transformants
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(Table III-2), sizes which are sufficient to represent most of possible random peptide
combinations.
Most small peptides that bind specifically to target proteins in vivo are constrained,
commonly by disulfide bridging. Phage displayed libraries have been used to isolate high
affinity cyclic ligands for several proteins, including integrins (Pasqualini et al., 1995), the
erythropoietin receptor (Wrighton et al., 1996), the Grb2 SH2 domain (Oligino et al. 1997),
calmodulin (Pierce et al., 1996), and syntrophin PDZ domains (Gee et al., 1998). In most
cases, these peptide ligands do not resemble the primary sequence of the natural interacting
proteins. Instead, they act as structural mimics (Gee et al., 1998).
The use of libraries of constrained peptides have both advantages and disadvantages.
Constraining peptides might increase their affinity, and perhaps specificity, but constraining
peptides into an incorrect conformation would probably prevent binding (Clakson and Wells,
1994). Imposing constraints on the displayed peptides can confer a number of important
advantages, a few of them are described here.
A constrained peptide can show higher affinity for a target than an unconstrained peptide
(Ladner, 1995). A ligand that has the shape to complement a binding site should have higher
affinity than a similar ligand that has high entropy when it is separated from the target. The
more tightly a peptide segment is constrained (for some small stable constrained peptides, the
structure may be so rigid that only side groups have significant freedom; Cunningham et al.,
1994) , the less likely it is to bind to any particular target. However, if it does bind, binding is
likely to be tighter and more specific.
In addition, a constrained peptide can present exposed residues that may be in an
unfavorable conformation within a linear peptide. For example, hydrophobic parts of side
groups tend to become buried unless they are constrained to remain on the surface.
An important feature of constrained peptides, is that their binding properties are
transferable between phage-bound protein and phage-free protein to a much greater extent
than those of linear peptides (Dennis and Lazarus, 1994; Roberts et al., 1992). Therefore,
further work with synthetic peptides might be more successful, since more faithful, in the case
of constrained peptides.
Constrained peptides are more stable than linear ones, under many chemical and
biological conditions.
Peptides containing disulfide-closed loop, selected for binding to sera of patients
(Folgori et al., 1994) or to monoclonal antibodies (Meola et al., 1995) have been found to be
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better immunogens than are linear peptides.
Taken together, these data show that isolating ligands from constrained libraries
provides good chances to identify high affinity and specificity ligands, if the constraints
imposed on the displayed peptides, are advantageous for the interaction with the target.
However, using constrained library to isolate ligands against SH3 domains was not a project
without risks, since at the beginning of this work, it was acquired that SH3 ligands prefer or
require a polyproline type II helix, to be able to interact with the SH3 domains.
In the light on these data, the unsuccessful panning selections on SH3 domains were not
entirely surprising.
It has to be emphasized that other groups have reported difficulties in screening for SH3
binding molecules, using constrained libraries, however, not biased (Chen et al., 1993;
Cheadle et al., 1994; Yu et al., 1994; Kay and Quilliams, personal communication). To our
knowledge, only one group succeeded to isolate a cyclic Src SH3 ligand, by using a “mirror
image phage display” technology which allows characterization of D-peptide ligands
(Schumacher et al., 1996).
By using this “mirror image” phage display method, Schumacher et al. (1996) succeeded
to isolate non proline rich ligands against Src SH3 domain. In this technique, a D-enantiomer
of the Src SH3 domain was synthesized, and used to isolate L-ligands, from a biased phage
library (S/CX10S/C). The synthesized D-enantiomeric forms of the L-peptide ligands were
expected to interact with the natural L-Src SH3 domain (Figure IV-1). This method was
developed to overcome problems linked with naturally occurring L-peptides within cells: D-
peptides provide useful starting points for the design or selection of novel drugs, since
opposite to the L-peptides, they are not subject to degradation by naturally occurring
enzymes. Due to their sensitivity to cellular proteases, peptides composed of L-amino acids
can be efficiently digested by antigen presenting cells, and exposed on their surface, with the
major histocompatibility complex class II. As a result, they are presented to the T helper cells
which induce an immune response that impairs the activity of L-peptide drugs.
The two L-ligands isolated with this technique against the D-SH3 domain do not
resemble the usual SH3 ligands, and are bracketed by cysteines. But since it is a D-
enantiomer, the sequences are not comparable. An unique cyclic D-enantiomer peptide
(CLSGLRLGLVPC) was shown to bind in vitro to the L-Src SH3 domain with a weak
dissociation constant of 63 µM, however, only when the disulfide bridge was maintained.
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Since the disulfide bridge imposes constraints on the peptide, its structure is not comparable
with usual SH3 ligands.
       1
    L-Src SH3   Hypothetical D-Src SH3 domain
      domain
       3    2
        Hypothetical
          D-peptide
L-phage library
Figure IV-1: Illustration of the mirror image phage display technique, according to
Schumacher et al. (1996). A D-enantiomer of the Src SH3 domain is synthesized (1), and
used as target for screening with a phage library (2). A D-enantiomer of the isolated peptide
interacting with D-Src SH3 is synthesized (3), and interaction with the L-Src SH3 domain is
tested.
Greater success was expected with the constrained pSKAN8 libraries, since they were
biased, and that the introduction of fixed proline(s), or structural motifs within the sequence,
should have increased the average affinity of the ligands for the SH3 domains. In addition,
our libraries displayed longer peptides on the surface of the phage (7 to 9 amino acids,
between the two cysteines, whereas Chen et al. (1993) used a 5 amino acid long peptide
library, and Cheadle et al. (1994), 6). This should have increased our chances of more
completely covering the SH3 binding site, and in addition, to give a larger freedom to the
displayed peptides, since the larger the loop, the less the constraints.
Another reason for pessimism with this approach, was the risk that the constraint
imposed on the peptides due to the disulfide bridge which takes place between the two
cysteines (on both extremities of the hypervariable domain), prevented the formation of the
polyproline type II (PPII) helix, essential for ligand binding to SH3 domains. The residues of
a disulfide-closed loop are only partially constrained by the disulfide bridge, and the amino
acid sequence within the loop can impose additional constraints (Cunningham et al., 1994).
However, it is not known whether these additional constraints can be as complex as a helix
and, in our case, as a PPII helix.
Furthermore, it is admitted that disulfide-closed loop sequences that are rich in prolines,
valines, or isoleucines are more constrained than others (SH3 ligands are prolines rich, but
also commonly possess Ile between its prolines), further reducing the chances for our
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displayed peptides, to form a PPII helix (Ladner, 1995).
The experiments with SH3 ligands bracketed by cysteines, and expressed on the surface
of the phage particles, at sites where the hypervariable domains were located, and the four
constrained libraries generated, tend to demonstrate the impossibility for peptides constrained
by disulfide bridges, to adopt a PPII helix conformation (section III-B-4).
The SH3 ligand used for this experiment was chosen on the basis of work carried out by
other groups. Brian Kay’s group isolates ligands for various SH3 domains, and investigates
them for cross-reaction (Sparks et al., 1996). The selected SH3 ligand was originally
identified against the N terminal SH3 domain of Grb2 (Grb2N), but showed strong cross-
reaction on phage ELISA, with other SH3 domains, including Src, Yes, and the N terminal
SH3 domain of Nck (NckN).
Two forms of this SH3 ligand were prepared, which only varied by the size of the
displayed peptides (9 and 18 amino acids between the cysteines, respectively). Both forms
were used to check if the number of residues between both cysteines, influences or not, the
formation of the polyproline type II helix, since it is known that a longer constrained peptide
has more opportunities to form additional constraint. The sequences of the short and long SH3
ligands used in the test, were as followed:
   Cys Pro Tyr Tyr Gln Arg Pro Leu Pro Pro Leu Pro Leu Ser His Phe Glu Ser Val Cys
  Short SH3 ligand (bracketed by cysteines)
            Long SH3 ligand
On phage ELISA, neither the short nor the long SH3 ligands were able to interact with
any of the various tested SH3 domains (Src, Grb2, Grb2N and NckN). This suggests that the
presence of both cysteines, and the resulting disulfide bridge (E.coli periplasm, where the
phage particles are assembled, is an oxidizing environment), obstructs the interaction between
the SH3 domains and the tested SH3 ligands, likely by preventing the formation of the
required PPII helix.
However, a positive control is missing to clearly demonstrate the hypothesis that
disulfide bridges within short peptides, obstruct the formation of polyproline type II helices. It
would have been necessary to check if the original SH3 ligand, that was tested in this
experiment, was also able to bind, in our hands, to the Src, Grb2N and NckN SH3 domains, in
the absence of cysteines. Another positive control could have been to test if the presence of
the reducing agent DTT allows interaction between short or long SH3 ligands and SH3
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domains (Gee et al., 1998).
 One could think that another cause of disturbance of the formation of the PPII helix,
would be if the immediate environment on the surface of the PSTI, interferes with the
hypervariable domain. However, this should not be the case. The hypervariable region
replaced a 7 amino acid loop within the PSTI. In the natural PSTI, two cysteines bracketed
this 7 amino acid fragment and impose a constraint on this region, resulting in a loop. PSTI is
56 amino acid long, of which 6 amino acids are cysteines. Except for the random peptides
which would contain an extra cysteine, the equilibrium of the protein is conserved, and the
cysteines flanking the variable domain are unlikely to form disulfide bridges with one of the
four other cysteines present in PSTI. Furthermore, PSTI also does not interact with the pIII
phage protein to which it is fused, as shown by Röttgen and Collins (1995). In their work, the
pSKAN8 vector was successfully used to display a 7-8 residue peptide within the PSTI loop,
on the surface of a phage. The resulting library permitted the isolation of ligands for
chymotrypsin and elastase.
B- Cosmix-plexing® library: CPLPPXP
The second approach, based on developing a cosmix-plexing® library, allowed the
identification of ligands for Src and nephrocystin SH3 domains, but also for EVH1 domains.
The Src and nephrocystin SH3 ligands show excellent KD value 100 to 1000 fold lower than
previously reported SH3 ligands (in the range of nM, instead of µM). The advantage of
cosmix-plexing® libraries, is that recombination between left and right parts of the
hypervariable domain is induced by simple digestion with type IIs restriction enzyme, which
recognizes a defined DNA sequence, in the constant region flanking the hypervariable
domain, but cuts a fixed distance away from the binding site, within the hypervariable region.
Religation of both parts of the variable domain, leads to the creation of new clones, allowing
dramatic increase of the library diversity, and optimization of the whole region.
The cosmix-plexing® library generated for the screening on SH3 and EVH1 domains, the
CPLPPXP library, is a biased peptide library, displaying essentially monovalently, a 13 amino
acid long peptide as a linear prolongation of the pIII protein, on the surface of phage particles.
The library was constructed in two steps (Figure III-11), in the phagemid vector pROCOS4/7.
First, a synthetic hypervariable oligonucleotide encoding for a 8 amino acid random peptide,
was cloned into pROCOS4/7. Then, the second stage was the introduction of a project
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specific cassette, encoding for a proline rich motif, within the previous 8 amino acid peptide
insert.
The primary libraries have been prepared in four sets, differing only by the dinucleotide
corresponding to the cohesive ends, generated upon cleavage by the type IIs restriction
enzyme (at the ZZ position, in Figures III-11, and III-12). This ZZ position was designed to
prevent head to head joining of the cohesive ends, during religation, to maintain the right
orientation of the fragments. In addition, when the four libraries were pooled, the NZZ codon
allowed presentation of all amino acids, except cysteine.
The four primary banks together, reached a total diversity of 2x108 transformants. Since
the libraries were recombined together by cosmix-plexing®, to introduce the proline rich
cassette within the 8 amino acid insert, many new clones were created, and the diversity has
been increased. The quality of the four banks have been evaluated, and was shown to be
sufficient to continue with insertion of the project specific cassette. For each of the libraries,
around 80% of the clones were properly formed (Table III-9), and these clones present an
amino acid frequency correlating with the expected values (Table III-10). The four primary
libraries were pooled before introduction of the proline rich cassette.
The project specific cassette was designed to introduce a proline rich core motif within
the hypervariable domain, so as to improve the possibilities of finding SH3 and EVH1
domain ligands.
16 sets of cassettes were prepared, which differed only at the ZZ dinucleotide positions,
at both extremities of the cassettes (Figure III-11/B), i.e. the sites used for insertion. During
insertion of the cassette within the 8 amino acid hypervariable stretch where the ZZ
dinucleotides varied at its right and left ends, formation of concatemers were induced by
ligation at high DNA concentration. The concatemers were required to recombine both parts
of the hypervariable domains, and to increase the diversity of the bank. The concatemers were
resolved into single phagemid molecules on cleavage with a restriction enzyme recognizing
an unique region within the vector, followed by ligation at low DNA concentration, to favor
formation of monomers.
The diversity obtained for the CPLPPXP library was equivalent to 2,3x108
transformants. The principle of cosmix-plexing®, however relies on the fact that the diversity
is increased each time a cosmix-plexing® is performed. The size of the library was therefore
thought to be sufficient. In addition, the frequency of the amino acids was very similar to the
expected values of a NNB library (Table III-12).
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Analysis of randomly picked clones revealed that 91% of the clones were correctly
formed (having continuous open-reading frame), and thus, adequate for panning selections.
These correct clones formed two groups. 71% of the library displayed the proline rich 13
amino acid long peptides on the surface of the phage (Table III-11). The other 20% of the
clones, were religated without the cassette, and therefore, only the 8 amino acid entirely
random peptide of these clones, was exposed on the surface of the phage. The formation of
these latter could have been avoided, by dephosphorylation of the ends of the cleaved vector
before ligation with the cassette. However, this would have resulted in a reduction of the
efficiency of the subsequent transformations, i.e. an unacceptable reduction in library
diversity. The two types of displayed peptides were as followed:
  Xxx5 Pro Pro Xxx Pro Xxx4 71% of CPLPPXP
  +
   Xxx8 20% of CPLPXP
The CPLPPXP library is convenient to carry on panning selection. Due to the fixed
prolines, this cosmix-plexing® library has a strong selective advantage to isolate ligands
against the SH3 and EVH1 domain targets.
1- SH3 domains
Several groups previously successfully isolated ligands against various SH3 domains.
Originally, two proteins that bind specifically to the Abl SH3 domain, were isolated by
screening a λgt11 cDNA library with a GST-Abl fusion protein (Cicchetti et al., 1992). One
of these proteins, 3BP-1, contains a region of similarity to GAP-rho, the guanosine
triphosphate-activating protein for the Ras-related protein rho. Because of this similarity, it
has been thought that 3BP-1 could function as an intermediary between SH3 domains and the
signal transduction pathway mediated by the Ras-related guanosine triphosphate (GTP).
Further work on these two proteins (3BP-1 and 3BP-2) allowed the localization of the SH3
binding sites to a 10 amino acid stretch very rich in proline residues (APTMPPPLPP, for
3BP-1; Ren et al., 1993). Individual positions were mutated to alanine (alanine scanning), to
determine which residues were important. The positions P2, P7, and P10 (referring to the
positions of the amino acid in 3BP-1), but also A1, and P9, seem crucial to binding affinity
with Abl SH3 domain (APxxxxPxPP). A GenBank data search led to the identification of
some other peptides showing affinity for Abl SH3 domain, and alignment of their binding
sites showed a clear consensus sequence: xPxxPPPΨxP (where Ψ represents hydrophobic
residues; Ren et al., 1993).
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Taken together, these data showed the importance of the proline core motif for peptides
to interact with Abl SH3 domain, but also with Src SH3 domain, since some cross-reactions
were noticed. Random peptide libraries (Sparks et al., 1994; Rickles et al., 1994) and
screening of expression libraries (Viguera et al., 1994; Alexandropoulos et al., 1995) were
then extensively used against various SH3 domains, and confirmed the crucial role of proline
rich core motif for interaction between SH3 domains and their ligands.
Introduction of the use of biased libraries to characterize SH3 ligands (Rickles et al.,
1994; Yu et al., 1994; Rickles et al., 1995; Feng et al., 1995; Sparks et al., 1996), confirmed
the essential need of a proline core motif, but furthermore enabled the determination of more
information about structural requirements of the proline motif flanking regions, within SH3
ligands. The amino acid preferences of the flanking regions allowed the classification of
isolated ligands into two classes, I and II, which bind the SH3 domain in opposite orientations
(Feng, et al., 1994; Yu, et al., 1994; Lim et al., 1994). The class I ligands show the consensus
sequence RXLPPXP, while the class II ligands present as consensus sequence XPPLPXR.
The major difference between both classes is the position of a critical arginine (in bold),
which forms a salt bridge with a conserved acidic residue in the SH3 domain, and thus,
determine the orientation of the ligand. Class I and II ligands bind in NH2 - COOH and in
COOH - NH2 orientation respectively.
SH3 domains have been shown to bind to ligands either of class I or II (Sparks et al.,
1996). Only Src, PI3K and Grb2N appear to be able to bind to ligands belonging to both
classes (Feng et al., 1994; Yu et al., 1994). The Table IV-1 classified the SH3 ligands,
according to their ligand class preferences.
    Class I ligands     Class II ligands
Src Src
PI3K PI3K
Grb2N Grb2N
Yes Cortactin
Abl p53bp2
PLCγ
CrkN
Table IV-1: Classification of SH3 domains, according to the type of ligands that they
bind. The ligands were assigned to be class I or II, with respect to the position of an arginine,
before (I), or after (II) the proline core motif (Sparks et al., 1996).
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SH3 ligands are centered on a proline core motif, which adopts the PPII helix
conformation, and interacts with the aromatic pockets of SH3 domains. Peptides with PPII
conformation form an extended molecular scaffold that is well suited for the shallow groove
of the SH3 ligand-binding site (Yu et al., 1994). PPII helices on globular proteins (natural
SH3 ligands) are ideal mediators of protein-protein interactions since most of these motifs are
located on the surface of their proteins (Adzhubei and Sternberg, 1993).
The proline core motif is flanked by N and C terminal amino acids, one of each being
assumed to be responsible for the specificity of each SH3 domain. The binding of the flank
appears to require the presence of the core, since a peptide having only the flank sequence
does not bind SH3 domain (Feng, et al., 1995). The core is assumed to serve as a common
anchor used by SH3-binding peptides for initial docking, while the flank allows more
extensive contact at the intermolecular interface, thereby providing increased affinity and
specificity.
The ligand binding site of SH3 domain, consists of three pockets that together form a
relatively shallow groove on one side of the molecule (Feng et al., 1994). Two hydrophobic
pockets (n-Src and RT-loop) accommodate the proline core motif of SH3 ligands, whereas the
specific pocket (formed by side chain of Asp99 and Trp118 in Src SH3 domain), accommodates
the SH3 ligand arginine residue (Feng et al., 1994).
1-1 Src SH3 domain
The idea to use Src SH3 domain as model to optimize the affinity selection protocol was
based on results previously achieved in other laboratories. Src is probably the SH3 domain
which was, until now, the most studied, and the Src ligand preferences were already quite
precise before the beginning of this thesis. This was considered as an advantage, since it was
expected to isolate ligands showing high consensus sequence homologies to the known Src
ligands (even if it was hoped to find ligands with higher binding affinities). It was assumed
that having an idea about the expected type of sought ligands, would help characterizing the
best experimental conditions, for the panning procedure against SH3 domains.
Src presents particular interests, since, along with the phosphatidylinositol 3-kinase
(PI3K) SH3 domain, is the only SH3 domain to bind to ligands belonging to both classes
(with RPLPPLP and XPPLPXR consensus sequences for Src, and RXLPPRP and KPPLPXR
for PI3K, for class I and II respectively). However, for both Src and PI3K SH3 domains, class
I ligands were predominantly isolated, with respect to the class II ligands (Yu et al., 1994;
Sparks et al., 1996). Sparks et al. (1996) also reported that N terminal SH3 domain of Grb2
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has the capacity to bind both classes I and II peptide ligands.
1-1-1 Libraries previously generated to define SH3 ligand preferences
The work done on Src SH3 domains, to determine the consensus sequence of their
ligands, from phage display libraries, has been accomplished by many laboratories. However,
three of them performed extensive work on Src SH3 domain. Their results are summarized in
Table IV-2.
In 1994, Sparks et al. generated three random phage libraries which, after panning
selection on Src, established that a sequence RPLPPLP is the preferred binding site for Src
(Table IV-2). The first two libraries, were random peptide libraries displaying 22 or 36 amino
acid long peptides, and containing 2x108 unique variants. The third library has been
established by taking advantage of the knowledge about Src, obtained from the analysis of Src
natural ligands. They create a kind of biased library supposed to display peptides containing
many of the residues identified in naturally occurring SH3-binding sequences. This library
presents ((C/A)NN)8 peptides, and its diversity is 1x10
6. This codon scheme encodes amino
acids in the following proportions: 6R, 4P, 4L, 4T, 3I, 2H, 2Q, 2K, 2N, 2S, and 1M.
With this study, Sparks et al. showed that natural ligands and phage display isolated
binders have similarities, and therefore, that it might be possible to compete in vivo the
natural ligands, with synthetic peptides. In addition, they specified the Src consensus
sequence (RPLPPLP), and proved that a 7 amino acid peptide is able to show binding
capacity for the Src SH3 domain, whereby the presence of flanking regions appear to increase
the affinity. Finally, by checking the relative binding of their selected peptides and potential
cross reaction with other SH3 domains, they demonstrated that SH3 domains possess distinct
ligand preferences.
In 1994, Rickles et al., also generated phage display libraries, in order to isolate ligands
against Src. They first prepared a 6 residue peptide, flanked by glycine. After 8 cycles of
panning, they sequenced 10 clones, which were all identical. Interestingly, a point mutation
occurred, and the first glycine was replaced by an arginine, to give a RSLPPIPG sequence.
These results confirm the importance of an arginine just prior the proline-rich motif. They
assumed that the proline-rich motif was important for Src recognition, and they created a
second biased library, consisting of 6 random amino acids, flanking the proline rich motif
defined with the first library: X6PPIPG. After three cycles of binding selection, the
sequenced clones show the expected RPL consensus sequence before the proline fixed motif
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(Table IV-2). To investigate the sequence preferences in the proline motif of the Src SH3
ligands, another biased library was generated: RSLRPLX6. The C-terminal consensus
sequence derived from this library was PPLPXP, a sequence containing the Src consensus
sequence previously characterized by Sparks et al., RPLPPLP.
Also in 1994, Yu et al. designed  and constructed a biased combinatorial peptide library
of the form X3PPXPX2, containing 2x10
6 variant peptides. The screen of this library on Src
SH3 domain, allowed the characterization of ligands which can be categorized into two
distinct classes, the class I and class II ligands, showing RXLPPLP and PPLPXR consensus
sequences, respectively (Table IV-2). It has to be specified that the class I clones were largely
dominant. Yu et al. suggested that these two classes of peptides bind to Src SH3 domain in
reverse orientations, and confirmed it by structural analysis of SH3-ligand complexes (Feng et
al., 1994).
Library  Consensus sequence References
  X22        Sparks et al., 1994
  X36                RPLPPLP
    ((C/A)NN)8
        GX6G         RSLPPIPG     Rickles et al., 1994
      X6PPIPG             XXXRPLPPIPG
    RSLRPLX6            RSLRPLPPLPXP
    X3PPXPX2                   RXLPPLP    Yu et al., 1994
          PPLPXR
   X5RPLPPLP            XSLXXRPLPPLP     Rickles et al., 1995
GAAPPLPPRX5               GAAPPLPPRN(R/K)XRL
    X6PXXPX6                    LXXRPLPXΨPX6     Sparks et al., 1996
Table IV-2: Comparison of Src SH3 consensus sequences, obtained from ligands isolated
with different phage display libraries (combinatorial peptide library for the work done
by Yu et al., 1994). Underlined residues are fixed within the library. Red amino acids
represent the determined ligand preferences of Src SH3 domain. The italic residue, in
consensus motif obtained from GX6G (Sparks et al., 1994) represents a point mutation which
replaces a G by a R. Ψ stands for hydrophobic residues.
Then, in 1995, Rickles et al. developed new libraries, to further explore the ligand
residues important for specific SH3 domain recognition. They stressed the investigation of the
flanking regions other than the arginine responsible for the classification as class I or II. They
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generated two banks, of the form X5RPLPPLP and GAAPPLPPRX5, to study additional Src
SH3 binding preferences, of class I and class II ligands. After four rounds of selection, they
isolated clones showing distinct consensus sequences, of the form SLXXRPLPPLP for the
class I ligands, and GAAPPLPPPRN(R/K)XRL for class II (Table IV-2).
In 1996, Sparks et al. came back to a library which gave the possibilities to the SH3
domains to interact with a peptide showing more freedom, since only two prolines were fixed.
Furthermore, this bank explored 6 residues on both sides of the proline core motif, allowing
selection of both class I and II ligands. This bank was of the form X6PXXPX6, and its
diversity was 3x108 variants. However, the clones isolated from this bank, after panning
against Src SH3 domain, were nearly exclusively belonging to the class I ligands, with the
LXXRPLPXΨP consensus sequence (Table IV-2), confirming the predominance of class I
ligands, and the importance of the RPL residues, before the proline rich motif. Only one clone
shows a sequence which might be related to the class II ligands. However, Sparks et al. did
not investigate the relative binding capacity of this clone to the Src domain.
1-1-2 Advantages of the CPLPPXP library over previously described banks
The CPLPPXP library used in this work to isolate proline rich ligands against SH3 and
EVH1 domains, looks similar to some of the banks shown above. However, although it was
intended to characterize ligands showing high consensus sequence homologies to the ligands
previously described, the aim of the work was to characterize ligands which show higher
binding affinity for their target.
The main limitation of the banks utilized in the work already done, was their diversities
(Table IV-3). The libraries generated by Sparks et al. (1994, 1996) contain a maximum of
3x108 variants, for banks which consist of 14, 22, or 36 random amino acids. With 3x108
variants within a library, one can expect to have only 5 or 6 positions containing all possible
amino acids, with a 99% confidence (Table III-1). The library prepared by Yu et al. (1994) is
even less complete. Its diversity was estimated to be 2x106, however, a bank containing 6
random amino acids would require at least 2x109 transformants (Tables III-1 and IV-3). The
diversities of libraries synthesized by Rickles et al. (1994, 1995) were appropriate and should
allowed, for most of the banks, the randomisation of all 5 or 6 random amino acids.
The CPLPPXP possessed a diversity of 2x108 variants, which is similar to the sizes of
the libraries developed by Sparks et al. (1994, 1996). However, the number of random amino
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acids was reduced to 10 positions (compared to 14, 22, or 36). The libraries generated by
Sparks et al. (1994), during the first part of their work, were appropriate to the knowledge of
the moment about SH3 domains, but it seems nowadays more interesting to employ biased
libraries, for a general work on a panel of SH3 domains. Their choice of a ((C/A)NN)8 bias
has limitations, since only a fraction of the codons were represented in the library. This type
of bank might in most of the cases prevents isolation of ligands for particular targets, since 9
of the amino acids are not represented. The biased library developed in 1996 by Sparks et al.,
was ingenious, as demonstrated by the resulting ligands, for a large variety of SH3 domains.
A minimum proline motif was fixed, and a large freedom was given to both proline flanking
regions (X6PXXPX6). However, this library suffered a serious diversity problem (Table IV-3),
i.e. in the potentially diversified regions containing 14 amino acids, probably a maximum of 6
residues would be optimized. This might have limited the number of characterized ligands.
Library         Random    Diversity   Required diversity   References
        positions   90%    99%
  X22     22       2x10
8 2x1033  4x1033   
  X36     36             2x10
8    3x1054  6x1054         Sparks et al., 1994
    ((C/A)NN)8         8       1x10
6 2,5x1012  5x1012
        GX6G      6       2,5x10
9     
      X6PPIPG      6               2x10
9 2,5x109 5x109       Rickles et al., 1994
    RSLRPLX6      6               5,8x10
8
    X3PPXPX2      6       2x10
6 2,5x109 5x109       Yu et al., 1994
   X5RPLPPLP      5       7,5x10
7    7,7x107 1,6x108       Rickles et al., 1995
  GAAPPLPPRX5       5                2,2x10
7
    X6PXXPX6     14       3x10
8    2,5x1021 5x1021       Sparks et al., 1996
Table IV-3: Comparison of estimated and required diversities, of combinatorial and
phage display libraries, generated by other groups to isolate ligands against SH3
domains. Required diversities represent the necessary sizes of the banks, according the their
number of random amino acids, to ensure representation of all possible peptides, with a 90%
or 99% confidence level. The confidence that a library contains all possible amino acid
sequences is calculated assuming a Poisson distribution (Lowman and Wells, 1991).
The CPLPPXP library is similar to the bank of Yu et al. (X3PPXPX2; 1994), since in
both cases, a Pro Pro Xxx Pro core motif was introduced within the hypervariable region.
However, CPLPPXP diversity was significantly higher that of Yu et al. In addition, the library
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used by Yu et al. (1994) was a combinatorial chemistry library, where isolation of ligands is
limited to a single round of selection. There, one does not analyze single sequences, but
obtains an impression of a consensus sequence. If there are several possible sets of consensus
sequences, information is lost with this method.
The sizes of the proline motif flanking regions were more appropriate in the case of the
CPLPPXP library, since in the Yu bank, the randomized N and C terminal parts of the proline
motif, only allowed isolation of ligands showing class I or II characteristics. The flanking
regions of SH3 ligands are responsible for specificity between the ligand, and a particular
SH3 domain (the proline rich motif is common to every SH3 domain). However, since the
SH3 domains are classified in two groups, according to their ability to interact with ligands
from class I or II, the RXL (from RXLPPXP class I ligand), and XR (from PPLPXR of class
II ligands) are still assumed to represent a motif common to a group of SH3 domains.
Therefore, to really learn about SH3 domain specificity, longer flanking regions are required.
The libraries designed by Rickles et al. (1994, 1995) allowed characterization of ligands
against a large variety of SH3 domains. The libraries had an adequate diversity, and were so
successful due to step by step successive optimization, termed the “extension library”
approach. Their strategy was to use a random library against SH3 domains, to search for
consensus motif against a particular SH3 domain. Once obtained, they created a secondary
library, presenting the defined motif, and additional random amino acids, to further explore
the flanking regions and extend the determined primary motif. The next library was then
applied, obtaining larger consensus sequences. The only drawback of their work, is the short
size of the random peptides displayed on the surface of the phage (6 residues), used in the
primary library, compared to the number of fixed positions (5 residues) within the secondary
bank. Some specific ligands which might have made use of novel synergistic interaction
between sub-segments may have been lost by defining so many positions.
Despite the limited diversity of the CPLPPXP library, the bank was considered to be
large enough, since it was designed as a cosmix-plexing® library, and therefore, can be
recombined as required, increasing the size of the bank.
However, the main advantage of the cosmix-plexing®, is the recombination among
peptides of a preselected population of clones which have at least weak affinity for the target
(i.e. enriched for “target significant” sequence space). The populations selected after one or
two rounds of panning selection were collected, and submitted to cosmix-plexing®
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recombination. This leads to the reassortment of the amino and carboxy proximal sections
within the hypervariable domain, among clones which are highly enriched in SH3 ligands.
Another reason to believe that the CPLPPXP library was particularly suitable for the
isolation of high affinity SH3 ligands, was that CPLPPXP is a phagemid library. Sparks et al.
(1994, 1996), and Rickles et al. (1994, 1995), worked with phage display libraries, by fusing
their random peptides to the pIII phage protein. In the CPLPPXP library, the pIII protein is
also used as fusion partner, however, a phagemid system was used. In phage libraries, the
random peptides are present five times on the surface of the phage, while in the CPLPPXP
phagemid library, they were expected to be essentially displayed once per particle.
Monovalent presentation is of high advantage when strong affinity ligands have to be isolated.
The reduced valency is valuable in eliminating avidity. Only the latter method permits real
discriminative selection for high affinity as compared to modest affinity peptides.
1-1-3 Src ligands, isolated from CPLPPXP library
The panning procedure on Src SH3 domain was performed in parallel under various
conditions, to determine the optimal affinity selection protocol for SH3 domains. Microtiter
plates were used as support material for the panning. It has been shown that glutathione
microtiter plates were not applicable to the screening on GST-Src fusion protein. Such a plate
was supposed to capture the GST part of the GST-SH3 fusion protein, with the glutathione
fixed on the wells, and therefore, the SH3 protein was expected to be orientated such that it
was available for interactions with potential ligands. Surprisingly, using glutathione plates, no
enrichment was observed, and the output values were very similar to the one of the blank,
suggesting that no selection occurred. The results indicated that the GST-Src fusion proteins
were possibly not retained sufficiently tightly by the glutathione, or that the interaction
between the glutathione and the GST might have oriented the Src molecules in manner
unfavorable for interactions with their ligands. Therefore, maxisorb microtiter plates were
employed, and provided satisfactory results.
The best washing conditions were defined experimentally, aiming to achieve an
equilibrium between washing away weak binders and thus, removing the background, but still
retaining interesting ligands. This is of particular importance during the first cycle of
selection, where discrimination between non-specific, and specific binders takes place within
the starting population, where the specific ligands may be still under-represented. This was
obtained by using mild washing steps, with a PBS buffer containing 0,05% of Tween 20. The
stringency was increased with each cycle of selection, since after each round of panning, the
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eluted phage were amplified. This means that the high affinity ligands are more and more
enriched, and higher stringency is required for better discrimination.
The elution of the bound phage was achieved by using a low pH glycine buffer.
The panning procedures were carried out in the same way for all other targets.
The screening of the CPLPPXP library on the Src SH3 domain led to the isolation of
ligands which allowed the conception of a clear consensus sequence (Figure IV-2). In the case
of the Src domain, cosmix-plexing® recombination of the population selected after first and
second rounds of panning led to the enrichment, directly after the first round, of a unique
clone (S1), identical to the clone which already dominated over the other ligands, after
standard panning. This demonstrates a very strong binding preferences of Src SH3 domain,
for this S1 clone, since reassortments amongst pre-selected clones did not allow the creation
of new clones which would have shown new features, optimal for the target. The clones
selected for Src SH3 domain, are presented in the Figure IV-2.
                     Sequences against Src SH3 domain                     E      B
 P1    P2     P3     P4     P5     P6     P7    P8     P9     P10   P11    P12   P13
S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe  +       +
S4 Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser     +       +
S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg Trp  +       +
S3 Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser Ala  +       -
Consensus sequence
Xxx Xxx Arg Pro Leu Pro   P/L  Ψ Pro  Ψ Pro Pro Ser
S5 Ser His Tyr Ser Leu Pro   Pro Gly Pro Leu Arg Gly Phe      -        -
S6 Asn Ala Cys Thr Leu Pro   Pro Phe Pro Trp Asp Arg Cys      -        -
S7 Gly Ala Gly Ser Leu Pro   Pro Cys Pro Ala Asp Leu Leu     -        -
Figure IV-2: Sequences of single clones isolated against Src SH3 domain, and the
deduced consensus sequence. The clones are classified according to their relative affinity on
phage ELISA, for the target. Only the clones positive in phage ELISA and/or BIAcore
measurements, are taken into account for the conception of the consensus sequence. A residue
is considered as representative for the consensus sequence, when it occurs in 50% or more of
the sequences. Underlined amino acids are fixed residues within the CPLPPXP library. Ψ
represents hydrophobic amino acids. E and B stand for phage ELISA and BIAcore analysis. A
simple + or – indicates whether the clones reacted positively or not, in ELISA or BIAcore
tests. P1 to P13 refer to the amino acid position within the sequence. For occurrence of each
clone, or precise phage ELISA values, refer to Figures III-21 and III-23.
Only four of the seven enriched ligands are shown to react strongly in vitro with the Src
SH3 domain. However, these four clones allowed the obtention of a long consensus sequence
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(11 amino acids). These four ligands are all showing characteristics belonging to the class I
ligands, mainly with the presence of a conserved arginine, at P3, before the proline motif, but
also with the Arg Pro Leu motif. Src SH3 domain has been previously shown to be able to
interact with ligands (natural or not), belonging to both classes (Yu et al., 1994; Feng et al.,
1994; Sparks et al., 1996). However, class I ligands largely dominate over class II (Figures
IV-3 and IV-4).
It should be noticed that a clone which reacts positively on phage ELISA does not
necessarily interact with the target under the conditions of the BIAcore analysis. One example
is clone S3, positive in ELISA (even if it was the weakest positive clone), but negative with
Src in the BIAcore test. This might be explained by the absence of Pro at position P4, which
has been demonstrated to be required for binding of the ligands to Src SH3 domain. However,
it is not expected to have always similar reactions between phage ELISA and BIAcore.
Indeed, in BIAcore, the ligands are in flow. This means that if the dissociation is fast, the
ligands are released from the target, and washed away. In phage ELISA, when dissociation
between both partners is fast, the ligands are still present in the microtiter wells, and still have
a chance to interact with the target, and the ELISA signal, in such a case, might be stronger
than observed on BIAcore. In phage ELISA, there is little discrimination between low or high
dissociation rate.
The S5 clone is the only selected clone which might be considered as a class II ligand,
due to the arginine at P11. However, S5 does not show leucine at P8, as class II ligands for Src
SH3 domain do. This is may be why the S5 clone is not reacting on phage ELISA.
The S1 clone was the clone isolated most frequently in standard panning, and the sole
clone selected after cosmix-plexing® recombination. In phage ELISA, it shows the best
relative affinity for the Src domain. S1 might be so advantageous for the Src domain, because
it could be classified under both classes of ligands. The Arg Pro Leu motif, at P3-P5, are
characteristics of class I ligands. However, the His at P11, and the Ile at P8 suggest a class II
ligand. Class II ligands usually present an Arg at P11, and not the His found in S1. However,
His and Arg, are both basic amino acids, and the histidine might be able to establish the
required stabilizing salt bridge with the conserved Asp within the Src SH3 domain. Such
clones have already been reported by Rickles et al. (1995), against the PI3K SH3 domain: a
phage displaying RSLRPLPPLPPRPXX was selected, which also presents both class I
(underlined) and class II (boldface type) consensus sequences. Such clones might potentially
bind in either orientation to the SH3 domain.
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The S1 displayed peptide has been synthesized as free peptide, and was used as
competitor in competitive phage ELISA. Src SH3 domain was immobilized in a microtiter
plate well, and incubated with fixed concentrations of S1, S2, S3, or S4 phage variants. After
washing away non bound phage, increasing concentrations of the synthetic free S1 peptide
was added. The amount of bound phage remaining was estimated, after new washing steps
(Figure III-44). All four clones were competed away from the Src binding site, by the free S1
peptide. This demonstrates, as it was expected, that all four peptides were interacting with Src
SH3 domain, at the same binding site. But moreover, it proves that the linear S1 displayed
peptide properties, were transferable between phage-bound peptide, and phage-free peptide.
This is not the case for every phage displayed peptide, since the linear peptide might be
constrained by its local environment (Ladner, 1995). This feature promotes the S1 peptide as
valid for in vivo testing.
1-1-4 Comparison of Src ligands, from various libraries
The S1 clone sequence was compared with Src ligands isolated by other groups (Sparks
et al., 1996: X6PXXPX6; Yu et al., 1994: X3PPXPX2), with biased library, displaying a
proline core motif. The Figure IV-3 presents the sequences.
The comparison of the class I Src ligands, obtained from different biased libraries
(Figure IV-3), shows distinct features. This was expected, since the three libraries used for the
selection of binders studied here, were based on various fixed core sequences in addition to
differences in the valency of presentation. The CPLPPXP library is a phagemid library.
Sparks et al., used a phage library, and Yu et al., employed a combinatorial chemistry library.
The common characteristic of the ligands isolated from these three libraries, is the motif
before the proline core. Arg at P3 and Leu at P5 appear to be essential for the ligands.
However, the Pro at P4, which was demonstrated as crucial, in our experiments, for high
affinity binding between the ligands and the Src domain (ligands without Pro at P4, lost their
binding for Src on phage ELISA; see Figure III-31), is present only in half of the clones of
Sparks, and in 1/4 of the variants of Yu.
However, it has to be emphasized that the CPLPPXP library was designed to isolate
strong ligands against SH3 domains, while the phage library of Sparks, with a display of 5
peptides per particle, created an avidity phenomenon, and therefore, tended to isolate weaker
affinity binders. Furthermore, their sequenced clones were picked from the third round of
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panning, before a strong enrichment of the higher affinity ligands occurred, and most of their
clones were isolated only once (the sequenced clones, previous to sequencing, were shown to
react positively on phage ELISA). As far as the library of Yu was concerned, since it was a
combinatorial chemistry library, only one round of selection was possible, and no significant
discrimination between low or high affinity ligands was possible. So, the fact that Pro at P4 is
not systematic in Sparks and Yu libraries, might simply reflect isolation of weaker binders.
Major differences appear on the flanking region C terminal from the proline motif
(Figure IV-3). In our consensus sequence, a stretch of proline or hydrophobic residues
appeared to be advantageous for the interaction (Figure III-23).
For Sparks clones, no clear consensus can be conceived from this region, however, a
significantly high amount of acidic residues (Asp and Glu) is found, at various positions,
between P10 and P14, since 8 from the 13 isolated clones present at least one acidic amino acid
at one of these positions. A comparison with the ligands isolated with the CPLPPXP library
demonstrate that only ligands which are too weak to show a positive interaction with the Src
domain on phage ELISA, also possess an Asp (however, localized at P11, and present in 2/3 of
the clones; Figure IV-2).
Similarly, in Sparks clones, several prolines are found, also between P10 and P14 (8 from
the 13 isolated clones possess at least one proline at one of these positions).
Curiously, an association between Pro and an aromatic residue (preferentially Phe) is
observed several times, within the C terminal flanking region, in both ligands from CPLPPXP
(S1 and S2) and Sparks libraries (overlaid in yellow).
For Yu ligands, a clear consensus sequence is observed on the C terminal flanking
region, even though limited to only two residues. Arg, or eventually other basic residues, are
clearly defined at P10, while aromatic residues determined the position P11. 
Figure IV-3: Comparison of Src SH3 domain class I ligands, isolated from various
biased libraries. The S1 clone was isolated from the CPLPPXP phagemid library. Sparks
sequences were selected from a X6PXXPX6 phage library (Sparks et al., 1996). Yu sequences
are derived from a X3PPXPX2 combinatorial chemistry library (Yu et al., 1994). Consensus
sequences for Sparks and Yu clones are given. A residue is considered as representative for
the consensus sequence, when it occurs in 50% or more of the sequences. Ψ and ϕ represent
hydrophobic and aromatic amino acids, respectively. Underlined amino acids are fixed
residues within the libraries. P1 to P13 refer to the amino acid position within the sequence.
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                  Sequences against Src SH3 domain – Class I ligands
 P1     P2     P3     P4     P5     P6     P7    P8     P9     P10   P11    P12   P13
S1 dominant clone  (X5PPXPX4)
Gly Asn Arg Pro Leu Pro Pro  Ile Pro Ser His Pro Phe
X5PPXPX4 consensus sequence
Xxx Xxx Arg Pro Leu Pro  P/L   Ψ Pro Val Pro Pro S/Ψ
Sparks sequences (X6PXXPX6)
Leu Ala Ser Arg Pro Leu Pro Leu Leu Pro Asn Ser Ala Pro Gly Gln
Leu Thr Gly Arg Pro Leu Pro Ala Leu Pro Pro Pro Phe Ser Asp Phe
Pro Ala Tyr Arg Pro Leu Pro Arg Leu Pro Asp Leu Ser Val Ile Tyr
Arg Ala Leu Arg Val Arg Pro Leu Pro Pro Val Pro Gly Thr Ser Leu
Gly Ser Leu Pro Phe Arg Pro Leu Pro Pro Val Pro Thr
Leu Lys Val Arg Ala Leu Pro Pro Leu Pro Glu Thr Asp Thr Pro Tyr
Ile Ser Gln Arg Ala Leu Pro Pro Leu Pro Leu Met Ser Asp Pro Ala
Leu Thr Ser Arg Pro Leu Pro Asp Ile Pro Val Arg Pro Ser Lys Ser
Asn Thr Asn Arg Pro Leu Pro Pro Thr Pro Asp Gly Leu Asp Val Arg
Met Lys Asp Arg Val Leu Pro Pro Ile Pro Thr Val Glu Ser Ala Val
Leu Gln Ser Arg Pro Leu Pro Leu Pro Pro Gln Ser Ser Tyr Pro Ile
Phe Ile Asn Arg Arg Leu Pro Ala Leu Pro Pro Asp Asn Ser Leu Leu
Phe Arg Ala Leu Pro Leu Pro Pro Thr Pro Asp Asn Pro Phe
Sparks consensus sequence 
Leu Xxx Xxx Arg Pro Leu Pro  Ψ   Ψ Pro Xxx Xxx Xxx Xxx Xxx Xxx
Yu sequences  (X3PPXPX2)
Arg Ala Leu Pro   Pro Leu Pro Arg Ala
Arg Glu Leu Pro   Pro Leu Pro Arg Phe
Arg Ala Leu Pro   Pro Leu Pro Arg Tyr
Arg Asn Leu Pro   Pro Leu Pro Arg Ile
Arg Ala Leu Pro   Pro Leu Pro Arg Trp
Arg Thr Leu Pro   Pro Leu Pro Arg Phe
Arg Ala Leu Pro   Pro Leu Pro Arg Ile
Arg Pro Leu Pro   Pro Leu Pro Thr Ser
Arg Met Leu Pro   Pro Leu Pro Ala Trp
Arg Pro Leu Pro   Pro Leu Pro Ala Trp
Arg Gln Leu Pro   Pro Leu Pro Ala Phe
Arg Arg Leu Pro   Pro Leu Pro Gln Leu
Arg Asp Leu Pro   Pro Leu Pro His Arg
Arg Glu Leu Pro   Pro Ile Pro Val Phe
Arg Pro Leu Pro   Pro Val Pro Met Phe
Arg Pro Leu Pro   Pro Thr Pro Lys Tyr
Yu consensus sequence
Arg Xxx Leu Pro   Pro Leu Pro Arg   ϕ
Discussion
233
Determination of the KD of the ligands was performed. Sparks et al. (1996) estimated the
dissociation constant of their ligands, by comparing the phage ELISA signals of their positive
ligands to those obtained with previously characterized Src SH3 binding clones, and the KD
were assumed to range between 5 and 75 µM.
Yu et al. (1994), evaluated the KD of some of their clones, by fluorescence titration
assays, and found values, between 7 and 70 µM. In both cases, determined KD values are
similar to those for natural SH3 ligands, however ligands with a KD of 0,2 µM were
previously characterized,  providing evidence that the ligands isolated by Sparks et al. (1996),
and by Yu et al. (1994) are not amongst those with the highest affinities.
The KD of the clones isolated from the CPLPPXP library were determined by BIAcore
real time interaction measurements, and a KD value of 7,3 nM was obtained for the S1 clone
(Figure III-50), around 1000 fold better than the best clones isolated by Sparks et al. (1996) or
by Yu et al. (1994). Actually, S1 was the only Src ligand for which the KD value was properly
defined, since the Src SH3 domain stock used for these tests were not concentrated enough to
repeat the experiment performed with Src, and to reach the equilibrium phase necessary for
the evaluation of the KD. However, they are expected to show similar range dissociation
constants, since their plots of Req versus Src concentration, looked very similar to that of S1
(Figure III-51).
The Table IV-4 presents ligands previously characterized against diverse SH3 domains.
According to the huge number of existing ligands, whether natural or isolated from phage
display techniques, a severe selection was done, to present only the highest affinity SH3
binders.
Until now, the highest affinity SH3 natural ligands was the Nef protein, from HIV-1,
which binds with a KD of 0,25 µM to the Hck SH3 domain (belongs to the Src SH3 family).
The highest affinity ligands characterized for Src, where isolated by Cheadle et al. (1994), and
Rickles et al.(1995), and are in the range of 0,2 µM.
The S1 Src ligand, isolated with the cosmix-plexing® CPLPPXP library, has a KD of 7,3
nM. To our knowledge, this is the first time that a SH3 ligand possessing a KD in the range of
nM is described. The affinity of S1 for Src is around 30 fold higher than the best characterized
ligands until now (from Cheadle and Rickles), however, it is much higher than natural ligands
(around 3500 fold higher than SOS natural ligand) and might be able to compete in vivo
experiment (considering work with cells non infected by HIV).
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References Natural ligands SH3     KD
Viguera et al., 94 3BP-1 Abl 34  µM
3BP-1 Fyn 34  µM
3BP-1 Src 200 µM
3BP-2 Abl 5    µM
SOS1-3 Src 27  µM
SOS1-4 Src 26  µM
Lee et al., 95 Nef (HIV-1) Hck 0,25 µM
Nef (HIV-1) Fyn 0,38 µM
References Optimized natural ligands SH3        KD
Pisabarro et al., 96   3BP-1 Abl 34  µM
opt 3BP-1 Abl 0,4 µM
References Combinatorial library clones SH3        KD
Yu et al., 94 RKLPPRPSK PI3K 9,1  µM
RALPPLPRY Src 7,8  µM
Cheadle et al., 94 TGPRPLPLPPLRSMS Src 0,18 µM
Rickles et al., 94 PPPYPPPIP Abl 2,0  µM
RSSRPLPPIP Src 19,5 µM
Rickles et al., 95     RPLPPLPGGK Src 17,7 µM
VSLARRPLPPLPGGK Src 0,86 µM
KGGGAAPPLPPR Src 20,3 µM
KGGGAAPPLPPRNRPRL Src 0,24 µM
Horn and Collins GNRPLPPIPSHPF (S1clone) Src 7,36 nM
 (in preparation) KGRPLPPVPGTPS (S4 clone) Nephrocystin 0,42 nM
Table IV-4: KD values of some SH3 ligands. Ligands were selected according to their KD
values, only the higher affinity ligands are shown. Presented SH3 ligands were isolated by
different groups, and are either original natural ligands, optimized natural ligands, or ligands
characterized by combinatorial libraries (phage display libraries, except Yu et al., (1994) who
worked with combinatorial chemistry library). The highest affinity ligands characterized until
now are shown in blue (µM range), the S1, and S4 clones identified against Src and
nephrocystin SH3 domains from CPLPPXP library are presented in red (nM range).
As far as the class II ligands are concerned, not a lot can be said, according to the low
number of isolated ligands (Figure IV-4).
From the two ligands isolated from CPLPPXP library, S1 cannot completely be
considered as a class II ligand, since it does not show an Arg, but a His at P11. The S5 ligand
does not react on phage ELISA with Src SH3 domain. The unique clone described from
Sparks variants has not been demonstrated to bind to the target in vitro. And only one of the
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clones of Yu et al. interacts with Src, however, with a low KD (73 µM). Therefore, no real
consensus sequence can be designed.
                Sequences against Src SH3 domain – Class II ligands
CPLPPXP library (X5PPXPX4)
S1 Gly Asn Arg Pro Leu Pro Pro Ile Pro Ser His Pro Phe
S5 Ser His Tyr Ser Leu Pro   Pro Gly Pro Leu Arg Gly Phe
Sparks sequences  (X6PXXPX6)
Leu Tyr Ser Ala Ile Ala Pro Asp Pro Pro Pro Arg Asn Ser Ser Ser
Yu sequences         (X3PPXPX2)
Arg Asp Leu Pro   Pro Leu Pro His Arg
Pro Tyr His Pro   Pro Leu Pro Arg Arg
Ala Phe Ala Pro   Pro Leu Pro Arg Arg
Similarities between the sequences
Xxx Xxx   Ψ Pro Pro   Ψ Pro   β Arg
Figure IV-4: Comparison of Src SH3 domain class II ligands, isolated from various
biased libraries. The S1 clone was isolated from the CPLPPXP phagemid library. Sparks
sequences were selected from a X6PXXPX6 phage library (Sparks et al., 1996). Yu sequences
are derived from a X3PPXPX2 combinatorial chemistry library (Yu et al., 1994). Underlined
amino acids are fixed residues within the libraries. Ψ and β represent hydrophobic and basic
amino acids, respectively. P1 to P13 refer to the amino acid position within the sequence.
1-1-5 Swissprot comparison of Src ligands isolated from CPLPPXP library
A computer-assisted sequence search with the Swissprot database failed to identify
existing proteins showing homology with the Src isolated ligands, except for the S3 clone.
This is not surprising that the high affinity isolated ligands do not resemble natural proteins.
Our ligands are shown to have extremely high KD for the Src SH3 protein. However, natural
ligands require a weaker interaction, in order to allow sensitive and dynamic modulations in
response to changing signals. That might be the reason why the only clone (S3) for which
homologue proteins were observed, was the clone showing weaker relative affinity in phage
ELISA, and was not positive in BIAcore measurements.
The Swissprot database revealed that the S3 sequence shows 70% identity in a stretch of
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13 amino acids with the human WASP (Wiskott-Aldrich Syndrome Protein), and 89%
identity in a stretch of 9 residues, with the rat CAP1 protein (Adenylyl cyclase associated
protein 1), as shown in Table IV-5.
S3 ligand RSLPLPPVPT SSA
Human WASP RSGPLPPVPLGIA
S3 ligand RSLPLPPVPTSSA
Rat CAP1 PGPPPPPVPTSSG
Table IV-5: Amino acid of S3 clone and comparison to human WASP (amino acids 338-
350), and rat CAP1 (amino acid 237-245), according to Swissprot database analysis.
Regions of identity are shown in red, and of homology in blue.
1-1-5-1 CAP1 homologies
The identity between the S3 clone and the CAP1 was first thought unlikely to be of
significance, since the first Arg, along with the following Leu, at the third position, are
assumed to be crucial for the interaction with Src, but these three amino acids do not belong
to the region which has similarity with the CAP1 sequence. This reduces the chance that
CAP1 might be a natural ligand of Src SH3 domain.
However, the yeast CAP protein has been proved to be involved in interaction with the
SH3 domain of the Abp1p yeast protein (Freeman et al., 1996). Genetic studies suggested two
roles for CAP which are independently regulated. One as a positive regulator of cAMP levels
in yeast (Shima et al., 1997), and a second as a cytoskeletal regulator, through an actin
sequestering activity (Freeman et al., 1995). CAP protein contains a proline rich region
subdivided into two domains (Yu et al., 1999). The first proline rich region contains a 10-12
amino acid stretch composed almost entirely of prolines. The second proline rich region
contains a SH3 binding motif, which binds in vitro to SH3 domains, and is required to direct
the CAP to corticol actin patches (Freeman et al., 1996). Recently, Yu et al. (1999)
demonstrated that monomeric CAP efficiently binds actin and adenylyl cyclase, but not the
Abp1-SH3. The formation of a dimeric CAP complex exposes the CAP SH3 binding site. In
theory, CAP could serve as an adapter protein to direct adenylyl cyclase to actin corticol
patches (Yu et al., 1999).
CAP1, the first characterized mammalian homologue of the yeast CAP protein, was
isolated as actin-monomer binding protein (Gieselmann and Mann, 1992). All CAP
homologues contain a unique centrally located proline-rich region, corresponding to the first
70% identity in 13 aa overlap
89% identity in 9 aa overlap
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yeast proline rich region (10-12 amino acid stretch composed almost entirely of prolines).
The identity between the S3 clone, and the CAP1 concerned the CAP1 amino acids 237
to 245, which overlaps with the proline rich region of the rat CAP1, extended from amino
acids  229 to 240. The data suggest that the Src SH3 domain might be a mammalian
homologue of the yeast Abp1 SH3 domain, and that the S3 clone might mimic the CAP1
protein, for interaction with Src. However, if the mammalian and yeast CAP proteins have
similar functions, interaction between S3 and Src should disrupted Src roles in actin
organization. Indeed, since CAP has distinct binding sites for SH3 domain, actin monomer,
and the adenylyl cyclase, but that the S3 clone would only provide a SH3 binding site, the
adapter function would then be lost, and the adenylyl cyclase could not be directed anymore
to the actin corticol patches. S3 might be a CAP1 competitor.
1-1-5-2 WASP homologies
The second protein which shows identity with the S3 clone, is WASP. The S3 region
involved in the homology, is the same as the one expected to bind to Src SH3 domain,
through the proline motif, completed with the Arg Xxx Leu motif before the proline core.
WASP has been shown to interact with the Itk, Src, Lck, Abl SH3 domains (Bunnell et
al., 1996), the C terminal SH3 domains of Nck (Nck3) (Rivero-Lezcano et al., 1994; Anton et
al., 1998), and with the N terminal Grb2 SH3 domain (She et al., 1997). Furthermore, The Itk,
Src, Abl and Lck have been demonstrated to bind to distinct sets of proline rich regions in
WASP (Bunnell et al., 1996).
Wiskott-Aldrich syndrome, the disease associated with defects in WASP is characterized
by platelet and lymphocyte cell abnormalities, most likely caused by defects in actin
cytoskeleton organization (Ochs et al., 1980). WASP is a proline rich protein (it contains 7
distinct proline rich regions) that has been shown to directly interact with activated Cdc42
(small GTP-binding protein; Symons et al., 1996), and with WIP (WASP Interacting Protein;
Anton et al., 1998), which are both involved in actin cytoskeletal organization. Src is found
ubiquitously, but most abundantly in platelets, brain and osteoclasts. The fact that WASP
defects are associated with severe platelet anomalies, might be correlated with an obstructed
interaction with Src (taking into account that Src SH3 domain is one of the binding partners of
WASP).
Bunnell et al. (1996) and Anton et al., (1998) showed that interaction of WASP with Src,
Abl, and Nck3 SH3 domains requires the presence of several WASP domains. Interaction
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between Src and WASP requires the presence of two WASP fragments. Both sites have not
been precisely mapped, so that it cannot be discriminated if both sites synergize to yield high
affinity binding, or if interaction takes place through divalent binding. For the Itk SH3
domain, two domains are also required, but since they are consecutive, it might be that the
binding site is split between both regions, and lies at their junction. However, the possibility
that binding needs the presence of two binding sites cannot be ruled out.
The binding of Nck3 with the WASP protein involved a WASP region repeated twice,
showing the consensus sequence GRSGPXPPXP (Finan et al., 1996). The S3 homology with
WASP is concerning one of these regions since out of the 10 amino acids of the WASP
stretch, 8 are identical to the S3 ligand.
S3 ligand RS LPLPPVPTSSA
Human WASP       GRSGPLPPVPLGIA
  Nck3 binding domain
This strongly suggests that S3 ligand interacts with Src in the same way that WASP and
Nck3 are interacting (Figure IV-5/A). Additionally to the binding of WASP to the C terminal
SH3 domain of Nck (Nck3), the WIP protein (WASP Interacting Protein) specifically
interacts with its central SH3 domain (Nck2). WIP also specifically binds to WASP, to
profilin (probably with two profilin molecules, since WIP has two profilin binding sites) and
contains an actin binding site (Anton et al., 1998). The actin regulatory protein profilin binds
to actin monomer. Therefore, WASP and WIP may link Nck to the actin cytoskeleton, and
WIP might amplify the recruitment of actin monomers. Nck may simultaneously engage
WASP and WIP, thereby increasing the local concentration of both proteins, and enhancing
their interaction. Since Nck is recruited via its SH2 domain to phosphotyrosine residues in
receptor tyrosine kinases following their activation by ligand binding, the Nck-WASP-WIP
interaction may provide an important link between extracellular signaling via receptor
tyrosine kinases and reorganization of the cytoskeleton.
Src also interacts via its SH2 domain with phosphotyrosine residues in receptor tyrosine
kinases, and therefore, the homology between S3 and WASP suggests that Src could also be
linked to the actin cytoskeleton through the WASP-WIP-profilin-actin interaction, as
illustrated in Figure IV-5/B).
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A      Nck   SH3-1      SH3-2          SH3-3           SH2
   WIP    WASP
Actin binding site 
      Profilin
B    Src SH3          SH2          kinase
  WIP
 Actin binding site     WASP
      Profilin
Figure IV-5: Illustration of Nck and potentially Src SH3 domains are linked to the actin
cytoskeleton organization. (A-) WIP interactions with Nck, WASP and profilin as
demonstrated by Anton et al. (1996). (B-) Hypothetical link between Src and actin
organization. The red circles represent specific interaction between partner proteins.
1-2 Nephrocystin SH3 domain
The nephrocystin SH3 domain has been recently discovered by Hildebrandt’s group
(Hildebrandt et al., 1997a; Hildebrandt et al., 1998), and to our knowledge, was used here, for
the first time as target in phage display, to isolate specific nephrocystin ligands.
Nephrocystin is a region of the NPHP1 gene, and might be involved in juvenile
nephronophthisis disorder, since 80% of the families suffering from this disease show a
deletion within the nephrocystin gene. The nephrocystin region has been demonstrated to
have strong homology and to be related, to previously characterized SH3 domains. The
potential function of nephrocystin SH3 domain is still unknown. Therefore, characterization
of nephrocystin SH3 domain ligands is of medical interest.
1-2-1 Nephrocystin ligands isolated from CPLPPXP library
The panning procedure was performed similarly to that for Src SH3 domain. However,
the analysis of the output/input values, indicated enrichment factors very different from those
observed for Src. After standard panning selection on Src, an enrichment factor of 120 was
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obtained after the third round, and of 1500 after the fourth cycle, whereas for nephrocystin,
the enrichment factor is inferior to 3 after three rounds of panning. However, a 20 fold
enrichment was observed between the second and third round of affinity selection, and
sequencing of randomly picked clones provided sequences of only three different clones
(Figure IV-6), each recovered up to 7 times. Alignment of the three variants allowed the
conception of a clear consensus sequence, which showed strong homologies with the
consensus sequence defined for the Src SH3 domain, as shown:
Nephrocystin Arg Xxx Leu Pro   Pro Xxx Pro Val Pro
Src Arg Pro  Leu Pro   P/L    Ψ  Pro   Ψ   Ψ Pro S/Ψ
The population recovered after the first round of panning was submitted to cosmix-
plexing recombination, and the resulting secondary library was screened against
nephrocystin SH3 domain. Very  few clones were rescued from the first panning cycle after
cosmix-plexing, however, the second round showed a dramatic increase, demonstrating that
the first round was sufficient to wash away the background phage (Figure III-29/B). After
three rounds of panning, an enrichment factor of 570 was observed.
This strongly suggests that the recombined clones, selected after the first round of
primary panning, were a good starting material for the cosmix-plexing. Even if the
enrichment obtained during the primary affinity selection could not be considered as
significant, it has been now obviously demonstrated that  the preselected population contained
clones showing binding affinity for nephrocystin. This affinity was then further optimized
during the cosmix-plexing recombination, as proved by the output, and enrichment values of
the secondary panning procedure (Figure III-29/A).
Randomly picked clones were sequenced, and provided clones which had not occurred
during the primary panning selection (Figure IV-6). This suggests that the newly isolated
variants have a selective advantage for nephrocystin, compared to the three clones previously
described, this also being supported by phage ELISA analysis (Figure III-31). Clones isolated
against nephrocystin, but also against Src, are able to interact with nephrocystin (Figure IV-
6).
Half of the clones identified during the cosmix-plexing panning, do not contain the
proline rich cassette introduced in the CPLPPXP library, and are reduced to 8 amino acid long
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peptides. It was possible to isolate such short peptides, due to the two steps protocol used to
generate the CPLPPXP library. A primary bank was created with the insertion of a 8 amino
acid encoding oligonucleotide, and then, the final CPLPPXP library was produced by the
introduction of the proline rich cassette within the hypervariable oligonucleotide. When the
cassette was ligated with the vector, 20% of vectors were shown to religate without cassette,
forming back the parental vectors, containing the 8 amino acid peptide (Figure III-11).
Half of the nephrocystin selected clones after cosmix-plexing, were selected from only
20% of the library, whereas for Src, none of the 8 residue variants was isolated, indicating
that the shorter clones were providing a strong selective advantage for nephrocystin.
The analysis of the clones shows that nephrocystin ligands, contrary to Src ligands, do
not necessarily require a Pro Pro Ψ Pro core motif, but prefer a Pro Ψ Xxx Pro motif. This
latter motif is not present in the CPLPPXP library variants containing the proline rich
cassette, explaining that the GST-nephrocystin target interacts preferentially with the 20% of
the variants which did not contain the fixed proline motif.
Furthermore, since SH3 ligands required a motif of only 6 to 7 amino acids, the 8 amino
acid variants displayed on the surface of 20% of the phage particle of the CPLPPXP library,
are sufficient.
The second major variable between Src and nephrocystin ligands, involves the P3 to P5
motif. Src ligands were demonstrated to require at the positions P3-P5 the Arg Pro Leu motif.
In clones where the proline was replaced by another amino acid, no strong interaction was
possible with Src. However, nephrocystin ligands require a Arg Xxx Leu motif. A proline at
P4 is not disturbing, but is also not especially advantageous. The highest affinity nephrocystin
ligand isolated (N5), according to phage ELISA test, exhibits a methionine at P4, along with a
Pro Val Tyr Pro core motif.
The only clone isolated on nephrocystin SH3 domain, but not able to interact with the
target, was the N9 clone. N9 is the only reported clone (to our knowledge), isolated on SH3
domain, bracketed by two cysteines, and containing a proline core motif. As described in the
section A of the discussion, panning on SH3 domains, with constrained libraries, failed to
isolate SH3 ligands. The only reported peptide constrained by two cysteines was isolated
against Src, through a “mirror image phage display” (Schumacher et al., 1996). However, this
peptide is composed of non naturally occurring D-amino acids, and shows no similarity with
characterized SH3 ligands (no proline rich motif). This suggests that disulfide closed loop
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peptides would adopt a conformation different from the polyproline type II helix usually
required for interactions with SH3 domains. The disulfide bridge was demonstrated to be
crucial for interaction between this D-peptide and Src SH3 domain, indicating that the
constraints imposed by both cysteines on D-peptide give a correct conformation to the
peptide.
The N9 clone, which contains two cysteines, and the proline rich core motif, might not
be able to form a conformation optimal for SH3 binding.
A clear consensus sequence was obtained from strongly binding nephrocystin ligands,
however, a minimal consensus sequence showing the absolute requirements of nephrocystin
ligands, can also be conceived, which takes into account only residues which are conserved in
each high affinity ligand. The Src consensus sequence has very high homology with the
nephrocystin consensus sequence, explaining the common cross-reaction of Src and
nephrocystin ligands, for both SH3 domains. However, Src has more precise ligand
preferences and is therefore more selective; more Src ligands bind to nephrocystin, than
nephrocystin ligands to Src SH3 domain. The consensus sequences are presented here:
Consensus sequence from clones interacting with nephrocystin (Figure IV-6)
   β Xxx Arg (Pro)Leu Pro P/Ψ (Ψ) Pro P/V Xxx Pro Xxx
Nephrocystin minimal consensus sequence (shown by all high affinity clones)
Arg Xxx Leu Pro   Ψ Xxx Pro
Src consensus sequence
Arg Pro  Leu Pro   P/L    Ψ  Pro    Ψ   Ψ Pro S/Ψ
The ligands characterized against nephrocystin SH3 domain elevate the debate about
biased libraries. Biased libraries are considered advantageous when working with targets of
known ligand preferences, since they increase the chance of finding ligands with affinity of
their displayed peptides for the target. However, the results obtained for nephrocystin
demonstrate the potential risk in using such libraries.
We designed a biased library aimed to isolate strong ligands against SH3 domains, and it
was chosen to define a PPXP proline core motif within the peptides of our CPLPPXP library.
The library has been shown to be adequate in characterizing Src ligands, however, panning
selection with nephrocystin revealed that a PXXP core motif would have been more
appropriate for this target. To acquire ligands containing this required proline motif, the
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nephrocystin had to interact with the 20% of the CPLPPXP library which show no fixed
proline, leading to enrichment of variants exhibiting two prolines separated by two other
amino acids. If the CPLPPXP library would have been designed by insertion of a unique
sequence encoding the proline core motif within the hypervariable region (as done by several
other groups), the bank would not have contained the optimal sequences, and the 8 residue
PXXP ligands would not have been isolated. On this basis, it can be postulated that many
potential ligands, against a large number of target proteins might have been lost, by a too
systematic use of biased libraries containing a too highly defined motif.
                  Sequences against Nephrocystin SH3 domain E B
 P1     P2      P3     P4     P5    P6     P7    P8     P9    P10    P11    P12   P13
Strong binding clones
N5 Arg Met Leu Pro Val Tyr Pro Pro Asp Pro +     +
S4 Lys Gly Arg Pro Leu Pro   Pro Val Pro Gly Thr Pro Ser        + +
N8 Arg Pro Leu Pro Pro Thr Pro   Pro Ile Pro Gly Ser + +
N10/S1 Gly Asn Arg Pro Leu Pro   Pro Ile Pro Ser His Pro Phe + +
S2 Arg Pro Leu Pro Leu Pro   Pro Val Pro Trp Val Arg + +
N3* His Ser Arg Gln Leu Pro   Pro Lys Pro Val Pro Ser Leu + -
N4 Arg Thr Arg Arg Leu Pro Val Leu Pro Asp Pro + -
Consensus sequence
    β Xxx Arg (Pro)Leu Pro P/Ψ (Ψ) Pro P/V Xxx Pro Xxx
Weak binding clones
N2* Ser Val Arg Leu Leu Pro   Pro Val Pro Trp His Phe Gly + -
N1/S3* Arg Ser Leu Pro Leu Pro   Pro Val Pro Thr Ser Ser + -
N6 Arg Thr Pro Pro Thr Glu Pro Gln Thr + -
N7 Arg Met Leu Pro Val Lys Ile Tyr + -
N11 Arg Ala Arg Val Val Pro   Pro Val Pro Arg Leu His Thr + -
N9 Cys Ser Gln His Asp Pro   Pro Phe Pro Trp Arg Val Cys - -
Figure IV-6: Sequences of single clones isolated against nephrocystin SH3 domain, and
the deduced consensus sequence. The clones are classified according to their relative
affinity on phage ELISA, for the target. Only the strongly positive clones in phage ELISA
(Figure III-31), are taken into account for the conception of the consensus sequence. A
residue is considered as representative for the consensus sequence, when it occurs in 50% or
more of the sequences. Underlined amino acids are fixed residues within the CPLPPXP
library. Ψ and β represent hydrophobic and basic amino acids, respectively. E and B stand for
phage ELISA and BIAcore analysis. A simple + or – indicates whether the clones reacted
positively or not, in ELISA or BIAcore tests. P1 to P13 refer to the amino acid position within
the sequence. The red asterisks indicate clones characterized during standard panning
procedure. N clones were isolated against Nephrocystin, and S clones, against Src. Two
clones (N10/S1 and N1/S3) were isolated against both nephrocystin and Src. For occurrence
of each clone, or precise phage ELISA values, refer to Figures III-28, III-30 and III-31.
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Ligand preferences for nephrocystin SH3 binding appear to be slightly different than that
reported for SH3 domains. Until now, it has been thought that SH3 domains bind to proline
rich ligands. Therefore, the use of biased libraries appeared to be an advisable approach to
characterize SH3 ligands. However, it was recently reported that the SH3 domain of Eps8, a
substrate of receptor and non receptor tyrosine kinases, displays novel binding preferences
(Mongiovi et al., 1999). Eps8 SH3 domain interacts with ligands containing a PXXDY
consensus sequence, with a KD of 35 µM, similar to that found for SH3 domain/SH3 ligand
interaction. Use of proline rich biased libraries with Eps8 would have lead to unsuccessful
panning selection.
Biased libraries have to be carefully used. The ideal way to use a biased library, would
be first, to isolate ligands against the target of interest, from a random peptide library. Then,
in the eventuality that a consensus sequence can be defined, a biased library may be created,
which contains the defined motif. This would minimize the risk of eliminating the high
affinity ligands for a particular target, within a biased library. Biased libraries should be
regarded as secondary libraries.
Cosmix-plexing libraries are optimal for such strategies. Used as primary random
libraries to allow determination of a consensus sequence, they can then be converted into
biased libraries, since they are designed for facile insertion of a project specific cassette
within the hypervariable domain.
1-2-2 BIAcore analysis of nephrocystin ligands
The five clones which showed the highest relative binding on phage ELISA are also
reacting positively on BIAcore real time interaction measurements (N5, N8, N10/S1, S2, S4;
Figure III-47/B). Their KD were determined by steady state affinity data evaluation, with
BIAcore measurements, and ranged between 0,42 and 1,05 nM (Figure III-51).
When compared with usual KD values of SH3 ligands (Table IV-4), the nephrocystin
ligands are the highest affinity ligands ever characterized. Nephrocystin ligands appear to
interact with nephrocystin with an affinity 20 fold higher than for the CPLPPXP S1 clone/Src
interaction, and approximately 500 fold higher than the best SH3 ligands ever characterized
before this work.
The S1 clone binds nephrocystin with different kinetics compared to other nephrocystin
ligands, also different from the way S1 binds to Src (Figure III-47). S1 shows a extremely
rapid association with nephrocystin, compared to other clones, but the dissociation is also
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very fast, while other clones form a more stable complex with nephrocystin. However, their
KD values are very similar (0,52 nM for S1 and 0,42 for S4), and do not reflect the different
binding features. S1 and S4 show similar dissociation constants, however, their association
and dissociation rate constants are different. It might therefore be of general interest to
evaluate the ka and kd along with the KD. Kinetic information about biospecific interactions
can complement affinity measurements. S1 and S4 interactions with nephrocystin, present
different interests for in vitro analysis. Their distinct behaviors in interacting with
nephrocystin SH3 domain might compete differently other ligands.
1-2-3 Swissprot comparison of nephrocystin ligands
A computer-assisted sequence search with the Swissprot database revealed homology
between several nephrocystin ligands and naturally existing proteins.
The Table IV-6 presents the diverse homologies of the nephrocystin ligands.
N1 ligand RSLPLPPVPTSSA
Rat CAP1 PGPPPPPVPTSSG
N1 ligand RSLPLPPVPT SSA
Human WASP RSGPLPPVPLGIA
N3 ligand HSRQLPPKPVPSL 77,7% identity in 9 aa overlap
Mouse WASP ERRQLPPP PAPIN WASP: aa 159-167
Human WASP DRRQLPPPPTPAN
N8 ligand RPLPPTPP IPGSGS 75% identity in 12 aa overlap
Mouse WASP PP PPPPPPCPGSGP WASP: aa 416-427
Human WASP PP PPPPPPSSGNGP
N8 ligand RP LPPTPP I PGSGS 60% identity in 10 aa overlap
Human RHG1 KPMPPRPPLPNQQF RHG1: aa 229-238
N4 ligand TRRLPV LP 75% identity in 8 aa overlap
Human Sck TRRAPVAP Sck: aa 357-364
N6 ligand RTPPTEPQT 100% identity in 6 aa overlap
HIV1 Nef RTPPTETGV Nef: aa 22-27
Table IV-6: Swissprot database analysis of nephrocystin ligands. Regions of identity are
shown in red, and of homology in blue.
70% identity in 13 aa overlap
WASP: aa 338-350
89% identity in 9 aa overlap
CAP1: aa 237-245
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N1 (also called S3) shows 70% identity in a stretch of 13 amino acids with the human
WASP (Wiskott-Aldrich Syndrome Protein), and 89% identity in a stretch of 9 residues, with
the rat CAP1 protein (Adenylyl cyclase associated protein 1). N1 homologies are analyzed
under section B-1-5 of the discussion, as homologies of the S3 clone.
N3 and N8 also show homologies to WASP: 77,7% identity in a stretch of 9 amino
acids, and 75% identity in a 12 residue stretch, respectively. In addition, N8 has 60% identity
in a 10 amino acid stretch, with the human Rho-GTPase activating protein 1 (RHG1).
N4 shows a 75% identity with the human Sck, in a 8 residue stretch.
And finally, N6 shows a 100% identity with the HIV-1 Nef protein, in a 6 amino acid
stretch.
The identity between the N1 (also called S3) clones and the CAP1 protein was
previously discussed under section A from discussion, and therefore, is not repeated here.
1-2-3-1 WASP homologies
Homologies of N1, N3 and N8 for WASP appear very curious, since the three ligands
have identity with various sections of the WASP protein.
Defective WASP is associated with the Wiskott-Aldrich syndrome, leading to death
usually before the age of 10, and characterized by platelet and lymphocyte cell abnormalities,
most likely caused by defects in actin cytoskeleton organization (Ochs et al., 1980).
WASP has been shown to interact with many SH3 domains, Itk, Src, Lck, Abl, Nck3 and
Grb2 (Bunnell et al., 1996; Rivero-Lezcano et al., 1994; She et al., 1997). Bunnell et al.
(1996) also demonstrated that WASP contains distinct binding sites for its interactions with
Itk, Src, Lck and Abl SH3 domains. The N1 (S3) homology with WASP was demonstrated to
concern a region a WASP involved in interaction with C terminal SH3 domain of Nck.
However, the WASP binding sites for the other SH3 domains were not clearly defined, and
further homology analysis is not possible.
1-2-3-2 rho-GTPase activating protein 1 homologies
In addition to its similarity with a region of the WASP protein, the N8 ligand shows 60%
identity in a stretch of 10 residues, with the human RHG1. Like the nephrocystin N8 ligand,
the 3BP-1 protein, which was the first isolated SH3 ligand, showing 71% identity over a 17
amino acid region with the RHG1 (former described as GAP-rho) which participate in
cytoskeletal organization (Cicchetti et al., 1992). However, N8 and 3BP-1 present homologies
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with a different region of the RHG1.
The function of the RHG1, as its full name indicates, is to activate the GTPases of the
rho, Rac, and cdc42 proteins, and to convert them to the putatively inactive GDP-bound state.
Cdc42 appears to be its preferred substrate. RHG1 contains a functional SH3 binding domain
(Barfod et al., 1993), however, the N8 ligand homology for RHG1 does not concern the SH3
binding site (aa 251 to 262), but a region short before (aa 229 to 238).
The Rho family member cdc42 interact with multiple proteins belonging to the family of
the serine/threonine kinases. Interaction of cdc42 with Ser/Thr kinases, activates their kinase
domain. Ser/Thr kinases can then regulate the MAP kinase signaling cascades, leading to
actin cytoskeletal rearrangements.
The activated cdc42 protein has been shown to interact with WASP (Symons et al.,
1996).
Homologies for nephrocystin ligands with WASP or RHG1, even if not always clear,
seem to indicate a link between nephrocystin SH3 domain, and the actin cytoskeleton.
1-2-3-3 Sck homologies
The nephrocystin N4 ligand show 75% identity on a region of 8 residues with the human
Sck protein. Sck contains a SH2 domain (Kavanaugh et al., 1994). The homology between N4
and Sck suggests that Sck could be recruited by Src SH3 domain, or the contrary.
1-2-3-4 HIV-1 Nef homologies
The nephrocystin N6 ligand also shows complete identity (100%) with a 6 amino acid
region of the Human Immunodeficiency Virus type 1 (HIV-1) Nef protein. Nef is required for
enhancing viral infectivity, however, its in vivo role in pathogenicity remains unclear (Lee et
al., 1996). Nef acts at an early step of the viral replication cycle. The Nef protein has been
shown to interact with a subset of Src family kinase SH3 domains, with a very high affinity
(KD of 0,25µM for Hck SH3; Saksela et al., 1995). The physiological relevance of the
interaction of Nef with SH3 domains is unknown. Nef has also been shown to bind  a
serine/threonine kinase, through a RR motif in Nef, and it appears that other cellular factor(s)
are involved in the efficiency of the viral entry (Tokunaga et al., 1999). However, the identity
is unlikely to be significant, since Nef binds SH3 domain at a different region than the one
showing homology with the N6 ligand.
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 1-3 Nck SH3 domains
Difficulties appeared when panning selections were performed on N terminal and central
Nck SH3 domains (Nck1 and Nck2). After standard affinity selections, no enrichment was
observed. However, sequencing of picked clones led to the determination of a short consensus
sequence, Asp Gly Tyr, conceived from only two clones which occurred several times, for
both Nck1 and Nck2.
NP1 Ser  Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
Curiously, these two clones do not present a proline motif (so, both clones were called
Non Proline 1 and 2 clones: NP1 and NP2), and belong to the 20% of the CPLPPXP library
which does not contain the proline rich cassette.
A cosmix-plexing recombination, followed by screening of the secondary library were
performed, and as far as Nck1 was concerned, gave the same results as for the primary
panning, only NP1 and NP2 were found.
For Nck2, even though no significant enrichment was detected, randomly selected
clones allowed the characterization of clones corresponding to expected SH3 ligands,
containing a proline rich core motif. The clones occurred only once each, indicating that none
of them showed a dominant affinity for Nck2 over the other variants. However, surprisingly,
the alignment of the clones show some homologies. The variants were divided into three
groups, according to their similarities. All three sets present an over-representation of
aromatic residues, especially tryptophan and tyrosine, directly after the proline core motif
(P10), but differ in other characteristics (Figure IV-7).
The first group of clones were grouped together by virtue of the proline residue at P12.
Other similarities were obvious; Phe at P8, Cys or Thr at P3, or hydrophobic residues at P4.
Clones of the second group were selected because of their arginine at P5, but other
homologies were observed, such as Ser at P1 and Ser or Cys at P13, and Leu at P11.
The third group contained the clones which did not belong to the previous two
classifications. However, even though no position was defined as a particular residue, except
the aromatics at P10, a very high content of hydrophobic residues was observed.
However, after a further cycle of panning, NP1 and NP2 largely dominate other clones.
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Sequences against Nck2 SH3 domain, from cosmix plexing library
  P1    P2     P3    P4      P5     P6     P7     P8    P9     P10   P11   P12   P13
  First group
Ser Leu Gly Ile Trp Pro   Pro Phe Pro Trp Ile Pro Ile
Ala Ser Cys Phe Gln Pro   Pro Phe Pro Trp Thr Pro Leu
Arg His Cys Val Gly Pro   Pro Asp Pro Tyr Val Pro Met
Thr Cys Thr Ala Leu Pro   Pro Phe Pro Trp Ser Pro Arg
Leu Val Thr Cys Val Pro   Pro Phe Pro Trp Pro Pro Pro
Consensus sequence
Xxx Xxx  C/T   Ψ Xxx Pro   Pro Phe Pro W/YXxx Pro  Ψ
Second group
Pro Arg Asn Val Arg Pro   Pro Ala Pro Trp His Gly Ser
Ser Thr Gly Arg Arg Pro   Pro His Pro Phe Leu Val Ser
Lys Phe Met Asn Arg Pro   Pro Gly Pro Trp Leu Ala Cys
Ala Ser Ser Thr Arg Pro   Pro Cys Pro Tyr Leu Asp Ile
Arg Pro Arg His Arg Pro   Pro Val Pro Val Val Lys Pro
Ser  Val Phe Leu Arg Pro   Pro Cys Pro Ala Leu Gly Asn
Ser Ser Tyr Arg Arg Pro   Pro Leu Pro Ser His Arg Cys
Consensus sequence
       (Ser) Xxx Xxx  (β) Arg Pro   Pro Xxx Pro  ϕ Leu Xxx S/C
Third group
Met Phe Gln Phe Gly Pro   Pro Cys Pro Tyr Leu Asp Ile
Val Gly Leu His Trp Pro   Pro Val Pro Trp Val Gln Arg
Leu Lys Leu Val Asn Pro   Pro Gln Pro Tyr Phe Ile  Leu
Asp Ser Leu Ala Glu Pro   Pro Phe Pro Tyr Met Ile  Val
Gly Glu Tyr Val Trp Pro   Pro Val Pro Trp Ser  Met Met
Consensus sequence
   Ψ Xxx Leu   Ψ Xxx Pro   Pro  Ψ Pro W/Y   Ψ     Ψ      Ψ
Figure IV-7: Sequences of single clones, after two rounds of cosmix-plexing panning
against Nck2 SH3 domain, and the deduced consensus sequences. The clones occurred
only once each. A residue is considered as representative for the consensus sequence, when it
occurs in 50% or more of the sequences. Underlined amino acids are fixed residues within the
CPLPPXP library. Ψ, β, and ϕ represent hydrophobic, basic and aromatic amino acids,
respectively. P1 to P13 refer to the amino acid position within the sequence.
It was reported that strong negative selection commonly occurs against odd number of
cysteines residues (Kay et al., 1993). It was hypothesized that phage that express unpaired or
lone cysteines may be detrimental to phage propagation, since the cysteines are likely to form
disulfide bridges with cysteines of other displayed peptides, or with cysteines of the phage.
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The pIII protein contains 8 cysteines, which are all involved in disulfide bridges (Kremser and
Rashed, 1994). Displayed peptides containing unpaired cysteines, might connect with one of
the cysteines of the pIII, and therefore, disturb the conformation of the complete particle.
However, the clones selected against Nck2 SH3 domain show an extremely high
frequency of lone cysteines. From the first two groups of variants, 66% of the clones
contained a single cysteines. None of the clones possess a pair of cysteines. Within the first
group, the cysteines are located N terminally from the proline rich motif, while in the second
group, the cysteines are localized C terminally. It has to be pointed out that stable phage
displaying peptides containing a single cysteine have already been reported (Armstrong et al.,
1996). Presumably, these lone cysteines were buried in an inaccessible region of the peptides
which fold up on themselves.
The reason of the presence of single cysteines within Nck2 SH3 domain is unclear. It
might be possible that these cysteines form a disulfide bridge with a cysteine of the Nck2
protein.
It was concluded that cosmix-plexing recombination allowed the isolation of proline
rich clones which could be grouped in three consensus sequences. However, these clones
were not quantitatively enriched, and failed to react with the Nck2 SH3 domain on phage
ELISA, indicating that the clones if really interacting with Nck2, were binding too weakly to
give a signal. The only clones giving a signal in phage ELISA on Nck1 and Nck2 SH3
domains, were the non prolines NP1 and NP2 clones.
One consideration would be that the incapacity of isolating strong proline rich ligands
against Nck1 and Nck2 would be explained by the fact that NP1 and NP2 competed
effectively with other clones. However, this is unlikely, since NP1 and NP2 react moderately,
on phage ELISA,  with Nck1, and very weakly with Nck2 SH3 domains.
In the light of the results obtained for nephrocystin, it might be possible that failure to
isolate high affinity clones for the various Nck SH3 domains is due to a non appropriate use
of biased libraries, as discussed in the previous section. It is possible that the PPXP core motif
imposed to the CPLPPXP library, is not advantageous for Nck SH3 domains. Furthermore,
reported Nck ligands seem to be longer than for other SH3 domains (10 to 12 amino acid long
regions), reducing the chance that Nck SH3 domains interact with some of the 8 amino acid
random peptides, constituting 20% of the CPLPPXP library. However, these Nck ligands are
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natural binders, and peptide ligands, isolated from phage display might be different, or present
a minimal core motif necessary for interaction with Nck, which would consists only of a
portion of known ligands.
Isolation of ligands for one of the Nck SH3 domains using phage display has not been
reported. Spark et al. (1996) described the expression of GST constructs, where the GST was
independently fused to the Nck1, Nck2 and Nck3 SH3 domains, however, no results on Nck
have been presented, suggesting a failure in the panning procedure. Sparks et al. were also
using a biased library (X6PXXPX6).
Nck has been shown to interact with a large variety of proteins. The three SH3 domains
of Nck (Nck1, Nck2, Nck3) can interact selectively with target proteins. The Nck1 domain
mediates Nck association with the Nck-Associated Protein 1 (Nap1) (Kitamura et al., 1996).
Nck2 domain links Nck with many ligands, including p21-Associated Kinase (PAK)
(Galisteo et al., 1996; Lu et al., 1997), Sos, a guanidine nucleotide exchange factor for Ras
(Hu et al., 1995), the serine/threonine kinase PRK2/NAK (Quilliams et al., 1996; Chou and
Hanafusa, 1995),  Nck, Ash-, and phospholipase Cγ-binding protein 4 (Matuoka et al., 1997),
and WIP (WASP Interacting Protein; Anton et al., 1998).
The Nck3 domain mediates Nck interaction with the Wiskott-Aldrich syndrome protein
(WASP) (Rivero-Lezcano, et al., 1995), and the γ isoform of the serine/threonine kinase
casein kinase I (CKI-γ2) (Lussier et al., 1997).
Other proteins that have been shown to interact with Nck, but for which the specific SH3
domain that mediates binding has not been defined, include c-Cbl (Rivero-Lezcano et al.,
1994), focal adhesion kinase (Choudhury et al., 1996), pp105, a lymphocyte-type CRK-
associated substrate that bind to FAK and Crk (Minegishi et al., 1996), and Nck Interacting
Kinase (NIK; Su et al., 1997).
Despite the number of possible Nck interactions, no phage display isolated ligands were
reported. In this work, as well as in Sparks (Sparks et al., 1996), interactions with individual
SH3 domains of Nck were investigated. However, presence of three distinct SH3 domains
suggests that Nck may be capable of simultaneously associate with several ligands, or that
binding partners require more than one SH3 domain.
Dynamin selectively interacts with one of the C terminal Nck SH3 domain (Wunderlich
et al., 1999a). Similarly the PRK2 binds to the second SH3 domain of Nck (Quilliams et al.,
1996). In both cases, the proteins bind the individual Nck SH3 domains, and the full length
Discussion
252
Nck with similar affinity.
However, Sos (Wunderlich et al., 1999a), WASP (Finan et al, 1996) and PAK1 (Bokoch
et al., 1996) were demonstrated to bind specifically with the third (Sos, WASP) or second
(PAK1) Nck SH3 domains, but, for the three proteins, combined SH3 domains contributed to
a high affinity binding.
Cbl binds to constructs containing the first and the second Nck SH3 domains, however,
it do not interact with any of the individual SH3 domains. Proteins like Cbl, Bcr/Abl, p155,
and NIK bind in vitro, only to combined SH3 domains (Wunderlich et al., 1999b).
Since it is proved that Nck SH3 domain cooperation enhances the binding of proteins
(Wunderlich et al., 1999b), work with full length Nck would have enhanced the chances of
isolating high affinity ligands.
Furthermore, it seems that Nck ligands contain several proline rich domains (e.g. WASP,
WIP, Sos, NIK) and therefore it could be that some Nck ligands interact simultaneously with
several Nck domains. If multiple interactions are required, short peptides are not relevant to
reproduce such interactions, and would fail to bind to Nck with high affinity.
2-EVH1 domains
In 1997, it was demonstrated for the first time that the EVH1 domains interact with
proline rich ligands (Niebuhr et al., 1997). Since then, an EVH1 domain-containing protein
family has been characterized, and several new binding targets were discovered, allowing
specification of their ligand preferences. However, to our knowledge, this is the first time that
phage display was used to isolate ligands against various EVH1 domains.
2-1 Vesl/Homer EVH1 domain
Vesl (also called Homer) belongs to the family of EVH1 domain containing proteins, but
structurally, and functionally, appears to be different (Figure IV-8). While EVH1 domain
binding mediates proper localization of Ena, VASP, Mena, Evl, and WASP, which then
recruit components of the actin assembly machinery (Prehoda et al., 1999), Vesl functions in
synaptic plasticity (Brakeman et al., 1997; Kato et al., 1997).
The variations within the consensus sequences of EVH1 ligands, reflect the functional
differences between Vesl and the other members of the EVH1 family. EVH1 domains
involved in actin dynamics recognize ligands with a Phe Pro Pro Pro Pro Pro consensus
sequence, while Vesl interacts with ligands containing the Pro Pro Xxx Pro Phe Arg Asp
Discussion
253
consensus sequence, which look quite similar to the SH3 class II ligands (Pro Pro Xxx Pro
Xxx Arg) (Figure III-33).
Ena, Evl, VASP
 EVH1             SH3             profilin       EVH2
          binding          binding
   motif             motif
WASP
            cdc42   WH2   Arp2/3
       binding motif     binding
Vesl
      dimerization
Figure IV-8: Illustration of the structure of the EVH1 domain containing proteins. Ena,
Evl, VASP, and WASP are involved in regulation of the actin cytoskeleton and contain motifs
that can interact with various signaling proteins, and actin binding proteins. The Vesl plays a
role in synaptic plasticity (Prehoda et al., 1999).
Panning selection was performed on Vesl, according to the protocol optimized for Src
SH3 domain. Standard panning led to high enrichment (600) after four cycles, and to the
obtention of a consensus sequence: Arg Ψ (ϕ/Ψ) Xxx Pro Pro (ϕ/Ψ) Pro W/Y Xxx D/F
The cosmix-plexing recombination, followed by affinity selection, led to an enrichment
factor of 1000 after three rounds of panning. Clones sequenced from the first round showed
predominance of the V1 clone, which was already the most frequent variant after standard
panning, but in addition, several new clones were isolated, which clarify the consensus
sequence: Ser Arg Ψ Y/F(α) Pro Pro F/P ProW/YXxx Ψ Ψ
However, the alignment of clones which interact strongly with Vesl, on phage ELISA
(Figure III-38), led to the consensus sequence which reflects the strongest ligand preferences
of Vesl: Arg Ψ Y/F (Asp) Pro Pro F/Ψ Pro W/Y Xxx Asp Ψ
The clones isolated against Vesl are presented in Figure IV-9, according to their relative
binding for Vesl. The essential positions for high affinity binding with Vesl EVH1 domain are
most of all, the aromatic residue (tryptophan or tyrosine) at P10, along with Arg at P2 and an
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aromatic residue (tyrosine, or eventually phenylalanine) at P4. The aspartic acid at position P12
appears to be advantageous, since the three best clones have it, however, it is not crucial for
the interaction. It may favor the binding between Vesl and its ligands, through the formation
of a salt bridge, which would stabilize the interaction.
    Phage ELISA on Vesl EVH1 domain       OD492
                    (positive clones)
 P1     P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
Strong binding clones
V1 Asp Arg His Tyr Arg Pro   Pro Phe Pro Trp Ala Asp Gly 0,87
V2 Asn Arg Leu Tyr Pro Pro   Pro Trp Pro Tyr Ser Asp Pro 0,76
V6 Tyr Leu Ile Leu Ser Pro   Pro Ala Pro Trp Arg Asp Arg 0,67
V3 Ser Arg Ser Val Tyr Pro   Pro Pro Pro Tyr Pro Phe Ala 0,55
V8 His Met Leu Phe Asp Pro   Pro Phe Pro Tyr Ser Asn Glu 0,52
V9 Ser His Ile Phe Asp Pro   Pro Phe Pro Tyr Gly Pro Met   0,48
Consensus sequence
Xxx Arg  Ψ Y/F (Asp)Pro   Pro F/Ψ Pro W/YXxx Asp  Ψ
Weak binding clones
V4 Asp Arg Ile Tyr Leu Pro   Pro Val Pro Trp Ala Asn Ser 0,21
V11 Ser Arg Val Tyr Pro Pro   Pro Phe Pro Trp Arg Ala Val      0,17
V7 Cys Ser Arg Ser Arg Pro   Pro Val Pro Leu Gly Pro Phe 0,05
V5 Arg Thr Gly Val Trp Pro   Pro Pro Pro His Asp Phe Arg 0,03
V10 Ser Leu Leu Tyr Glu Pro   Pro Pro Pro Trp Asn Ser Pro 0
Figure IV-9: Relative affinity, according to a phage ELISA test, of the clones isolated
against Vesl EVH1 domain. The clones are classified according to their phage ELISA
signals. None of the clones react with GST alone (not shown). A new consensus sequence is
conceived from the strongest clones. Underlined residues are fixed within the CPLPPXP
library. Ψ represents hydrophobic residues.
Comparison with the consensus sequence deduced from alignment of clones isolated
from phage display technology, with the consensus sequence obtained from alignment of Vesl
natural ligands shows homology.
Phage display consensus sequence
Arg  Ψ Y/F (Asp)Pro   Pro F/Ψ Pro W/YXxx Asp  Ψ
Natural ligand consensus sequence
Xxx Pro Pro Xxx Pro Phe Arg Asp
Similarities between both
Pro Pro Xxx Pro AromXxx Asp
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The proline core motif, the aromatic position directly following, and the Asp three
residues after the proline motif, are conserved between natural ligands and the clones isolated
with phage display. However, natural ligands preferred a phenylalanine as aromatic amino
acid, while the peptide ligands exhibit a tyrosine or a tryptophan. The only position defined
for the natural ligands, but not for the peptides, is an Arg, between the aromatic residue, and
the aspartic acid, on the C terminal part of the proline motif.
The consensus sequence deduced from the phage display ligands provides more
information about the region N terminal to the proline core motif.
It is interesting to notice that the Vesl motif possesses similarities to the SH3 motif,
especially, according to our results, to the ligand preferences of Nck2, which also possess an
important aromatic residue directly after the core motif. The observation that Sos which is
known as an SH3 ligand, can bind Vesl, using the same sequence for SH3 and Vesl EVH1
domains, confirms the link between SH3 domains and Vesl EVH1 domain ligand preferences
(Prehoda et al., 1999).
As with studies of SH3 interactions, the Vesl ligand peptides should provide a valuable
tool to assess the functions of Vesl.
A Swissprot analysis of the various clones obtained after affinity selection showed 80%
identity between the V3 clone and the human MGR1 (metabotropic glutamate receptor 1
precursor), a receptor for glutamate, belonging to the mGluR5 family, a G protein coupled
receptor.
V3 ligand SRSVYPPPPYPFA 80% identity in 10 aa overlap
Human MGR1 LRSLYPPPPPPQH MGR1: aa 1063-1072
Group1 metabotropic glutamate receptors (mGluR) represent a family of seven
membrane-spanning proteins, coupled to G proteins and which activate phospholipase C.
Members of the family include mGluR5. Activation of these receptors activate protein kinase
C, and inositol triphosphate (IP3) production, which induce the IP3 receptors to release
intracellular calcium.  Metabotropic signaling has been implicated in several forms of activity
dependent synaptic plasticity, but its role remains controversial (Tu et al., 1998).
However, the mGluR5 binds Vesl, through a TPPSPFR region entirely conserved in the
MGR1, on the C terminal domain, which is not the one concerned by the homology with the
V3 clone.
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2-2 Mena, Evl and VASP EVH1 domains
Standard panning selection on Mena, Evl and VASP EVH1 domains led to the isolation
of clones, which were not quantitatively enriched, but which share homologies. However, the
characterized variants did not react against the EVH1 domains, on phage ELISA. A large
number of unproductive clones were found (40 to 70% of the sequenced clones, according to
the proteins). In addition, the non proline clones NP1 and NP2 were isolated several times.
However, consensus sequences have been conceived for all three proteins, and are
shown, along with the consensus sequence of natural ligands interacting with the EVH1
containing proteins, involved in actin assembly:
  P1    P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
Evl   ϕ Xxx   Ψ   Ψ    Ψ Pro   Pro  Ψ Pro W/YXxx Xxx Xxx
VASP   Ψ Xxx   Ψ Xxx Ψ/ϕ Pro   Pro Phe Pro Tyr Xxx Y/F Xxx
Mena Xxx Xxx Xxx   Ψ  α/L Pro   Pro  Ψ Pro Met  Y/L   Ψ Ψ/Y
Natural EVH1 family ligands
Xxx Xxx   Ψ   α Phe Pro Pro Pro Pro Pro   Ψ  α   Glu/Ψ
The EVH1 ligand preferences observed with our clones, do not correspond to
expectations, regarding the consensus sequence deduced from EVH1 domain natural ligands.
The main feature of EVH1 natural ligands, is the phenylalanine position directly before
the proline core motif, at P5. Individual mutations showed that the phenylalanine can be
replaced by tyrosine or tryptophan, which even improved the binding between the natural
ligand and the EVH1 domain. Every other amino acid at this position disrupted the interaction
(Niebuhr et al., 1997). This aromatic position has been shown to be absolutely essential for
the interaction. According to the peptide scan performed by Niebuhr et al. (1997), the proline
replacements were quite well tolerated, at least if the prolines were mutated one at a time.
However, prolines at positions P7 and P8 appeared to be more sensitive than at P6 and P9.
Substitutions at P10 are do not alter the binding.
However, according to the consensus sequences obtained after primary panning, from
the phage display clones, EVH1 characteristics appear as a mirror image of that observed with
the natural ligands. Indeed, the most defined position, for the three proteins, is P10 (which was
silent in natural ligands). Furthermore, this position is determined, for Evl and VASP, as an
aromatic residue (tyrosine or tryptophan for Evl, tyrosine for VASP), while aromatic residues
were found at P5 in natural ligands. This crucial P5 aromatic position of the natural ligands,
appears mainly as hydrophobic positions in our clones, even if VASP seems to prefer
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aromatic hydrophobic residues (tryptophan or phenylalanine).
This might suggest, as proposed by Tu et al. (1998), Mahoney et al (1999), and Fedorov
et al. (1999), that the degeneracy observed for SH3 domains, and profilin might also be valid
for EVH1 domains, and that they might be able to bind their proline rich ligands in two
orientations. Fedorov et al. (1999) even suggested that the polarity would then be determined
by the phenylalanine (at P5 within the natural ligands, and at P10, like in our clones, for the
second class of ligands), which would interact with a number a methylene groups contributed
by four conserved hydrophilic residues. However, this has not yet been proven, and no
ligands containing the aromatic residue after the proline motif have been characterized
previously.
A cosmix-plexing recombination was performed, but screening of the secondary library
led exclusively to the isolation of the non-proline clones, NP1 and NP2. These NP1 and NP2
variants were shown to specifically interact in vitro with the various EVH1 domain containing
proteins. However, their binding shows target specificity. Vesl and Mena react strongly with
the non proline clones; NP1 and NP2-VASP interactions are quite weak, whereas ELISA
signals between the non proline variants and Evl EVH1 domain are almost non-existent, i.e.
OD values are nearly at the background level (Figure III-40). Up to now, parallels between
SH3 and EVH1 domains were limited to the observation that they both prefer proline-rich
ligands adopting a polyproline type II helix. It was also suggested that both SH3 and EVH1
domains were able to interact with their ligands in two orientations (shown for SH3 domains,
but not for EVH1 domains). However, the non proline clones provide evidence of a stronger
link, since it is the first time that a common ligand between both modules is characterized
(Niebuhr et al. (1997) showed that usual SH3 ligands were not binding EVH1 domains in
vitro).
Since the consensus sequences obtained for Evl and VASP show homologies with those
for Vesl, especially the aromatic residue at position P10, it was decided to screen the cosmix-
plexed library optimized for Vesl, against the other EVH1 domains.
The affinity selection against Mena was unsuccessful, as expected since the Mena
consensus sequence was not resembling that of Vesl (Mena binding does not require aromatic
residue at P5 as do Vesl, or at P10 like Evl and VASP, but rather at P11 or P13).
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However, this system allowed characterization of new clones against Evl, and VASP,
which were in some cases quantitatively enriched. This permitted the conception of consensus
sequences.
Evl clones could be classified into two groups, which allowed consensus sequences to be
made. However, these consensus sequences are very different from those obtained from the
original CPLPPXP library. They also show no similarity with the natural ligand consensus
sequence.
Evl, first group Xxx Xxx Xxx  Ile Xxx Pro   Pro Cys Pro Ser Xxx   ϕ Xxx
Evl, second group Xxx Xxx   Ψ     Ψ Xxx Pro   Pro Phe Pro Asp   Ψ     Ψ Xxx
However, every clone identified with the Vesl optimized library, against Evl, possesses
an acidic residue, at P3, P5, P10 (preferred) or P11 (Figure III-41), which is a particular
characteristic of natural EVH1 ligands. However, none of the clones (even the dominant one
isolate 7 fold) was able to interact in vitro with Evl, according to phage ELISA.
Clones identified against VASP also yielded to two consensus sequences, which showed
homologies with the consensus sequence conceived after panning selection using the original
CPLPPXP library.
  P1    P2     P3     P4     P5     P6     P7    P8     P9    P10    P11    P12   P13
CPLPPXP library   Ψ Xxx    Ψ Xxx Ψ/ϕ Pro   Pro Phe Pro Tyr Xxx Y/F Xxx
VASP first group Asp Arg Leu Tyr   α Pro   Pro  F/Ψ Pro  W/Y Xxx Xxx  Ψ
VASP second group Xxx Leu   β  Y/V Arg Pro   Pro Xxx Pro Trp    Ψ Xxx Xxx
All three consensus sequences present an aromatic residue at P10. Otherwise, the new
consensus sequences are longer, and more defined than the one obtained on standard panning,
indicating that the screening performed with a library optimized for another target, but which
showed strong homologies with VASP, was appropriate.
The Vesl optimized library consensus sequences show for both groups a high preference
for tyrosine at P4. This position might be a link between our clones, and the natural ligands,
which all contain a phenylalanine directly before the core motif, which can be replaced by
other aromatic residues (Niebuhr et al., 1997).
For both newly obtained consensus sequences, the region N terminal from the proline
motif is more defined than the C terminal part.
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More charged residues occurred within the sequences. 8 out of the 9 isolated clones
(Figure III-42), possessed one or two acidic residues (especially within the first group). This
is important, since EVH1 ligands are assumed to stabilize their interaction with the domains,
through salt bridge contacts between their acidic residues, and conserved basic amino acids of
the EVH1 domains. A high frequency of basic residues are also observed, especially for the
variants of the second group. However, their function is unclear.
Nevertheless, in spite of the homologies between the clones, and with previous
consensus sequences, the variants were unable to interact with VASP in vitro, on phage
ELISA.
3- Non proline ligands
3-1 NP1 and NP2 specifically interact with the binding site of SH3 domains
Unexpectedly, several SH3 and EVH1 domains have been shown to interact with two
clones which are not enriched in proline residues, the NP1 and NP2 variants.
NP1 Ser Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
When tested on phage ELISA, both clones were demonstrated to bind with all of the
SH3 and EVH1 domains tested (Figure III-43). However, NP1 and NP2 interact with each
module with different relative affinities, demonstrating higher specificity for particular
domains (Src, nephrocystin, Grb2, Nck1 and Abl SH3 domains, Vesl and Mena EVH1
domains). Both non proline clones react weakly with Nck2 and Crk SH3 domains, and with
Evl and VASP EVH1 domains.
Panning selections on Src, nephrocystin and Nck2 SH3 domains provided interesting
ligand consensus sequences. However, the CPLPPXP library was screened on several other
SH3 modules, which led only to the isolation of both non proline clones (such as Nck1, Abl,
ALP, p67phox or p53bp2 SH3 domains).
The recurrent isolation of these both clones, might mean that NP1 and NP2 were the best
ligands for the target, which could have been selected from CPLPPXP library. This is
unlikely, since the CPLPPXP library was designed to isolate high affinity ligands, but
possible if the PPXP core motif was not the most appropriate proline motif for the target (as
was observed for the nephrocystin SH3 domain).
The second hypothesis to explain the high frequency identification of NP1 and NP2, is
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that the CPLPPXP library might have been contaminated with the non proline clones, and that
it was then more difficult to select other variants, since NP1 and NP2 have a selective
advantage, due to their shorter replication time (their are 5 amino acids shorter than proline
rich clones). Lowman and Wells (1991) discussed the problem of contamination of phagemid
libraries with wild-type or affinity selected variants. In some cases, the contaminants have
high affinity for the target, and are amplified round after round at the expense of the desired
clones. However, it happens that the contaminants are low affinity binding clones, but
repetitive contamination of a library may give rise to a significant subpopulation of
contaminant.
NP1 ands NP2 have been shown to interact in vitro, on phage ELISA, with a panel of
SH3 and EVH1 domains. But it was also demonstrated that they bind to the domains, through
their active binding site, where the proline rich ligands specifically interact. This was tested
by competitive phage ELISA, where interaction between Src SH3 domain, and NP1 or NP2
clones was analyzed, in the presence of increasing amounts of competitor (Figure III-45). The
chosen competitor was the S1 synthesized free peptide, assumed to be the best characterized
Src ligand, according to its affinity constant. On phage ELISA, free S1 peptide competed with
the S1, S2, S3, S4, NP1 and NP2 phage displayed peptides for SH3 binding (Figures III-44
and III-45).
This clearly demonstrated that both types of non-proline and proline rich ligands interact
with Src SH3 domains at the same binding site. It might then be expected that NP1 and NP2
bind the other tested SH3 and EVH1 domains at their active binding site.
The relative binding differences observed from interaction between NP1, NP2 and
individual SH3 or EVH1 domains on phage ELISA, suggest that the non proline clones bind
the domains in a protein specific way. The SH3 binding site is composed of a hydrophobic
groove flanked by the n-Src and RT loops, where the proline core motif anchors a ligand to
the module, and of a specificity pocket, which is structurally diverse amongst the SH3 family
members, and which allows extensive contact with the residues flanking the proline motif.
The specificity for each particular SH3 domain is determined by this latter interaction.
Therefore, the NP1 and NP2 ligands are expected to bind to SH3 domains, via interaction
with all or a part of the specificity pocket.
3-2 Non proline ligands for SH3 domains
SH3 domains are known to bind proline rich ligands. However, several cases have been
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 reported, where SH3 domains were shown to be able to interact with non proline rich binders.
In their study of left handed polyproline II helices, Adzhubei and Sternberg (1993)
showed that proline is the most preferred residue of PPII helices, and is highly advantageous
for protein regions which fold as PPII helices. However, proline is not crucial for PPII helices,
since within the 96 PPII helices listed by Adzhubei and Sternberg, 28 are formed without a
single proline.
The cdc25 protein of the Saccharomyces cerevisiae which stimulates the Ras protein
activity, includes a SH3 domain. Buu et al. (1995) isolated a yeast protein, the
glyceraldehyde-3-phosphate dehydrogenase (GAP3DH) able to interact with the cdc25 SH3
domain. However, sequences of GAP3DH revealed no proline rich regions susceptible of
interaction with SH3 domains. Nevertheless, Adzhubei and Sternberg (1993) have pointed out
that GAP3DH presents one short stretch encompassing three residues which adopts a PPII
helix. Buu et al. suggested that the interaction between the cdc25 SH3 domain, and the
GAP3DH is mediated through this PPII region. However, they did not demonstrate it
experimentally, and the binding region was not mapped.
Growth factors that activate transmembrane tyrosine kinase receptors also activate Src.
The Src protein exists in repressed and activated states. SH3 and SH2 domains, and the C
terminal tail have roles in regulating Src kinase activity. Phosphorylation of Tyr527 inhibits
Src catalytic activity, by creating an intramolecular binding site for the SH2 domain, which
locks the molecules in an inactive state (Cooper and Howell, 1993). Xu et al. (1997)
crystallized human c-Src in a closed inactive conformation. They showed that a 14 residue
polypeptide linker which joins the SH2 and the catalytic domains, interacts along its course
with the SH3 domain, and that this interaction contributes to the stability of the closed state.
Although this linker contains only one proline (PTAKPQTQGLAKDA), it adopts, from
residues 249 to 253 (in bold), a polyproline type II helical conformation in complex with the
recognition surface of the SH3 domain. C terminal to the Gln253, the linker is not in PPII
conformation, but continues to make extensive contact with the SH3 domain.
By using an original “mirror image” phage display method, Schumacher et al. (1996)
succeeded to isolate D-enantiomer non proline rich ligands against Src SH3 domain. The two
D-ligands characterized with this technique against the Src SH3 domain do not resemble the
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usual SH3 ligands, and are bracketed by cysteines. But since they are D-enantiomer, the
sequences are not comparable with usual ligands.
More recently, Mongiovi et al. (1999) described a novel peptide-SH3 interaction. They
demonstrated that the SH3 domain of Eps8, a substrate of receptor and non-receptor tyrosine
kinases, interact with peptides containing the minimal consensus sequence: PXXDY.
The crystal structure of Eps8-SH3 domain revealed an intertwined dimer, in which the
two anti-parallel β sheets that are characteristic for the SH3 fold, are constituted by different
polypeptide chains (Kishan et al., 1997).
In Eps8 dimer, the n-Src loop from each monomer extends into the neighboring
molecule. As a result, part of the classical PPII binding groove of each monomer is included
in the dimer interface, and is therefore inaccessible to ligands as they are bound in other SH3
domains (Kishan et al., 1997). Kishan et al. (1997) suggested that this unique organization of
the Eps8 SH3 binding site appears to be the explanation for the observation that the usual
PXXP proline motif peptides are not the optimal ligands.
However, Mongiovi et al. (1999) showed that the monomer form of Eps8 SH3 domain is
the one active in ligand binding, meaning that peptides with the PXXDY consensus motif
bind the monomeric form of Eps8 SH3 domain. The three dimensional structure of the
monomeric Eps8 SH3 domain is unknown. However, amino acid conservation at positions
involved in the formation of the hydrophobic groove suggests high structural conservation
between Eps8 SH3 domain, and other members of the SH3 family whose monomeric three
dimensional structures are known. Thus, the difference in specificities between Eps8 and
other SH3 domains, might be due to residues which are not conserved in the SH3 family,
likely in the specificity pocket which is diverse amongst SH3 family members.
It is interesting to compare the non proline clones isolated in this work, NP1 and NP2,
with the ligand preferences of Eps8 SH3 domain. Some similarities are evident, since the
Eps8 presents a Asp Tyr motif, and both NP1 and NP2 contain a Asp Gly Tyr motif. The
question as to whether these motifs are related remains opened. Could the NP1 and NP2
ligands bind Eps8 SH3 domain? The presence of the glycine between the Asp and the Tyr
might disrupt the interaction, however, since Gly is the smallest naturally occurring amino
acid, contact between Eps8 SH3 binding site, and NP1 or NP2 could be conceived. NP2 is the
most likely from NP1 and NP2 ligands, to be able to interact with Eps8 SH3 domain, due to
the presence of the proline three positions before the Asp.
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Eps8 motif Pro Xxx Xxx Asp Tyr
NP1 Ser Thr Leu Cys Asp Gly Tyr Cys
NP2 Asn Pro Met Gly Asp Gly Tyr Phe
The Eps8 consensus sequence proves that is possible for a ligand to bind SH3 domains
without the commonly conserved Arg responsible of the classification of SH3 ligands. It is
not known if the aspartic acid found in NP1, NP2 and the Eps8 motif, can form a salt bridge
with a conserved residue of the SH3 domains.
Taken together, these data proved that non proline clones can interact with SH3
domains, even if they represent a minority of the isolated ligands. It has also been
demonstrated that proline-free sequences are able to form PPII helices (Adzhubei and
Sternberg, 1993). This suggests that SH3 ligand preferences require the presence of the PPII
helices, and that prolines are found in the SH3 ligands, since they are advantageous to adopt a
PPII conformation, and not for their particular side-chain interaction with the modules. This is
supported by the work of Nguyen et al. (1998), who showed that SH3 domains broadly
interact with ligands containing non natural amide N-substituted residues, instead of the usual
prolines. They suggested that proline might be specifically selected because it is the only
endogenous N-substituted amino acid. In addition, Pisabarro and Serrano (1996) showed that
all proline residues of a SH3 ligand can be substituted by other amino acids, as long as a
replacement, or a compensating mutation is introduced elsewhere. They suggested that there
is no essential proline residue in the interaction of a peptide with a SH3 domain, and that
proline rich ligands are selected due to the reduction of the entropic cost they provide, when a
region has to adopt a PPII helix.
4- Transfection of the isolated peptides - in vivo interaction
The ligands isolated with the CPLPPXP library against Src and nephrocystin SH3
domains were shown to interact in vitro with their target with very a high affinity (KD in the
nanomolar range). Such high affinity ligands might be able to compete in vivo with natural
SH3 ligands, and thus, to be used to elaborate cellular models where the signal transduction
pathways could be tightly controlled and regulated. Such models would provide information
allowing a better understanding of the signal transduction pathways, and of the roles of SH3
domains. Before elaborating cellular models, it is crucial to ensure that the CPLPPXP isolated
peptides are able to bind in vivo to the SH3 domains.
The Tat fusion system developed by Dowdy’s group (Nagahara et al., 1998) was used to
Discussion
264
deliver the best characterized ligands against Src and nephrocystin SH3 domains within NIH
3T3 fibroblast cells. The Tat-S4 peptide, specific for Src and nephrocystin SH3 domains, was
used for the in vivo analyses. Tat fusion peptides were fused to the fluorochrom FITC, to
facilitate their detection within the cells. It was shown by FACS analysis that 77% of the cells
were efficiently transduced with the FITC-peptide, after one hour incubation (Figure III-55/A-
B). However, no clear concentration dependence was detected (Figure III-55/C), in contrast
to the data reported by Dowdy (Nagahara et al., 1998; Vocero-Akbani et al., 1999).
Confocal microscopic analysis of cells transfected with the Tat fusion peptides provided
interesting observations (Figure III-56). The FITC-Tat-peptides were detected within the
cytoplasm, but not within the nucleus. However, since the Tat protein sequence contains a
nuclear localization signal, the Tat fusion peptides were expected to be located in both
cytoplasmic and nuclear compartments, as observed in Dowdy’s work (Nagahara et al., 1998).
The retention of the Tat fusion peptide within the cytoplasm, suggest that the peptides are
maintained there, likely by interaction with the cytoplasmic SH3 containing proteins.
The FITC-Tat-peptides were still detected within the cytoplasm of the cells after a few
days of culture. No trace of FITC labeled Tat-peptides was detected in the nucleus. However,
Tat fusion protein transfection is transient, and the fusion proteins are able to cross the cell
membrane in both directions. Therefore, the observation that Tat-peptides are maintained
within the cytoplasm also supports the hypothesis that peptides are retained there through an
in vivo interaction with other proteins, which are likely to be Src protein, or relatives.
The confocal microscopy analysis shows different localization of the FITC-Tat-peptides
in healthy or dead cells (Figure III-56). In healthy cells, the fusion peptide was found
ubiquitously in the cytoplasm, whereas, in dead cells, the Tat fusion peptide is shown to be
exposed at the border of the cell, close to the cell membrane.
It is unclear why the Tat fusion peptides are directed at this location. Src family kinases
are proteins associated with both plasma and intracellular membranes. It is however, unknown
whether after cell death, the Src proteins are directed or not to the cell plasma membrane,
where they would trap the Tat-fusion peptides. Further investigations would be necessary to
answer these questions.
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V - CONCLUSION
A dedicated biased cosmix-plexing phage-display library, CPLPPXP, displaying the
partially hypervariable sequence X5PPXPX4, has been created, in order to isolate high affinity
ligands for specific targets, namely from the SH3- and EVH1-domain families.
The initial use of the cosmix-plexing library on SH3 and EVH1 domains, showed that
long consensus sequences for specifically binding ligands can be readily obtained.
During this work, it was noticed that the cosmix-plexing recombination strategy offers
advantages that vary from one target to another: In the case of Src SH3 domain, the cosmix-
plexing recombination of a population selected after panning with the primary library,
permitted the confirmation of the importance of the S1 ligand in Src interactions; in other
cases, it allowed the isolation of novel ligands for a particular target, for instance nephrocystin
SH3 domain and Vesl EVH1 domain; in general, the cosmix-plexing strategy led to less
ambiguities and longer consensus sequences for each target used (an exception was the Src-
SH3 domain, since exclusively one clone was enriched); in the case of Nck2 SH3 domain,
only the post-recombination cosmix-plexing library allowed characterization of Nck2
ligands, leading to the conception of a consensus sequence. Affinity selection with the
primary library remained unsuccessful, and did not result in quantitative enrichment of clones.
The use of the cosmix-plexing library clearly allowed isolation of SH3 ligands with
affinities 100- to 1000-fold higher than ligands previously described, according to BIAcore
analysis. On the basis of this data, the cosmix-plexing recombination system can be
considered as the most powerful technique for the isolation of high affinity ligands.
From the initial experiments to deliver the cosmix-plexing SH3 ligands in vivo into
NIH-3T3 fibroblasts, it seems that they specifically interact with their target, since they do not
enter the nucleus, but are maintained within the cytoplasm. Moreover they remain a few days
within the cytoplasm despite the fact that they are freely permeable to the cell membranes.
We conclude that the method is convenient to characterize high affinity ligands, which
might bind strongly enough to the target, to compete in vivo with natural ligands.
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VI - ABSTRACT
Phage display is a technique by which variant peptides can be displayed as fusion
proteins to a coat protein on the surface of filamentous phage particles. The development of a
novel phage display strategy, termed cosmix-plexing, which allows the isolation of high
affinity ligands against a particular target, is described here.
The work focused on characterization of high affinity ligands to SH3 domains, modules
found in a variety of unrelated proteins, many of which are involved in signal transduction,
indicating their important role in protein-protein interactions. SH3 domains show a high
preference for proline-rich ligands, and therefore, a dedicated biased cosmix-plexing library
was designed, containing three prolines at fixed positions (X5PPXPX4). EVH1 domains,
protein-protein interaction modules implicated in the spatial control of actin assembly, also
mediate the interaction with their partners through a proline rich motif, and were therefore
also considered as a target of interest for this library.
Cosmix-plexing allows recombination within hypervariable DNA regions, due to a type
IIs enzyme, which binds at a defined sequenced, but cleaves at a site a fixed distance away,
i.e. in a region with no demands on sequence specificity. This technique permits to increase
the diversity of an initial library, however, its main strength is to allow the reassortment of the
right and left sections of hypervariable domains of a preselected population, which showed
affinity for a particular target, and thus, to optimize the binding capacities of the variants, for
this target.
High affinity ligands to SH3 and EVH1 domains, were isolated from the cosmix-
plexing library. BIAcore analyses were performed on SH3 ligands, which demonstrated that
these cosmix-plexing ligands show dissociation constants in the low nanomolar range, i.e.
they interact with SH3 domains with an affinity approximately 1000 fold higher than
previously described SH3 binders.
Such high affinity ligands allow the development of tools to investigate the function of
SH3 domain containing proteins in the signal transduction cascade. One of these is the
elaboration of  cellular models, where SH3 natural ligands might be competed away in vivo,
and where the signal transduction pathways could be tightly controlled and regulated.
Preliminary experiments to deliver the cosmix-plexing SH3 peptides into living cells in cell
culture, using the Tat-fusion protein transduction system, allow optimism regarding these
cellular models.
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Zusammenfassung
Phage display stellt eine Technik dar, mit der verschiedene Peptide zusammen mit
einem Oberflächenprotein des filamentösen Phagenpartikels als Fusionsproteine exprimiert
werden können. Hier wird die Entwicklung einer neuen Phage display Strategie beschrieben,
die als cosmix-plexing bezeichnet wird. Sie erlaubt die Isolation hoch affiner Liganden.
Die Arbeit konzentriert sich auf die Charakterisierung von Liganden mit hoher
Affinität gegen SH3-Domänen. SH3-Domänen finden sich in vielen nicht verwandten
Proteinen und vermitteln häufig Signaltranduktion, was ihre wichtige Rolle bei Protein-
Protein-Wechselwirkungen verdeutlicht. Es wurde gezeigt, dass SH3-Domänen vorwiegend
an Prolin reiche Liganden binden. Deshalb wurde eine Ziel gerichtete cosmix-plexing
Bibliothek generiert, die drei Prolinreste an definierten Positionen beinhaltet (X5PPXPX4).
EVH1 Domänen, die an der Kontrolle der Aktin-Zusammenlagerung beteiligt sind,
vermitteln die Protein-Wechselwirkung mit ihren Liganden ebenfalls durch ein Prolin reiches
Motiv. Deshalb kamen sie als interessante Domäne für diese Bibliothek in Betracht.
Cosmix-plexing erlaubt die Rekombination in hypervariablen DNA Regionen. Dazu
ist ein Restriktionsenzym vom Typ IIs erforderlich, das an eine definierte DNA Sequenz
bindet, aber in einem festgelegten Abstand dazu schneidet: Das heißt, die Bindung erfolgt in
einer Region ohne Sequenzspezifität. Diese Technik erlaubt es die Diversität der
Ausgangsbibliothek zu steigern. Der Hauptvorteil dieser Methode liegt aber darin, dass sie die
Rekombination der rechten und linken Spaltstücke der hypervariablen Domänen einer
vorselektierten Population erlaubt, die bereits eine Affinität für ihre bestimmte Zieldomäne
besitzt. Dadurch wird die Affinität der Varianten für ihr Zielprotein optimiert.
Liganden mit hoher Affinität für SH3 und EVH1 Domänen konnten mit einer cosmix-
plexing Bibliothek isoliert werden. BIAcore Analysen für diese isolierten SH3 Liganden
zeigten Dissoziationskonstanten im unteren Nanomolar-Bereich, d.h. sie besitzen eine etwa
tausendfach höhere Affinität zu SH3-Domänen, als die bisher beschriebenen SH3-Liganden
Solche hoch affinen Liganden stellen Hilfsmittel dar, um die Funktion von SH3
Domänen enthaltenden Proteinen in Signaltransduktions-Kaskaden zu untersuchen. Zelluläre
Modellsysteme könnten ausgearbeitet werden, in denen natürliche SH3-Liganden in vivo
kompetitiert und in denen Signaltransduktionswege streng kontrolliert und reguliert werden.
Vorläufige Experimente, in denen cosmix-plexing SH3 Peptide mit Hilfe des Tat-fusion
protein transduction systems in lebende Zellen eingebracht wurden, lassen auf neue Einblicke
in solchen zellulären Modellen hoffen.
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VIII - ABBREVIATIONS
1- General abbreviations
A Adenosine/Desoxyadenosine (-phosphate)
Amp Ampicilin
AmpR Ampicilin resistance
APS Ammoniumpersulfate(-solution)
bla 13-Lactamase gene (ampicillin resistance)
bp Basepairs
BSA Bovine Serum Albumin
C Cytidine/Desoxycytidine (-phosphate)
CAP1 Adenylyl Cyclase Associated Protein 1
cat Gene encoding for chloramphenicol-acetyltransferase
cDNA Complementary DNA
CDR Complementary Determining Region
cfu Colony Forming Unit
CPPI Cell-Permeable Peptide Import
ddH2O Double Deionized Water
ddNTP Dideoxyribonucleoside triphosphate
dNTP Deoxyribonucleoside triphosphate
DMEM Dulbecco’s Modified Eagle’s Medium
DMSO Dimethylsulfoxide
DNA DeoxyriboNucleic Acid
DTT Dithiothreitol
E. coli Escherichia coli
EDC N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride
EDTA Ethylendiamintetraacetate
EGF Epidermal Growth Factor
EGTA Ethylenbis(oxyethylennitrilo)tetraacetic acid
ELISA Enzyme Linked ImmunoSorbent Assay
EVH1 Ena-VASP Homology domain 1
Evl Ena-VASP-Like
FACS Fluorescent Activated Cell Sorting
Abbreviations
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FITC Fluorescein IsoThioCyante
FGF Fibroblast Growth Factor
G Guanosine/Desoxyguanosine (-phosphate)
GAP3DH Glyceraldehyde-3-phosphate dehydrogenase
GBF Gesellschaft für Biotechnologische Forschung
GST Glutathione-S-Transferase
h Hour
h region Hydrophobic region
HAc Acetic acid
HEPES N-(2-Hydroxyethyl)-piperazine- N'-2-ethane sulfonic acid
HIV-1 Human Immunodeficiency Virus Type 1
HRP HorseRadish Peroxidase
IP3 Inositol Triphosphate
IPTG Isopropyl-β-D-thiogalactopyranoside
kb Kilobase
KD Dissociation constant
KDa Kilodalton
KmR Kanamycin resistance
LB Luria-Bertina medium
L. monocytogenes Listeria monocytogenes
λPL Major leftward promoter of the bacteriophage λ
MBP Maltose-Binding Protein
mGluR Group 1 Metabotropic Glutamate Receptor
MGR1 Metabotropic Glutamate Receptor 1
min Minute
MPS Magnetic Particle Concentrator
MTS Membrane Translocating Sequence
Nap1 Nck-Associated Protein1
NHS N-hydroxysuccinimide
NLS Nuclear Localization Signal
NP1 Clone Non Proline 1
NP2 Clone Non Proline 2
NMR Nuclear Magnetic Resonance
NPH Nephronophthisis
Abbreviations
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NPH1 Gene locus for nephronophthisis
NPHP1 Gene locus for nephronophthisis often deleted in NPH1 families
OD Optical density
ompL Sequence of E. coli derived from the outer membrane protein OmpA
ori fd Origin of replication for single stranded DNA of the bacteriophage fd
ori E Origin of replication for plasmids (colE1)
PAGE PolyAcrylamide Gel Electrophorese
PBS Phosphate Buffer Saline
PCR Polymerase Chain Reaction
PEG Polyethylene Glycol 6000
pfu Plaque Forming Unit
PPII Polyproline Type II helix
PSTI Human Pancreatic Secretory Trypsin Inhibitor
RF Replicative Form
RHG1 Rho-GTPase Activating Protein 1
rpm Rounds Per Minute
scFv Single Chain Fv antibody fragment
SDS Sodium Dodecyl Sulfate
sec Seconde
SH2 Src Homology 2
SH3 Src Homology 3
SPR Surface Plasmon Resonance
T Thymidine
TAE Tris/Sodium acetate/EDTA
TcR Tetracycline resistance
TE Tris/EDTA
TEMED N,N,N',N'-Tetramethyl-ethylendiamin
TRAP Tartrate Resistant Acid Phosphatase
Tris Tris-(hydroxymethyl)-aminomethane
Trx Thioredoxine
U Unit
UV Ultra Violet
V Volt
VASP Vasodilator-Stimulated Phosphoprotein
Abbreviations
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VEGF Vascular Endothelial cell Growth Factor
v/v Volume/volume
WAP Wiskott-Aldrich Syndrome
WASP Wiskott-Aldrich Syndrome protein
WH2 WASP Homology 2
WIP WASP Interacting Protein
w/v Weight/volume
2- Amino acid codes
A Ala Alanine M Met Methionine
C Cys Cysteine N Asn Asparagine
D Asp Aspartic Acid P Pro Proline
E Glu Glutamic Acid Q Gln Glutamine
F Phe Phenylalanine R Arg Arginine
G Gly Glycine S Ser Serine
H His Histidine T Thr Threonine
I Ile Isoleucine V Val Valine
K Lys Lysine W Trp Tryptophan
L Leu Leucine Y Tyr Tyrosine
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